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1 Summary	  
Autophagy	   summarizes	   a	   family	   of	   intracellular	   lysosomal	   (vacuolar)	  
degradative	   transport	   process.	   It	   is	   used	   for	   the	   removal	   and	   recycling	   of	  
cytoplasm,	  protein	   aggregates	   and	  organelles	   to	  maintain	   cellular	  homeostasis.	  
During	   macroautophagy	   in	   yeast,	   the	   double	   membrane	   layered	   transport	  
vesicles	   (autophagosomes)	   are	   formed	   at	   the	   pre-­‐autophagosomal	   structure	  
(PAS).	  They	   finally	   fuse	  with	   the	  vacuole	   for	  degradation	  and	  recycling	  of	   their	  
contents.	   Beside	   this	   unselective	   degradation	   of	   bulk	   cytoplasm	   including	  
organelles,	   there	   are	   several	   selective	   types	   of	   autophagy.	   In	   yeast,	   the	  
Cytoplasm-­‐to-­‐vacuole	   (Cvt)	   pathway	   selectively	   transports	   the	   hydrolases	   α-­‐
mannosidase,	  proaminopeptidase	  I	   and	  aspartyl	   aminopeptidase	   to	   the	  vacuole	  
under	  nutrient	  rich	  conditions.	  	  
A	   hallmark	   of	   autophagy	   is	   the	   use	   of	   two	   ubiquitin-­‐like	   conjugation	   systems.	  
One	   covalently	   couples	   the	   ubiquitin-­‐like	   Atg12	   to	   Atg5.	   The	   resulting	   Atg12-­‐
Atg5	  conjugate	  forms	  a	  complex	  with	  Atg16	  that	  acts	  as	  an	  E3-­‐like	  enzyme	  in	  the	  
second	  ubiquitin-­‐like	  conjugation	  reaction,	  which	  couples	  Atg8	  to	  the	  head	  group	  
of	   the	   membrane	   lipid	   phosphatidylethanolamine	   (PE).	   Atg16	   specifies	   the	  
lipidation	   site,	   but	  how	   it	   selectively	   recognizes	  and	  binds	   to	   the	  PI3P-­‐positive	  
PAS	  remained	  unclear.	  	  
In	   this	   study,	   the	   localization	  and	   function	  of	  Atg21	  was	   investigated	  using	   the	  
model	  organism	  Saccharomyces	  cerevisiae.	  Atg21	  forms	  a	  WD40	  propeller	  that	  is	  
peripherally	   membrane	   associated	   by	   binding	   to	   PI3P	   and	   PI(3,5)P2.	   So	   far,	  
Atg21	   has	   only	   been	   detected	   at	   endosomal	   compartments	   and	   at	   vertices	   of	  
vacuolar	  junctions.	  Atg21	  is	  required	  for	  selective	  types	  of	  autophagy	  as	  the	  Cvt	  
pathway	   and	   efficient	   bulk	   macroautophagy.	   In	   the	   absence	   of	   Atg21	   no	   Cvt	  
vesicles	  are	  formed,	  suggesting	  a	  fundamental	  role	  for	  Atg21	  in	  the	  PAS	  assembly	  
especially	  during	  selective	  types	  of	  autophagy.	  Indeed,	  growing	  atg21∆	  cells	  fail	  
to	  efficiently	  lipidate	  Atg8	  and	  to	  recruit	  Atg8	  and	  Atg5	  to	  the	  PAS.	  Since	  Atg21	  
has	   not	   been	   detected	   at	   the	   PAS	   so	   far,	   its	   precise	  molecular	   function	   during	  
autophagy	  remained	  elusive.	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Using	  direct	  fluorescence	  microscopy,	  this	  study	  revealed,	  for	  the	  first	  time,	  that	  
part	   of	   Atg21	   is	   also	   present	   at	   the	   PAS.	   The	   presence	   of	   Atg21	   at	   the	   PAS	   is	  
dependent	   on	  Atg14	   and	   therefore	   on	   the	  PAS-­‐specific	   PI3P	  pool.	  Moreover,	   it	  
could	  be	  shown	  in	  this	  study,	  that	  Atg21	  recruits	  the	  Atg12-­‐Atg5/Atg16	  complex	  
to	   the	   PAS	   via	   direct	   interaction	   with	   Atg16.	   Two	   conserved	   surface	   residues	  
within	   the	   coiled-­‐coil	   domain	   of	   Atg16	   (D101	   and	   E102)	   were	   identified	   to	  
specifically	   bind	  Atg21.	   Thereby	   the	   underlying	  mechanism	  of	  Atg16-­‐mediated	  
recruitment	   of	   the	   Atg12-­‐Atg5/Atg16	   complex	   to	   autophagosomal	  membranes	  
has	   been	   elucidated	   in	   this	   study.	   More	   importantly,	   it	   was	   shown,	   that	   the	  
interaction	  of	  Atg21	  and	  Atg16	  was	  not	  only	  a	  prerequisite	   for	   the	  proper	  PAS	  
localization	   of	   the	   Atg12-­‐Atg5/Atg16	   complex	   but	   also	   for	   its	   autophagic	  
function.	   Consequently,	   interaction	   of	   Atg16	   and	   Atg21	   is	   needed	   for	   efficient	  
Atg8	  lipidation.	  	  
Importantly,	  this	  study	  also	  revealed	  that	  Atg21	  and	  Atg8	  probably	  interact	  with	  
each	   other.	   This	   interaction	   occurred	   with	   unlipidated	   Atg8,	   suggesting,	   that	  
Atg21	   not	   only	   mediates	   the	   membrane	   association	   of	   the	   E3	   enzyme	   Atg12-­‐
Atg5/Atg16,	   but	   also	   acts	   as	   a	   scaffold	   for	   Atg8	   lipidation	   reaction.	   Therefore,	  
Atg21	  represents	  the	  missing	  link	  that	  mediates	  PI3P-­‐dependent	  PAS	  association	  
of	  the	  lipidation	  machinery	  by	  recruiting	  the	  activated	  substrate	  Atg8	  and	  the	  E3	  
enzyme	   required	   for	   the	   transfer	   of	   Atg8	   to	   PE.	   Atg21	   thus	   represents	   a	   key	  
factor	  to	  specify	  the	  lipidation	  site.	  This	  model	  provides	  a	  reasonable	  explanation	  
for	  the	  elementary	  function	  of	  Atg21	  in	  Cvt	  vesicle	  formation.	  
	  
By	   using	   gelfiltration	   chromatography	   and	   sorbitol	   gradient	   density	  
centrifugation	  Atg21	  was	  identified	  as	  part	  of	  a	  high	  molecular	  weight	  complex.	  
This	   Atg21	   complex	   is	   very	   sensitive	   to	   the	   cell	   lysis	   procedure	   and	   buffer	  
conditions.	   Therefore,	   a	   mild	   cell	   lysis	   procedure	   was	   established	   to	   keep	   the	  
sensible	   complex	   intact	   as	   a	   prerequisite	   not	   only	   for	   further	   analysis	   of	   the	  
complex	   but	   also	   for	   the	   identification	   and	   verification	   of	   additional	   potential	  
Atg21	  interacting	  proteins.	  
Pull	  down	  experiments	  and	  following	  mass	  spectrometry	  analysis	  identified	  the	  
target	  of	  rapamycin	  complex	  I	  (TORC1)	  as	  potential	  interaction	  partner	  of	  Atg21.	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It	   is	   already	   known,	   that	   the	   kinase	   activity	   of	   TORC1	   negatively	   regulates	  
autophagy.	  	  
A	  specific	  interaction	  of	  Atg21	  with	  the	  type	  I	  membrane	  protein	  Atg27	  but	  with	  
no	  other	  member	  of	  the	  trimeric	  Atg27-­‐Atg9-­‐Atg23	  complex	  was	  detected	  using	  
the	  split-­‐ubiquitin	  system.	  Moreover,	  it	  could	  be	  suggested	  that	  Atg21	  interacted	  
with	   the	   cytosol-­‐facing	   C-­‐terminal	   part	   of	   Atg27.	   In	   addition,	   using	   direct	  
fluorescent	  microscopy	  it	  could	  be	  shown	  here	  that	  a	  considerable	  part	  of	  Atg21	  
colocalized	  with	  Atg27,	  supporting	  a	  potential	  interaction.	  The	  relevance	  of	  this	  
putative	  interaction	  will	  be	  topic	  of	  further	  studies.	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2 Introduction	  
2.1 The	  yeast	  Saccharomyces	  cerevisiae	  as	  a	  model	  organism	  
The	  eukaryotic	  organism	  Saccharomyces	  cerevisiae	   belongs	   to	   the	   family	  of	   the	  
budding	  yeasts.	   It	   is	  a	  unicellular	  organism	  and	  has	  a	  round	  to	  oval	  shape	  with	  
5	  to	  10	  µm	  in	  diameter.	  S.	  cerevisiae	  has	  a	  simple	  life	  cycle	  (Figure	  1).	  It	  can	  exist	  
in	  a	  either	  haploid	  or	  diploid	  form.	  Both	  forms	  grow	  by	  mitosis	  and	  budding	  and	  
are	  able	  to	  double	  in	  about	  100	  min,	  when	  exposed	  to	  sufficient	  nutrients.	  Under	  
nutrient-­‐deficient	  conditions,	  diploid	  cells	  undergo	  meiosis	  to	  produce	  an	  ascus	  
containing	  four	  haploid	  spores.	  After	  a	  change	  in	  nutrient	  conditions,	  the	  spores	  
can	  grow	  as	  haploid	  cells.	  Two	  haploid	  cells	  with	  different	  mating	  type	  (a	  and	  α)	  
can	  mate	  to	  form	  a	  diploid	  cell.	  	  
	  
	  
Figure	  1:	  Life	  cycle	  of	  Saccharomyces	  cerevisiae	  
Using	   S.	   cerevisiae	   as	   a	  model	   organism,	   it	   can	   be	   grown	   on	   defined	  media	   to	  
control	   its	  chemical	  and	  physical	  environment.	  The	  S.	  cerevisiae	  genome	  is	  fully	  
sequenced.	   A	   haploid	   cell	   harbors	   a	   set	   of	   16	   chromosomes	   coding	   for	   about	  
6000	  genes	   (Goffeau	  et	  al.,	  1996).	   In	   the	   last	  decades,	  efficient	   techniques	  have	  
been	   developed,	   that	   easily	   enable	   a	  modification	   or	   deletion	   of	   a	   target	   allele	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with	  absolute	  precision	  (Goffeau	  et	  al.,	  1996;	  Janke	  et	  al.,	  2004;	  Knop	  et	  al.,	  1999;	  
Longtine	  et	  al.,	  1998;	  Wach	  et	  al.,	  1997;	  Wach	  et	  al.,	  1994).	  Most	  of	  the	  proteins	  
in	  S.	  cerevisiae	  are	  highly	  conserved	  and	  information	  obtained	  in	  yeast	  can	  often	  
be	  transferred	  to	  higher	  eukaryotes	  making	  the	  baker`s	  yeast	  S.	  cerevisiae	  to	  an	  
ideal	  and	  favored	  model	  organism	  in	  genetic	  and	  biochemical	  research.	  	  
2.2 Autophagy	  
Autophagy	   describes	   a	   specific	   transport	   mechanism	   to	   the	   degradative	  
organelle	  within	  a	  cell.	  It	  is	  highly	  conserved	  among	  all	  eukaryotes	  and	  primarily	  
protects	   cells	   under	   stress	   conditions.	   Under	   starvation	   conditions,	   the	  
unspecific	   degradation	   of	   cytoplasm	   and	   organelles	   produces	   free	   amino	   and	  
fatty	  acids,	  which	  are	  subsequently	  used	  for	  the	  synthesis	  of	  new	  proteins	  or	  as	  
energy	  source.	  In	  addition	  to	  cellular	  homeostasis,	  autophagy	  plays	  a	  crucial	  role	  
in	   several	   physiological	   processes	   as	   autophagic	   programmed	   cell	   death,	  
organelle	  homeostasis,	  developmental	  processes,	  ageing,	   immunity	  and	  defense	  
against	   microbial	   invasion	   (Chen	   and	   Klionsky,	   2011).	   Autophagy	   is	   also	  
involved	   in	   several	   human	   pathophysiologies	   such	   as	   cancer,	   myopathies,	  
neurodegeneration,	  heart	  and	  liver	  diseases	  and	  gastrointestinal	  disorders	  (Choi	  
et	   al.,	   2013).	   In	   yeast,	   autophagy	   can	   be	   divided	   into	   two	   major	   groups:	  
microautophagy	  and	  macroautophagy.	  
2.2.1 Microautophagy	  
During	  microautophagy	  a	  cargo	  is	  directly	  engulfed	  by	  the	  vacuolar	  membrane.	  
In	  S.	  cerevisiae,	  micronucleophagy	  or	  piecemeal	  microautophagy	  of	   the	  nucleus	  
(PMN)	   is	   one	   specific	   variant	   of	   microautophagy	   (Krick	   et	   al.,	   2008b).	   During	  
PMN	   non-­‐essential	   portions	   of	   the	   nucleus	   are	   directly	   sequestrated	   and	  
degraded	  by	   the	  vacuole.	  PMN	  occurs	  at	  nucleus-­‐vacuole	  (NV)	   junctions,	  which	  
are	  generated	  by	  the	  interaction	  of	  the	  vacuolar	  membrane	  protein	  Vac8	  and	  the	  
outer	   nuclear	  membrane	   protein	   Nvj1	   (Pan	   et	   al.,	   2000;	   Roberts	   et	   al.,	   2003).	  
Nvj1	  additionally	  recruits	  Tsc13	  and	  Osh1,	  both	  involved	  in	  lipid	  metabolism,	  to	  
the	  NV	  junctions	  (Kvam	  and	  Goldfarb,	  2007).	  Upon	  starvation,	  the	  NV	  junctions	  
bud	   into	   invaginations	  at	   the	  vacuolar	  membrane	  to	  create	  a	  PMN	  vesicle.	  This	  
PMN	  vesicle	   is	  released	  into	  the	  vacuolar	   lumen	  after	   fusion	  of	   the	  nuclear	  and	  
the	  vacuole	  membrane	  and	  finally	  degraded	  by	  vacuolar	  hydrolases	  (Krick	  et	  al.,	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2008b).	   Three	   membranes	   limit	   a	   PMN	   vesicle;	   the	   two	   inner	   membranes	  
originate	  from	  the	  nuclear	  envelope,	  the	  outermost	  membrane	  from	  the	  vacuole	  
membrane	   (Krick	   et	   al.,	   2008b).	   PMN	   requires	   both,	   core	   components	   of	   the	  
macroautophagic	   machinery	   and	   components	   of	   the	   selective	   autophagic	  
machinery,	  defining	  PMN	  as	  a	  novel	  variant	  of	  selective	  microautophagy	  (Krick	  
et	   al.,	   2008b;	   Roberts	   et	   al.,	   2003).	   Interestingly,	   PMN	   does	   not	   require	   the	  
homotypic	  vacuole	  fusion	  machinery,	  suggesting	  a	  crucial	  role	  for	  the	  autophagic	  
machinery	   in	   the	   terminal	   engulfment	   and	   fusion	   stages	   of	   PMN	   (Krick	   et	   al.,	  
2008b).	  	  
2.2.2 Macroautophagy	  
In	   contrast	   to	   microautophagy,	   macroautophagy	   is	   characterized	   by	   the	  
formation	   of	   double-­‐membrane	   layered	   transport	   vesicles	   at	   the	   pre-­‐
autophagosomal	  structure	  (PAS).	  In	  yeast,	  the	  formation	  of	  the	  transport	  vesicles	  
starts	  with	  a	  cup-­‐shaped	  membrane,	  the	  phagophore,	  which	  expands	  and	  finally	  
closes	   to	   form	   a	   double-­‐membrane	   layered	   transport	   vesicle,	   named	  
autophagosome	   (Yorimitsu	   and	   Klionsky,	   2005)	   (Figure	   2).	   The	   origin	   of	   the	  
membranes	   for	   autophagosome	   biogenesis	   is	   still	   under	   debate	   and	   there	   are	  
several	  organelles	  discussed	  as	  possible	  sources	  such	  as	  the	  plasma	  membrane,	  
the	   endoplasmatic	   reticulum,	   the	   Golgi	   apparatus,	   endosomes	   or	  mitochondria	  
(Lynch-­‐Day	  et	   al.,	   2010;	  Mari	   et	   al.,	   2010;	  Taylor	   et	   al.,	   2012;	  Yamamoto	  et	   al.,	  
2012).	   Due	   to	   the	   extensive	   need	   of	   membranes	   during	   autophagy,	   most	  
probably	  different	  rather	  than	  one	  single	  organelle	  might	  serve	  as	  a	  membrane	  
source.	  
The	  outer	  membrane	  of	  the	  autophagosome	  fuses	  with	  the	  vacuolar	  membrane	  
to	   release	   a	   still	   one	  membrane-­‐layered	   vesicle,	   the	   autophagic	   body,	   into	   the	  
vacuole	  (Baba	  et	  al.,	  1994).	  This	  fusion	  event	  depends	  on	  the	  homotypic	  vacuolar	  
fusion	  machinery	  (Ishihara	  et	  al.,	  2001).	  Within	  the	  vacuole,	  the	  membrane	  of	  the	  
autophagic	   body	   is	   lysed	   and	   the	   cargoes	   are	   subsequently	   degraded	   or	  
processed	   by	   vacuolar	   hydrolases.	   Under	   normal	   growth	   conditions	  
macroautophagy	   acts	   as	   constitutive	   process	   at	   a	   low	   level,	   but	   it	   is	   strongly	  
upregulated	   under	   stress	   conditions	   as	   nutrient	   or	   energy	   starvation	   (Parzych	  
and	  Klionsky,	  2013;	  Yorimitsu	  and	  Klionsky,	  2005).	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Figure	  2:	  Scheme	  of	  macroautophagy	  and	  the	  Cvt-­‐pathway	  (Yorimitsu	  and	  Klionsky,	  2005)	  
The	  term	  macroautophagy	  is	  often	  used	  for	  the	  unselective	  degradation	  of	  bulk	  
cytoplasm	   including	   organelles.	   There	   are	   also	   several	   selective	   variants	   of	  
autophagy	  for	  the	  specific	  degradation	  of	  superfluous	  or	  damaged	  organelles	  as	  
mitochondria	   (mitophagy),	   peroxisomes	   (pexophagy),	   endoplasmatic	   reticulum	  
(reticulophagy)	  and	  ribosomes	  (ribophagy)	  (He	  and	  Klionsky,	  2009).	  In	  general,	  
selective	   macroautophagy	   is	   characterized	   by	   the	   use	   of	   a	   receptor	   protein,	  
which	   links	   the	   cargo	   to	   the	   autophagic	   machinery	   (Mijaljica	   et	   al.,	   2012).	   In	  
addition,	  the	  transport	  vesicles	  are	  specifically	  formed	  around	  a	  particular	  cargo	  
und	   exclude	   therefore	   cytoplasm	   or	   unspecific	   components	   (Reggiori	   and	  
Klionsky,	  2013).	  	  
2.2.3 The	  Cytoplasm-­‐to-­‐Vacuole	  (Cvt)	  Pathway	  
In	   yeast,	   the	   Cytoplasm-­‐to-­‐Vacuole	   (Cvt)	   pathway	   displays	   another	   selective	  
variant	  of	  autophagy	  and	  represents	  the	  constitutive	  transport	  of	  the	  hydrolases	  
α-­‐mannosidase	   I	   (AmsI),	   the	   aspartyl	   aminopeptidase	   (Ape4)	   and	  
aminopeptidase	   I	   (ApeI)	   to	   the	   vacuole	   (Harding	   et	   al.,	   1995;	   Hutchins	   and	  
Klionsky,	  2001;	  Yuga	  et	  al.,	  2011).	  ApeI	  is	  synthesized	  as	  a	  precursor	  form	  with	  a	  
N-­‐terminal	   propeptide	   (prApeI)	   in	   the	   cytosol,	   where	   it	   forms	   a	   dodecameric	  
complex.	   The	   propeptide	  mediates	   the	   formation	   of	   prApeI	   dodecamers	   into	   a	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large	  oligomeric	  structure	  (ApeI-­‐complex)	  and	  also	  binds	   to	   the	  cargo	  receptor	  
Atg19,	   which	   links	   the	   ApeI-­‐complex	   to	   the	   autophagic	   machinery	   at	   the	   PAS	  
(Chang	   and	   Huang,	   2007;	   Morales	   Quinones	   et	   al.,	   2012;	   Scott	   et	   al.,	   2001;	  
Shintani	  and	  Klionsky,	  2004;	  Yorimitsu	  and	  Klionsky,	  2005).	   In	  addition,	  Atg19	  
binds	   to	   the	   additional	   cargoes	  AmsI	   and	  Ape4,	   allowing	   them	   to	  use	   the	  ApeI	  
transport	   system	  (Shintani	  et	  al.,	  2002;	  Yuga	  et	  al.,	  2011).	  prApeI,	  Atg19,	  AmsI	  
and	   Ape4	   are	   packed	   into	   a	   sequestering	   vesicle	   called	   Cvt	   vesicle,	   that	   is	  
significantly	   smaller	   in	   size	   compared	   to	   autophagosomes	   and	   exclude	  
cytoplasm.	   The	   Cvt	   vesicle	   is	   transported	   to	   the	   vacuole,	   where	   prApeI	   is	  
processed	  by	  cleavage	  of	  its	  propeptide	  to	  generate	  the	  matured	  and	  active	  form	  
of	  ApeI	  (mApeI)	  (Klionsky	  et	  al.,	  1992;	  Morales	  Quinones	  et	  al.,	  2012;	  Scott	  et	  al.,	  
1997;	  Scott	  et	  al.,	  1996;	  Shintani	  et	  al.,	  2002;	  Suzuki,	  2012)	  (Figure	  2).	  mApeI	  still	  
forms	  dodecamers,	  but	  due	  to	  the	  lack	  of	  the	  propeptide,	  does	  not	  form	  the	  ApeI	  
complex	   in	   the	   vacuole	   (Morales	   Quinones	   et	   al.,	   2012).	   The	   Cvt	   pathway	   is	   a	  
constitutive	   transport	   mechanism	   and	   takes	   place	   under	   growing	   conditions	  
(Scott	  et	  al.,	  1997).	  As	  a	  selective	   form	  of	  autophagy,	   it	  relies	  on	  the	  same	  core	  
autophagy	  related	  proteins	  like	  macroautophagy	  and	  additionally	  requires	  some	  
specific	   proteins.	   Therefore,	   information	   obtained	   in	   selective	   types	   of	  
autophagy,	   can	   often	   be	   transferred	   to	   other	   autophagic	   pathways	   (Lynch-­‐Day	  
and	  Klionsky,	  2010;	  Morales	  Quinones	  et	  al.,	  2012).	  
2.2.4 The	  pre-­‐autophagosomal	  structure	  (PAS)	  
The	   pre-­‐autophagosomal	   structure	   (PAS)	   is	   defined	   as	   that	   site	   within	   a	   cell,	  
where	  the	  formation	  of	  the	  autophagosomes	  and	  Cvt	  vesicles	  is	  initiated	  (Suzuki	  
et	  al.,	  2001;	  Suzuki	  et	  al.,	  2007).	  Yeast	  cells	  usually	  have	  one	  PAS,	   located	  near	  
the	  vacuole	  under	  both	  normal	  and	  starvation	  conditions.	  Most	  of	  the	  autophagy-­‐
related	  proteins,	  termed	  Atg,	  are	  at	  least	  partially	  localized	  to	  the	  PAS	  (Klionsky	  
et	  al.,	  2003;	  Suzuki	  et	  al.,	  2007)	  In	  yeast,	  more	  than	  30	  Atgs	  are	  known.	  Among	  
them,	  18	  proteins	  belong	  to	  the	  core	  autophagic	  machinery,	  characterizing	  those	  
proteins	   required	   for	  both	  macroautophagy	  and	   its	   selective	  variants	   (Araki	   et	  
al.,	   2013;	  Motley	   et	   al.,	   2012;	   Suzuki,	   2012;	   Suzuki	   and	   Ohsumi,	   2010).	   These	  
proteins	  are	  recruited	  to	  the	  PAS	  in	  a	  specific	  hierarchy	  (Suzuki	  et	  al.,	  2007)	  and	  
are	   commonly	   classified	   into	   six	   functional	   groups:	   I)	  the	  Atg1	   kinase	   complex	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II)	  the	   Atg9-­‐containing	   vesicles	   	   III)	  the	   Atg14-­‐containing	   phosphoinositides	   3-­‐
kinase	   complex	   IV)	  the	   Atg12-­‐conjugating	   system	   V)	  the	   Atg8-­‐conjugating	  
system	  and	  VI)	  the	  Atg2-­‐Atg18	  complex.	  	  	  
2.2.4.1 The	  Atg1	  kinase	  complex	  
The	   Atg1	   kinase	   complex	   serves	   as	   a	   basic	   scaffold	   structure	   for	   the	   PAS	  
assembly	   and	   is	   required	   for	   the	   recruitment	   of	   further	   autophagy-­‐related	  
proteins.	   Atg1	   is	   the	   solely	   serine/threonine	   kinase	   involved	   in	   autophagy	  
(Matsuura	   et	   al.,	   1997).	   Besides	   Atg1	   itself,	   no	   other	   target	   for	   the	   kinase	   has	  
been	   identified	   so	   far.	   Atg1	   directly	   interacts	   with	   its	   regulator	   Atg13,	   what	  
enhances	   its	   kinase	   activity	   (Kamada	   et	   al.,	   2000).	   Atg1	   and	   Atg13	   probably	  
exhibit	   a	   core	   regulator	   function	   at	   an	   early	   step	   in	   autophagy	   induction	  
(Reggiori	   and	   Klionsky,	   2013).	   The	   Atg13-­‐Atg1	   complex	   itself	   is	   regulated	   by	  
nutrients.	   Under	   nutrient-­‐rich	   conditions,	   Atg13	   and	   Atg1	   are	   highly	  
hyperphosphorylated	   (Scott	   et	   al.,	   2000).	   The	   phosphorylation	   is	   partly	  
mediated	   by	   the	   nutrient	   sensors	   Target	   of	   rapamycin	   complex	   1	   (TORC1)	  
and/or	   protein	   kinase	   A	   (PKA)	   (Budovskaya	   et	   al.,	   2005;	   Kamada	   et	   al.,	   2010;	  
Yorimitsu	   et	   al.,	   2009).	   The	   kinase	   TORC1	   acts	   as	   a	   negative	   regulator	   of	  
autophagy.	   It	   is	   active	   under	   nutrient-­‐rich	   conditions	   and	   inhibits	   autophagy.	  
Upon	  starvation	  it	  is	  inactivated	  and	  autophagy	  is	  induced.	  Since	  TORC	  regulates	  
Atg13	   phosphorylation,	   Atg13	   becomes	   rapidly	   dephosphorylated	   upon	  
autophagy	  induction	  (Loewith	  and	  Hall,	  2011;	  Scott	  et	  al.,	  2000).	  For	  yeast,	  it	  was	  
originally	   reported	   that	   the	   phosphorylation	   of	   Atg13	   leads	   to	   a	   reduced	  Atg1	  
binding	   affinity,	   preventing	   the	   Atg1	   kinase	   activity	   under	   nutrient-­‐rich	  
conditions	   (Kamada	   et	   al.,	   2000).	   However,	   recent	   studies	   revealed,	   that	   Atg1	  
and	   Atg13	   might	   interact	   constitutively	   with	   each	   other,	   independent	   of	   the	  
nutrient	  conditions	  (Kraft	  et	  al.,	  2012).	  This	  model	  would	  fit	  nicely	  with	  results	  
from	  higher	  eukaryotes	  and	  indicates	  that	  the	  phosphorylation	  of	  yeast	  Atg1	  and	  
most	  likely	  Atg13	  rather	  than	  their	  interaction	  is	  essential	  for	  Atg1	  activity	  (Kraft	  
et	   al.,	   2012).	   In	   general,	   Atg1	   has	   a	   dual	   role	   in	   autophagy.	   Atg1	   mutants	  
defective	  in	  Atg13	  binding,	   fail	  to	  efficiently	  assemble	  the	  PAS	  under	  starvation	  
conditions,	   suggesting	  a	  scaffold	   function	   for	  Atg1	  at	   the	  PAS.	   In	  contrast,	  Atg1	  
kinase	  mutants	   assemble	   the	   PAS	   but	   are	   defective	   in	  Atg	   protein	   dissociation	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kinetics	  (Cheong	  et	  al.,	  2008).	  Thus,	  the	  Atg1	  kinase	  activity	  is	  probably	  involved	  
in	  later	  steps	  of	  autophagy.	  	  
In	   addition	   to	   Atg1	   and	   Atg13,	   the	   Atg1	   kinase	   complex	   includes	   the	   ternary	  
Atg17-­‐Atg31-­‐Atg29	  complex	  and	  also	  Atg11,	  Atg20	  and	  Atg24	  (Figure	  3).	  
	  
	  
Figure	  3:	  Scheme	  of	  the	  Atg1	  kinase	  complex	  (Reggiori	  and	  Klionsky,	  2013)	  
So	  far,	   it	   is	  not	  known,	  if	  all	  of	  these	  proteins	  are	  present	  in	  the	  complex	  at	  the	  
same	  time	  or	  if	  there	  are	  subcomplexes	  that	  vary	  in	  their	  composition	  depending	  
on	   nutrient	   conditions	   (Inoue	   and	   Klionsky,	   2010).	   Atg17	   acts	   as	   a	   central	  
component	  in	  PAS	  assembly	  under	  autophagy-­‐inducing	  conditions	  (Cheong	  et	  al.,	  
2008;	  Suzuki	  et	  al.,	  2007).	  It	  forms	  a	  constitutive	  complex	  with	  Atg29	  and	  Atg31	  
(Kabeya	  et	  al.,	  2009;	  Kawamata	  et	  al.,	  2008).	  In	  addition,	  self-­‐interaction	  of	  Atg17	  
leads	   to	   a	   stable	   dimeric	   Atg17-­‐Atg29-­‐Atg31	   complex,	   which	   is	   probably	  
recruited	  to	  the	  PAS	  under	  both,	  nutrient-­‐rich	  condition	  and	  starvation	  (Chew	  et	  
al.,	  2013;	  Ragusa	  et	  al.,	  2012).	  Atg17	  also	  enhances	  the	  Atg1	  kinase	  activity	  by	  an	  
unknown	  mechanism	  (Kamada	  et	  al.,	  2000).	  Atg17	  is	  essential	  for	  PAS	  assembly	  
during	  macroautophagy,	  but	  not	   for	   selective	   types	  of	   autophagy.	  For	   selective	  
types	   of	   autophagy,	   Atg11	   adopts	   the	   function	   of	   Atg17	   and	   acts	   as	   a	   scaffold	  
protein	   that	   directs	   further	   Atg	   proteins	   to	   the	   PAS	   (Suzuki	   et	   al.,	   2007).	  
However,	  though	  involved	  in	  the	  formation	  of	  the	  starvation-­‐specific	  PAS,	  Atg11	  
is	  not	  required	  for	  bulk	  autophagy.	  Atg11	  also	  serves	  as	  an	  adaptor	  for	  selective	  
autophagic	  cargoes	  at	  the	  PAS	  by	  binding	  receptor	  proteins	  involved	  in	  selective	  
autophagy	  such	  as	  Atg19	  (Cvt	  pathway)	  and	  Atg32	  (mitophagy)	  (Mijaljica	  et	  al.,	  
2012).	  	  
2.2.4.2 The	  Atg9-­‐containing	  vesicles	  
Among	   the	   core	   autophagy	   machinery,	   Atg9	   is	   the	   sole	   integral	   membrane	  
protein.	   It	   contains	   six	   membrane-­‐spanning	   domains,	   its	   C-­‐	   and	   N-­‐terminus	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facing	  the	  cytosol	  (Legakis	  et	  al.,	  2007).	  Atg9	  is	  one	  of	  the	  first	  proteins	  recruited	  
to	   the	  PAS	  (Suzuki	  et	  al.,	  2007).	   It	   cycles	  between	   the	  PAS	  and	  a	  non-­‐PAS	  pool	  
and	  was	  reported	  to	  directly	  participate	  in	  the	  phagophore	  formation	  (Legakis	  et	  
al.,	   2007;	  Mari	   et	   al.,	   2010;	   Yamamoto	   et	   al.,	   2012).	  At	   the	  non-­‐PAS	  pool,	   Atg9	  
resides	   in	   tubular	   and	   vesicular	   structures.	   These	   Atg9	   reservoirs	   consist	   of	  
clustered	  20-­‐30	  nm	  vesicles	  and	  are	  often	  located	  close	  to	  mitochondria.	  In	  yeast,	  
they	   derive	   from	   Golgi-­‐related	   secretory	   and	   endosomal	   pathways,	   but	   their	  
origin	   is	   still	   under	   debate	   (Mari	   et	   al.,	   2010;	   Ohashi	   and	   Munro,	   2010;	  
Yamamoto	  et	  al.,	  2012).	  At	  the	  PAS,	  Atg9	  interacts	  with	  the	  Atg1	  kinase	  complex	  
by	   direct	   interaction	  with	   the	   scaffold	   proteins	   Atg17	   and/or	  Atg11	   (He	   et	   al.,	  
2006;	   Sekito	   et	   al.,	   2009).	   In	   addition,	   Atg1	   contains	   a	   C-­‐terminal	   EAT	   (early	  
autophagosome	  targeting/tethering)	  region	  that	  has	  been	  reported	  to	  selectively	  
bind	   highly	   curved	   20-­‐30	  nm	   vesicles	   and	   to	   be	   capable	   of	   tethering	   them	  
(Ragusa	   et	   al.,	   2012).	   In	   the	   current	   model,	   the	   Atg9	   containing	   vesicles	   are	  
brought	   together	   at	   the	   PAS	  mediated	   by	   lipid	   binding	   of	   Atg1	   and	   additional	  
protein	  interaction	  with	  Atg17.	  The	  vesicles	  then	  fuse	  in	  a	  probably	  SNARE-­‐	  and	  
the	   tethering	   proteins	   Ypt1	   and	   Trs85-­‐dependent	   manner	   to	   form	   the	  
phagophore,	   that	   finally	   expands	   to	   an	   autophagosome	   (Kakuta	   et	   al.,	   2012;	  
Lipatova	  et	  al.,	  2012;	  Lynch-­‐Day	  et	  al.,	  2010;	  Ragusa	  et	  al.,	  2012)	  (Figure	  4).	  	  
	  
	  
Figure	  4:	  Atg9-­‐containing	  vesicles	  contribute	  in	  membrane	  dynamics	  in	  autophagy	  	  
(IM=inner	  autophagosomal	  membrane;	  OM=outer	  autophagosomal	  membrane)	   ((Yamamoto	  et	  al.,	  
2012);	  modified)	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However,	   quantitative	   fluorescence	   microscopy	   revealed	   that	   only	   three	   Atg9	  
vesicles	  contribute	  to	  the	  formation	  of	  a	  single	  autophagosome	  during	  starvation	  
(Yamamoto	  et	  al.,	  2012).	  Based	  on	  the	  reported	  small	  diameter	  of	  these	  vesicles,	  
most	   likely	   essential	   amounts	   of	   the	   phagophore	   lipids	   derive	   from	   other	  
membrane	   sources	   (Stanley	   et	   al.,	   2013).	   Atg9	   vesicles	   are	   translocated	   to	   the	  
PAS	  immediately	  after	  assembly	  of	  the	  scaffold	  complex,	  but	  before	  recruitment	  
of	  further	  Atg	  protein.	  Therefore,	  Atg9	  may	  play	  a	  crucial	  role	  in	  a	  very	  early	  step	  
of	   autophagosome	   formation	   such	   as	   nucleation	   of	   the	   phagophore	   or	  
recruitment	  of	  other	  Atg	  proteins	  to	  the	  PAS	  (Yamamoto	  et	  al.,	  2012).	  	  
The	  peripherally	  membrane	  associated	  protein	  Atg23	  and	  the	  type	  I	  membrane	  
protein	   Atg27	   form	   a	   trimeric	   complex	   with	   Atg9	   that	   links	   both	   proteins	  
(Legakis	   et	   al.,	   2007)	   (Figure	   5).	   Interestingly,	   Atg9	   belongs	   to	   the	   core	  
autophagy	  machinery,	  but	  Atg27	  is	  only	  essential	  for	  the	  Cvt	  pathway	  (Legakis	  et	  
al.,	  2007;	  Yen	  et	  al.,	  2007).	  
	  
Figure	  5:	  Model	  of	  the	  Atg23-­‐Atg9-­‐Atg27	  complex	  ((Legakis	  et	  al.,	  2007);	  modified)	  
As	  Atg9,	  Atg23	  and	  Atg27	  cycle	  between	  the	  non-­‐PAS	  pool	  and	  the	  PAS	  and	  the	  
cycling	   of	   all	   three	   proteins	   depends	   upon	   one	   another.	   Atg23	   and	   Atg27	   are	  
essential	   for	   both,	   transport	   of	   Atg9	   vesicles	   from	   the	   Golgi	   to	   its	   reservoir	  
(Ragusa	   et	   al.,	   2012;	   Stanley	   et	   al.,	   2013;	   Yamamoto	   et	   al.,	   2012)	   and	   from	   its	  
reservoir	  to	  the	  PAS	  (Legakis	  et	  al.,	  2007).	  After	  autophagosome	  formation,	  Atg9	  
clusters	  on	   the	  outer	  membrane	  of	   the	  autophagosomes	  and	  recruits	   the	  Atg2-­‐
Atg18	   complex,	   which	   mediates	   together	   with	   Atg1	   the	   Atg9	   recycling	   by	   an	  
unknown	  mechanism	  (Ragusa	  et	  al.,	  2012;	  Stanley	  et	  al.,	  2013;	  Yamamoto	  et	  al.,	  
2012).	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2.2.4.3 The	  Atg14-­‐containing	  phosphoinositide	  3-­‐kinase	  complex	  
The	   yeast	   S.	   cerevisiae	   has	   only	   one	   phosphoinositide	   3-­‐kinase,	   named	   Vps34,	  
which	   specifically	   phosphorylates	   phosphoinositides	   at	   the	  D-­‐3	   position	   of	   the	  
inositol	   ring	   to	   create	   phosphatidylinositol-­‐3-­‐phosphate	   (PI3P)	   (Schu	   et	   al.,	  
1993).	   Vps34	   is	   present	   in	   two	   distinct	   complexes,	   which	   share	   the	   subunits	  
Vps34,	   Vps15	   and	   Atg6.	   Each	   complex	   additionally	   contains	   a	   unique	   factor,	  
which	   specifies	   the	   localization	  and	  cellular	   function	  of	   the	   respective	   complex	  
(Kihara	  et	  al.,	  2001)	  (Figure	  6).	  
	  
Figure	  6:	  Vps34	  is	  present	  in	  two	  complexes	  required	  for	  different	  cellular	  processes	  ((Obara	  et	  al.,	  
2011);	  modified)	  
Complex	   II,	   containing	   Vps38,	   localizes	   to	   endosomes	   and	   acts	   in	   the	   vacuolar	  
protein	   sorting	   pathway	   (Kihara	   et	   al.,	   2001;	   Obara	   et	   al.,	   2006).	   Complex	   I	  
specifically	   integrates	  Atg14	  and	  Atg38	  and	  is	  essential	   for	  autophagy	  (Araki	  et	  
al.,	   2013;	   Kihara	   et	   al.,	   2001).	   Atg14	   links	   complex	   I	   to	   the	   PAS,	   where	   it	  
generates	  the	  PAS-­‐specific	  PI3P	  pool	  (Jao	  et	  al.,	  2013;	  Obara	  et	  al.,	  2006).	  PI3P	  is	  
essential	  for	  autophagy	  since	  it	  recruits	  autophagy	  relevant	  PI3P	  effectors	  to	  the	  
PAS.	   Deletion	   of	   ATG14	   and	   therefore	   the	   PI3P	   pool	   at	   the	   PAS,	   affects	   the	  
recruitment	   of	   Atg8,	   the	   Atg12-­‐Atg5/Atg16	   complex	   and	   the	   Atg2-­‐Atg18	  
complex	   (see	  below)	   to	   the	  PAS	   leading	   to	   a	   complete	   block	   in	   the	   autophagic	  
process	  (Suzuki	  et	  al.,	  2007).	  Consequently,	  the	  deletion	  of	  VPS38	  does	  not	  affect	  
autophagy,	   whereas	   in	   the	   absence	   of	   Atg14	   the	   vacuolar	   protein	   sorting	   is	  
unaffected	   (Kihara	   et	   al.,	   2001).	   This	   provides	   a	   suitable	   tool	   to	   distinguish	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between	   the	   two	   Vps34	   complexes.	   Furthermore,	   the	   influence	   of	   the	   PAS-­‐
specific	   PI3P	   pool	   on	   the	   localization	   of	   particular	   proteins	   can	   be	   specifically	  
investigated.	  	  	  
2.2.4.4 The	  Atg12-­‐	  and	  Atg8-­‐conjugating	  system	  
With	   the	   Atg12-­‐	   and	   Atg8-­‐conjugating	   systems,	   autophagy	   uses	   two	   unique	  
ubiquitin-­‐like	  protein	  conjugation	  procedures,	  which	  involve	  approximately	  half	  
of	  the	  core	  autophagy	  machinery.	  The	  primary	  sequence	  of	  both,	  Atg12	  and	  Atg8,	  
has	  low	  similarity	  to	  ubiquitin,	  but	  the	  crystal	  structure	  of	  the	  mammalian	  Atg8	  
homologue	   (LC3)	   revealed	   a	   C-­‐terminal	   ubiquitin-­‐like	   domain	   for	   LC3/Atg8.	  
Compared	   to	   ubiquitin	   they	   additionally	   contain	   a	   N-­‐terminal	   helical	   domain	  
(Sugawara	   et	   al.,	   2004).	   Similarly,	   based	   on	   the	   plant	   Atg12	   homologue	  
(ATG12b),	   Atg12	   is	   proposed	   to	   contain	   a	   ubiquitin-­‐like	   fold	   at	   its	   C-­‐terminus	  
(Suzuki	   et	   al.,	   2005).	   Furthermore,	   Atg12	   and	   Atg8	   are	   conjugated	   to	   their	  
specific	  targets	  in	  a	  manner	  similar	  to	  protein	  ubiquitination	  (Figure	  7	  A).	  	  
	  
	  
Figure	  7:	  The	  two	  ubiquitin-­‐like	  protein	  conjugation	  machineries	  in	  autophagy	  
(A)	  Scheme	  of	  both	  ubiquitin-­‐like	  conjugation	  reactions	  ((Yorimitsu	  and	  Klionsky,	  2005);	  modified)	  
(B)	  Model	  of	  the	  Atg12-­‐Atg5/Atg16	  complex;	  CCD:	  coiled-­‐coil	  domain	  (Fujioka	  et	  al.,	  2010)	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The	  C-­‐terminal	  glycine	  of	  Atg12	  is	  activated	  by	  the	  E1	  enzyme	  Atg7,	  transferred	  
to	   the	  E2	  enzyme	  Atg10	  and	   finally	  covalently	  attached	   to	  an	   internal	   lysine	  of	  
the	  target	  protein	  Atg5	  (Kuma	  et	  al.,	  2002;	  Mizushima	  et	  al.,	  1998;	  Shintani	  et	  al.,	  
1999;	   Tanida	   et	   al.,	   1999).	   Remarkably,	   no	   E3	   enzyme	   is	   involved	   in	   the	  
conjugation	  reaction.	  The	  substrate	  specificity	  is	  mediated	  by	  direct	  recognition	  
of	  the	  target	  protein	  Atg5	  by	  the	  E2	  enzyme	  Atg10	  (Yamaguchi	  et	  al.,	  2012).	  Atg5,	  
preferentially	  as	  Atg12-­‐Atg5	  conjugate,	  non-­‐covalently	  binds	   to	   the	  N-­‐terminus	  
of	   Atg16	   (Atg12-­‐Atg5/Atg16	   complex)	   (Mizushima	   et	   al.,	   1999).	   Atg12-­‐
Atg5/Atg16	  is	  most	  likely	  a	  dimeric	  complex	  mediated	  by	  dimerization	  of	  the	  C-­‐
terminal	   coiled-­‐coil	   domain	   of	   Atg16	   (Fujioka	   et	   al.,	   2010;	   Kuma	   et	   al.,	   2002)	  
(Figure	   7	  B).	   The	   dimerization	   of	   Atg16	   is	   crucial	   for	   the	   Atg12-­‐Atg5/Atg16	  
complex	  activity	  as	  an	  E3-­‐like	  enzyme	  in	  the	  Atg8	  conjugation	  reaction	  (Kuma	  et	  
al.,	  2002).	  	  
Atg8	   is	   synthesized	   with	   an	   additional	   arginine	   at	   its	   C-­‐terminus.	   Before	  
conjugation	  reaction,	  the	  cysteine	  protease	  Atg4	  cleaves	  this	  arginine	  resulting	  in	  
an	   exposed	   C-­‐terminal	   glycine	   (Kirisako	   et	   al.,	   2000).	   This	   glycine	   is	   also	  
activated	  by	  the	  E1	  enzyme	  Atg7,	  transferred	  to	  the	  unique	  E2	  enzyme	  Atg3	  and	  
finally	   covalently	   attached	   to	   the	   head	   group	   of	   the	   membrane	   lipid	  
phosphatidylethanolamine	  (PE)	  (Ichimura	  et	  al.,	  2000;	  Kim	  et	  al.,	  1999;	  Kirisako	  
et	  al.,	  2000;	  Shintani	  et	  al.,	  1999;	  Tanida	  et	  al.,	  1999).	  The	  conjugation	  reaction	  of	  
Atg8	  represents	  a	  unique	  mechanism	  different	  to	  ubiquitination	  as	  it	  results	  in	  a	  
covalent	   membrane	   anchoring	   of	   Atg8	   via	   conjugation	   to	   a	   lipid	   and	   not	   a	  
protein.	  	  
As	  mentioned	  before,	  the	  Atg12-­‐Atg5/Atg16	  complex	  promotes	  this	  conjugation	  
as	  an	  E3-­‐like	  enzyme.	  Atg12	  directly	  binds	  and	  probably	  activates	  Atg3,	  so	  that	  
the	  Atg12-­‐Atg5/Atg16	  complex	  may	  act	  as	  a	  platform	  to	  bring	  the	  Atg8-­‐carrying	  
E2	   enzyme	   Atg3	   into	   close	   proximity	   to	   the	   substrate	   PE	   (Noda	   et	   al.,	   2012;	  
Romanov	  et	  al.,	  2012;	  Sakoh-­‐Nakatogawa	  et	  al.,	  2013).	  The	  Atg12-­‐Atg5	  conjugate	  
alone	  was	   shown	   to	   accelerate	   the	  Atg8-­‐PE	   conjugation	   in	  vitro,	   revealing	   that	  
Atg16	   is	   dispensable	   for	   the	   E3-­‐like	   function	   of	   the	   Atg12-­‐Atg5	   conjugate.	  
However,	  as	  a	  prerequisite	   for	   the	  conjugation	  of	  Atg8	  to	  PE,	  Atg16	  directs	   the	  
Atg12-­‐Atg5/Atg16	  complex	  to	  autophagy-­‐related	  membranes	  in	  vivo	  (Hanada	  et	  
al.,	   2007).	   The	   Atg16-­‐mediated	   PAS	   localization	   of	   the	   Atg12-­‐Atg5/Atg16	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complex	  is	  dependent	  on	  Atg14	  respectively	  the	  PAS-­‐specific	  PI3P	  pool.	  Because	  
Atg16	   has	   no	   obvious	   PI3P	   binding	   motif,	   the	   mechanism	   of	   membrane	  
association	  remains	  still	  elusive	  (Cebollero	  et	  al.,	  2012;	  Matsushita	  et	  al.,	  2007;	  
Suzuki	  et	  al.,	  2001).	  	  
Atg8-­‐PE	   is	   found	   on	   all	   autophagy-­‐related	   membranes	   (Kabeya	   et	   al.,	   2000;	  
Kirisako	  et	  al.,	  1999).	  At	  the	  forming	  autophagosomes,	  it	  is	  located	  on	  the	  inner	  
and	   outer	   membrane	   (Kirisako	   et	   al.,	   2000).	   The	   part,	   present	   on	   the	   inner	  
membrane	   of	   the	   expanding	   phagophore,	   is	   trapped	   inside	   the	   matured	  
autophagosome	   and	   transported	   to	   the	   vacuole,	   where	   it	   is	   finally	   degraded	  
(Huang	   et	   al.,	   2000;	  Kabeya	   et	   al.,	   2000;	  Kirisako	   et	   al.,	   1999).	   In	   contrast,	   the	  
part	  of	  Atg8,	   located	  on	  the	  outer	  membrane	  of	   the	   forming	  autophagosome,	   is	  
cleaved	   off	   by	   the	   protease	   Atg4	   and	   subsequently	   used	   for	   another	   round	   of	  
lipidation	  (Kirisako	  et	  al.,	  2000).	  Beside	  the	  recycling	  aspect,	  the	  release	  of	  Atg8	  
from	  the	  outer	  membrane	  of	  the	  expanding	  phagophore	  is	  crucial	  to	  facilitate	  the	  
maturation	   into	   a	   fusion-­‐capable	   autophagosome	   (Nair	   et	   al.,	   2012;	   Yu	   et	   al.,	  
2012).	  	  
The	  expression	  of	  Atg8	  is	  highly	  upregulated	  upon	  autophagy	  induction	  (Huang	  
et	  al.,	  2000;	  Kirisako	  et	  al.,	  1999)	  and	  the	  amount	  of	  Atg8	  directly	  correlates	  with	  
the	   size	   of	   the	   autophagosomes,	   suggesting	   that	   Atg8	   plays	   a	   role	   in	  
autophagosome	  expansion	  (Nakatogawa	  et	  al.,	  2007;	  Xie	  et	  al.,	  2008).	  In	  addition,	  
the	   part	   of	   Atg8,	   which	   is	   present	   on	   the	   inner	   membrane	   of	   the	   forming	  
autophagosome,	   binds	   receptor	   proteins	   in	   selective	   types	   of	   autophagy	   and	  
serves	   therefore	   as	   an	   adaptor	   to	   link	   the	   specific	   cargoes	   to	   the	   forming	  
autophagosomes	   (Chang	   and	   Huang,	   2007;	  Mijaljica	   et	   al.,	   2012;	  Motley	   et	   al.,	  
2012;	  Shintani	  et	  al.,	  2002).	  Almost	  all	  of	  the	  Atg8-­‐interacting	  proteins	  bind	  to	  a	  
certain	   region	   within	   Atg8	   via	   a	   particular	   binding	   motif,	   called	   AIM	   (Atg8-­‐
interacting	  motif)	  or,	  with	  regard	  to	  the	  mammalian	  Atg8	  homologue,	  LIR	  (LC3-­‐
interacting	   region).	   The	   AIM	   typically	   consists	   of	   a	   four	   amino	   acid	   motif,	  
beginning	   with	   a	   tryptophan,	   followed	   by	   two,	   often	   acidic	   amino	   acids	   and	  
ending	  with	  a	  lysine	  (WXXL)	  (Alemu	  et	  al.,	  2012;	  Mijaljica	  et	  al.,	  2012;	  Noda	  et	  al.,	  
2008).	  This	  binding	  motif	  is	  specific	  for	  Atg8	  homologues,	  since	  the	  side	  chains	  of	  
the	   tryptophan	   and	   the	   lysine	  within	   the	   AIM	   bind	   to	   hydrophobic	   pockets	   in	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Atg8,	   which	   are	   conserved	   among	   all	   Atg8	   homologues	   but	   not	   among	   other	  
ubiquitin-­‐like	  proteins	  (Noda	  et	  al.,	  2009).	  	  
2.2.4.5 The	  Atg2-­‐Atg18	  complex	  
The	   Atg18-­‐family	   proteins	   belong	   to	   the	   family	   of	   β-­‐propellers	   that	   bind	  
polyphosphoinositides	   (PROPPINs).	   PROPPINs	   are	   conserved	   from	   yeast	   to	  
humans.	  With	  Atg18,	  Atg21	  and	  Hsv2,	  yeast	  contains	   three	  PROPPINs	  (Dove	  et	  
al.,	  2009;	  Dove	  et	  al.,	  2004;	  Krick	  et	  al.,	  2006;	  Michell	  et	  al.,	  2006;	  Stromhaug	  et	  
al.,	   2004).	   Mammalia	   exhibits	   four	   PROPPIN	   orthologs,	   called	   WIPIs	   (WD40	  
repeat-­‐containing	   protein	   that	   interacts	   with	   PtdIns)	   (Jeffries	   et	   al.,	   2004;	  
Proikas-­‐Cezanne	   et	   al.,	   2004).	  WIPI1	   and	  WIPI2	   share	   common	   ancestry	   with	  
Atg18,	   whereas	  WIPI3	   and	  WIPI4	   form	   a	   clade	   with	   Hsv2	   (Krick	   et	   al.,	   2012;	  
Polson	   et	   al.,	   2010).	   Atg21	   orthologs,	   however,	   have	   been	   only	   found	   in	   yeast	  
species	  so	  far	  (Meijer	  et	  al.,	  2007).	  
Atg18	   and	   its	   homologues	   contain	   seven	   WD-­‐40	   repeats,	   each	   consisting	   of	  
around	  40	  amino	  acids	  and	  ending	  with	  a	  tryptophan	  (W)	  and	  an	  aspartate	  (D)	  
residue.	  They	  fold	  into	  a	  seven-­‐bladed	  β-­‐propeller.	  The	  blades	  are	  comprised	  of	  
four-­‐stranded	   antiparallel	   β-­‐sheets,	   and	   are	   interconnected	   through	   six	   loops	  
(Barth	  et	  al.,	  2001;	  Dove	  et	  al.,	  2004).	  Like	  members	  of	  the	  PROPPIN	  family	  from	  
other	  species,	  they	  contain	  a	  conserved	  lipid	  binding	  motif,	  consisting	  of	  the	  four	  
amino	  acid	  Phe-­‐Arg-­‐Arg-­‐Gly	  (FRRG)	  (Dove	  et	  al.,	  2004;	  Krick	  et	  al.,	  2006;	  Nair	  et	  
al.,	   2010;	   Stromhaug	   et	   al.,	   2004).	   Recent	   studies	   revealed,	   that	   this	   motif	  
participate	  in	  two	  different	  lipid	  binding	  sites	  (Baskaran	  et	  al.,	  2012;	  Krick	  et	  al.,	  
2012;	  Watanabe	   et	   al.,	   2012),	   which	   preferentially	   bind	   to	   PI3P	   and	   PI(3,5)P2	  
and	  mediate	  their	  peripheral	  membrane	  association	  (Dove	  et	  al.,	  2004;	  Krick	  et	  
al.,	  2006)	  (Figure	  8).	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Figure	  8:	  Structure	  of	  Kluyveromyces	  lactis	  Hsv2	  
(A)	   KlHsv2	   forms	   a	   seven-­‐bladed	   β-­‐propeller	   scaffold.	   Each	   blade	   consists	   of	   a	   four-­‐stranded	  
antiparallel	  β-­‐sheet	  (A-­‐D).	  The	  lipid	  binding	  motif	  (FRRG)	  is	  located	  within	  the	  fifth	  loop	  between	  
blade	   5	   and	   6	   and	   participate	   in	   two	   different	   lipid-­‐binding	   pockets.	   (B)	  Model	   of	  membrane	  
recognition	   of	   PROPPINs.	   The	   headgroup	   groups	   of	   the	   two	   PI3P	   molecules	   are	   indicated	   in	  
green.	  ((Krick	  et	  al.,	  2012);	  modified)	  
	  
WD-­‐40	  domain	  containing	  proteins	  commonly	  serve	  as	  a	  stable	  protein-­‐protein	  
interaction	   platform	   to	   coordinate	   the	   assembly	   of	   protein	   complexes	   (Xu	   and	  
Min,	  2011).	  	  
Atg18,	   Atg21	   and	   Hsv2	   are	   highly	   homologues,	   but	   they	   are	   required	   for	  
different	   types	   of	   autophagy.	   Atg18	   as	   a	   member	   of	   the	   core	   autophagy	  
machinery	   is	   essential	   for	   all	   types	   of	   autophagy,	   whereas	   Hsv2	   only	   affects	  
efficient	  PMN	  (Barth	  et	  al.,	  2001;	  Guan	  et	  al.,	  2001;	  Krick	  et	  al.,	  2008b;	  Stromhaug	  
et	  al.,	  2004).	  Bulk	  macroautophagy	  is	  severely	  impaired	  in	  the	  absence	  of	  Atg21.	  
In	  contrast,	  Atg21	  is	  required	  for	  selective	  types	  of	  autophagy	  as	  the	  Cvt	  pathway	  
or	  PMN.	  Consequently,	  the	  biogenesis	  of	  Cvt	  vesicles	  is	  blocked	  in	  the	  absence	  of	  
Atg21.	   In	  detail,	  Atg21	   is	   essential	   for	   the	   recruitment	  of	  Atg8	  and	  Atg5	   to	   the	  
PAS	  under	  nutrient-­‐rich	  conditions	  and	  efficient	  lipidation	  of	  Atg8,	  suggesting	  a	  
crucial	  role	  for	  Atg21	  in	  PAS	  organization	  during	  the	  Cvt	  pathway.	  Though,	  Atg21	  
has	  not	  been	  detected	  at	   the	  PAS	  so	   far	   (Barth	  et	  al.,	  2002;	  Krick	  et	  al.,	  2008b;	  
Meiling-­‐Wesse	  et	  al.,	  2004;	  Stromhaug	  et	  al.,	  2004).	  
All	  three	  homologues	  localize	  at	  endosomal	  compartments	  in	  a	  PI3P-­‐dependent	  
manner,	  but	  their	  function	  there	  remains	  elusive	  (Krick	  et	  al.,	  2008a).	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Atg18	   also	   localizes	   PI(3,5)P2-­‐	   and	   PI3P-­‐dependent	   at	   the	   vacuolar	  membrane	  
and	  the	  PAS,	  where	  it	  exhibits	  autophagic	  and	  non-­‐autophagic	  functions	  (Dove	  et	  
al.,	   2004;	   Guan	   et	   al.,	   2001).	   At	   the	   vacuolar	   membrane	   it	   is	   involved	   in	  
retrograde	   vesicular	   transport	   from	   the	   vacuole	   to	   the	   Golgi	   and	   in	   vacuole	  
homeostasis	  by	  regulating	   the	  PI3P	  5-­‐kinase	  Fab1	  (Dove	  et	  al.,	  2004;	  Efe	  et	  al.,	  
2007;	  Jin	  et	  al.,	  2008;	  Michell	  and	  Dove,	  2009).	  Atg21	  is	  also	  found	  at	  vertices	  of	  
vacuolar	  junctions.	  However,	  Atg21	  is	  not	  required	  for	  the	  retrograde	  transport	  
from	   the	   vacuole	   as	   its	   homolog	   Atg18	   (Dove	   et	   al.,	   2004;	   Krick	   et	   al.,	   2006;	  
Meiling-­‐Wesse	  et	  al.,	  2004).	  At	  the	  PAS,	  Atg18	  in	  a	  complex	  with	  Atg2	  is	  required	  
for	   the	   retrograde	   transport	  of	  Atg9	   from	   the	  PAS	   to	   its	  non-­‐PAS	  pool,	   but	   the	  
underlying	  mechanism	  remains	  elusive	  so	  far	  (Legakis	  et	  al.,	  2007;	  Reggiori	  et	  al.,	  
2004).	   In	  addition	   to	  PI3P,	   the	  protein	   interaction	  partner	  Atg2	   is	   required	   for	  
proper	  PAS	   localization	  of	  Atg18	  (Obara	  et	  al.,	  2008b;	  Rieter	  et	  al.,	  2013).	  Atg2	  
interacts	   with	   the	   transmembrane	   protein	   Atg9,	   thereby	   mediating	   the	  
membrane	  association	  of	  the	  Atg18-­‐Atg2	  complex	  (Obara	  et	  al.,	  2008b;	  Reggiori	  
et	   al.,	   2004).	  The	  proper	  PAS	   localization	  of	  Atg18	   requires	  both,	  PI3P	  and	   the	  
protein	   interaction	   partner	   Atg2.	   The	   absence	   of	   only	   one	   of	   the	   components	  
leads	   to	   a	   cytosolic	   localization	   and	   as	   a	   consequence	   to	   a	   block	   in	  
autophagosome	  biogenesis	  at	  an	  early	  step	  (Rieter	  et	  al.,	  2013).	  Atg18	  and	  Atg2	  
have	   been	   reported	   to	   constitutively	   form	   a	   complex	   in	   the	   cytosol,	   which	   is	  
subsequently	   recruited	   to	   the	   PAS	   dependent	   on	   the	   PI3P	   binding	   ability	   of	  
Atg18	   (Obara	   et	   al.,	   2008b).	   In	   contrast,	   recent	   studies	   revealed,	   that	   Atg2	   is	  
recruited	   to	   the	   PAS	   independently	   from	  Atg18	   and	   that	   the	   presence	   of	   both,	  
Atg2	   and	   PI3P,	   cooperatively	   mediates	   Atg18	   PAS	   recruitment	   (Rieter	   et	   al.,	  
2013).	  Furthermore,	  the	  Atg2-­‐binding	  site	  within	  Atg18	  has	  been	  located	  in	  the	  
loop	  connecting	  blade	  2	  and	  3	  of	  the	  β-­‐propeller	  and	  therefore	  on	  the	  opposite	  
side	  to	  the	  PIP	  binding	  region	  located	  in	  loop	  5	  (Rieter	  et	  al.,	  2013;	  Watanabe	  et	  
al.,	  2012)	  (Figure	  8	  A+B).	  Thus,	  a	  simultaneous	  binding	  of	  PIP	  and	  Atg2	  should	  
be	  possible.	  	  
Not	  only	  the	  localization	  of	  Atg18	  at	  the	  PAS	  is	  mediated	  by	  PI3P	  and	  a	  protein	  
interaction	  partner.	  The	  localization	  at	  the	  vacuolar	  membrane	  is	  determined	  by	  
binding	  to	  PI(3,5)P2	  and	  interaction	  with	  the	  PI3P	  5-­‐kinase	  Fab1	  complex	  (Dove	  
et	   al.,	   2004;	  Efe	   et	   al.,	   2007;	  Krick	  et	   al.,	   2008a).	  At	   endosomes	   the	   interaction	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partner	   of	   Atg18	   and	   the	   other	   homologues	   Atg21	   and	   Hsv2	   are	   still	   missing.	  
PI3P	   and	   PI(3,5)P2	   are	   enriched	   at	   the	   PAS,	   endosomes	   and	   the	   vacuolar	  
membrane	   (Gillooly	   et	   al.,	   2000;	   Obara	   and	   Ohsumi,	   2008).	   Therefore,	   the	  
correct	  temporal	  and	  spatial	  PROPPIN	  localization	  in	  the	  living	  cell	  seems	  to	  be	  
mainly	   determined	   by	   the	   particular	   protein	   interaction	   partner	   (Krick	   et	   al.,	  
2012;	  Rieter	  et	  al.,	  2013).	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3 Materials	  and	  Methods	  
3.1 Material	  
3.1.1 Saccharomyces	  cerevisiae	  strains	  
Table	  1:	  Yeast	  strains	  used	  in	  this	  study	  
S.	  cerevisiae	  strain	   Genotype	   Reference	  
WCG4	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  
(Thumm	  et	  al.,	  1994)	  
atg1∆	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  atg1∆::KAN	  
(Straub	  et	  al.,	  1997)	  
atg2∆	  atg21∆	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  atg2∆::HISMX6	  atg21∆::KAN	  
AG	   Thumm	   (University	  
Göttingen)	  
atg3∆	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  ade2∆1	  atg3∆1::ADE2	  
(Schlumpberger	  et	  al.,	  1997)	  
	  
atg4∆	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  atg4∆::HISMX6	  
T.	   Lang	   (AG	   Thumm,	  
University	  Göttingen)	  
atg5∆	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  atg5∆::KAN	  
AG	   Thumm	   (University	  
Göttingen)	  
atg8∆	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  atg8∆::KAN	  
AG	   Thumm	   (University	  
Göttingen)	  
atg8∆	  atg16∆	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  atg8∆::KAN	  atg16∆::NatNT2	  
AG	   Thumm	   (University	  
Göttingen)	  
atg8∆	  atg21∆	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  atg8∆::KAN	  atg21∆::NatNT2	  
AG	   Thumm	   (University	  
Göttingen)	  
atg9∆	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  atg9∆::KAN	  
AG	   Thumm	   (University	  
Göttingen)	  
atg11∆	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  atg11∆::HISMX6	  
AG	   Thumm	   (University	  
Göttingen)	  
atg14∆	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  atg14∆::NatNT2	  
this	  study	  
atg16∆	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  atg16∆::NatNT2	  
AG	   Thumm	   (University	  
Göttingen)	  
Atg16-­‐HA	   WCG4a	   MATα	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  ATG16-­‐6xHA::NatNT2	  
R.	   Krick	   (AG	   Thumm,	  
University	  Göttingen)	  
Atg161-­‐57-­‐HA	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  ATG161-­‐57-­‐6xHA::NatNT2	  
this	  study	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Atg161-­‐119-­‐HA	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  ATG161-­‐119-­‐6xHA::NatNT2	  
this	  study	  
Atg16-­‐HA	  atg8∆	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	   ATG16-­‐6xHA::NatNT2	  
atg8∆::KAN	  
this	  study	  
atg19∆	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  atg19∆::KAN	  
AG	   Thumm	   (University	  
Göttingen)	  
atg21∆	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  atg21∆::KAN	  
(Barth	  et	  al.,	  2002)	  
	  
atg21∆	  pep4∆	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  atg21∆::KAN	  pep4∆::HISMX6	  
AG	   Thumm	   (University	  
Göttingen)	  
atg23∆	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  atg23∆::KAN	  
AG	   Thumm	   (University	  
Göttingen)	  
atg27∆	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  atg27∆::HISMX6	  
AG	   Thumm	   (University	  
Göttingen)	  
Atg27-­‐HA	   WCG4a	   MAT	  α	   his	  2-­‐11,15	   leu	  2-­‐3,112	  
ura	  3	  ATG27-­‐6xHA::NatNT2	  
R.	   Krick	   (AG	   Thumm,	  
University	  Göttingen)	  
Sey	  6210	   Sey	   6210	   MAT	  α	   ura	  3-­‐52	   leu	  2-­‐3,112	  
his	  3-­‐∆200	   lys	  2-­‐801	   trp	  1-­‐∆901	   suc	  2-­‐
∆9	  mel	  GAL	  
G.	   Fischer	   von	   Mollard	  
(University	  Bielefeld)	  
atg4∆	   Sey	   6210	   MAT	  α	   ura	  3-­‐52	   leu	  2-­‐3,112	  
his	  3-­‐∆200	   lys	  2-­‐801	   trp	  1-­‐∆901	   suc	  2-­‐
∆9	  mel	  GAL	  atg4∆::NatNT2	  
(Krick	  et	  al.,	  2010)	  
	  
atg5∆	   Sey	   6210	   MAT	  α	   ura	  3-­‐52	   leu	  2-­‐3,112	  
his	  3-­‐∆200	   lys	  2-­‐801	   trp1-­‐∆901	   suc	  2-­‐
∆9	  mel	  GAL	  atg5∆::NatNT2	  
this	  study	  
atg16∆	   Sey	   6210	   MAT	  α	   ura	  3-­‐52	   leu	  2-­‐3,112	  
his	  3-­‐∆200	   lys	  2-­‐801	   trp	  1-­‐∆901	   suc2-­‐
∆9	  mel	  GAL	  atg16∆::NatNT2	  
this	  study	  
Atg27-­‐GFP	   ATTC201388	   Mat	  a	   ura	  3	   leu	  2	   his	  3	  
ATG27-­‐GFP::HIS3MX6	  
Invitrogen	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3.1.2 Escherichia	  coli	  strains	  
Table	  2:	  E.	  coli	  strains	  used	  in	  this	  study	  
E.	  coli	  strain	   Genotyp	   	   Reference	  
DH5α	   F´(Φ	   80	   (∆lacZ)	   M15)	   ∆	   (lacZYA-­‐argF)	   U169	  
recA1	  endA1	  hsdR17	  rK-­‐mK	  +	  supE44	  thi-­‐1	  gyrA	  
relA	  
	   (Hanahan,	  1983)	  
BL21	  (DE3)	  pLysS	   F`dcm	   ompT	   hsdSB	   (rB-­‐,	   mB-­‐)	   gal	   λ	   (DE3);	  
pLysS	  (CamR)	  
	   Stratagene	  
3.1.3 Plasmids	  
Table	  3:	  Plasmids	  used	  in	  this	  study	  
Name	   Genotype	   Reference	  
ApeI-­‐RFP	   pRS313	  CEN6	  HIS3	  ApeI-­‐RFP	   AG	  Thumm	  	  
(University	  Göttingen)	  
ApeI-­‐RFP	   pRS315	  CEN6	  LEU2	  ApeI-­‐RFP	   AG	  Thumm	  	  
(University	  Göttingen)	  
ApeI-­‐YFP	   pRS313	  CEN6	  HIS3	  ApeI-­‐YFP	   AG	  Thumm	  	  
(University	  Göttingen)	  
Atg4	  C-­‐YC	   p426	  2µ	  URA3	  ADH	  Atg4	  C-­‐YC	   this	  study	  
Atg5-­‐Cub	   pRS313	  CEN6	  HIS3	  MET25	  Atg5-­‐Cub-­‐RURA3	   this	  study	  
Atg5-­‐YFP	   pRS316	  CEN6	  URA3	  Atg5-­‐YFP	   Y.	  Ohsumi	  	  
(Tokyo	   Institute	   of	  
Technology)	  
Atg16-­‐Cub	   pRS313	  CEN6	  HIS3	  MET25	  Atg16-­‐Cub-­‐RURA3	   this	  study	  
Atg16-­‐GFP	   pRS313	  CEN6	  HIS3	  Atg16-­‐GFP	   AG	  Thumm	  	  
(University	  Göttingen)	  
Atg16-­‐GFPD101A	   pRS313	  CEN6	  HIS3	  Atg16-­‐GFPD101A	   this	  study	  
Atg16-­‐GFPE102A	   pRS313	  CEN6	  HIS3	  Atg16-­‐GFPE102A	   this	  study	  
Atg16-­‐GFPD101A_E102A	   pRS313	  CEN6	  HIS3	  Atg16-­‐GFPD101A_E102A	   this	  study	  
Atg16-­‐GFPK94A	   pRS313	  CEN6	  HIS3	  Atg16-­‐GFPK94A	   this	  study	  
Atg16-­‐HA	   pRS313	  CEN6	  HIS3	  CUP1	  Atg16-­‐HA	   this	  study	  
Atg16-­‐HA1-­‐57	   pRS313	  CEN6	  HIS3	  CUP1	  Atg16-­‐HA	   this	  study	  
Atg16-­‐HA1-­‐119	   pRS313	  CEN6	  HIS3	  CUP1	  Atg16-­‐HA1-­‐119	   this	  study	  
Atg16-­‐HA58-­‐150	   pRS313	  CEN6	  HIS3	  CUP1	  Atg16-­‐HA58-­‐150	   this	  study	  
Atg16-­‐HAD101A	   pRS313	  CEN6	  HIS3	  CUP1	  Atg16-­‐HAD101A	   this	  study	  
Atg16-­‐HAE102A	   pRS313	  CEN6	  HIS3	  CUP1	  Atg16-­‐HAE102A	   this	  study	  
Atg16-­‐HAD101A_E102A	   pRS313	  CEN6	  HIS3	  CUP1	  Atg16-­‐HAD101A_E102A	   this	  study	  
Atg16-­‐HAK94A	   pRS313	  CEN6	  HIS3	  CUP1	  Atg16-­‐HAK94A	   this	  study	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Atg16-­‐HAE97A	   pRS313	  CEN6	  HIS3	  CUP1	  Atg16-­‐HAE97A	   this	  study	  
Atg21-­‐Cub	   pRS313	  CEN6	  HIS3	  MET25	  Atg21-­‐Cub-­‐RURA3	   R.	   Krick	   (AG	   Thumm,	  
University	  Göttingen)	  
Atg21	  C-­‐YC	   p426	  2µ	  URA3	  ADH	  Atg21	  C-­‐YC	   this	  study	  
Atg21	  C-­‐YC	   p416	  CEN	  URA3	  MET25	  Atg21	  C-­‐YC	   this	  study	  
Atg21-­‐TAP	   pRS316	  CEN6	  URA3	  Atg21-­‐TAP	   AG	  Thumm	  	  
(University	  Göttingen)	  
Atg21-­‐YFP	   pRS316	  CEN6	  URA3	  Atg21-­‐YFP	   (Meiling-­‐Wesse	   et	   al.,	  
2004)	  
Atg23-­‐Cub	   pRS313	  CEN6	  HIS3	  MET25	  Atg23-­‐Cub-­‐RURA3	   this	  study	  
Atg27-­‐Cub	   pRS313	  CEN6	  HIS3	  MET25	  Atg27-­‐Cub-­‐RURA3	   this	  study	  
Atg27-­‐Cub1-­‐198	   pRS313	   CEN6	   HIS3	   MET25	   Atg27-­‐Cub1-­‐198-­‐
RURA3	  
R.	   Krick	   (AG	   Thumm,	  
University	  Göttingen)	  
Atg27-­‐Cub1-­‐221	   pRS313	   CEN6	   HIS3	   MET25	   Atg27	   Cub1-­‐221-­‐
RURA3	  
R.	   Krick	   (AG	   Thumm,	  
University	  Göttingen)	  
C-­‐YC	   p426	  2µ	  URA3	  ADH	  C-­‐YC	   (Skarp	  et	  al.,	  2008)	  
C-­‐YC	   p416	  CEN6	  URA3	  C-­‐YC	   this	  study	  
GFP-­‐Atg8	   pRS313	  Cen6	  HIS3	  GFP-­‐Atg8	   AG	  Thumm	  	  
(University	  Göttingen)	  
GFP	   pUG36	  CEN6	  HIS3	  GFP	   AG	  Thumm	  	  
(University	  Göttingen)	  
GFP-­‐Atg21	   pUG36	  CEN6	  HIS3	  GFP-­‐Atg21	   (Krick	  et	  al.,	  2008a)	  
GST	   pGEX-­‐4T-­‐3	  GST	   Amersham	  
GST-­‐Atg16	   pGEX-­‐4T-­‐3	  GST-­‐Atg16	   this	  study	  
GST-­‐Atg161-­‐57	   pGEX-­‐4T-­‐3	  GST-­‐Atg161-­‐57	   this	  study	  
GST-­‐Atg161-­‐119	   pGEX-­‐4T-­‐3	  GST-­‐Atg161-­‐119	   this	  study	  
GST-­‐Atg1658-­‐150	   pGEX-­‐4T-­‐3	  GST-­‐Atg1658-­‐150	   this	  study	  
mCherry	   pUG36	  	  CEN6	  URA3	  mCherry	   R.	   Krick	   (AG	   Thumm,	  
University	  Göttingen)	  
mCherry-­‐Atg19	   pUG34	  CEN6	  HIS3	  mCherry-­‐Atg19	   P.	   Rube	   (AG	   Thumm,	  
University	  Göttingen)	  
mCherry-­‐Atg21	   pUG36	  	  CEN6	  URA3	  mCherry-­‐Atg21	   R.	   Krick	   (AG	   Thumm,	  
University	  Göttingen)	  
Nui-­‐Atg1	   pRS314	  CEN6	  TRP1	  CUP1	  Nui-­‐Atg1	   F.	  Reggiori	  	  
(University	   Medical	  
Center	  Utrecht)	  
Nui-­‐Atg5	   pRS314	  CEN6	  TRP1	  CUP1	  Nui-­‐Atg5	   R.	   Krick	   (AG	   Thumm,	  
University	  Göttingen)	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Nui-­‐Atg7	   pRS314	  CEN6	  TRP1	  CUP1	  Nui-­‐Atg7	   this	  study	  
Nui-­‐Atg8	   pRS314	  CEN6	  TRP1	  CUP1	  Nui-­‐Atg8	   R.	   Krick	   (AG	   Thumm,	  
University	  Göttingen)	  
Nui-­‐Atg9	   pRS314	  CEN6	  TRP1	  CUP1	  Nui-­‐Atg9	   F.	  Reggiori	  	  
(University	   Medical	  
Center	  Utrecht)	  
Nui-­‐Atg12	   pRS314	  CEN6	  TRP1	  CUP1	  Nui-­‐Atg12	   this	  study	  
Nui-­‐Atg16	   pRS314	  CEN6	  TRP1	  CUP1	  Nui-­‐Atg16	   this	  study	  
Nui-­‐Atg18	   pRS314	  CEN6	  TRP1	  CUP1	  Nui-­‐Atg18	   F.	  Reggiori	  	  
(University	   Medical	  
Center	  Utrecht)	  
Nui-­‐Atg19	   pRS314	  CEN6	  TRP1	  CUP1	  Nui-­‐Atg19	   this	  study	  
Nui-­‐Atg21	   pRS314	  CEN6	  TRP1	  CUP1	  Nui-­‐Atg21	   F.	  Reggiori	  	  
(University	   Medical	  
Center	  Utrecht)	  
Nui-­‐Atg23	   pRS314	  CEN6	  TRP1	  CUP1	  Nui-­‐Atg23	   this	  study	  
Nui-­‐Atg27	   pRS314	  CEN6	  TRP1	  CUP1	  Nui-­‐Atg27	   this	  study	  
Nui-­‐Hsv2	   pRS314	  CEN6	  TRP1	  CUP1	  Nui-­‐Hsv2	   R.	   Krick	   (AG	   Thumm,	  
University	  Göttingen)	  
Nui-­‐Ubc6	   pRS314	  CEN6	  TRP1	  CUP1	  Nui-­‐Ubc6	   R.	   Krick	   (AG	   Thumm,	  
University	  Göttingen)	  
Nui-­‐Trs85	   pRS314	  CEN6	  TRP1	  CUP1	  Nui-­‐Trs85	   F.	  Reggiori	  	  
(University	   Medical	  
Center	  Utrecht)	  
Nui-­‐Vam1	   pRS314	  CEN6	  TRP1	  CUP1	  Nui-­‐Vam1	   AG	  Thumm	  	  
(University	  Göttingen)	  
N-­‐YC	   p426	  2µ	  URA3	  ADH	  N-­‐YC	   (Skarp	  et	  al.,	  2008)	  
N-­‐YN	   p425	  2µ	  LEU2	  ADH	  N-­‐YN	   (Skarp	  et	  al.,	  2008)	  
N-­‐YN	   p415	  CEN6	  LEU2	  MET25	  N-­‐YN	   this	  study	  
N-­‐YN	  Atg8	   p425	  2µ	  LEU2	  ADH	  N-­‐YN	  Atg8	   this	  study	  
N-­‐YN	  Atg8	   p415	  CEN6	  LEU2	  MET25	  N-­‐YN	  Atg8	   this	  study	  
N-­‐YC	  Atg4	   p426	  2µ	  URA3	  ADH	  N-­‐YC	  Atg4	   this	  study	  
N-­‐YC	  Atg21	   p426	  2µ	  URA3	  ADH	  N-­‐YC	  Atg21	   this	  study	  
pFA6-­‐natNT2	   pFA6-­‐natNT2	   Euroscarf;	   (Janke	   et	   al.,	  
2004)	  
pRS313-­‐CUP1	   pRS313	  CEN6	  HIS3	  CUP1	   R.	   Krick	   (AG	   Thumm,	  
University	  Göttingen)	  
pRS314	   pRS314	  CEN6	  TRP1	   AG	  Thumm	  	  
(University	  Göttingen)	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p415-­‐MET25	   p415	  CEN	  LEU2	  MET25	  
672	  
(Mumberg	  et	  al.,	  1995)	  
p416-­‐MET25	   p416	  CEN	  URA3	  MET25	  
673	  
(Mumberg	  et	  al.,	  1995)	  
Ste14-­‐Cub	   pRS313	  CEN6	  HIS3	  MET25	  Ste14-­‐Cub-­‐RURA3	   F.	  Reggiori	  	  
(University	   Medical	  
Center	  Utrecht)	  
SUMO	   K27	  6xHIS	  SUMO	   AG	  Rehling	  	  
(University	  Göttingen)	  
SUMO-­‐Atg21	   K27	  6xHIS	  SUMO-­‐Atg21	   R.	   Krick	   (AG	   Thumm,	  
University	  Göttingen)	  
3.1.4 Oligonucleotides	  
Table	  4:	  Oligonucleotides	  used	  in	  this	  study	  
Name	   Sequence	  (5`to	  3`)	  





ATG14::NatNT2	   	  
atg14_ko_fw	   CGAGTAGAGAAAAAGGGAAGTAAAAGTTAAAAACTAGAATCCTAGTATG
ACATG	  CGTACGCT	  GCAGGTCGAC	  
atg14_ko_rev	   GACTGACTACATGCAACTTTATACACACGGCAGGAAAAAAAGTGCGCACT
CTA	  ATCGATGAATTCGAGCTCG	  
ATG21::NatNT2	   	  
ATG21	  KO-­‐S1:	   CAAAAGACAATTCCACTCCTTTGGATTTGAAATAGACAGATAGAAAAGGA
TATGCGTACGCTGCAGGTCGAC	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Nui-­‐Atg23_BamHI_fwd	   AGTAGCAATggatccctgggtctgggGAACTGAATCAGGTTTTAG	  
Nui_Atg23_KpnI_rev	   ATTCCTACTTGGTACCGAAAGCCTAGATCATGATC	  
Atg23-­‐Cub_StuI_fwd	   AGTAGCAATaggcctATGGAACTGAATCAGGTTTTAG	  
Atg23_Cub_SalI_rev	   ATTCCTACTTgtcgacCCTTCAACTTTTTTTGATATGGCATC	  
Nui-­‐Atg12_StuI_fwd	   AGTAGGAATggatcaggccttctgggAGTAGGATCCTAGAGAGCG	  
Nui-­‐Atg12_XhoI_rev	   ATTCCTACTTCTCGAGgtgagtttataacgctcaagtac	  
Nui-­‐Atg27_BamHI_fwd	   AGTAGCAATggatccctgggtctgggGTATCGAAGACTTGGATATGTGG	  
Nui-­‐Atg27_XhoI_rev	   ATTCCTACTTCTCGAGgtataatgtagatataaaagcttag	  
Nui-­‐Atg16_BamHI_fwd	   AGTAGCAATggatccctgggtctgggGGCAATTTCATTATAACAGAAAGG	  
Nui-­‐Atg16_XhoI_rev	   ATTCCTACTTCTCGAGacctctttattgcaaacactttg	  
Nui-­‐Atg19_BamHI_fwd	   AGTAGCAATggatccctgggtctgggAACAACTCAAAGACTAACCAACAG	  
Nui-­‐Atg19_XhoI_rev	   ATTCCTACTTCTCGAGggaagtaaagagtttcgaaaaggg	  
Nui-­‐Atg7_BamHI_fwd	   AGTAGCAATggatccctgggtctgggTCGTCAGAAAGGGTCTTAAG	  
Nui-­‐Atg7_KpnI_rev	   ATTCCTACTTGGTACCGTATGCAAAATAGTATAGCAAG	  
Atg5Cub_StuI_fwd	   AGTAGCAATaggcctATGAATGACATTAAACAATTACTTTG	  
Atg5Cub_SalI_rev	   ATTCCTACTTgtcgacCCGAGCTCAGAGGAAGCTTTATC	  
Atg16Cub_ClaI_fwd	   AGTAGCAATatcgatATGGGCAATTTCATTATAACAG	  
Atg16Cub_SalI_rev	   ATTCCTACTTgtcgacCCTTTCGTTCCATCTATTTCGCTG	  
Atg27Cub_ClaI_fwd	   AGTAGCAATatcgatATGGTATCGAAGACTTGGATATG	  
Atg27Cub_SalI_rev	   ATTCCTACTTgtcgacCCAACGGCGCTATAACCGCCTC	  
GST-­‐Atg16	   plasmid	  
variants	  
	  
GST-­‐Atg16_BamHI_fwd	   AGTAGCAATggatccATGGGCAATTTCATTATAACAG	  
GST-­‐Atg16_XhoI_rev	   ATTCCTACTTCTCGAGTCATTTCGTTCCATCTATTTCG	  







Atg16-­‐HA	   plasmid	  
variants	  
	  
Atg16Cub_ClaI_fwd	   AGTAGCAATatcgatATGGGCAATTTCATTATAACAG	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Atg16	  point	  mutants	   	  
Atg16_K94A_fwd	   GCGTTGAAAAATgcGAATACGGAAAGGTTGAATGACG	  
Atg16_K94A_rev	   CGTCATTCAACCTTTCCGTATTCGCATTTTTCAACGC	  
Atg16_E97A_fwd	   GAATACGGcAAGGTTGAATGACGAATTGATTAGTGGAACCATTG	  
Atg16_E97A_rev	   CAATGGTTCCACTAATCAATTCGTCATTCAACCTTGCCGTATTC	  
Atg16_D101A_fwd	   GAATACGGAAAGGTTGAATGcCGAATTGATTAGTGGAACC	  
Atg16_D101A_rev	   GGTTCCACTAATCAATTCGgCATTCAACCTTTCCGTATTC	  
Atg16_E102A_fwd	   GAATACGGAAAGGTTGAATGACGcATTGATTAGTGGAACC	  
Atg16_E102A_rev	   GGTTCCACTAATCAATgCGTCATTCAACCTTTCCGTATTC	  
Atg16_DE_fwd	   GAATACGGAAAGGTTGAATGcCGcATTGATTAGTGGAACCATTG	  
Atg16_DE_rev	   CAATGGTTCCACTAATCAATgCGgCATTCAACCTTTCCGTATTC	  








Atg21_N-­‐YC_SalI_rev	   gatgatgtcgacTTATGTAAATTTATTATTTTTAGTCAGC	  
Atg8_N-­‐YN_BamHI_fwd	   atcatcggatccAAGTCTACATTTAAGTCTGAATATC	  
Atg8_N-­‐YN_SalI_rev	   atcatcggatccCTACCTGCCAAATGTATTTTCTC	  
Atg4_C-­‐YC_EcoRI_fwd	   atcatcgaattcATGCAGAGGTGGCTACAACTG	  
Atg4_C-­‐YC_SalI_rev	   gatgatgtcgacgcatttttcatcaataggactgtg	  
Atg4	  N-­‐YC_EcoRI_fwd	   atcatcgaattcGCAGAGGTGGCTACAACTGTGG	  
Atg4	  N-­‐YC_SalI_rev	   gatgatgtcgacCTAGCATTTTTCATCAATAGGACTG	  
Control	  Primer	   	  
Atg5_K1_fwd	   GAAGTAGCATGCTCAGAAGTG	  
NatNT2_r	   cgattcgtcgtccgattcgtc	  	  
Atg5_K3_rev	   CAACGTAGGATTGACTCCAGTC	  
atg14_K1_fw	   GGGAAAGGACCAAATACAAAAGTG	  
atg14_K3_rev	   TGAGTTGGTTCTTACCCGAATGC	  
Atg21_pro_f	   GAGCGTGAGCTGCAGAAAG	  
atg21-­‐seq1r	   caacaatttcatgtgggaaaac	  
Sequencing	  primer	   	  
pRS313-­‐CUP1_fwd	   GCAATATGGATTGTCAGAATC	  	  
pRS313-­‐CUP1_rev	   CACACAGGAAACAGCTATGACC	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pGEX-­‐4T3_fwd	   gatcatgtaacccatcc	  
pGEX-­‐4T3_rev	   GCCACCTGACGTCTAAG	  
Atg16	  seq	  2	  rev	   CTTCGTATTTCTTGCTCC	  
Nui-­‐Seq3_f	   CTTGTCTTGTATCAATTG	  
Atg23_Seq1_fwd	   CTTCTGCGGATCAAATGATAC	  
Atg23_seq1_rev	   GTATCATTTGATCCGCAGAAG	  
Atg23_Seq2_fwd	   GTAGGAGATTTGGAAAGC	  
ATG16_seq_6_rev	  	  	  	   GGATAACAATTTCACACAGG	  
Cub-­‐RURA3-­‐seq	  f	   CACCTTGTCCAATTGAAC	  
Cub_Seq_rev	   CTAACTCCAGTAATTCCTTG	  
Atg12	  Seq	  1	  fwd	   CAAGAATTAAGATCATCTCC	  
Atg12	  Seq2	  fwd	   CGTTTGCGCCAAGTCCGCAG	  
Atg12	  Seq2	  rev	   CTGCGGACTTGGCGCAAACG	  
Atg27	  Seq1	  fwd	   CAGGTGGGAAAATTTAGCTC	  
Atg27	  Seq2	  fwd	   GGACTTCGTGGTTCACTTGG	  
Atg27	  Seq2	  rev	   CCAAGTGAACCACGAAGTCC	  
ATG16	  seq	  2	  for	  	  	   GGAGCAAGAAATACGAAG	  
Atg16	  seq	  3	  fwd	   GCCATGAACAGCGAAATAG	  
Atg16	  seq3	  rev	   CTATTTCGCTGTTCATGGC	  
Atg19	  Seq1	  fwd	   GCTTGGATAACTTCATGAAAC	  	  
Atg19	  Seq1	  rev	   GTTTCATGAAGTTATCCAAGC	  
Atg19	  Seq2	  fwd	   CCAACCACGCAAATTATTGAC	  
Atg19	  Seq2	  rev	   GTCAATAATTTGCGTGGTTGG	  
Atg7_Seq1_fwd	   GGCTGTTCTCAAAGTGTC	  
Atg7_Seq1_rev	   GACACTTTGAGAACAGCC	  
Atg7_Seq2_fwd	   GTAAACGAGGAGGCTCAG	  
Atg7_Seq2_rev	   CTGAGCCTCCTCGTTTAC	  
Atg7_Seq3_fwd	   GACTTCCTTACTACAGACC	  
Atg5_Seq1_fwd	   CCCCTCATTTGGAACAAG	  
Atg5_Seq1_rev	   CTTGTTCCAAATGAGGGG	  
Atg5_Seq2_fwd	   GTTCATCAAGACCGCGAC	  
Atg5_Seq2_rev	   GTCGCGGTCTTGATGAAC	  
pADH	  1	  for	   CGGTATACGGCCTTCCTTCC	  
C-­‐YC	  Seq	  rev	   CTCGTCCATGCCGAGAGTG	  
N-­‐YC	  Seq	  fwd	   GTGCAGCTCGCCGACCAC	  
Atg4	  C-­‐YC	  Seq1	  f	   CAGAGGTGGCTACAACTGTG	  
Atg4	  C-­‐YC	  Seq1	  r	   CTATAGGAACAAATCTTGTCCG	  
Atg4	  C-­‐YC	  Seq2	  f	   CCGATCAGTACAATAGAGGAC	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Atg4	  C-­‐YC	  Seq2	  r	   GATGCCACATTCGGGGAAGC	  
Atg4	  C-­‐YC	  Seq3	  f	   GTTCTTGTTGGGCGTGAAGC	  
Atg4	  C-­‐YC	  Seq3	  r	   GTTGCCAGTCTTTTTCGCCC	  
Atg4	  C-­‐YC	  Seq4	  f	   GGATGACGTGGAAAGTGTAAG	  
Atg4	  C-­‐YC	  Seq4	  r	   CATCAATAGGACTGTGAATACC	  
3.1.5 Media	  
All	  media	   listed	   in	   this	   chapter	  were	   prepared	  with	   deionized	  water	   (ddH2O).	  
The	  respective	  pH	  was	  adjusted	  using	  NaOH	  or	  HCl.	  The	  media	  were	  autoclaved	  
at	   121°C	   for	   20	  min	   for	   sterilization.	   The	   listed	   percent	   values	   indicate	  weight	  
per	  volume	  (w/v).	  For	  the	  preparation	  of	  solid	  media	  to	  generate	  plates,	  2%	  of	  
preheated,	  sterile	  agar	  was	  added.	  	  
3.1.5.1 YPD-­‐medium,	  pH	  5.5	  
YPD	  is	  a	  rich	  medium	  for	  yeast	  cells	  consisting	  of:	  
1%	  Bacto®	  Yeast	  Extract	  
2%	  Bacto®	  Pepton	  
2%	  D-­‐glucose	  
3.1.5.2 CM-­‐medium,	  pH	  5.6	  
CM-­‐medium	   is	   a	   synthetic	   medium	   for	   yeast	   cells	   and	   was	   used	   as	   selective	  
medium.	  	  
0.67%	  Yeast	  Nitrogen	  Base	  w/o	  amino	  acids	  
2%	  D-­‐glucose	  
0.0117%	  	  L-­‐alanine	   	   	   	   	   0.0117%	  L-­‐methionine	  
0.0117%	  L-­‐arginine	   	   	   	   	   0.0117	  %	  L-­‐phenylalanine	  
0.0117%	  L-­‐asparagine	   	   	   	   0.0117%	  L-­‐proline	  
0.0117%	  L-­‐aspartic	  acid	   	   	   	   0.0117%	  L-­‐serine	  
0.0117%	  L-­‐cysteine	   	   	   	   	   0.0117%	  L-­‐threonine	  
0.0117%	  L-­‐glutamine	   	   	   	   0.0117%	  L-­‐tyrosine	  
0.0117%	  L-­‐glutamic	  acid	   	   	   	   0.0117%	  L-­‐valine	  
0.0117%	  L-­‐glycine	   	   	   	   	   0.0117%	  myo-­‐inositol	  
0.0117%	  L-­‐isoleucine	   	   	   	   0.0117%	  p-­‐aminobenzoic	  acid	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For	   overexpression	   experiments	   using	   MET25	   promoter	   L-­‐methionine	   was	  
excluded	  from	  the	  drop	  out	  mix.	  
Following	  supplements	  were	  added	  depending	  on	  selection	  of	  genetic	  markers:	  
0.3	  mM	  L-­‐histidine	   	   	   	   0.4	  mM	  L-­‐tryptophan	  
1.7	  mM	  L-­‐leucine	   	   	   	   0.3	  mM	  adenine	  
1	  mM	  L-­‐lysine	   	   	   	   0.2	  mM	  uracil	  
3.1.5.3 SD(-­‐N)-­‐medium	  
Nitrogen	  free	  SD(-­‐N)-­‐medium	  was	  used	  as	  starvation	  medium	  for	  yeast	  cells.	  
0.67%	  	  	  Yeast	  Nitrogen	  Base	  w/o	  amino	  acids	  and	  w/o	  ammonium	  sulfate	  
2%	   	  	  D-­‐glucose	  
3.1.5.4 LB-­‐medium,	  pH	  7.5	  
LB-­‐medium	  was	  used	  as	  standard	  growth	  medium	  for	  E.	  coli	  cultures.	  
1%	   Bacto®	  Trypton	  
0.5%	   Bacto®	  Yeast	  extract	  
0.5%	   sodium	  chloride	  
For	   plasmid	   selection	   75	  µg/ml	   ampicillin,	   50	  µg/ml	   kanamycin,	   and/or	  
25	  µg/ml	  chloramphenicol	  was	  added.	  
3.1.5.5 SOC-­‐medium,	  pH	  7.5	  
SOC-­‐medium	  was	  used	  as	  regeneration	  medium	  for	  electroporated	  E.	  coli	  cells.	  
2%	   Bacto®	  Trypton	  
0.5%	   Bacto®	  Yeast	  extract	  
0.4%	   D-­‐glucose	  
10	  mM	  sodium	  chloride	   	   	   10	  mM	  magnesium	  sulfate	  
10	  mM	  magnesium	  chloride	  	   	   2.5	  mM	  potassium	  chloride	  
3.1.6 Antibodies	  
Table	  5:	  Antibodies	  used	  in	  this	  study	  
Antibody	  
Dilution	  
(in	  TBST	  containing	  1%	  
skim	  milk	  powder	  (w/v))	  
Source	  
anti-­‐mouse-­‐HRPO-­‐conjugate	   1	  :	  10.000	   Dianova,	  Hamburg	  
anti-­‐rabbit-­‐HRPO-­‐conjugate	   1	  :	  5000	   Medac,	  Hamburg	  
anti-­‐rat-­‐HRPO-­‐conjugate	   1	  :	  10.000	   Jackson	  ImmunoResearch,	  UK	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rabbit-­‐anti-­‐ApeIp	   1	  :	  3000	   Eurogentech,	  Belgium	  
rabbit-­‐anti-­‐Aut7	   1	  :	  10.000	  in	  TBST	   M.	  Thumm	  
rabbit-­‐anti-­‐CPY	   1	  :	  10.000	   Molecular	  Probes,	  Leiden,	  NL	  
mouse-­‐anti-­‐GFP*	   1	  :	  10.000	   Roche,	  Mannheim	  
mouse-­‐anti-­‐GFP**	   1	  :	  10.000	   Abcam,	  Cambridge,	  UK	  
mouse-­‐anti-­‐PGK	   1	  :	  10.000	   Molecular	  Probes,	  Leiden,	  NL	  
rat-­‐anti-­‐Red	   1	  :	  1000	   Chromotek,	  München	  
mouse-­‐anti-­‐HA	   1	  :	  10.000	   Santa	   Cruz	   Bio-­‐technology,	  
Heidelberg	  	  
*In	  general,	  the	  GFP-­‐antibody	  from	  Roche	  was	  used	  if	  not	  stated	  otherwise.	  
**The	  GFP-­‐antibody	  from	  Abcam	  was	  used	  to	  detect	  both	  fragments	  of	  eYFP	  on	  
immunoblots	  prepared	  for	  BiFC	  (see	  chapter	  4.3.5.1).	  	  
3.1.7 	  Commercial	  available	  Kits	  
Kit	   systems	   listed	   in	   Table	   6	   were	   used	   according	   to	   the	   manufacturer`s	  
recommendations.	  	  
Table	  6:	  Commercial	  available	  Kits	  used	  in	  this	  study	  
Name	  of	  the	  Kit	   	   Source	  
ECL	   Western	   Blotting	   Detection	  
Reagents	  
	   Amersham	  Biosciences,	  GB	  
QIAquick	  Gel	  Extraction	  Kit	   	   Qiagen,	  Hilden	  
QIAquick	  PCR	  Purification	  Kit	   	   Qiagen,	  Hilden	  
QuikChange	   II	   Site-­‐Directed	  
Mutagenesis	  Kit	  
	   Agilent	  Technologies;	  Santa	  Clara,	  USA	  
Wizard	  Plus	  SV	  Miniprep	  Kit	   	   Promega,	  Mannheim	  
3.1.8 Chemicals	  and	  consumables	  
Standard	   chemicals	   were	   used	   in	   analytical	   grade	   quality	   and	   obtained	   from	  
AppliChem	   (Darmstadt),	   Sigma	   (Deisenhofen),	   Roth	   (Karlsruhe)	   or	   Merck	  
(Darmstadt).	   Restriction	   enzymes	   were	   obtained	   from	   NEB	   (Frankfurt).	  
Deoxyoligonucleotides	   were	   ordered	   from	   Eurofins	   MWG	   Operon	   (Ebersberg)	  
and	  used	  as	  primers	  for	  PCR	  or	  site-­‐directed	  mutagenesis.	  Special	  chemicals	  and	  
enzymes	  are	  listed	  in	  Table	  7.	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Table	  7:	  Special	  chemicals	  
Name	   Source	  
Bacto®	  -­‐Agar	   Becton	  Dickinson,	  Heidelberg	  
Bacto®	  Peptone	   Becton	  Dickinson,	  Heidelberg	  
Bacto®	  Tryptone	   Becton	  Dickinson,	  Heidelberg	  
Bacto®	  Yeast	  Extract	   Becton	  Dickonson,	  Heidelberg	  
Benzonase	   Sigma,	  Deisenhofen	  
clon	  NAT	  (nourseotricine)	   Werner	  BioAgents,	  Jena	  
CompleteTM	  protease	  inhibitor	  (EDTA-­‐free)	   Roche,	  Mannheim	  
Deoxyadenosin-­‐triphosphate	  (dATP)	   NEB,	  Frankfurt	  
Deoxycytidin-­‐triphosphate	  (dCTP)	   NEB,	  Frankfurt	  
Deoxyguanosin-­‐triphosphate	  (dGTP)	   NEB,	  Frankfurt	  
Deoxythymidin-­‐triphosphate	  (dTTP)	   NEB,	  Frankfurt	  
DNA-­‐marker	  (1kb	  DNA-­‐ladder)	   NEB,	  Frankfurt	  
ECL	   USB,	  Santa	  Clara,	  CA	  
Glass	  beads	   Schütt,	  Göttingen	  
Herring-­‐sperm-­‐DNA	   Promega,	  Madison,	  USA	  
Immersion	  oil	  	   Applied	  Precision,	  USA	  
Ligation	  buffer	  	   NEB,	  Frankfurt	  
DNA	  polymerase	  (FideliTaq)	   USB,	  Santa	  Clara,	  USA	  
DNA	  polymerase	  (Klenow)	   NEB,	  Frankfurt	  
DNA	  polymerase	  (KOD)	   Novagen,	  Darmstadt	  
DNA	  polymerase	  (Taq)	   NEB,	  Frankfurt	  
DNA	  polymerase	  (Vent)	   NEB,	  Frankfurt	  
Precision	  Plus	  Protein	  All	  Blue	  Standards	   Biorad,	  Munich	  
Protease	  inhibitor	  cocktail	  (bacteria)	   Sigma,	  Deisenhofen	  
RNAse	  A	   Applichem,	  Darmstadt	  
Sepharose	  /	  Slurry	   GE	  Healthcare,	  München	  
Skim	  milk	  powder	   Granovita,	  Lüneburg	  
T4-­‐Ligase	   NEB,	  Frankfurt	  
Difco	  Yeast	  nitrogen	  base	  w/o	  amino	  acids	   Becton	  Dickinson,	  Heidelberg	  
Difco	  Yeast	  nitrogen	  base	  e/o	  amino	  acids	  and	  ammonium	   Becton	  Dickinson,	  Heidelberg	  
Zymolyase	  T100	   Seikagaku,	  Japan	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3.1.9 Equipment	  
Table	  8:	  Equipment	  used	  in	  this	  study	  
Name	  of	  product	   Source	  
Agarose	  gel	  equipment	  
Bio	  RAD	  Mini-­‐SUB	  Cell	  GT	  
Bio-­‐Rad	  Laboratories	  GmbH,	  München	  
ÄKTApurifier	  10	  UPC	   GE	  Healthcare,	  München	  
Autoclave	   Adolf	  Wolf,	  SANOclav,	  Bad	  Überkingen-­‐Hausen	  
Autoclave	  DX200	   Systec,	  Wettenberg	  
Bench	   BDK	   Luft-­‐	   und	   Reinraumtechnik	   GmbH,	  
Sonnenbühl	  
Blot	  Shaker	  GFL	  3019	   GFL,	  Burgwedel	  
Centrifuge	  5804	   Eppendorf,	  Hamburg	  
Centrifuge	  5404R	  	   Eppendorf,	  Hamburg	  
Centrifuge	  5415D	   Eppendorf,	  Hamburg	  
Centrifuge	  5415R	   Eppendorf,	  Hamburg	  
Chemical	  balance	   Sartorius,	  Göttingen	  
Cuvettes	  no.	  67.742	   Sarstedt,	  Nümbrecht	  
Cuvettes	  for	  electroporation;	  2mm	   peqlab,	  Erlangen	  
Electroporator	  2510	   Eppendorf;	  Hamburg	  
Freezer	  (-­‐20°C)	   Liebherr,	  Bulle,	  CH	  
Freezer	  (-­‐80°C)	   Heareus,	  Hanau	  
Glassbeads	   Schütt,	  Göttingen	  
Hood	   BDK	  Luft-­‐	  und	  Reinraumtechnik,	  Sonnenbrühl-­‐
Genkingen	  
Incubator	  (37°C)	   Heraeus,	  Hanau	  
Incubator	  4200	   Innova,	  USA	  
Incubator	  Thermomixer	  comfort	   Eppendorf,	  Hamburg	  
Labshaker	  for	  diverse	  culture	  sizes	   A.	  Kühner,	  Birsfelden,	  Schweiz	  
LAS	  3000	  Intelligent	  Dark	  Box	   Fuji/Raytest,	  Benelux	  
Magnetic	  stirrer	  MR	  3001	   Heidolph,	  Kelheim	  
Microscope	  DeltaVision,	  Olympus	  IX71	   Applied	  Precision,	  USA	  
Microscope	  slides	  (76x26mm)	   Menzel-­‐Gläser,	  Braunschweig	  
Microscope	  cover	  slips	   Menzel-­‐Gläser,	  Braunschweig	  
Microwave	  R-­‐939	   Sharp,	  Hamburg	  
Multivortex	  IKA	  vibray	  VXR	  basic	   IKA,	  Staufen	  
Over	  head	  shaker	  Roto-­‐Shake	  Genie	   Scientific	  Industries	  Inc,	  USA	  
PCR	  Mastercycler	  gradient	   Eppendorf,	  Hamburg	  
pH	  meter	  pH537	   WTW,	  Weilheim	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Photometer	   Eppendorf,	  Hamburg	  
Pipettes	   Eppendorf,	  Hamburg	  
PowerPac	  Basic	  Power	  Supply	   Bio-­‐Rad	  Laboratories	  GmbH,	  München	  
PowerPac	  HC	  Power	  Supply	   Bio-­‐Rad	  Laboratories	  GmbH,	  München	  
PVDF	  membrane	  Hybond-­‐P	   Amersham;	  GE	  healthcare,	  Freiburg	  
Refrigerator	  (4°C)	   Bosch,	  Stuttgart	  /	  Liebherr,	  Bulle,	  CH	  
Rotor	  JA	  10	   Beckmann,	  Krefeld	  
Rotor	  JA	  20	   Beckmann,	  Krefeld	  
Rotor	  TLA-­‐100.3	   Beckmann,	  Krefeld	  
Rotor	  TLS-­‐55	   Beckmann,	  Krefeld	  
OmniTrays	  Nunc	   SIGMA-­‐ALDRICH,	  St.	  Louis,	  USA	  
SuperoseTM	  6	  10/300	  GL	  column	   Amersham	  Pharmacia	  Biotech,	  Schweden	  
SDS-­‐PAGE	   equipment	   BioRAD	   Mini	  
Protean	  cell	  
Bio-­‐Rad	  Laboratories	  GmbH,	  München	  
Pipette	  tips,	  petri	  dishes,	  …	   Sarstedt,	  Nümbrecht	  /	  Eppendorf,	  Hamburg	  
Sterile	  filter	   Whatman,	  GE	  healthcare,	  München	  
Thermomixer	  Comfort	   Eppendorf,	  Hamburg	  
Transilluminator	  TI	  1	   Whatman	  Biometra,	  Göttingen	  
Ultracentrifuge	   Beckman,	  Krefeld	  
vacuum	  pump	   Vacuubrand,	  Wertheim	  
Water	  bath	  SWB25	   Thermo	  Electron,	  Karlsruhe	  
Western	  Blot	  equipment	  Trans	  Blot	  Cell	   Bio-­‐Rad	  Laboratories	  GmbH,	  München	  	  
3.2 Cultivation	  of	  S.	  cerevisiae	  	  
3.2.1 Growth	  of	  liquid	  yeast	  cultures	  
For	   liquid	   yeast	   precultures,	   the	   yeast	   strain	   was	   inoculated	   with	   a	   sterile	  
toothpick	  from	  an	  agar	  plate	  and	  incubated	  at	  30°C	  with	  220	  rpm	  over	  night.	  The	  
preculture	  was	   used	   to	   inoculate	   the	  main	   liquid	   yeast	   culture	  with	   a	   defined	  
dilution	  depending	  on	  the	  requested	  OD600	  and	  growth	  ability	  of	  the	  respective	  
strain.	   Cultures	  were	   shaken	   at	   220	  rpm	  and	  30°C	  over	  night	   (12	  -­‐	  14	  h)	   if	   not	  
pointed	  otherwise.	  	  
3.2.2 Short-­‐term	  storage	  
For	  short-­‐term	  storage	  of	  yeast	  stocks,	  yeast	  strains	  were	  stored	  on	  agar	  plates	  
up	  to	  4	  -­‐	  6	  weeks	  at	  4°C.	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3.2.3 Long-­‐term	  storage	  
For	   long-­‐term	   storage	   of	   yeast	   strains,	   0.65	  ml	   of	   a	   yeast	   culture	   was	  
supplemented	  with	  0.65	  ml	  of	  sterile	  30%	  glycerine	  and	  stored	  at	  -­‐80°C.	  	  
3.2.4 Cell	  density	  determination	  
The	  cell	  density	  was	  determined	  by	  OD600	  measurement	  using	  a	  photometer	  in	  a	  
dilution	  of	  1:10.	  The	  empty	  medium	  was	  used	  as	  reference.	  1	  OD600	  of	  yeast	  cells	  
corresponds	  to	  3	  x	  107	  cells	  per	  ml.	  	  
3.2.5 Split-­‐ubiquitin	  assay	  
1	  OD600	  of	  a	  yeast	  preculture	  was	  diluted	  1:10,	  1:100,	  1:1000	  and	  1:10	  000	  with	  
sterilized	   ddH20.	   4	  µl	   was	   spotted	   on	   three	   different	   solid	   plates	   (Laser	   et	   al.,	  
2000):	  
	   1)	  growth	  control	  plate	  consisting	  of	  selective	  medium	  (CM-­‐His-­‐Trp)	  
	   2)	  negative	  interaction	  control	  plate	  consisting	  of	  selective	  medium	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (CM-­‐His-­‐Trp)	  lacking	  uracil	  but	  containing	  250	  µM	  methionine	  and	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  100	  µM	  CuSO4	  	  
	   3)	  positive	  interaction	  control	  plate	  consisting	  of	  selective	  medium	  	  
	   	  	  	  	  	  (CM-­‐His-­‐Trp)	  containing	  250	  µM	  methionine,	  100	  µM	  CuSO4	  and	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  mg/ml	  FOA	  	  
Plates	  were	  incubated	  for	  two	  to	  three	  days	  at	  30°C	  and	  imaged	  using	  LAS-­‐3000	  
(Fujifilm)	  for	  growth	  pattern	  analysis.	  	  
3.3 Cultivation	  of	  E.	  coli	  cultures	  
3.3.1 Growth	  of	  liquid	  E.	  coli	  cultures	  
Liquid	  E.	  coli	  cultures	  were	  inoculated	  with	  cells	  from	  an	  agar	  plate,	  a	  short-­‐term	  
or	  long-­‐term	  culture	  using	  a	  sterile	  toothpick.	  The	  cells	  were	  shaken	  at	  37°C	  and	  
220	  rpm	   over	   night	   (12	  -­‐	  14	  h)	   or	   for	   a	   depicted	   time	   period	   in	   LB	   medium	  
containing	  the	  appropriate	  antibiotic/s	  for	  selection.	  	  
3.3.2 E.	  coli	  short-­‐term	  storing	  
For	   short-­‐time	   storage,	   over	   night	   liquid	   cultures	  were	   stored	   at	   4°C	   for	   up	   to	  
4	  weeks.	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3.3.3 E.	  coli	  long-­‐term	  storing	  
For	  long-­‐term	  storage,	  0.65	  ml	  of	  an	  over	  night	  liquid	  culture	  was	  supplemented	  
with	  0.65	  ml	  of	  sterile	  60%	  glycerine	  and	  stored	  at	  -­‐80°C.	  
3.3.4 Preparation	  of	  electrocompetent	  E.	  coli	  cells	  
Competent	   E.	  coli	   cells	   were	   prepared	   from	   a	   1	  l	   culture	   of	   OD600	  ~	  0.6.	   Cells	  
were	  cooled	  down	  on	  ice	  for	  10	  min	  and	  afterwards	  harvested	  by	  centrifugation	  
(8	  min,	  6500	  rpm,	  4°C).	  They	  were	  washed	   two	   times	  with	   ice-­‐cold	  ddH2O	  and	  
once	  with	   ice-­‐cold	  10%	  (v/v)	  glycerine.	  Finally,	  cells	  were	  resuspended	  in	  2	  ml	  
ice-­‐cold	  10%	  (v/v)	  glycerine,	  split	  into	  40	  µl	  aliquots	  and	  stored	  at	  -­‐80°C.	  	  
3.4 Microscopy	  
3.4.1 Fluorescence	  microscopy	  
An	   essential	   part	   of	   this	   work	   represented	   the	   in	   vivo	   visualization	   and	  
evaluation	   of	   proteins	   labeled	   with	   a	   fluorescent	   tag	   by	   direct	   fluorescence	  
microscopy.	  Yeast	  cells	  expressing	  the	  desired	  fluorescent-­‐tagged	  proteins	  were	  
grown	  over	  night	  at	  30°C	  in	  CM	  selection	  media	  to	  the	  preferred	  growth	  phase.	  
To	  cells	  expressing	  pMET25-­‐mCherry-­‐Atg21,	  0.3	  mM	  methionine	  was	  added	   to	  
induce	  endogenous	  protein	  expression	  level.	  4	  -­‐	  5	  µl	  of	  the	  culture	  was	  dropped	  
on	  a	  slide	  and	  covered	  with	  a	  cover	  slip.	  Pictures	  were	  taken	  using	  a	  DeltaVision	  
Spectris	   fluorescence	  microscopy	   (Olympus	   IX71,	   Applied	   Precision)	   equipped	  
with	  a	  CoolSNAP	  HQ	  camera	  and	  either	  FITC	  and	  TRITC	  filter	  or	  specific	  GFP,	  YFP	  
and	   mCherry	   filter	   sets	   (see	   Table	   9).	   Images	   were	   generating	   using	   a	  
100	  x	  objective	   by	   collecting	   a	   stack	   of	   at	   least	   18	   pictures	   with	   focal	   planes	  
0.20	  µm	   apart.	   Pictures	   were	   deconvoluted	   using	   SoftWoRx	   software	   (Applied	  
Precision)	   and	   processed	   using	   Adobe	   Systems	   Photoshop	   and	   Illustrator.	   A	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Table	  9:	  Overview	  of	  the	  used	  filter	  sets	  in	  fluorescence	  microscopy	  
Filter	  Sets	   Excitation	  wavelength	  (nm)	   Emmision	  wavelength	  (nm)	  
FITC	   475/28	   523/36	  
TRITC	   542/27	   594/45	  
GFP	   475/28	   525/50	  
YFP	   513/17	   559/38	  
mCherry	   575/25	   632/60	  
POL	   -­‐50/28	   -­‐50/0	  
3.4.2 Bimolecular	  Fluorescence	  Complementation	  (BiFC)	  
Bimolecular	  Fluorescence	  Complementation	  is	  described	  as	  a	  suitable	  method	  to	  
study	   protein-­‐protein	   interaction	   in	   their	   cellular	   environment	   using	   direct	  
fluorescence	  microscopy	   (Skarp	  et	  al.,	  2008).	  For	   this	  purpose,	   two	  proteins	  of	  
interest	  were	  fused	  to	  one	  fragment	  of	  eYFP.	  Expression	  vectors	  allowing	  high-­‐
copy	   expression	   of	   the	   fusion	   protein	   tagged	   either	   at	   the	   amino-­‐	   or	   carboxy	  
terminus	  with	   eYFP	   fragments	   from	   a	   constitutive	  ADH	   promotor	  were	   kindly	  
provided	  by	  Skarp	  et	  al.	  (2008).	  In	  addition,	  expression	  vectors	  enable	  inducible	  
expression	   of	   the	   tagged	   target	   proteins	   from	   a	  MET25	   promotor	   were	   used.	  
Constructs	  were	  made	  as	  described	  in	  chapter	  3.5.10.2.	  	  
Cells	   expressing	   fusion	   proteins	   from	   the	   ADH	   promoter	   were	   grown	   to	   log	  
phase	  and	  visualized	  using	  a	  DeltaVision	  Deconvolution	  microscope	  as	  described	  
in	  chapter	  3.4.1.	  	  
Cells	  expressing	  fusion	  proteins	  from	  the	  MET25	  promoter	  were	  grown	  to	  mid-­‐
log	  phase	  in	  CM	  selective	  medium	  containing	  an	  excess	  of	  methionine.	  Cells	  were	  
subsequently	   diluted	   to	   an	   OD600	   of	   0.3	   in	   CM	   selective	   medium	   containing	  
0.5	  mM	   methionine	   to	   induce	   fusion	   protein	   expression.	   Cells	   were	   grown	   at	  
30°C	   for	   an	   indicated	   period	   of	   time	   and	   visualized	   using	   a	   DeltaVision	  
Deconvolution	  microscope	  as	  described	  in	  chapter	  3.4.1.	  	  
For	   determination	   of	   the	   expression	   level	   of	   the	   fusion	   proteins,	   cells	   were	  
grown	   in	   selective	   medium	   containing	   an	   indicated	   amount	   of	   methionine	   at	  
30°C	  over	  night	  to	  mid-­‐log	  phase.	  Cells	  were	  subsequently	  alkaline	  lysed	  and	  the	  
samples	   subjected	   to	   immunoblotting	   and	   analyzed	   using	   anti-­‐GFP	   antibody	  
(Abcam).	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3.4.3 Determination	  of	  colocalization	  rates	  
In	   this	   study,	   direct	   fluorescence	   microscopy	   was	   predominantly	   used	   for	  
localization	   studies	   of	   a	   particular	   protein.	   For	   this,	   the	   localization	   of	   this	  
protein	  was	   determined	  by	   colocalization	  with	   other	   proteins	   that	   served	   as	   a	  
reference	  like	  a	  PAS	  marker.	  	  
For	   the	   PAS	   localization	   studies	   of	   Atg21-­‐YFP,	   first	   the	   percentage	   of	   cells	  
positive	  for	  both,	  an	  Atg21-­‐YFP	  and	  ApeI-­‐RFP	  signal	  (PAS	  rate),	  was	  determined	  
by	   analyzing	   at	   least	   130	   cells	   from	   at	   least	   three	   independent	   experiments.	  
Subsequently,	   the	   quantity	   of	   ApeI-­‐RFP	   dots	   colocalized	   with	   Atg21-­‐YFP	   was	  
determined	  (Colocalization	  Rate).	  	  
Similarly,	   the	  PAS	  and	   colocalization	   rate	  of	  mCherry-­‐Atg21	  and	  ApeI-­‐YFP	  was	  
determined	   as	   described	   above	   by	   analyzing	   at	   least	   190	   cells	   from	   three	  
independent	  experiments.	  	  
To	   determine	   the	   Atg5/Atg16	   rate,	   at	   least	   322	   cells	   from	   three	   independent	  
experiments	  were	  observed	  for	  a	  perivacuolar	  Atg5-­‐YFP	  respectively	  Atg16-­‐GFP	  
puncta.	  
For	   colocalization	   studies	   of	  mCherry-­‐Atg21	   and	  Atg16-­‐GFP	   respectively	  Atg5-­‐
YFP,	   the	   quantity	   of	   Atg16-­‐GFP	   respectively	   Atg5-­‐YFP	   dots	   colocalized	   with	  
mCherry-­‐Atg21	  was	  determined	  by	  analyzing	  at	  least	  350	  cells	  from	  at	  least	  four	  
independent	  experiments.	  
For	  colocalization	  studies	  of	  mCherry-­‐Atg21	  and	  cAtg27-­‐GFP,	  first	  the	  quantity	  of	  
mCherry-­‐Atg21	   dots	   colocalized	   with	   cAtg27-­‐GFP	   per	   cell	   was	   determined	   by	  
analyzing	  76	  cells	   from	  two	  independent	  experiments.	  These	  cells	  were	  aligned	  
into	  four	  categories:	  	  
1)	  no	  mCherry-­‐Atg21	  dot	  colocalized	  with	  cAtg27-­‐GFP	  	  
2)	  1	  –	  49%	  of	  the	  mCherry-­‐Atg21	  dots	  colocalized	  with	  cAtg27-­‐GFP	  	  
3)	  49	  –	  99%	  of	  the	  mCherry-­‐Atg21	  dots	  colocalized	  with	  cAtg27-­‐GFP	  
4)	  all	  of	  the	  mCherry-­‐Atg21	  dots	  colocalized	  with	  cAtg27-­‐GFP	  
3.5 Molecular	  biology	  methods	  
3.5.1 Isolation	  of	  chromosomal	  DNA	  
For	   the	   isolation	   of	   chromosomal	   DNA,	   1.5	  ml	   of	   an	   over	   night	   liquid	   yeast	  
culture	  was	  harvested	  by	  centrifugation	  (13200	  rpm,	  1	  min),	  washed	  once	  with	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ddH2O	   and	   resuspended	   in	   200	  µl	   breaking	   buffer	   (10	  mM	   Tris/HCl	   pH	  8.0,	  
100	  mM	  NaCl,	  1	  mM	  EDTA,	  1%	  SDS,	  2%	  Triton	  X-­‐100).	  After	  addition	  of	  200	  µl	  
phenol/chloroform	   solution	   (50%	   (v/v)	   phenol,	   50%	   (v/v)	   chloroform)	   and	  
200	  µl	  glass	  beads,	  the	  cells	  were	  lysed	  by	  harsh	  mixing	  for	  20	  min	  at	  4°C.	  200	  µl	  
ddH2O	  was	  added	  and	  the	  sample	  was	  centrifuged	  for	  10	  min	  at	  13200	  rpm.	  The	  
upper	  phase	  was	  transferred	  into	  a	  new	  reaction	  tube,	  mixed	  with	  1	  ml	  ice-­‐cold	  
ethanol	   and	   incubated	   for	   10	  min	   at	   -­‐20°C	   for	   precipitation	   of	   DNA.	   After	  
centrifugation	   for	  10	  min	  at	  13200	  rpm	  and	  4°C	   the	  supernatant	  was	  removed.	  
The	  pellet	  was	  resuspended	  in	  400	  µl	  ddH2O	  and	  3	  µl	  RNase	  A	  (10	  mg/ml)	  and	  
incubated	   for	  5	  min	   at	  37°C	   to	  digest	   the	  RNA.	   For	   further	  precipitation	  of	   the	  
remaining	  DNA,	  1	  ml	  of	  ice-­‐cold	  ethanol	  and	  10	  µl	  5	  M	  ammonium	  acetate	  were	  
added.	   After	   incubation	   of	   15	  min	   at	   -­‐20°C,	   the	   DNA	   was	   harvested	   by	  
centrifugation	  for	  10	  min	  at	  13200	  rpm	  and	  4°C.	  The	  supernatant	  was	  removed,	  
the	  DNA	  pellet	  was	  dried	  at	  37°C	  and	  finally	  resolved	  in	  35	  µl	  ddH2O.	  	  
3.5.2 High	  efficiency	  transformation	  of	  DNA	  in	  yeast	  
A	  50	  ml	  liquid	  yeast	  culture	  was	  inoculated	  from	  a	  log	  phase	  yeast	  culture	  with	  a	  
dilution	  of	  1:10.	  The	  cells	  were	  grown	  for	  2	  -­‐	  6	  h	  at	  30°C	  to	  an	  OD600	  of	  0.5	  -­‐	  0.8	  
and	  subsequently	  harvested	  by	  centrifugation	  (5	  min,	  2000	  rpm,	  RT).	  After	  two	  
washing	   steps	   with	   ddH2O	   and	   one	   with	   LiOAC-­‐Sorb	   (100	  mM	   lithiumacetate,	  
10	  mM	   Tris/acetate	   pH	  8.0,	   1	  mM	   EDTA,	   1	  M	   sorbitol)	   the	   cells	   were	  
resuspended	   in	   100	  –	  500	  µl	   LiOAC-­‐Sorb	   and	   incubated	   for	   15	  min	   at	   30°C	   for	  
recovery.	  50	  µl	  cells	  were	  used	  for	  one	  transformation	  reaction.	  For	  this,	  300	  µl	  
PEG	   in	  Li-­‐TE	  buffer	   (100	  mM	   lithiumacetate,	   10	  mM	  Tris/acetate	  pH	  8.0,	   1	  mM	  
EDTA,	  40%	  PEG	  3350),	  5	  µl	  herring	  sperm	  DNA	  and	  3	  –	  10	  µl	  of	   the	   respective	  
DNA	  were	  added.	  The	  reaction	  was	  first	   incubated	  for	  30	  min	  at	  30°C	  and	  then	  
shifted	   to	   42°C	   for	   15	  min.	   For	   recovery,	   the	   cells	   were	   transferred	   into	   2	  ml	  
YPD-­‐medium	   and	   shaken	   for	   2	  h	   at	   30°C.	   Finally,	   the	   cells	   were	   harvested	   by	  
centrifugation	   (5	  min,	   2000	  rpm,	   RT)	   and	   spread	   on	   the	   respective	   selection	  
medium.	  	  
3.5.3 “Quick	  and	  Dirty”	  transformation	  of	  plasmid-­‐DNA	  in	  yeast	  
For	  the	  fast	  transformation	  of	  plasmid-­‐DNA,	  yeast	  cells	  were	  taken	  from	  an	  agar	  
plate	   and	   resuspended	   in	   300	  µl	   PEG	   in	   Li-­‐TE	   buffer	   (100	  mM	   lithiumacetate,	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10	  mM	  Tris/acetate	  pH	  8.0,	  1	  mM	  EDTA,	  40%	  PEG	  3350).	  5	  µl	  of	  herring	  sperm	  
DNA	  and	  3	  –	  5	  µl	  of	  the	  plasmid/s	  were	  added.	  After	  gently	  mixing,	  the	  cells	  were	  
incubated	   for	   30	  min	   at	   30°C	   and	   then	   shifted	   to	   42°C.	   Afterwards,	   cells	  were	  
harvested	  by	  centrifugation	  (5	  min,	  2000	  rpm,	  RT),	  resuspended	  in	  70	  µl	  ddH2O	  
and	  directly	  spread	  on	  the	  respective	  selection	  medium.	  	  
3.5.4 Transformation	  of	  plasmid-­‐DNA	  into	  E.	  coli	  
In	   this	   study,	   transformation	   of	   plasmid-­‐DNA	   in	   E.	   coli	   was	   achieved	   by	  
electroporation.	  Here,	  the	  permeability	  of	  the	  cell	  membrane	  is	  increased	  by	  an	  
applied	   electric	   impulse	   resulting	   in	   the	   uptake	   of	   external	   DNA	   (Sheng	   et	   al.,	  
2005).	  For	  transformation,	  electrocompetent	  E.	  coli	  cells	  (see	  3.3.4)	  were	  thawed	  
on	   ice,	   mixed	   with	   1	  -­‐	  2	  µl	   of	   the	   appropriate	   DNA	   and	   transferred	   to	   a	   pre-­‐
chilled	   electroporation	   tube.	   The	   electroporation	   occurred	   at	   2500	  V.	   The	   cells	  
were	   resuspended	   in	   900	  µl	   SOC-­‐medium	   and	   shaken	   for	   1	  h	   at	   37°C	   for	  
recovery.	   After	   harvesting	   by	   centrifugation	   (5	  min,	   3000	  rpm,	   RT),	   the	   cells	  
were	   spread	   on	   LB-­‐plates	   containing	   the	   appropriate	   antibiotics	   for	   plasmid	  
selection.	  	  
3.5.5 Plasmid-­‐DNA	  isolation	  from	  E.	  coli	  
Liquid	  E.	  coli	  cultures	  were	  inoculated	  with	  cells	  from	  either	  an	  agar	  plate	  using	  a	  
sterile	  toothpick,	  from	  a	  short-­‐term	  culture	  or	  from	  a	  long-­‐term	  culture.	  The	  cells	  
were	   shaken	   at	   37°C	   over	   night	   (12	  -­‐	  14	  h)	   at	   220	  rpm.	   Plasmid-­‐DNA	   was	  
isolated	   using	   the	   Wizard	   Plus	   SV	   Kit	   from	   Promega	   according	   to	   the	  
manufacturer´s	  instructions.	  	  
3.5.6 DNA	  agarose	  gel	  electrophoresis	  
The	  DNA	  agarose	  gel	  electrophoresis	  was	  used	  as	  a	  standard	  method	  to	  separate	  
DNA	  fragments	  according	  to	  their	  size	  in	  an	  electric	  field.	  Depending	  on	  the	  size	  
of	   the	   DNA	   fragments,	   1	  –	  2%	   agarose	   gels	   supplemented	   with	   1	  µg/ml	  
ethidiumbromide	   in	   TAE	   buffer	   (40	  mM	   Tris/acetate	   pH	  8.1,	   2	  mM	   EDTA,	  
0.114%	  acetic	  acid)	  were	  used.	  The	  DNA	  samples	  were	  mixed	  with	  DNA	  sample	  
buffer	   (1	  M	  Tris/HCl	   pH	  8.0,	   50%	   (v/v)	   glycerol,	   0.1%	   (w/v)	  bromphenolblue)	  
and	  separated	  for	  20	  –	  30	  min	  at	  120	  V.	  To	  determine	  the	  DNA	  fragment	  size,	  the	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DNA	  Ladder	  Mix	  TriDye	  (1	  kb,	  NEB)	  was	  used.	  DNA	  bands	  were	  documented	  by	  
an	  UV-­‐transilluminator.	  
3.5.7 DNA	  gel	  extraction	  (Gel	  Extraction	  Kit)	  
For	  purification	  of	  DNA	  fragments	   from	  agarose	  gels,	   the	  Qiagen	  Gel	  Extraction	  
Kit	  from	  Qiagen	  (Hilden)	  was	  used	  according	  to	  the	  manufacturer´s	  instructions.	  	  
3.5.8 Polymerase	  chain	  reaction	  
DNA	  fragments	  used	  for	  molecular	  cloning	  or	  for	  homologous	  recombination	  in	  
yeast	  were	  amplified	  by	  PCR	  using	  the	  Taq	  DNA	  polymerase	  (NEB)	  or	  for	  longer	  
DNA	  fragments	  the	  KOD	  Hot	  Start	  DNA	  Polymerase	  (Novagen)	  according	  to	  the	  
recommendations	   of	   the	  manufacturer.	   Therefore,	   standard	  PCR	   reactions	   in	   a	  
50	  µl	   scale	  were	  performed.	  Plasmid	  DNA	  or	  yeast	   genomic	  DNA	  were	  used	  as	  
templates.	   The	   respective	   program	   was	   adapted	   for	   each	   PCR	   reaction	  
depending	  on	  oligonucleotides	  and	  product	  size.	  The	  amplified	  DNA	  was	  purified	  
using	   the	   Qiagen	   PCR	   Purification	   Kit	   from	   Qiagen	   according	   to	   the	  
manufacturer´s	  instructions.	  	  
3.5.9 Molecular	  cloning	  
In	  this	  study,	  several	  plasmids	  were	  constructed	  for	  the	  expression	  of	  a	  desired	  
fusion	  protein	  (see	  Table	  3).	  Therefore,	  the	  insert	  DNA	  sequence	  was	  amplified	  
by	  PCR	  using	  chromosomal	  DNA	  or	  another	  plasmid	  as	  template.	  Here,	  flanking	  
restriction	  sites	  for	  cloning	  were	  introduced	  by	  the	  designed	  primers	  (see	  Table	  
4).	  The	  DNA	  fragment	  was	  analyzed	  by	  agarose	  gel	  electrophoresis	  and	  purified	  
using	  the	  Qiagen	  Gel	  Extraction	  Kit	  (see	  chapter	  3.5.6	  +	  3.5.7).	  	  
The	   insert	   DNA	   fragment	   and	   the	   plasmid	   backbone	   were	   digested	   with	   the	  
respective	   restriction	   enzymes	   (NEB)	   according	   to	   the	   manufacturer´s	  
instructions	   in	   a	   scale	   of	   30	  µl.	   The	   reaction	   was	   incubated	   for	   90	  min	   at	   the	  
enzyme	  optimal	  temperature.	  Afterwards	  the	  fragments	  were	  again	  purified	  and	  
used	   for	   ligation.	   For	   determination	   of	   the	   optimal	   DNA	   ratio	   the	   following	  
equation	  was	  used:	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Equation	  1:	  Equation	  to	  calculate	  optimal	  plasmid-­‐insert	  ratio	  in	  ligation	  mix	  
mass  insert   ng =




To	  the	  appropriate	  volumes	  of	  plasmid	  and	  insert	  DNA,	  1	  µl	  of	  ligation	  buffer	  and	  
2.5	  U	  T4-­‐DNA-­‐ligase	   (NEB)	  were	   added	   and	   the	   reaction	  was	   filled	  up	   to	   10	  µl	  
with	  ddH2O.	  The	  ligation	  reaction	  was	  incubated	  for	  2	  h	  at	  room	  temperature	  or	  
over	  night	  at	  16°C.	  The	   ligated	  constructs	  were	   transformed	   in	  E.	  coli	  Dh5α	  by	  
electroporation	  (see	  chapter	  3.5.4).	  Potential	  clones	  were	  analyzed	  by	  restriction	  
analysis	  and	  finally	  verified	  by	  sequencing.	  	  
3.5.10 Plasmid	  construction	  
3.5.10.1 	  Plasmid	  constructs	  used	  in	  split-­‐ubiquitin	  assay	  
For	   the	   construction	   of	   all	   split-­‐ubiquitin	   plasmids,	   the	   plasmids	   pRS313-­‐
MET25-­‐STE14-­‐Cub-­‐RURA3	  (provided	  by	  F.	  Reggiori	   (University	  Medical	  Centre	  
Utrecht,	   Utrecht,	   The	   Netherlands)	   and	   N.	   Johnsson	   (Universität	   Ulm,	   Ulm,	  
Germany))	  and	  pRS314-­‐CUP1-­‐Nui-­‐UBC6	  (provided	  by	  N.	  Johnsson;	  (Wittke	  et	  al.,	  
1999))	  were	  used	  as	  initial	  plasmid	  backbone.	  The	  gene	  sequence	  of	  STE14	  was	  
cut	   out	   with	   ClaI	   and	   SalI	   (if	   not	   stated	   otherwise)	   and	   replaced	   with	   the	  
respective	   gene	   sequence.	   Similarly,	   the	   sequence	   of	   UBC6	   was	   cut	   out	   with	  
BamHI	  and	  XhoI,	  if	  not	  stated	  otherwise.	  	  
For	   MET25-­‐ATG16-­‐Cub-­‐RURA3,	   ATG16	   was	   amplified	   with	   Atg16Cub_ClaI_fwd	  
and	  Atg16Cub_SalI-­‐rev,	  cut	  with	  ClaI	  and	  SalI	  and	  ligated	  in	  MET25-­‐Cub-­‐RURA3.	  	  
For	   MET25-­‐ATG27-­‐Cub-­‐RURA3,	   ATG27	   was	   amplified	   with	   Atg27Cub_ClaI_fwd	  
and	  Atg27Cub_SalI_rev,	  cut	  with	  ClaI	  and	  SalI	  and	  ligated	  in	  MET25-­‐Cub-­‐RURA3.	  	  
For	   MET25-­‐ATG23-­‐Cub-­‐RURA3,	   ATG23	   was	   amplified	   with	   Atg23Cub_StuI_fwd	  
and	  Atg23Cub_SalI_rev.	  For	  MET25-­‐ATG5-­‐Cub-­‐RURA3,	  ATG5	  was	  amplified	  with	  
Atg5Cub_StuI_fwd	  and	  Atg5Cub_SalI_rev.	  Both	   fragment	  were	  cut	  with	  StuI	  and	  
SalI	   and	   ligated	   in	   MET25-­‐Cub-­‐RURA3.	   Before,	   pRS313-­‐MET25-­‐STE14-­‐Cub-­‐
RURA3	  was	  cut	  with	  ClaI,	  treated	  with	  the	  DNA-­‐polymerase	  Klenow	  to	  generate	  
a	  blunt	  side	  and	  finally	  cut	  with	  SalI	  to	  remove	  STE14.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  Mülhardt,	  Cornel:	  Der	  Experimentator	  Molekularbiologie/Genomics;	  5.	  Auflage,	  München	  2006,	  
Seite	  136	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For	  CUP1-­‐Nui-­‐ATG16,	  ATG16	  was	  amplified	  with	  Nui-­‐Atg16_BamHI_fwd	  and	  Nui-­‐
Atg16_XhoI_rev.	   For	   CUP1-­‐Nui-­‐ATG27,	   ATG27	   was	   amplified	   with	   Nui-­‐
Atg27_BamHI_fwd	   and	   Nui-­‐Atg27_XhoI_rev.	   All	   DNA	   fragments	   were	   cut	   with	  
BamHI	  and	  XhoI	  and	  ligated	  into	  pRS314-­‐CUP1-­‐Nui.	  	  
For	  CUP1-­‐Nui-­‐ATG23,	  ATG23	  was	  amplified	  with	  Nui-­‐Atg23_BamHI_fwd	  and	  Nui-­‐	  
Atg23_KpnI_rev,	   cut	   with	   BamHI	   and	   KpnI	   and	   ligated	   in	   pRS314-­‐CUP1-­‐Nui.	  
Before,	  pRS314-­‐CUP1-­‐Nui-­‐UBC6	  was	  cut	  with	  BamHI	  and	  KpnI	  to	  remove	  UBC6.	  
For	   CUP1-­‐Nui-­‐ATG12,	  ATG12	   was	   amplified	  with	   Nui-­‐Atg12_StuI_fwd	   and	   Nui-­‐
Atg12_XhoI_rev,	  cut	  with	  StuI	  and	  ligated	  in	  pRS314-­‐CUP1-­‐Nui.	  Before,	  pRS314-­‐
CUP1-­‐Nui-­‐UBC6	  was	  cut	  with	  BamHI,	  treated	  with	  the	  DNA-­‐polymerase	  Klenow	  
to	  generate	  a	  blunt	  side	  and	  finally	  cut	  with	  XhoI	  to	  remove	  UBC6.	  	  
3.5.10.2 	  	  Plasmid	  constructs	  for	  BiFC	  
Plasmids	   for	   expression	   of	   proteins	   fused	   to	   one	   half	   of	   eYFP	   were	   kindly	  
provided	   by	   Skarp	   et	  al.	   (2008).	   p426-­‐ADH-­‐C-­‐YC	   and	   p426-­‐ADH-­‐N-­‐YC	   allowed	  
fusion	   of	   the	   C-­‐terminal	   fragment	   of	   eYFP	   (amino	   acids	   173	   to	   238)	   to	   the	   C-­‐	  
respectively	  N-­‐terminus	   of	   a	   target	   protein.	   p425-­‐ADH-­‐N-­‐YN	   allowed	   fusion	   of	  
the	  N-­‐terminal	   fragment	  of	  eYFP	  (amino	  acids	  1	  to	  172)	  to	  the	  N-­‐terminus	  of	  a	  
target	  protein	  (Skarp	  et	  al.,	  2008).	  	  
For	   ADH-­‐ATG21-­‐C-­‐YC,	   ATG21	   was	   amplified	   with	   Atg21_C-­‐YC_BamHI_fwd	   and	  
Atg21_C-­‐YC_SalI_rev,	  cut	  with	  BamHI	  and	  SalI	  and	  ligated	  in	  p426-­‐ADH-­‐C-­‐YC.	  For	  
ADH-­‐N-­‐YC-­‐ATG21,	   ATG21	   was	   amplified	   with	   Atg21_N-­‐YC_BamHI_fwd	   and	  
Atg21_N-­‐YC_SalI_rev,	  cut	  with	  BamHI	  and	  SalI	  and	  ligated	  in	  p426-­‐ADH-­‐N-­‐YC.	  	  
For	   ADH-­‐ATG4-­‐C-­‐YC,	   ATG4	   was	   amplified	   with	   Atg4_C-­‐YC_EcoRI_fwd	   and	  
Atg4_C-­‐YC_SalI_rev,	   cut	  with	  EcoRI	  and	  SalI	   and	   ligated	   in	  p426-­‐ADH-­‐C-­‐YC.	  For	  
ADH-­‐N-­‐YC-­‐ATG4,	   ATG4	   was	   amplified	   with	   Atg4_N-­‐YC_EcoRI_fwd	   and	   Atg4_N-­‐
YC_SalI_rev,	  cut	  with	  EcoRI	  and	  SalI	  and	  ligated	  in	  p426-­‐ADH-­‐N-­‐YC.	  	  
For	   ADH-­‐N-­‐YN-­‐ATG8,	   ATG8	   was	   amplified	   with	   Atg8_N-­‐YN_BamHI_fwd	   and	  
Atg8_N-­‐YN_SalI_rev,	  cut	  with	  BamHI	  and	  SalI	  and	  ligated	  in	  p425-­‐ADH-­‐N-­‐YN.	  
p416-­‐MET25-­‐C-­‐YC	   was	   constructed	   by	   ligating	   a	   SalI	   and	   XhoI	   C-­‐YC	   fragment	  
from	   p426-­‐ADH-­‐C-­‐YC	   into	   p416-­‐MET25.	   Similarly,	   p415-­‐MET25-­‐N-­‐YN	   was	  
constructed	  by	  ligating	  a	  SpeI	  and	  BamHI	  N-­‐YN	   fragment	  from	  p425-­‐ADH-­‐N-­‐YN	  
into	  p415-­‐MET25.	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p416-­‐MET25-­‐ATG21-­‐C-­‐YC	  was	  constructed	  by	  ligating	  a	  BamHI	  and	  XhoI	  ATG21-­‐
C-­‐YC	   fragment	   from	  p426-­‐ADH-­‐ATG21-­‐C-­‐YC	   into	  p416-­‐MET25.	  Similarly,	  p415-­‐
MET25-­‐N-­‐YN-­‐ATG8	  was	   constructed	   by	   ligating	   a	   SpeI	   and	  HindIII	  N-­‐YN	  ATG8	  
fragment	  from	  p425-­‐ADH-­‐N-­‐YN-­‐ATG8	  into	  p415-­‐MET25.	  	  
3.5.10.3 	  	  Atg16	  plasmid	  constructs	  
For	  pRS313-­‐CUP1-­‐Atg16-­‐HA,	  ATG16-­‐HA	  was	  amplified	  with	  Atg16Cub_ClaI_fwd	  
and	  Atg16HA_XhoI_rev	  using	  genomic	  DNA	  prepared	  from	  cAtg16-­‐HA	  yeast	  cells.	  
Similarly,	   for	   pRS313-­‐CUP1-­‐ATG161-­‐57-­‐HA	   and	   pRS313-­‐CUP1-­‐ATG161-­‐119-­‐HA,	  
ATG161-­‐57-­‐HA	   and	   ATG161-­‐119-­‐HA	   were	   amplified	   with	   the	   same	   primer	   using	  
genomic	   DNA	   prepared	   from	   cAtg161-­‐57-­‐HA	   respectively	   cAtg161-­‐119-­‐HA	   yeast	  
cells.	   For	   pRS313-­‐CUP1-­‐ATG1658-­‐150-­‐HA,	   ATG1658-­‐150-­‐HA	   was	   amplified	   with	  
Atg16HA_58-­‐150_ClaI_fwd	  and	  Atg16HA_XhoI_rev	  using	  genomic	  DNA	  prepared	  
from	  cAtg16-­‐HA	  yeast	  cells.	  The	  DNA	  fragments	  were	  cut	  with	  ClaI	  and	  XhoI	  and	  
ligated	  into	  pRS313-­‐CUP1.	  
pRS313-­‐CUP1-­‐Atg16D101A-­‐HA,	   pRS313-­‐CUP1-­‐Atg16E102A-­‐HA,	   pRS313-­‐CUP1-­‐
Atg16D101A_E102A-­‐HA,	   pRS313-­‐CUP1-­‐Atg16E97A-­‐HA	   and	   pRS313-­‐CUP1-­‐Atg16K94A-­‐
HA	   were	   constructed	   using	   the	   QuikChange	   II	   Site-­‐Directed	   Mutagenesis	   Kit	  
(Agilent)	  as	  described	  in	  the	  manufacturer´s	  manual	  (see	  chapter	  3.5.11).	  Point	  
mutations	   were	   introduced	   using	   the	   respective	   primers:	  
Atg16_D101A_fwd+_rev;	   Atg16_E102A_fwd+_rev;	   Atg16_DE_fwd+_rev;	  
Atg16_E97A_fwd+_rev;	  Atg16_K94A_fwd+_rev.	  	  
For	  pGEX-­‐4T3-­‐GST-­‐Atg16,	  ATG16	  was	  amplified	  with	  GST-­‐Atg16_BamHI_fwd	  and	  
GST-­‐Atg16_XhoI_rev	   using	   genomic	   yeast	   DNA.	   Similarly,	   ATG161-­‐57	   was	  
amplified	   with	   GST-­‐Atg16_BamHI_fwd	   and	   GST-­‐Atg161-­‐57_XhoI_rev,	   ATG161-­‐119	  
was	   amplified	   with	   GST-­‐Atg16_BamHI_fwd	   and	   GST-­‐Atg161-­‐119_XhoI_rev	   and	  
ATG1658-­‐150	   was	   amplified	   with	   GST-­‐Atg1658-­‐150_BamHI_fwd	   and	   GST-­‐
Atg16_XhoI_rev.	  DNA	  fragments	  were	  digested	  with	  BamHI	  and	  XhoI	  and	  ligated	  
into	  pGEX-­‐4T3.	  Point	  mutations	  were	  introduced	  as	  described	  above.	  	  
pRS313-­‐Atg16D101A-­‐GFP,	   pRS313-­‐Atg16E102A-­‐GFP,	   pRS313-­‐Atg16D101A_E102A-­‐GFP,	  
pRS313-­‐Atg16K97A-­‐GFP	  were	  generated	  as	  described	  above	  using	  pRS313-­‐Atg16-­‐
GFP	  as	  template.	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3.5.11 Site-­‐directed	  mutagenesis	  of	  plasmids	  
To	   introduce	  point	  mutations	   in	  previously	   cloned	  genes,	   the	  QuikChange	  Site-­‐
Directed	  Mutagenesis	  Kit	  (Agilent)	  was	  used	  as	  described	  in	  the	  manufacturer´s	  
manual.	   For	   this,	   complementary	   primers	   containing	   the	   respective	   nucleotide	  
exchange	  were	  generated.	  The	  successful	  introduction	  of	  the	  point	  mutation	  was	  
verified	  by	  sequencing.	  	  
3.5.12 Sequencing	  of	  DNA	  
All	   new	   designed	   constructs	   were	   verified	   by	   sequencing	   using	   the	   Sanger	  
method.	   For	   this	   purpose,	   1	  µl	   of	   template	   plasmid	   DNA	   was	   mixed	   with	   1	  µl	  
sequencing	   mix	   (polymerase,	   dNTP	   mix	   with	   fluorescent	   dyes,	   30	  mM	  
magnesium	   chloride	   and	   buffer	   substances),	   8	  pmol	   oligonucleotides	   and	   6	  µl	  
ddH2O.	  After	  the	  sequencing	  reaction	  (25	  cycles:	  96°C	  10	  sec;	  55°C	  15	  sec;	  60°C	  
4	  min),	   the	   DNA	  was	   precipitated	   by	   adding	   1	  µl	   3	  M	   sodium	   acetate	   (pH	  5.2),	  
1	  µl	  125	  mM	  EDTA	  and	  50	  µl	  ethanol.	  The	  DNA	  was	  harvested	  by	  centrifugation	  
(13200	  rpm,	  10	  min,	  RT),	  washed	  with	  70%	  ethanol	  and	  dried.	  Finally,	  the	  DNA	  
was	  resuspended	  in	  15	  µl	  HiDye	  (formamide)	  and	  analyzed	  by	  the	  Department	  of	  
Developmental	   Biology	   of	   the	   Georg-­‐August-­‐Universität	   Göttingen	   using	   the	  
Genetic	  Analyzer	  3100	  (Applied	  Biosystems).	  	  
At	  the	  end	  of	  this	  study,	  sequencing	  was	  performed	  by	  GATC	  Biotech	  (Konstanz)	  
as	  described	  in	  the	  manufacturer´s	  instructions.	  	  
3.5.13 Gene	  deletion	  using	  homologous	  recombination	  
In	   this	   study,	   several	   deletion	   strains	   were	   performed	   using	   homologous	  
recombination	  as	  described	   in	  Longtine	  et	  al.	   (1998).	  For	   this	  approach,	  a	  DNA	  
fragment	  was	  amplified	  by	  PCR	  with	  special	  designed	  primers	  built	  up	  of	  a	  45	  bp	  
homologous	   sequence	   to	   the	   flanking	   region	   of	   the	   target	   gene	   followed	   by	   a	  
20	  bp	   homologous	   sequence	   of	   the	   selection	   gene	   (NatNT2	   cassette).	   For	  
amplification	  of	  the	  DNA	  fragment,	  the	  respective	  primers	  listed	  in	  Table	  4	  and	  
pFA6a-­‐NatNT2	  (see	  Table	  3)	  as	  plasmid	  template	  were	  used.	  The	  resulting	  DNA	  
fragment,	  comprised	  of	  the	  selection	  gene,	  flanked	  by	  the	  homologous	  sequence	  
to	  the	  up-­‐	  and	  downstream	  region	  of	  the	  target	  gene,	  was	  transformed	  into	  the	  
respective	   yeast	   strain	   using	   the	   high	   efficiency	   transformation	   protocol	   for	  
yeast	   (see	   chapter	   3.5.2).	   In	   principle,	   the	   similar	   sequence	   to	   the	   flanking	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regions	   of	   the	   target	   gene	   results	   in	   the	   exchange	   with	   the	   selection	   gene	   by	  
homologous	   recombination.	   Potential	   clones	   were	   selected	   on	   medium	  
containing	   NatNT2.	   The	   successful	   deletion	   of	   the	   target	   gene	  was	   verified	   by	  
control	  PCR	  analysis	  using	  chromosomal	  DNA	  as	  template	  and	  primers	  binding	  
to	   a	   region	   upstream	   of	   the	   target	   gene	   and	   within	   the	   selection	   gene	  
respectively.	  	  
3.6 Biochemical	  methods	  
3.6.1 SDS-­‐Polyacrylamide-­‐Gel-­‐Electrophorese	  (SDS-­‐PAGE)	  
Discontinuous	   SDS-­‐PAGE	   was	   performed	   as	   a	   standard	   method	   to	   separate	  
proteins	  according	  to	   their	  electrophoretic	  mobility	  as	  described	   in	  Laemmli	  et	  
al.	  (1970).	  For	  this	  purpose	  5%	  acrylamide	  stacking	  gels	  and,	  depending	  on	  the	  
molecular	   size	   of	   the	   relevant	   proteins,	   10	  -­‐	  15%	   acrylamide	   separating	   gels	  
were	  used.	  	  
	  
Table	  10:	  Contents	  of	  the	  separating	  gel	  	  
Separating	  Gel	   2	  x	  10%	   2	  x	  12%	   2	  x	  15%	  
ddH2O	   3.9	  ml	   3.4	  ml	   2.4	  ml	  
1.5M	  Tris	  (pH	  8.8)	   2.5	  ml	   2.5	  ml	   2.5	  ml	  
Protogel	  	   3.5	  ml	   4	  ml	   5	  ml	  
10%	  SDS	   100	  µl	   100	  µl	   100	  µl	  
10%	  APS	   100	  µl	   100	  µl	   100	  µl	  
TEMED	   5	  µl	   5	  µl	   5	  µl	  
	   	   	   	  
Table	  11:	  Contents	  of	  the	  stacking	  gel	  
Stacking	  Gel	   2	  x	  
ddH2O	   6.1	  ml	  
0.5M	  Tris	  (pH	  6.8)	   2.5	  ml	  
Protogel	   1.3	  ml	  
10%	  SDS	   100	  µl	  
10%	  APS	   100	  µl	  
TEMED	   10	  µl	  
	  
By	  default,	  10	  µl	  of	  the	  protein	  sample	  and	  as	  a	  marker	  the	  Precision	  Plus	  Protein	  
All	  Blue	  Standard	  (Bio-­‐Rad)	  were	  loaded	  (molecular	  weights:	  250	  kDa,	  150	  kDa,	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100	  kDa,	  75	  kDa,	  50	  kDa,	  37.5	  kDa,	  25	  kDa,	  15	  kDa	  10	  kDa).	  Electrophoresis	  was	  
performed	   in	   a	   Mini-­‐PROTEAN	   III	   electrophoresis	   chamber	   from	   Bio-­‐Rad	   at	   a	  
voltage	  of	  150	  V	  until	  the	  bromphenolblue	  front	  reached	  the	  end	  of	  the	  gel.	  The	  
separating	  gel	  was	   subsequently	   stained	  with	   colloidale	  Coomassie	  or	  used	   for	  
Western	  Blot	  analysis	  (see	  chapter	  3.6.2	  and	  3.6.3).	  	  
SDS-­‐sample-­‐buffer:	  	   116	  mM	  Tris/HCl	  pH	  6.8,	  12%	  (w/v)	  glycerol,	  3.42%	  (w/v)	  SDS,	  	  
	  	  	  	  	  	  	   0.004%	  	  bromphenolblue,	  2%	  β-­‐mercaptoethanol	  
SDS-­‐running-­‐buffer:	  	   200	  mM	  glycerol,	  25	  mM	  Tris,	  0.1%	  SDS	  
3.6.2 Western	  Blot	  analysis	  
Proteins	  separated	  by	  SDS-­‐PAGE	  were	  transferred	  onto	  a	  PDVF	  membrane	  using	  
custom-­‐made	  semi	  dry	  blotting	  chambers	  or	  a	  wet	  blot	  Mini	  Trans-­‐Blot	  Cell	  from	  
Bio-­‐Rad.	  For	   the	  semi	  dry	  blotting,	   the	  SDS-­‐gel,	  a	  PVDF	  membrane	  and	  six	   thin	  
Whatman	  filter	  papers	  were	  soaked	  with	  semi	  dry	  blotting	  buffer	  (25	  mM	  Tris,	  
192	  mM	  glycine)	  and	  built	  up	  as	  shown	  in	  Figure	  9.	  The	  transfer	  took	  place	  with	  
70	  mA	  per	  gel	  for	  90	  min	  at	  room	  temperature.	  	  
	  
Figure	  9:	  Scheme	  of	  semi	  dry	  Western	  Blot	  setting	  
	  
For	  the	  wet	  blotting,	   the	  SDS-­‐gel,	  a	  PDVF	  membrane,	   four	  thick	  Whatman	  filter	  
papers	  and	  two	  filter	  pads	  were	  soaked	  with	  wet	  blotting	  buffer	  (192	  mM	  glycin,	  
25	  mM	   Tris	   and	   20%	   methanol),	   assembled	   and	   inserted	   into	   the	   gel	   holder	  
cassette	   as	   shown	   in	   Figure	   10.	   The	   gel	   holder	   cassette	   was	   injected	   into	   the	  
buffer	  tank	  filled	  with	  cold	  wet	  blotting	  buffer	  and	  an	  ice	  pack.	  The	  transfer	  was	  
performed	  with	  70	  mA	  per	  gel	  for	  at	  least	  four	  hours	  up	  to	  over	  night	  at	  4°C.	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Figure	   10:	   Scheme	   of	  Wet	  Western	   Blot	   settings	   (adapted	   from	  Mini	   Trans-­‐Blot®	   Electrophoretic	  
Transfer	  Cell	  Instruction	  Manual)	  
After	  successful	  blotting,	  the	  membrane	  was	  incubated	  in	  blocking	  buffer	  (TBST	  
(20	  mM	  Tris/HCl	  pH	  7.6,	  137	  mM	  NaCl2,	  0.1%	  (w/v)	  Tween20)	  containing	  10%	  
(w/v)	   skim	  milk	   powder)	   for	   at	   least	   one	   hour	   at	   room	   temperature	   or	   over	  
night	  at	  4°C	  to	  mask	  all	  unspecific	  binding	  sites	  on	  the	  membrane.	  After	  washing	  
three	   times	  with	  25	  ml	  TBST	   for	  5	  min,	   the	  membrane	  was	   incubated	  with	   the	  
primary	  antibody	  (see	  Table	  5)	  for	  at	  least	  2	  h	  at	  room	  temperature	  or	  over	  night	  
at	  4°C.	  After	  that,	  the	  membrane	  was	  washed	  again	  three	  times	  with	  25	  ml	  TBST	  
for	   10	  min	   and	   incubated	   for	   one	   hour	   at	   room	   temperature	   with	   the	   HRP	  
coupled	   secondary	   antibody	   in	   25	  ml	   TBST	   containing	   1%	   (w/v)	   skim	   milk	  
powder	  (see	  Table	  5).	  The	  membrane	  was	  washed	  again	  three	  times	  with	  TBST	  
for	  10	  min	  and	  the	  signals	  were	  analyzed	  using	  the	  ECLTM	  system	  (USB)	  and	  LAS-­‐
3000	   (Fujifilm)	   according	   to	   the	   manufacturer´s	   instructions.	   Quantitative	  
statistics	  were	   performed	   using	   the	  AIDA	   Software,	   Version	   4.06.116	   (Raytest,	  
2005).	  	  
It	  is	  possible	  to	  strip	  off	  the	  antibodies	  of	  once	  immunodetected	  membranes	  and	  
to	  incubate	  the	  membrane	  with	  another	  primary	  antibody.	  For	  this	  purpose,	  the	  
membrane	   was	   first	   activated	   by	   methanol	   and	   after	   washing	   with	   TBST	  
incubated	   in	   10%	   (v/v)	   acetic	   acid	   for	   10	  min	   at	   room	   temperature.	   After	  
washing	  three	  times	  with	  TBST	  the	  membrane	  was	  incubated	  in	  25	  ml	  blocking	  
buffer	  and	  the	  cycle	  started	  again	  (see	  above).	  	  
3.6.3 Colloidal	  Coomassie	  staining	  
Unselective	  protein	  staining	  of	  SDS-­‐gels	  was	  performed	  by	  colloidal	  Coomassie.	  
The	   SDS-­‐gel	   was	   first	   incubated	   for	   1	  h	   in	   25	  ml	   fixating	   solution	   (40%	   (v/v)	  
ethanol,	  10%	  (v/v)	  acetic	  acid).	  After	  three	  washing	  steps	  with	  ddH2O,	  proteins	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were	  incubated	  in	  staining	  solution	  (20%	  (v/v)	  methanol,	  0.1%	  (w/v)	  Coomassie	  
Brilliant	   Blue	   G250,	   2%	   (w/v)	   ortho-­‐phosphoric	   acid,	   10%	   (w/v)	   ammonium	  
sulfate)	  over	  night	  at	   room	  temperature.	  Background	  staining	  was	  removed	  by	  
incubating	  in	  1%	  acetic	  acid	  until	  satisfaction.	  The	  Coomassie-­‐stained	  gels	  were	  
stored	  in	  1%	  acetic	  acid	  or	  ddH2O	  at	  4°C.	  	  
3.6.4 Determination	  of	  protein	  concentrations	  
Protein	   concentrations	   were	   determined	   using	   a	   Bradford	   DCTM	   protein	   assay	  
(Bio-­‐Rad)	  according	  to	  the	  manufacturer´s	  instructions.	  	  
3.6.5 Alkaline	  lysis	  of	  yeast	  cells	  
For	  a	  quick	  and	  harsh	  lysis	  of	  yeast	  cells	  the	  alkaline	  lysis	  procedure	  was	  used.	  
For	   this	   purpose,	   1	  -­‐	  2	  OD600	   of	   yeast	   cells	   was	   harvested	   by	   centrifugation	  
(13200	  rpm,	  1	  min,	  RT)	  and	  resuspended	  in	  1	  ml	  ice-­‐cold	  ddH2O	  and	  150	  µl	  lysis	  
solution	  (1.85	  M	  NaOH,	  7.5%	  (v/v)	  β-­‐mercaptoethanol).	  After	  10	  min	  incubation	  
on	   ice	   and	   repeated	   harsh	   mixing,	   150	  µl	   50%	   TCA	   solution	   was	   added	   and	  
thoroughly	  mixed.	  After	  incubation	  on	  ice	  for	  10	  min,	  the	  sample	  was	  centrifuged	  
for	  10	  min	  at	  13200	  rpm	  (4°C).	  The	  supernatant	  was	  removed	  and	  the	  pellet	  was	  
washed	  twice	  with	  200	  µl	  ice-­‐cold	  acetone.	  Finally,	  the	  pellet	  was	  resuspended	  in	  
50	  -­‐	  100	  µl	  2	  x	  SDS-­‐sample	  buffer	  (116	  mM	  Tris/HCl	  pH	  6.8,	  12%	  (w/v)	  glycerol,	  
3.42%	   (w/v)	   SDS,	   0.004%	   bromphenolblue,	   2%	   β-­‐mercaptoethanol)	   and	  
analyzed	  by	  SDS-­‐PAGE	  and	  Western	  Blotting.	  	  
3.6.6 Cell	  lysis	  for	  detection	  of	  Atg8-­‐PE	  
For	  detection	  of	  Atg8-­‐PE,	  cells	  were	  lysed	  as	  described	  in	  Suzuki	  et	  al.	  (2001).	  In	  
detail,	   60	  OD600	   of	   growing	   yeast	   cells	   was	   harvested	   by	   centrifugation	   at	  
2000	  rpm	   for	   5	  min	   and	   resuspended	   in	   500	  µl	   lysis	   buffer	   (50	  mM	   Tris/HCl	  
pH	  7.5,	   150	  mM	   NaCl,	   5	  mM	   EDTA,	   5	  mM	   EGTA,	   1	  mM	   PMSF,	   CompleteTM	  
(Roche),	  protease	  inhibitor).	  After	  addition	  of	  200	  µl	  glass	  beads,	  the	  cells	  were	  
lysed	  by	  harsh	  mixing	  for	  10	  min	  at	  4°C.	  Afterwards,	  the	  cell	   lysate	  was	  cleared	  
by	  centrifugating	  for	  5	  min	  at	  3000	  rpm	  and	  4°C.	  200	  µl	  of	  the	  supernatant	  was	  
transferred	   into	   a	   new	   reaction	   tube	   and,	   after	   addition	   of	   40	  µl	   6	  x	  Laemmli,	  
boiled	   at	   95°C	   for	   5	  min.	   For	   separating	   Atg8	   and	   Atg8-­‐PE,	   the	   samples	   were	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separated	  on	  a	  15%	  SDS-­‐PAGE	  containing	  6	  M	  urea,	  subjected	  to	  immunoblotting	  
and	  analyzed	  using	  an	  anti-­‐Atg8	  antibody	  (see	  Table	  5).	  	  
3.6.7 Preparation	  of	  whole	  cell	  extracts	  –	  the	  mild	  cell	  lysis	  procedure	  
For	   gelfiltration	   chromatography,	   sorbitol	   density	   gradient	   centrifugation	   and	  
GFP-­‐TRAP®	  analysis,	  it	  was	  needed	  to	  prepare	  crude	  yeast	  cell	  lysate	  in	  a	  special	  
mild	   cell	   lysis	   procedure.	   For	   this	   purpose,	   the	   cells	   were	   first	   converted	   into	  
spheroblasts	   and	   subsequently	   mechanically	   lysed	   using	   a	   glass/ceramic	  
homogenizer.	  In	  detail,	  500	  OD600	  yeast	  cells	  was	  harvested	  by	  centrifugation	  at	  
2000	  rpm	   for	   5	  min.	   The	   cells	   were	   once	   washed	   with	   30	  ml	   10	  mM	   NaN3,	  
resuspended	   in	   5	  ml	   SP-­‐buffer	   (1.4	  M	   sorbitol,	   50	  mM	   KH2PO4	   pH	  7.5,	   10	  mM	  
NaN3,	   40	  mM	   β-­‐mercaptoethanol)	   containing	   1.5	  mg	   zymolyase	   T100	   (the	  
zymolyase	   has	   been	   shaken	   in	   SP-­‐buffer	   for	   30	  min	   at	   30°C	   before)	   and	  
incubated	   for	   40	  min	   at	   30	  min	   in	   a	   water	   bath	   under	   weak	   shaking.	   The	  
generated	  spheroblasts	  were	  harvested	  by	  centrifugation	  at	  1000	  x	  g	  for	  10	  min	  
at	  4°C	  and	  washed	  with	  5	  ml	   SP-­‐buffer.	   SP-­‐buffer	  was	  added	   in	  1	  ml	   steps	  and	  
the	   spheroblasts	  were	   carefully	   resuspended	  using	  a	   rounded	  glass	   stick.	  After	  
centrifugation	  at	  2000	  x	  g	  for	  10	  min	  at	  4°C,	  the	  spheroblasts	  were	  resuspended	  
in	  500	  µl	   of	   the	  particular	   lysis	  buffer	   (see	  below)	   and	   transferred	   into	   an	   ice-­‐
cooled	  glass/ceramic	  homogenizer.	  The	  cells	  were	  lysed	  with	  30	  pushes	  and	  the	  
cell	  lysate	  was	  transferred	  into	  a	  new	  reaction	  cup.	  The	  homogenizer	  was	  rinsed	  
with	   500	  µl	   lysis	   buffer,	   which	   was	   added	   to	   the	   cell	   lysate.	   If	   not	   stated	  
otherwise,	  0.5%	  Triton	  X-­‐100	  was	  added	  and	  the	  mix	  was	  incubated	  for	  5	  min	  at	  
4°C.	  Cell	  debris	  was	  removed	  by	  centrifugation	  at	  3000	  x	  g	  for	  10	  min	  at	  4°C	  and	  
the	   remaining	   crude	   cell	   lysate	   was	   used	   for	   the	   particular	   application	  
mentioned	   above.	   The	   volume	   of	   the	   SP-­‐	   and	   lysis	   buffer	   was	   adapted	   to	   the	  
particular	  yeast	  amount	  if	  the	  approach	  was	  scaled	  up	  or	  down.	  	  
3.6.8 GFP-­‐TRAP®	  
For	   the	   GFP-­‐TRAP®,	   350	  OD600	   yeast	   cells	  was	   harvested,	   treated	   and	   lysed	   in	  
350	  µl	   TRAP	   lysis	   buffer	   (1	  x	   PBS	   pH	  7.4,	   0.2	  M	   sorbitol,	   5	  mM	   MgCl2,	   1	  mM	  
PMSF,	   CompleteTM	   (Roche),	   protease	   inhibitors)	   as	   described	   in	   chapter	   3.6.7.	  
For	   immunoblot	   analysis,	   25	  µl	   of	   the	   cell	   lysate	   was	   diluted	   with	   25	  µl	  
6	  x	  Laemmli	   buffer	   containing	   6%	  β-­‐mercaptoethanol	   and	   boiled	   for	   10	  min	   at	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95°C	  (refer	  to	  as	  input).	  The	  remaining	  crude	  cell	  lysate	  was	  supplemented	  with	  
10	  µl	  GFP-­‐TRAP®	  bead	  slurry,	  which	  was	  washed	  twice	  with	  100	  µl	  PBS	  before	  
(2700	  x	  g,	   2	  min,	   4°C).	   After	   incubation	   for	   2	  –	  4	  h	   at	   4°C	   under	   constant	  
inverting,	   the	   beads	  were	   harvested	   by	   centrifugation	   at	   2000	  x	  g	   for	   2	  min	   at	  
4°C.	   25	  µl	   of	   the	   supernatant	   was	   diluted	   with	   25	  µl	   6	  x	  Laemmli	   buffer	  
containing	   6%	   β-­‐mercaptoethanol	   and	   boiled	   for	   10	  min	   at	   95°C	   (refer	   to	   as	  
supernatant).	   The	   beads	  were	  washed	   once	  with	   1	  ml	   and	   afterwards	   3	   times	  
with	   0.5	  ml	   lysis	   buffer	   (2000	  x	  g,	   2	  min,	   4°C)	   and	   finally	   eluted	   in	   50	  µl	   2	  x	  
Laemmli	  buffer	  containing	  2%	  β-­‐mercaptoethanol	  by	  boiling	  for	  10	  min	  at	  95°C	  
(refer	  to	  as	  bound).	  The	  samples	  were	  subjected	  to	  Wet	  Western	  Blot	  analysis	  as	  
described	  in	  chapter	  3.6.2.	  	  
3.6.9 Gelfiltration	  chromatography	  
For	  analysis	  of	  the	  high	  molecular	  weight	  Atg21	  complex,	  yeast	  cells	  were	  grown	  
in	   selection	  medium	   to	  mid-­‐log	  phase.	  1000	  OD600	   log	   cells	  were	  prepared	  and	  
lysed	   in	  1	  ml	  GF	   lysis	  buffer	   (0.8	  M	  sorbitol,	   10	  mM	  MOPS	  pH	  7.2,	  1	  mM	  EDTA,	  
2	  mM	   PMSF,	   CompleteTM	  (Roche),	   protease	   inhibitors)	   as	   described	   in	   chapter	  
3.6.7.	   After	   preclearing	   for	   10	  min	   at	   500	  x	  g	   and	   4°C,	   the	   cell	   lysate	   was	  
centrifuged	   at	   49	  000	  rpm	   for	   30	  min	   at	   4°C	   (Beckman	   ultracentrifuge,	   Rotor	  
TLA-­‐100.3).	   The	   resultant	   supernatant	   was	   separated	   by	   size	   exclusion	  
chromatography	   on	   a	   SuperoseTM	  6	   10/300	   GL	   column	   (Amersham	   Pharmacia	  
Biotech,	  Schweden),	  which	  was	  equilibrated	  with	  lysis	  buffer	  before.	  The	  elution	  
from	  the	  column	  was	  carried	  out	  at	  a	  flow	  rate	  of	  0.5	  ml/min	  and	  0.8	  ml	  fractions	  
were	   collected.	   The	   fractionated	   cell	   lysate	   was	   precipitated	   by	   adding	   80	  µl	  
100%	  TCA	   and	   10	  min	   storage	   on	   ice.	   After	   centrifugation	   for	   10	  min	   at	  
13	  200	  rpm	  at	  4°C,	  the	  pellet	  was	  washed	  twice	  with	  200	  µl	  acetone.	  The	  pellet	  
was	   dried	   at	   37°C	   for	   10	  min	   and	   finally	   resuspended	   in	   50	  µl	   Laemmli	   buffer	  
containing	   2%	   β-­‐ME	   and	   analyzed	   by	   SDS-­‐PAGE	   and	  Wet	  Western	   Blotting	   as	  
described	   in	   chapter	   3.6.2.	   To	   determine	   the	   size	   of	   potential	   high	   molecular	  
weight	   complexes,	   marker	   proteins	   (ApeI,	   PGK1	   and	   CPY1)	   with	   well	   known	  
molecular	  masses	  were	  detected	  by	  immunoblot	  analysis	  using	  anti-­‐ApeI,	  -­‐PGK1	  
and	  –CPY1	  antibodies	  (see	  Table	  5).	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3.6.10 Density	  gradient	  centrifugation	  
Density	  gradient	  centrifugation	  was	  used	  to	   further	  analyze	  the	  high	  molecular	  
weight	  Atg21	  complex.	  Cells	  expressing	  pMET25-­‐mCherry	  or	  pMET25-­‐mCherry-­‐
Atg21	  were	  grown	  in	  the	  absence	  of	  methionine	  to	  mid-­‐log	  phase.	  500	  OD600	  of	  
cells	  was	  harvested,	  treated	  and	  lysed	  in	  500	  µl	  lysis	  buffer	  (10	  mM	  MOPS	  pH	  7.2,	  
0.2	  M	   sorbitol,	   1	  mM	   EDTA,	   2	  mM	   PMSF,	  CompleteTM,	   protease	   inhibitor)	   as	  
described	   in	   chapter	   3.6.7.	   After	   preclearing	   of	   the	   crude	   cell	   extract	   (10	  min,	  
500	  x	  g,	  4°C),	  the	  supernatant	  was	  ultracentrifuged	  for	  30	  min	  at	  100	  000	  x	  g	  and	  
4°C	  (Beckman	  ultracentrifuge,	  Rotor	  TLA-­‐100.3).	  The	  resulting	  supernatant	  was	  
loaded	  on	  the	  top	  of	  a	  glycerol	  density	  gradient	  (per	  step	  450	  µl	  50%,	  40%,	  30%,	  
20%	   glycerol)	   or	   sorbitol	   density	   gradient	   (per	   step	   450	  µl	   2.5	  M,	   2	  M,	   1.5	  M,	  
0.9	  M	  sorbitol).	  After	  4	  h	  of	  ultracentrifugation	  at	  259	  000	  x	  g	  and	  4°C	  (Beckman	  
ultracentrifugation,	  Rotor	  TLS-­‐55),	  ten	  fractions	  each	  200	  µl	  were	  collected	  and	  
precipitated	  with	  20	  µl	  100%	  TCA.	  The	  sediments	  were	  washed	  two	  times	  with	  
200	  µl	   acetone,	   resuspended	   in	   100	  µl	   2	  x	  Laemmli	   buffer	   and	   subjected	   to	  
immunoblotting.	  
	  
Table	  12:	  Densities	  of	  the	  glycerol	  or	  sorbitol	  solutions	  used	  in	  density	  gradient	  centrifugation	  
density	  [g/ml]	   Glycerol	   Sorbitol	  
1.145	   50%	   2.5	  M	  
1.111	   40%	   2	  M	  
1.085	   30%	   1.5	  M	  
1.049	   20%	   0.9	  M	  
3.6.11 Pull	  down	  of	  His-­‐SUMO-­‐Atg21	  
3.6.11.1 	  Purification	  of	  recombinant	  6xHis-­‐SUMO-­‐Atg21	  and	  6xHis-­‐SUMO	  
Liquid	   precultures	   were	   inoculated	   with	   E.	   coli	   BL21	   (DE3)	   pLysS	   cells	  
expressing	   6xHis-­‐SUMO-­‐Atg21	   or	   6xHis-­‐SUMO	   alone	   from	   either	   an	   agar	   plate	  
using	  a	  sterile	  toothpick	  or	  from	  a	  short-­‐term	  culture.	  The	  cells	  were	  shaken	  at	  
37°C	   over	   night	   (12	  –	  14	  h)	   at	   220	  rpm.	   At	   the	   next	   morning	   the	   cells	   were	  
diluted	  to	  an	  OD600	  of	  0.2	  and	  shaken	  for	  90	  min	  at	  30°C	  and	  220	  rpm.	  To	  induct	  
the	   expression	   of	   6xHis-­‐SUMO-­‐Atg21	   or	   6xHis-­‐SUMO,	   0.2	  mM	   IPTG	   and	   1	  mM	  
PMSF	   were	   added.	   The	   cells	   were	   grown	   at	   30°C	   for	   4.5	  -­‐	  5	  h,	   harvested	   by	  
centrifugation	   (5	  min,	   5000	  rpm,	  RT),	  washed	  with	  10	  ml	  1	  x	  PBS	   (pH	  7.4)	   and	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finally	   frozen	   in	   liquid	  nitrogen.	  The	  cell	  pellets	  were	  stored	  at	   -­‐80°C	  until	  use.	  
The	  frozen	  cell	  pellets	  were	  resuspended	  in	  ice-­‐cold	  lysis	  buffer	  (1	  x	  PBS	  pH	  7.4,	  
2	  mM	  MgCl2,	  protease	   inhibitors	  (Sigma),	  1	  µl	  benzonase)	  and	  stored	  on	   ice	   for	  
10	  min.	  For	   immunoblot	  analysis,	  15	  µl	  of	   the	  cell	   lysate	  was	  diluted	  with	  15	  µl	  
6	  x	  Laemmli	  buffer	  containing	  50	  mM	  DTT	  and	  boiled	  for	  10	  min	  at	  72°C	  (refer	  to	  
as	  E.	  coli	   L).	  After	   addition	  of	  1%	   (v/v)	  Triton	  X-­‐100,	   the	  unsoluble	  parts	  were	  
spun	  out	  for	  10	  min	  at	  10	  000	  rpm	  and	  4°C.	  For	  immunoblot	  analysis,	  15	  µl	  of	  the	  
supernatant	  was	   diluted	  with	   15	  µl	   6	  x	  Laemmli	   buffer	   containing	   50	  mM	  DTT	  
and	  boiled	  for	  10	  min	  at	  72°C	  (refer	  to	  as	  E.	  coli	  T).	  To	  couple	  6xHis-­‐SUMO-­‐Atg21	  
to	   an	   agarose	  matrix	   via	   its	   His-­‐tag,	   the	   remaining	   supernatant	   was	   added	   to	  
100	  µl	  50%	  Ni-­‐NTA	  beads	  slurry	  (Qiagen,	  Hilden),	  which	  was	  washed	  twice	  with	  
1	  ml	  ddH2O	  and	  once	  with	  1	  ml	  1	  x	  PBS	  (pH	  7.4)	  before.	  After	  addition	  of	  20	  mM	  
imidazole	   (fresh	   prepared)	   to	   reduce	   unspecific	   background	   binding,	   the	   mix	  
was	   incubated	   for	   45	  min	   at	   4°C	   under	   constant	   shaking.	   The	   beads	   were	  
harvested	  by	  centrifugation	  (5	  min,	  500	  x	  g,	  4°C),	  washed	  four	  times	  with	  500	  µl	  
wash	  buffer	   (1	  x	  PBS	  pH	  7.4,	  20	  mM	   imidazole)	   and	   finally	   stored	   in	  500	  µl	  1	  x	  
PBS	  (pH	  7.4)	  on	  ice	  until	  use.	  	  
3.6.11.2 	  	  6xHis-­‐SUMO-­‐Atg21	  pull	  down	  with	  crude	  yeast	  cell	  extract	  
50	  OD600	   yeast	   cells	   was	   harvested	   by	   centrifugation	   (2000	  rpm,	   5	  min,	   4°C),	  
washed	  with	  5	  ml	  1	  x	  PBS	  (pH	  7.4)	  and	  subsequently	  resuspended	   in	  1	  ml	   lysis	  
buffer	   (1	  x	  PBS	   pH	  7.4,	   5	  mM	   EDTA,	   0.5%	   (v/v)	   Triton	  X-­‐100,	   1	  mM	   PMSF,	  
CompleteTM	   (Roche),	   protease	   inhibitors).	   After	   addition	   of	   0.2	  ml	   glass	   beads,	  
the	   cells	   were	   mixed	   harsh	   for	   20	  min	   at	   4°C	   followed	   by	   a	   preclearing	  
centrifugation	   step	   at	   3000	  rpm	   and	   4°C	   for	   5	  min.	   For	   immunoblot	   analysis,	  
50	  µl	   of	   the	   supernatant	   was	   diluted	  with	   10	  µl	   6	  x	  Laemmli	   buffer	   containing	  
50	  mM	   DTT	   and	   boiled	   for	   10	  min	   at	   72°C	   (refer	   to	   as	   yeast	   input).	   The	  
remaining	  supernatant	  was	  given	  to	  the	  prepared	  Ni-­‐NTA-­‐6xHis-­‐SUMO-­‐Atg21	  or	  
–SUMO	  beads	  (see	  chapter	  3.6.11.1).	  The	  mix	  was	  incubated	  2	  –	  4	  h	  at	  4°C	  under	  
constant	  shaking.	  After	  extensive	  washing	  with	  lysis	  buffer,	  bound	  proteins	  were	  
eluted	  with	   50	  µl	   Laemmli	   buffer	   containing	   50	  mM	  DTT,	   boiled	   for	   10	  min	   at	  
72°C	   (refer	   to	   as	   bound)	   and	   analyzed	   by	   12%	   SDS-­‐PAGE	   and	   following	   Wet	  
Western	  Blot	  analysis	  (see	  chapter	  3.6.2).	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3.6.11.3 	  	  Purification	  of	  GST-­‐Atg16	  	  
To	   test,	   if	   Atg21	   and	   Atg16	   interact	   directly	   with	   each	   other,	   recombinant	  
expressed	  GST-­‐Atg16	  was	   incubated	  with	   recombinant	  6xHis-­‐SUMO-­‐Atg21.	  For	  
this	  purpose,	  GST-­‐Atg16	  was	  expressed	  and	  purified	  analogous	  to	  6xHis-­‐SUMO-­‐
Atg21	   (see	   chapter	   3.6.11.1)	  without	   imidazole.	   Furthermore,	   100	  µl	   of	   a	   50%	  
Glutathione	  SepharoseTM	  4B	  (GE	  healthcare)	  was	  used	   for	  coupling.	  The	  bound	  
GST-­‐Atg16	  constructs	  were	  eluted	  with	  300	  µl	  glutathione	  elution	  buffer	  (10	  mM	  
reduced	  glutathione,	  50	  mM	  Tris/HCl	  pH	  8.0)	  in	  a	  three-­‐step	  procedure.	  For	  this	  
purpose,	  100	  µl	  of	  the	  elution	  buffer	  was	  added	  to	  the	  GST	  column	  and	  incubated	  
for	  10	  min	  at	   room	  temperature	  under	  constant	  mixing.	  After	  sedimentation	  of	  
the	  beads	  (3	  min,	  500	  x	  g,	  RT),	  the	  supernatant	  containing	  eluted	  GST-­‐Atg16	  was	  
collected	   and	   the	   elution	   procedure	   was	   repeated	   two	   times.	   The	   protein	  
concentration	   of	   the	   eluted	   GST-­‐Atg16	   constructs	   was	   determined	   using	  
Bradford	  assay	   (see	  chapter	  3.6.4).	  The	  purified	  GST-­‐Atg16	  variants	  were	  used	  
for	  the	  direct	  SUMO-­‐Atg21	  pull	  down	  (see	  chapter	  3.6.11.4).	  	  
3.6.11.4 	  	  6xHis-­‐SUMO-­‐Atg21	  pull	  down	  with	  recombinant	  proteins	  
To	   determine	   a	   direct	   interaction	   of	   Atg21	   and	   Atg16,	   purified	   recombinant	  
6xHis-­‐SUMO-­‐Atg21	   was	   incubated	   with	   purified	   recombinant	   GST-­‐Atg16.	   For	  
this	   purpose,	   purified	   GST-­‐Atg16	   variants	   (see	   chapter	   3.6.11.3)	   were	   diluted	  
with	  binding	  buffer	  (20	  mM	  Na-­‐P-­‐buffer	  pH	  7.4,	  150	  mM	  NaCl,	  1	  mM	  EDTA,	  0.2%	  
(v/v)	  Triton	  X-­‐100,	  1	  mM	  PMSF,	  1	  x	  Complete	  (Roche),	  protease	  inhibitors)	  to	  a	  
concentration	   of	   10	  µM	   in	   500	  µl.	   For	   immunoblot	   analysis,	   20	  µl	   of	   the	  
preparation	  was	   diluted	  with	   10	  µl	   6	  x	  Laemmli	   buffer	   containing	   50	  mM	   DTT	  
and	  boiled	  for	  10	  min	  at	  72°C	  (refer	  to	  as	  input).	  The	  remaining	  GST-­‐Atg16	  was	  
added	  to	  the	  purified	  and	  immobilized	  6xHis-­‐SUMO-­‐Atg21	  (see	  chapter	  3.6.11.1),	  
which	  was	   equilibrated	  with	   binding	   buffer	   before.	   After	   incubation	   for	   2	  h	   at	  
4°C	  under	  constant	  mixing,	  the	  beads	  were	  sedimented	  (5	  min,	  500	  x	  g,	  4°C)	  and	  
washed	   twice	   with	   500	  µl	   binding	   buffer	   and	   once	   with	   500	  µl	   wash	   buffer	  
(20	  mM	  Na-­‐P-­‐buffer	   pH	  7.4,	   150	  mM	  NaCl,	   1.5	  mM	  EDTA,	   0.2%	   (v/v)	   Triton	  X-­‐
100,	  1	  mM	  PMSF,	  CompleteTM	  (Roche),	  protease	  inhibitors).	  The	  bound	  proteins	  
were	  eluted	  with	  50	  µl	  Laemmli	  buffer	  containing	  50	  mM	  DTT,	  boiled	  for	  10	  min	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at	  72°C	  (refer	   to	  as	  bound)	  and	  analyzed	  by	  12%	  SDS-­‐PAGE	  and	   following	  Wet	  
Western	  Blot	  analysis	  (see	  chapter	  3.6.2).	  	  
3.6.12 	  Mass	  spectrometry	  analysis	  
Mass	   spectrometry	   analysis	   was	   performed	   by	   the	   Bioanalytical	   Mass	  
Spectrometry	   Group	   of	   Prof.	   Henning	   Urlaub	   (Bioanalytics,	   Department	   of	  
Clinical	  Chemistry,	  University	  Göttingen).	  
3.6.12.1 	  	  Materials	  
Chemicals	  used	  were	   from	  Sigma-­‐Aldrich,	  Taufkirchen.	   Solvents	  were	  obtained	  
from	   Merck	   KgaA	   (Darmstadt)	   in	   Lichrosolv	   quality.	   Porcine	   trypsin	   was	  
obtained	   from	   Serva	   Electrophoresis	   (Heidelberg).	   Chromatography	   materials	  
were	  obtained	  from	  Dr.	  Maisch	  (Ammerbuch-­‐Entringen).	  
3.6.12.2 	  	  In-­‐gel	  digestion	  
Gel	   spots	   were	   washed	   with	   water,	   reduced	   with	   DTT	   (10	  mM	   in	   100	  mM	  
NH4HCO3,	   50	  min,	   56°C)	   and	   alkylated	  with	   iodoacetamide	   (55	  mM	   in	   100	  mM	  
NH4HCO3,	  20	  min,	  room	  temperature,	  dark).	   In	  between	  sample	  handling	  steps,	  
the	  gel	  spots	  were	  washed	  with	  acetonitrile	  for	  15	  min	  and	  taken	  to	  dryness	  in	  a	  
Speedvac	   at	   35°C	   (Savant	   Model	   SPD111V,	   Thermo	   Scientific,	   Dreieich)	   to	  
remove	  excess	   solvent	  and	   improve	  uptake	  of	   reagent	   solution.	  Gel	   spots	  were	  
rehydrated	  with	   porcine	   trypsin	   (12.5	  ng/µl	   in	   50	  mM	  NH4HCO3,	   5	  mM	   CaCl2),	  
50	  mM	  NH4HCO3	  added	  as	  supernatant	  and	  digested	  over	  night	  at	  37°C.	  
3.6.12.3 	  Peptide	  extraction	  
Following	  digestion,	  10	  µl	  of	  water	  was	  added	  and	  the	  gel	  pieces	  were	  incubated	  
at	  37°C	  for	  15	  min.	  After	  a	  short	  centrifugation	  step,	  80	  µl	  acetonitrile	  was	  added	  
and	   the	   samples	   again	   incubated	   at	   37°C	   for	   15	  min.	   The	   supernatant	   was	  
removed	  and	  transferred	  to	  an	  Eppendorf	  vial.	  	  
65	  µl	  of	  5%	  formic	  acid	  was	  added	  to	  the	  gel	  pieces,	  vortexed	  and	  incubated	  at	  
37°C	  for	  15	  min.	  65	  µl	  of	  acetonitrile	  was	  added	  and	  again	  incubated	  at	  37°C	  for	  
15	  min.	   After	   a	   short	   centrifuge	   step,	   excess	   solvent	  was	   removed	   and	   pooled	  
with	  the	  supernatant	  from	  the	  first	  extraction	  step.	  The	  combined	  supernatants	  
were	  taken	  to	  dryness	  in	  a	  Speedvac	  at	  35°C	  and	  stored	  at	  -­‐20°C	  until	  analysis.	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3.6.12.4 	  	  Mass	  spectrometric	  analysis	  
The	   resulting	   peptide	   mixtures	   were	   concentrated	   on	   a	   Reversed	   Phase-­‐C18	  
precolumn	   (0.15	  mm	   ID	   x	   20	   mm	   self-­‐packed	   with	   Reprosil-­‐Pur	   120	   C18-­‐AQ	  
3	  μm	  material)	  and	  separated	  by	  Reversed	  Phase-­‐C18	  nanoflow	  chromatography	  
(0.075	  mm	  ID	  x	  200	  mm	  Picofrit	  column	  (New	  Objective,	  Woburn,	  MA/USA)	  self-­‐
packed	   with	   Reprosil-­‐Pur	   120	   C18-­‐AQ	   3	  μm	   material)	   using	   a	   22	  min	   linear	  
gradient	   (5	  -­‐	  35%	   acetronitrile	   vs.	   0.1%	   formic	   acid,	   240	  nl/min)	   on	   an	   EASY	  
nLC-­‐1000	  system	  (Thermo	  Scientific,	  Dreieich).	  The	  eluent	  was	  analyzed	  using	  a	  
Top10	   method	   in	   Data	   Dependent	   Acquisition	   mode	   on	   a	   Q	   Exactive	   high	  
resolution	   mass	   spectrometry	   system	   (Thermo	   Scientific,	   Dreieich)	   operated	  
under	  Tune	  2.2	  using	  HCD	  fragmentation,	  with	  a	  Normalized	  Collision	  Energy	  of	  
25%.	   Peak	   lists	   were	   generated	   using	   Raw2MSM	   v1.10	   software	   (MPI	   for	  
Biochemistry,	  Martinsried).	  
3.6.12.5 	  Database	  Searching	  
Tandem	   mass	   spectra	   were	   extracted	   by	   Raw2MSM	   software	   version	   1.7	  
including	  charge	  state	  deconvolution	  and	  deisotoping.	  All	  MS/MS	  samples	  were	  
analyzed	  using	  Mascot	  (Matrix	  Science,	  London,	  UK;	  version	  2.4.1).	  Mascot	  was	  
set	  up	  to	  search	  the	  SwissProt	  2012_11x	  database	  (selected	   for	  Saccharomyces	  
cerevisiae,	   538585	   sequences,	   191240774	   residues)	   assuming	   the	   digestion	  
enzyme	   trypsin.	   Mascot	   was	   searched	   with	   a	   fragment	   ion	   mass	   tolerance	   of	  
0.020	  Da	   and	   a	   parent	   ion	   tolerance	   of	   10.0	  PPM.	   Carbamidomethylation	   of	  
cysteine	  was	  specified	  in	  Mascot	  as	  a	  fixed	  modification.	  Oxidation	  of	  methionine	  
was	  specified	  in	  Mascot	  as	  a	  variable	  modification.	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4 Results	  
4.1 Aim	  of	  the	  study	  
Atg21	  and	  its	  homologues	  Atg18	  and	  Hsv2,	  belong	  to	  a	   family	  of	  PI3P	  effectors	  
involved	   in	   autophagy.	  They	   contain	   seven	  WD40	   repeats,	  which	   form	  a	   seven	  
bladed	  β-­‐propeller	  scaffold	  (Baskaran	  et	  al.,	  2012;	  Krick	  et	  al.,	  2012;	  Watanabe	  et	  
al.,	   2012).	   These	   proteins	   are	   known	   to	   serve	   as	   protein	   interaction	   platforms	  
(Xu	   and	  Min,	   2011).	   Atg21	   has	   two	   lipid-­‐binding	   pockets,	  which	   preferentially	  
bind	   to	   PtdIns(3)P	   and	   PtdIns(3,5)P2	   and	   mediate	   its	   peripheral	   membrane	  
association	   (Baskaran	   et	   al.,	   2012;	   Krick	   et	   al.,	   2012;	   Watanabe	   et	   al.,	   2012).	  
While	   macroautophagy	   is	   only	   significantly	   reduced	   in	   the	   absence	   of	   Atg21,	  
Atg21	  is	  required	  for	  selective	  types	  of	  autophagy	  like	  the	  Cvt-­‐pathway.	  Atg21	  is	  
involved	   in	   the	   biogenesis	   of	   the	   Cvt	   vesicles	   (Meiling-­‐Wesse	   et	   al.,	   2004).	   In	  
detail,	  Atg21	  is	  required	  for	  the	  efficient	  lipidation	  of	  Atg8	  and	  the	  recruitment	  of	  
Atg8	  and	  Atg5	  to	  the	  pre-­‐autophagosomal	  structure	  (PAS)	  (Meiling-­‐Wesse	  et	  al.,	  
2004;	   Stromhaug	   et	   al.,	   2004).	   Atg21	   has	   been	   detected	   at	   endosomal	  
compartments	  and	  at	  vertices	  of	  vacuolar	  junctions	  (Krick	  et	  al.,	  2008a;	  Meiling-­‐
Wesse	  et	  al.,	  2004).	  Despite	  its	  fundamental	  role	  in	  Cvt	  vesicle	  formation	  and	  the	  
PAS	  recruitment	  of	  other	  autophagy-­‐related	  proteins,	  up	   to	  now	  Atg21	  has	  not	  
been	   detected	   at	   the	   PAS	   itself	   (Stromhaug	   et	   al.,	   2004).	   Detection	   of	   its	  
localization	  at	   the	  PAS	  and	   the	   identification	  of	  potential	   interaction	  partner	  of	  
Atg21	  will	  elucidate	  its	  molecular	  function	  and	  its	  role	  in	  the	  autophagic	  process.	  	  
4.2 Localization	  studies	  of	  Atg21	  
4.2.1 Part	  of	  Atg21-­‐YFP	  was	  detected	  at	  the	  PAS	  
The	  PAS	   is	  defined	  as	   the	   site	  within	   a	   cell,	  where	   almost	   all	   of	   the	   autophagy	  
related	   proteins	   colocalize	   and	   where	   the	   formation	   of	   the	   autophagosome	   is	  
initiated.	   Although	   atg21∆	   cells	   fail	   to	   form	   Cvt	   vesicles,	   Atg21	   has	   not	   been	  
detected	  at	   the	  PAS	   so	   far.	  To	  get	   a	   closer	   look,	  Atg21-­‐YFP,	   expressed	   from	   its	  
own	   promoter	   (Meiling-­‐Wesse	   et	   al.,	   2004),	   was	   coexpressed	   with	   the	   PAS	  
marker	  aminopeptidase	  I-­‐RFP	  (ApeI-­‐RFP)	  in	  atg21∆	  cells	  and	  analyzed	  by	  direct	  
fluorescence	  microscopy.	  Since	  Atg21	  is	  required	  for	  the	  Cvt-­‐pathway,	  that	  acts	  
	   	   	   Results	  
	   59	  
under	  growing	  conditions,	  cells	  were	  imaged	  under	  these	  conditions.	  In	  growing	  
atg21∆	   cells,	  Atg21-­‐YFP	   formed	  one	   to	   six	  perivacuolar	  puncta	  per	   cell	   (Figure	  
11).	   Some	   of	   them	   have	   been	   reported	   to	   colocalize	   with	   the	   late	   endosomal	  
marker	  mRFP-­‐FYVE	   (Krick	   et	   al.,	   2008a).	   For	   further	   localization	   analysis,	   the	  
percentage	   of	   cells	   was	   determined,	   that	   exhibit	   an	   Atg21-­‐YFP	   signal	   and	   an	  
additional	  perivacuolar	  ApeI-­‐RFP	  dot	  (PAS	  rate).	  Furthermore,	  the	  percentage	  of	  
ApeI-­‐RFP	  dots	  was	  determined	   that	   colocalized	  with	  Atg21-­‐YFP	   (colocalization	  
rate).	   Interestingly,	   49%	   of	   the	   ApeI-­‐RFP	   dots	   colocalized	   with	   Atg21-­‐YFP	  
suggesting	  that	  part	  of	  Atg21-­‐YFP	  was	  indeed	  localized	  at	  the	  PAS.	  As	  a	  negative	  
control,	  atg14∆	  cells	  were	  utilized.	  Atg14	  directs	  the	  Vps34	  kinase	  complex	  I	  to	  
the	  PAS,	  where	  it	  is	  required	  to	  generate	  the	  PAS-­‐specific	  PI3P	  pool	  (Obara	  et	  al.,	  
2006).	   Atg21	   is	   peripherally	   membrane	   associated	   by	   binding	   to	   PI3P	   and	  
PI(3,5)P2	   (Krick	   et	   al.,	   2006).	   In	   the	   absence	   of	  Atg14,	   and	   thus	  PI3P	   from	   the	  
PAS,	   Atg21	   should	   be	   absent	   from	   the	   PAS	   as	   it	   was	   shown	   earlier	   for	   its	  
homologue	  Atg18	   (Suzuki	  et	  al.,	  2007).	   Indeed,	   the	  colocalization	  of	  Atg21-­‐YFP	  
with	  the	  PAS	  marker	  ApeI-­‐RFP	  was	  significantly	  reduced	  to	  only	  22%	  in	  atg14∆	  
log	  cells.	  	  
For	   the	   homologue	   Atg18	   an	   additional	   interaction	   with	   Atg2	   is	   needed	   for	  
proper	  membrane	  association	  at	  the	  PAS	  (Obara	  et	  al.,	  2008b;	  Rieter	  et	  al.,	  2013).	  
To	  determine,	  which	  protein	  partner	  is	  responsible	  for	  proper	  PAS	  localization	  of	  
Atg21,	   the	   colocalization	   rate	   of	  Atg21-­‐YFP	  and	   the	  PAS	  marker	  ApeI-­‐RFP	  was	  
analyzed	   in	   several	   deletion	   strains	   by	   fluorescence	   microscopy	   as	   described	  
above	  (Figure	  11	  +	  Figure	  12).	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Figure	  11:	  Part	  of	  Atg21	  is	  localized	  at	  the	  PAS	  
The	   indicated	   strains	   expressing	   Atg21-­‐YFP	   and	   the	   PAS	  marker	   ApeI-­‐RFP	  were	   grown	   to	   log	  
phase	   in	   selective	   medium	   at	   30°C	   and	   visualized	   by	   direct	   fluorescence	   microscopy	   using	   a	  
DeltaVision	   Deconvolution	   fluorescence	  microscope	   equipped	  with	   FITC	   and	   TRITC	   filter	   sets.	  
Pictures	  were	   deconvoluted	   using	   SoftWoRx	   (Applied	   Precision)	   software.	   For	   each	   strain,	   the	  
PAS	  rate	  and	  the	  Colocalization	  rate	  of	  Atg21-­‐YFP	  and	  ApeI-­‐RFP	  were	  determined.	  The	  PAS	  rate	  
indicated,	  how	  many	  of	  the	  cells	  with	  an	  Atg21-­‐YFP	  signal	  showed	  a	  perivacuolar	  ApeI-­‐RFP	  dot.	  
The	   Colocalization	   rate	   indicated,	   how	   many	   of	   those	   dots	   overlapped	   with	   Atg21-­‐YFP.	   The	  
number	  of	  evaluated	  cells	  (n)	  is	  indicated.	  	  
	  
In	   the	   absence	   of	   Atg11,	   a	   scaffold	   protein	   crucial	   for	   PAS	   formation	   under	  
growing	   condition,	   the	   colocalization	   rate	   of	   Atg21-­‐YFP	   and	   ApeI-­‐RFP	   was	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slightly	   reduced	   to	  34%	  compared	   to	   the	  wildtype	   (atg21∆	  =	  49%).	  The	   loss	  of	  
the	  transmembrane	  protein	  Atg9,	  which	  delivers	  at	   least	  part	  of	  the	  membrane	  
to	  the	  forming	  autophagosome	  or	  the	  loss	  of	  the	  Cvt	  cargo	  receptor	  Atg19,	  led	  to	  
a	   more	   significant	   reduction	   of	   the	   colocalization	   rate	   to	   26%	   and	   16%,	  
respectively.	   In	   the	   absence	   of	   Atg16,	   member	   of	   the	   E3	   enzyme	   complex	  
required	   for	   Atg8	   lipidation,	   the	   Atg18-­‐interacting	   protein	   Atg2,	   or	   the	  
membrane	  protein	  Atg27,	  the	  colocalization	  rate	  was	  slightly	  reduced	  to	  34%	  or	  
38%,	   respectively	   (Figure	   11+Figure	   12).	   In	   contrast,	   neither	   Atg8	   nor	   Atg23	  
showed	   an	   influence	   on	   the	   PAS	   localization	   of	   Atg21-­‐YFP	   (52%	   respectively	  
48%).	  	  
	  
Figure	  12:	  Additional	  analysis	  of	  the	  PAS	  localization	  of	  Atg21-­‐YFP	  
The	   indicated	   strains	   expressing	   Atg21-­‐YFP	   and	   the	   PAS	  marker	   ApeI-­‐RFP	  were	   grown	   to	   log	  
phase	   in	   selective	   medium	   at	   30°C	   and	   visualized	   by	   direct	   fluorescence	   microscopy	   using	   a	  
DeltaVision	   Deconvolution	   fluorescence	  microscope	   equipped	  with	   FITC	   and	   TRITC	   filter	   sets.	  
Pictures	  were	   deconvoluted	   using	   SoftWoRx	   (Applied	   Precision)	   software.	   For	   each	   strain,	   the	  
PAS	  rate	  and	  the	  colocalization	  of	  Atg21-­‐YFP	  and	  ApeI-­‐RFP	  were	  determined.	  PAS	  rate	  indicated,	  
how	   many	   of	   the	   cells	   with	   an	   Atg21-­‐YFP	   signal	   showed	   a	   perivacuolar	   ApeI-­‐RFP	   dot.	  
Colocalization	   indicated,	   how	  many	   of	   these	   dots	   overlapped	   with	   Atg21-­‐YFP.	   The	   number	   of	  
evaluated	  cells	  (n)	  is	  indicated.	  
	  
Furthermore,	   none	   of	   the	   tested	   proteins	   had	   an	   influence	   on	   the	   overall	  
punctate	  appearance	  of	  Atg21-­‐YFP.	  	  
In	  further	  approaches,	  a	  pMET25-­‐mCherry-­‐Atg21	  construct	  was	  used.	  To	  exclude	  
overexpression	   artefacts	   caused	   by	   the	   expression	   from	   the	   inducible	  MET25	  
promoter,	  the	  localization	  of	  mCherry-­‐Atg21	  was	  analyzed	  by	  direct	  fluorescence	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microscopy	  as	  described	  above.	  0.3	  mM	  methionine	  was	  added	   to	   the	   selective	  
medium	  to	  induce	  endogenous	  expression	  level	  (Krick	  et	  al.,	  2008a).	  In	  growing	  
atg21∆	   cells	   expressing	  mCherry-­‐Atg21	   and	   the	  PAS	  marker	  ApeI-­‐YFP,	   46%	  of	  
the	  ApeI-­‐YFP	   dots	   colocalized	  with	  mCherry-­‐Atg21,	  whereas	   the	   colocalization	  
rate	  was	  significantly	  reduced	  to	  only	  23%	  in	  growing	  atg14∆	  cells	  (Figure	  13	  A).	  
Both	   colocalization	   rates	   correlated	  with	   the	   respective	   rates	   from	  atg21∆	   and	  
atg14∆	  cells	  expressing	  Atg21-­‐YFP	  from	  its	  endogenous	  promoter	  and	  ApeI-­‐RFP,	  
indicating	  that	  mCherry-­‐Atg21	  behaves	  like	  Atg21-­‐YFP	  in	  living	  cells.	  	  
	  
	  
Figure	   13:	   Complementation	   study	   of	   mCherry-­‐Atg21	   by	   monitoring	   ApeI	   maturation	   and	  
determination	  of	  its	  PAS	  rate.	  
(A)	   Growing	   atg21∆	   and	   atg14∆	   cells	   expressing	   mCherry-­‐Atg21	   and	   ApeI-­‐YFP	   in	   selective	  
medium	   containing	   0.3	  mM	   methionine	   were	   visualized	   by	   direct	   fluorescence	   microscopy	  
(DeltaVision	  Deconvolution	  microscope).	  Pictures	  were	  deconvoluted	  using	  SoftWoRX	  (Applied	  
Precision)	   software.	   PAS	   rate	   and	   Colocalization	   rate	   were	   determined	   as	   described	   before	  
(Figure	   11).	   The	   number	   of	   counted	   cells	   (n)	   is	   indicated	   respectively.	   (B)	   Indicated	   strains	  
expressing	  mCherry-­‐Atg21	  or	  mCherry	  alone	  were	  grown	  in	  selective	  medium	  containing	  0.3	  mM	  
methionine.	   Mid-­‐log	   cells	   (0	  h)	   or	   cells	   starved	   for	   4	   h	   in	   SD-­‐N	   (4	  h)	   were	   alkaline	   lysed	   and	  
immunoblotted.	   Using	   an	   anti-­‐ApeI	   antibody,	   precursor	   ApeI	   (prApeI)	   and	   matured	   ApeI	  
(mApeI)	  were	  detected.	  
	  
To	  further	  prove	  the	  functionality	  of	  the	  mCherry-­‐Atg21	  construct,	   its	  ability	  to	  
rescue	  the	  ApeI	  maturation	  defect	  of	  atg21∆	  cells	  was	  tested	  (Figure	  13	  B).	  ApeI	  
is	   expressed	   as	   a	   preform	   (prApeI)	   in	   the	   cytosol,	   where	   it	   forms	   large	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dodecamers.	  These	  complexes	  are	  transported	  under	  growing	  conditions	  via	  the	  
selective	  Cvt	  pathway,	   or	  under	   starvation	  via	  macroautophagy	   to	   the	  vacuole,	  
where	  precursor	  ApeI	  is	  matured	  (mApeI).	  For	  the	  ApeI	  maturation	  analysis,	  WT,	  
atg1∆	  and	  atg21∆	  cells	  expressing	  the	  empty	  vector	  and	  atg21∆	  cells	  expressing	  
mCherry-­‐Atg21	   were	   grown	   to	   mid-­‐log	   phase	   (0	  h	   SD-­‐N)	   and	   subsequently	  
starved	  for	  four	  hours	   in	  SD-­‐N	  (4	  h	  SD-­‐N).	  Samples	  were	  taken	  at	  the	  indicated	  
time	  points,	  alkaline	  lysed	  and	  subjected	  to	  immunoblotting.	  prApeI	  and	  mApeI	  
were	  detected	  using	   an	   anti-­‐ApeI	   antibody	   (Figure	  13	  B).	   In	   growing	  WT	   cells,	  
about	  half	  of	  ApeI	  was	  matured,	  whereas	  after	  4h	  of	  nitrogen	  starvation	  most	  of	  
ApeI	  was	  found	  in	  its	  matured	  form.	  Atg1	  is	  a	  core	  autophagy	  protein,	  therefore	  
the	   maturation	   of	   ApeI	   was	   blocked	   under	   both	   growing	   and	   starvation	  
conditions	  in	  atg1∆	  cells.	  Since	  Atg21	  is	  required	  under	  growing	  conditions,	  ApeI	  
maturation	   was	   completely	   blocked	   under	   those	   conditions	   and	   severely	  
impaired	   in	   starved	   atg21∆	   cells.	   mCherry-­‐Atg21	   was	   able	   to	   fully	   rescue	   the	  
ApeI	   maturation	   defect	   of	   atg21∆	   cells	   under	   both,	   growing	   and	   starvation	  
conditions,	  implicating	  that	  the	  mCherry-­‐Atg21	  construct	  was	  functional	  (Figure	  
13	  B).	  
4.2.2 Atg21	  is	  not	  transported	  into	  the	  vacuole	  
Within	   the	   autophagic	   process,	   the	   outer	  membrane	  of	   the	   completed,	   double-­‐
membrane	  layered	  autophagosome	  fuses	  with	  the	  vacuolar	  membrane	  to	  release	  
the	  still	  one	  membrane	  layered	  autophagic	  body	  into	  the	  vacuole.	  In	  the	  vacuole	  
the	  autophagic	  body	  is	  lysed	  and	  its	  contents	  are	  degraded.	  From	  the	  autophagy	  
related	  proteins	  only	  those	  on	  the	  inside	  of	  the	  autophagosome	  are	  transported	  
into	  the	  vacuole.	  Atg8	  is	  evenly	  distributed	  across	  the	  outer	  and	  inner	  membrane	  
of	   the	   autophagosome.	   The	   part,	   located	   on	   the	   inner	   membrane,	   is	   trapped	  
inside	  the	  autophagosome	  and	  transported	  into	  the	  vacuole,	  whereas	  the	  Atg12-­‐
Atg5/Atg16	  complex	  is	  only	  associated	  to	  the	  outer	  membrane	  and	  therefore	  not	  
transported	  into	  the	  vacuole	  (Kirisako	  et	  al.,	  2000;	  Mizushima	  et	  al.,	  2001;	  Suzuki	  
et	   al.,	   2001).	   Part	   of	   Atg21	   was	   successfully	   detected	   at	   the	   PAS	   (see	   chapter	  
4.2.1).	   The	   PAS	   localization	   was	   dependent	   on	   Atg14	   and	   therefore	   on	   the	  
presence	   of	   PI3P	   on	   the	   forming	   autophagosome,	   suggesting	   that	   Atg21	   is	   at	  
least	   peripherally	   membrane	   associated	   there.	   To	   analyze,	   if	   Atg21	   is	   evenly	  
	   	   	   Results	  
	   64	  
distributed	  on	  the	  inner	  and	  outer	  membrane	  of	  the	  forming	  autophagosome	  or	  
if	   it	   is	   only	   associated	   to	   the	   outer	  membrane,	   the	   transport	   of	   Atg21	   into	   the	  
vacuole	   was	   tested.	   atg21∆	  pep4∆	   cells	   were	   transformed	   with	   pMET25-­‐
mCherry-­‐Atg21	  and	  pRS313-­‐GFP-­‐Atg8,	  grown	  to	  an	  OD600	  of	  2	  to	  3	  and	  analyzed	  
by	   direct	   fluorescence	  microscopy	   (Figure	   14).	   Again,	   0.3	  mM	  methionine	  was	  
added	  to	  the	  media	  to	  induce	  endogenous	  mCherry-­‐Atg21	  expression	  level.	  	  
	  
Figure	  14:	  mCherry-­‐Atg21	  is	  not	  transported	  into	  the	  vacuole	  
atg21∆	  pep4∆	   cells	   expressing	   GFP-­‐Atg8	   and	  mCherry-­‐Atg21	  were	   grown	   in	   selective	  medium	  
containing	   0.3	  mM	  methionine	   to	   an	   OD600	   of	   2	   to	   3.	   Pictures	   were	   taken	   using	   a	   DeltaVision	  
fluorescence	  microscope	   equipped	  with	   a	  mCherry	   and	   GFP	   filter	   set	   and	   deconvoluted	   using	  
SoftWoRX	  (Applied	  Precision)	  software.	  	  
	  
In	  cells	  lacking	  the	  vacuolar	  aspartyl	  protease	  (Pep4),	  the	  autophagic	  bodies	  are	  
not	  lysed	  within	  the	  vacuole	  and	  accumulate	  over	  the	  time.	  In	  this	  approach,	  they	  
were	  visible	  as	  green	  dots	  within	  the	  vacuole	  by	  labeling	  with	  GFP-­‐tagged	  Atg8.	  
But	   none	   of	   those	   dots	   showed	   an	   additional	   red	   fluorescence	   for	   mCherry-­‐
Atg21.	  Furthermore,	  no	  red	   fluorescent	  dots	  were	  visible	  within	   the	  vacuole	  at	  
all.	   Taken	   together,	   mCherry-­‐Atg21	   is	  most	   probably	   not	   transported	   into	   the	  
vacuole	   and	   therefore	   not	   evenly	   distributed	   across	   the	   autophagosomal	  
membranes.	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4.3 Identification	  of	  interaction	  partner	  of	  Atg21	  
Atg21	   is	   a	  WD40	   repeat	   β-­‐propeller.	  WD-­‐repeat	   propeller	   proteins	   commonly	  
create	   a	   stable	   platform	   for	   coordinating	   and	   mediating	   assembly	   of	   protein	  
complexes	   (Xu	   and	   Min,	   2011).	   Therefore,	   they	   often	   interact	   reversibly	   with	  
several	   protein	   interaction	   partners.	   Identification	   of	   potential	   interaction	  
partner	   of	   Atg21	   will	   elucidate	   its	   molecular	   function	   and	   its	   role	   in	   the	  
autophagic	  process.	  
4.3.1 Atg21	  is	  part	  of	  a	  high	  molecular	  weight	  complex	  
4.3.1.1 Gelfiltration	  analysis	  of	  Atg21	  
The	  PAS	   localization	  of	   the	  Atg21	  homologue	  Atg18	   is	   specifically	  mediated	  by	  
interaction	  with	  both,	  PI3P	  and	  Atg2	   (Obara	  et	  al.,	  2008b;	  Rieter	  et	  al.,	  2013)	   .	  
Obara	   et	   al.	   (2008)	   detected	   a	   large	   Atg18-­‐Atg2	   complex	   in	   gelfiltration	   (GF).	  
Intriguingly,	   this	   large	   complex	   disappeared	   in	   the	   absence	   of	   Atg2.	   The	  
gelfiltration	   approach	  was	  used	   to	   clarify,	   if	   Atg21	   can	   also	  be	   found	   in	   a	   high	  
molecular	   weight	   complex.	   Finding	   suitable	   conditions	   for	   purification	   of	   the	  
Atg21	   complex	   might	   lead	   to	   the	   identification	   of	   potential	   Atg21	   interaction	  
partner.	   For	   this	   purpose,	   pRS316-­‐Atg21-­‐TAP	   was	   transformed	   into	  
atg21∆	  pep4∆	   cells.	   First,	   the	   cells	   were	   resuspended	   in	   Obara’s	   GF-­‐buffer	  
(20	  mM	  Tris/HCl	   pH	  8.0,	   150	  mM	  KCL,	   5	  mM	  MgCl2,	   1	  mM	   PMSF,	   1%	  Triton	  X-­‐
100,	   protease	   inhibitors)	   and	   pneumatically	   lysed	   with	   a	   pressure	   of	   about	  
1500	  bar	  in	  three	  cycles	  using	  the	  homogenizer	  EmulsiFlex	  C3	  (Avestin).	  The	  cell	  
lysate	  was	  cleared	  by	  ultracentrifugation	  at	  100	  000	  x	  g	  for	  30	  min	  and	  subjected	  
to	   size	   exclusion	   chromatography	  on	   a	   Superose	  6	   column.	  The	   cell	   lysate	  was	  
eluted	   from	   the	   column	   at	   a	   flow	   rate	   of	   0.5	  ml/ml	   and	   0.8	  ml	   fractions	   were	  
collected	   as	   it	   was	   described	   by	   Obara	   et	   al.	   (2008).	   The	   fractions	   were	  
precipitated,	   dissolved	   in	   Laemmli	   buffer	   and	   processed	   for	   immunoblots	  
(Figure	  15).	  For	  molecular	  weight	  determination	  the	  immunoblot	  was	  decorated	  
with	   antibodies	   against	   commonly	   used	  proteins	  with	   known	   size	   as	  ApeI	   and	  
the	  phosphoglycerate	  kinase	   (PGK).	  ApeI	   is	   known	   to	   form	  dodecamers	  with	  a	  
predicted	  molecular	   weight	   of	   about	   670	  kDa	   (Morales	   Quinones	   et	   al.,	   2012)	  
and	   was	   present	   in	   fractions	   16	   to	   17.	   PGK	   is	   a	   housekeeping	   protein	   and	   is,	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independent	  from	  most	  conditions,	  randomly	  distributed	  in	  the	  cytosol.	  PGK	  has	  
a	  molecular	  weight	  of	  about	  45	  kDa	  and	  was	  eluted	  in	  fractions	  22	  to	  24.	  	  
	  
Figure	  15:	  Atg21-­‐TAP	  was	  present	  in	  a	  sensitive	  high	  molecular	  weight	  complex	  in	  gelfiltration	  
(A)	   Scheme	   of	   cell	   lysis	   and	   sample	   preparation	   for	   gelfiltration	   using	   the	   Homogenizer	  
EmulsiFlex	  C3	  (Avestin)	  (picture	  adapted	  from:	  http://www.avestin.com/	  German/c3page.html).	  
(B)	  atg21∆	  pep4∆	  cells	  expressing	  Atg21-­‐TAP	  were	  treated	  as	  shown	  in	  (A)	  and	  subjected	  to	  size	  
exclusion	  chromatography	  on	  a	  Superose	  6	  column.	  The	  cell	  lysate	  was	  eluted	  from	  the	  column	  at	  
a	   flow	  rate	  of	  0.5	  ml/ml	  and	  0.8	  ml	   fractions	  were	   collected	  as	   it	  was	  described	   in	  Obara	  et	  al.	  
(2008).	  Fractions	  were	  precipitated	  and	  analyzed	  by	  immunoblotting	  using	  anti-­‐TAP,	  -­‐ApeI	  and	  	  	  
-­‐PGK	  antibodies.	  (C)	  Part	  of	  Atg21-­‐TAP	  is	  also	  present	  in	  its	  monomeric	  form.	  (D)	  Quantification	  
of	  the	  distribution	  of	  the	  individual	  proteins	  in	  the	  respective	  fractions	  using	  AIDA	  software.	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Atg21-­‐TAP,	   with	   a	   predicted	  molecular	  weight	   of	   about	   76	  kDa,	   was	   eluted	   in	  
fractions	  18	  to	  20.	  Since	  fraction	  18	  corresponded	  to	  a	  molecular	  weight	  of	  about	  
670	  kDa,	   a	  part	  of	  Atg21-­‐TAP	  was	  present	   in	  a	   large	   complex	   (Figure	  15	  B+D).	  
Unfortunately,	   these	   data	   were	   not	   reproducible.	   In	   further	   experiments,	   the	  
main	   part	   of	   Atg21-­‐TAP	   was	   present	   in	   fractions	   21	   to	   22.	   These	   fractions	  
corresponded	  to	  the	  predicted	  molecular	  weight	  of	  Atg21-­‐TAP	  and	  are	  therefore	  
likely	   to	   represent	   its	  monomeric	   form	   (Figure	  15	  C+D).	   To	   keep	   the	   apparent	  
sensible	   large	   Atg21	   complex	   intact,	   the	   cells	   were	   lysed	   in	   a	   very	   mild	   and	  
preservative	  way.	  The	   cells	  were	   first	   converted	   to	   spheroblasts,	   solubilized	   in	  
lysis	   buffer	   (0.8	  M	   sorbitol,	   10	  mM	   MOPS	   pH	  7.2,	   1	  mM	   EDTA,	   2	  mM	   PMSF,	  
protease	   inhibitors)	   and	   then	   mechanically	   lysed	   with	   30	  beats	   of	   a	   cell	  
homogenizer.	  The	  cell	   lysate	  was	  cleared	  and	  subjected	  to	  a	  Superose	  6	  column	  
as	   described	   above	   (Figure	   16	  A).	   Again	   the	   immunoblot	   was	   decorated	   with	  
antibodies	   against	   marker	   proteins	   as	   the	   ApeI	   complex	   (670	  kDa)	   and	   the	  
carboxypeptidase	  Y	   (CPY;	   65	  kDa).	   Under	   these	   conditions,	   the	   ApeI	   complex	  
eluted	   in	   fractions	   12	   to	   13,	   whereas	   CPY	   was	   present	   in	   fractions	   16	   to	   17.	  
Atg21-­‐TAP	   was	   almost	   completely	   eluted	   in	   fractions	   9	   to	   11,	   which	  
corresponded	  to	  a	  molecular	  weight	  of	  670	  kDa	  and	  more.	  So	  Atg21-­‐TAP	  seemed	  
to	  be	  present	  in	  a	  high	  molecular	  weight	  complex	  (Figure	  16	  B).	  If	  the	  same	  cell	  
lysis	  procedure	  was	  carried	  out	  by	  adding	  0.5%	  Triton	  X-­‐100	  to	  the	  lysate	  after	  
cell	   homogenization,	   a	   small	   amount	   of	   Atg21-­‐TAP	   was	   present	   in	   additional	  
fractions	  corresponding	  to	  lower	  molecular	  weights	  (Figure	  16	  C).	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Figure	   16:	   Alternative	  mild	   cell	   lysis	   procedure	   keeps	   the	   sensitive	   high	  molecular	  weight	   Atg21	  
complex	  intact	  
(A)	   Scheme	   of	   mild	   cell	   lysis	   procedure	   and	   sample	   preparation	   for	   gelfiltration	   using	   a	  
mechanical	   cell	   homogenizer	   (B)	   atg21∆	   pep4∆	   cells	   expressing	   Atg21-­‐TAP	   were	   treated	   as	  
shown	  in	  (A)	  without	  detergence	  and	  analyzed	  by	  gelfiltration	  as	  described	  above.	  Distribution	  
pattern	   of	   the	   respective	   proteins	  were	   analyzed	  by	   immunoblotting	   using	   anti-­‐TAP,	   anti-­‐ApeI	  
and	  anti-­‐CPY	  antibodies.	  (C)	  atg21∆	  pep4∆	  cells	  expressing	  Atg21-­‐TAP	  were	  treated	  as	  shown	  in	  
(A)	   with	   addition	   of	   Triton	  X-­‐100	   to	   the	   cell	   lysate	   after	   cell	   homogenization.	   Cell	   lysate	   was	  
analyzed	   by	   gelfiltration	   as	   described	   in	   (B).	   (D)	   Quantification	   of	   the	   distribution	   of	   the	  
individual	  proteins	  in	  the	  respective	  fractions	  using	  AIDA	  software.	  
	  
In	  conclusion,	  a	  mild	  cell	  lysis	  procedure	  was	  established	  that	  keeps	  the	  sensitive	  
high	  molecular	  weight	  Atg21	  complex	  intact.	  Therefore,	  this	  cell	  lysis	  procedure	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was	   used	   in	   the	   following	   experiments	   to	   further	   analyze	   the	   high	   molecular	  
weight	  complex	  and	  to	  identify	  potential	  interaction	  partners	  of	  Atg21.	  	  
4.3.1.2 Sorbitol	  density	  gradient	  centrifugation	  
Density	   gradient	   centrifugation	   was	   used	   to	   further	   analyze	   the	   Atg21	   high	  
molecular	  weight	  complex.	  In	  this	  approach,	  proteins	  and	  protein	  complexes	  can	  
be	   separated	   by	   their	  mass	   but	   also	   density	   and	   shape.	   In	   principle,	   a	   density	  
gradient	  is	  created	  in	  a	  centrifugation	  tube.	  The	  cell	   lysate	  is	  placed	  on	  the	  top.	  
Applied	   to	   a	   strong	   centrifugal	   field,	   proteins	  migrate	   along	   the	   gradient	   until	  
they	  reach	  the	  point	  that	  corresponds	  to	  their	  density.	  	  
atg21∆	  pep4∆	   cells	   were	   transformed	   with	   pMET25-­‐mCherry-­‐Atg21	   or	   with	  
pMET25-­‐mCherry	  as	  a	  negative	  control.	  Cells	  were	  harvested	   in	  growing	  phase	  
and	  mildly	   lysed	   in	   the	   presence	   of	   Triton	  X-­‐100	   as	   described	   before	   (chapter	  
4.3.1.1).	  The	  cell	  lysate	  was	  placed	  on	  the	  top	  of	  a	  20%	  to	  50%	  glycerol	  density	  
gradient	   and	   subsequently	   centrifuged	   for	   four	   hours	   at	   259	  000	  x	  g	   (Figure	  
17	  A).	   Afterwards	   ten	   fractions	   were	   collected	   beginning	   from	   the	   top	   of	   the	  
gradient	   and	   precipitated	   with	   TCA.	   The	   pellets	   were	   dissolved	   in	   Laemmli	  
buffer	  and	  processed	  for	  immunoblots	  (Figure	  17	  B).	  	  
	  
	  
Figure	  17:	  The	  high	  molecular	  weight	  Atg21	   complex	   could	  not	   be	  detected	  after	   glycerol	   density	  
gradient	  centrifugation	  	  
(A)	   Scheme	   of	   glycerol	   density	   gradient	   centrifugation	   procedure	   (B)	   atg21∆	  pep4∆	   cells	  
expressing	  mCherry-­‐Atg21	  or	  mCherry	  alone	  were	  grown	  in	  selective	  medium	  in	  the	  absence	  of	  
methionine	   to	   induce	   protein	   expression,	   converted	   to	   spheroblasts	   and	   mechanically	   lysed	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using	  a	   cell	   homogenizer.	   Cell	   lysate	  was	   subjected	   to	   a	  20%	   to	  50%	  glycerol	  density	   gradient	  
centrifugation	   as	   described	   in	   (A).	   Ten	   fractions	  were	   collected	   beginning	   from	   the	   top	   of	   the	  
gradient	  and	  analyzed	  by	  immunoblot	  using	  an	  anti-­‐ApeI,	  -­‐CPY	  and	  –Red	  (specifically	  recognizes	  
mCherry)	  antibody.	  	  
	  
As	  a	  molecular	  weight	  marker	  monomeric	  CPY	   (65	  kDa)	  and	   the	  ApeI	   complex	  
(670	  kDa)	  were	  used	   (data	  not	   shown).	   CPY	  was	   found	   in	   fractions	  4	   to	  5,	   the	  
ApeI	  complex	  in	  fractions	  7	  to	  8.	  As	  expected,	  mCherry	  with	  a	  molecular	  weight	  
of	  about	  30	  kDa	  was	  present	   in	  the	  first	   fractions	  corresponding	  to	   low	  density	  
(fractions	   1	   to	   3).	   mCherry-­‐Atg21	   (82.5	   kDa)	   was	   detected	   in	   fraction	   4	   to	   6,	  
corresponding	   to	   the	   fractions	  where	  CPY	  was	  present.	   So	  mCherry-­‐Atg21	  was	  
rather	   present	   in	   its	   monomeric	   form	   than	   in	   a	   complex.	   As	   seen	   in	   the	  
gelfiltration	   analysis,	   the	  Atg21	   high	  molecular	  weight	   complex	  was	   extremely	  
sensitive	  (chapter	  4.3.1.1).	  One	  possibility	  for	  the	  instability	  of	  the	  complex	  could	  
be	  intolerance	  for	  glycerol.	  Sorbitol	  was	  present	  in	  the	  cell	  lysis	  buffer,	  where	  the	  
Atg21	  high	  molecular	  weight	  complex	  was	  stable	  as	  seen	  in	  gelfiltration	  (chapter	  
4.3.1.1).	   Therefore,	   the	   glycerol	   in	   the	   gradient	   was	   exchanged	   with	   sorbitol	  
solutions	   with	   the	   same	   density,	   respectively	   (Figure	   18	  A).	   Cell	   lysate	   of	  
atg21∆	  pep4∆	   cells	  expressing	  pMET25-­‐mCherry-­‐Atg21	  or	  pMET25-­‐mCherry	  as	  
a	   control	   were	   loaded	   on	   a	   0.9	  M	   to	   2.5	  M	   sorbitol	   density	   gradient	   and	  
centrifuged	   for	   four	   hours	   at	   259	  000	  x	  g	   (Figure	   18	  A).	   Again,	   ten	   fractions	  
beginning	  from	  the	  top	  of	  the	  gradient	  were	  taken	  and	  analyzed	  using	  anti-­‐Red,	  
anti-­‐ApeI	   and	   anti-­‐CPY	   antibodies	   in	   immunoblotting	   (Figure	   18	  B).	   The	   ApeI	  
complex	  (670	  kDa)	  was	  detected	  in	  fractions	  7	  to	  9,	  whereas	  CPY	  (67	  kDa)	  was	  
mainly	  present	  in	  fractions	  3	  to	  4.	  As	  expected,	  mCherry	  was	  again	  present	  in	  the	  
first	   fractions	   (fractions	   2	   to	   3)	   corresponding	   to	   low	   density	   and	   molecular	  
weight.	   In	   contrast,	   mCherry-­‐Atg21	   was	   found	   in	   fractions	   4	   to	   8	   and	   was	  
therefore	   at	   least	   partly	   present	   in	   fractions	   corresponding	   to	   high	   molecular	  
weight	  and	  density.	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Figure	  18:	  mCherry-­‐Atg21	  is	  present	  as	  a	  high	  molecular	  weight	  complex	  in	  sorbitol	  density	  gradient	  
centrifugation	  
(A)	   Scheme	   of	   sorbitol	   gradient	   centrifugation	   procedure	   (B)	   atg21∆	  pep4∆	   cells	   expressing	  
mCherry-­‐Atg21	   or	   mCherry	   were	   grown	   in	   selective	   medium	   without	   methionine	   to	   induce	  
protein	  expression.	  Cell	   lysates	  were	  prepared	  with	  0.5%	  Triton	  X-­‐100	  as	  described	  before	  and	  
subjected	  to	  sorbitol	  density	  gradient	  centrifugation	  as	  described	  in	  (A).	  Ten	  fractions	  beginning	  
from	   the	   top	   of	   the	   gradient	  were	   taken,	   TCA	   precipitated	   and	   analyzed	   by	   immunoblot	   using	  
anti-­‐Red,	   anti-­‐ApeI	   and	   anti-­‐CPY	   antibody.	   The	   distribution	   pattern	   of	   the	   respective	   proteins	  
within	  the	  gradient	  was	  quantified	  using	  AIDA	  software.	  (C)	  Cell	  lysate	  of	  atg21∆	  pep4∆,	  atg19∆,	  
atg27∆	  and	  atg1∆	  cells	  expressing	  mCherry-­‐Atg21	  were	  prepared	  in	  the	  absence	  of	  detergence	  as	  
described	  before	  and	  subjected	  to	  sorbitol	  gradient	  centrifugation	  as	  described	  in	  (A)	  and	  (B).	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Gelfiltration	  revealed	   that	  detergence	   influenced	  the	  stability	  of	   the	  Atg21	  high	  
molecular	  weight	   complex	   (chapter	  4.3.1.1).	  To	  determine,	   if	   this	   could	  also	  be	  
true	   for	   sorbitol	   density	   gradient	   centrifugation,	   cells	   expressing	   pMET25-­‐
mCherry-­‐Atg21	   were	   lysed	   in	   the	   absence	   of	   detergence	   and	   cell	   lysate	   were	  
again	   loaded	  on	   the	   top	  of	   a	  0.9	  M	   to	  2.5	  M	   sorbitol	   gradient.	   Indeed,	   a	  part	  of	  
mCherry-­‐Atg21	  could	  be	  detected	   in	   fractions	  corresponding	   to	  high	  molecular	  
weight	  and	  density	  (fraction	  9	  and	  10;Figure	  18	  C).	  	  
Sorbitol	  gradient	  centrifugation	  was	  performed	  with	  different	  knock	  out	  strains	  
expressing	  pUG36-­‐mCherry-­‐Atg21	  to	  determine	   if	  any	  of	   these	  proteins	  had	  an	  
influence	  on	  the	  formation	  of	  the	  Atg21	  high	  molecular	  weight	  complex	  or	  might	  
even	  be	  a	  component	  of	  it.	  To	  preserve	  the	  complex,	  cell	  lysates	  were	  prepared	  
in	  the	  absence	  of	  detergence.	  Surprisingly,	  nor	  Atg19,	  Atg27	  or	  Atg1	  changed	  the	  
distribution	   of	   mCherry-­‐Atg21	   in	   the	   sorbitol	   gradient	   compared	   to	  
atg21∆	  pep4∆	  cells	  (Figure	  18	  C).	  So	  none	  of	  the	  tested	  proteins	  was	  involved	  in	  
the	   formation	   of	   the	   high	   molecular	   weight	   Atg21	   complex	   or	   was	   a	  
stoichiometric	  component	  of	  it.	  	  
4.3.2 Pull	   down	   und	   mass	   spectrometry	   analysis	   to	   identify	   potential	  
Atg21	  interaction	  partner	  
Pull	   down	   experiments	   were	   used	   as	   one	   method	   to	   identify	   potential	   Atg21	  
interaction	   partner.	   Therefore,	   recombinant	   6xHis-­‐SUMO-­‐Atg21	  was	   incubated	  
with	  crude	  yeast	  cell	  extract	  and	  the	  co-­‐precipitated	  proteins	  were	  identified	  by	  
mass	   spectrometry	   analysis.	   Atg21	   was	   N-­‐terminally	   fused	   to	   SUMO	   and	   an	  
additional	   six	   histidine	   tag	   for	   purification	   (6xHis-­‐SUMO-­‐Atg21)	   (Figure	   19	  A).	  
To	   exclude	   those	   proteins,	   which	   bound	   to	   SUMO,	   SUMO	   alone,	   N-­‐terminally	  
tagged	   with	   six	   histidines,	   was	   used	   as	   a	   negative	   control	   (6xHis-­‐SUMO).	  
Recombinant	   6xHis-­‐SUMO-­‐Atg21	   and	   6xHis-­‐SUMO	   was	   purified	   via	   Ni-­‐NTA-­‐
beads	   (see	  chapter	  3.6.11).	   Samples	  were	   taken	  after	  E.	  coli	   cell	   lysis	   (E.	  coli	   L)	  
and	   after	   cell	   lysate	   clearance	   by	   centrifugation	   (E.	  coli	   S)	   to	   prove	   efficient	  
expression	   and	   the	   solubility	   of	   6xHis-­‐SUMO-­‐Atg21.	   6xHis-­‐SUMO-­‐Atg21	   and	  
6xHis-­‐SUMO	  coupled	  to	  Ni-­‐NTA	  beads	  were	  subsequently	  incubated	  with	  crude	  
cell	   extract	   of	  atg21∆	   cells	   expressing	  mCherry-­‐Atg19	   and	  GFP-­‐Atg8	   (yeast	   L).	  
Afterwards	   the	   supernatant	   containing	   the	   unbound	   proteins	   (yeast	   S)	   was	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removed.	   After	   extended	   washing,	   6xHis-­‐SUMO,	   6xHis-­‐SUMO-­‐Atg21	   and	   all	  
associated	  proteins	  (E)	  were	  eluted	  from	  the	  beads	  by	  adding	  NuPAGE®	  sample	  
buffer	  (Life	  Technologies)	  and	  boiling	  at	  72°C	  for	  10	  min.	  The	  samples	  were	  also	  
loaded	  on	  a	  SDS-­‐PAGE	  and	  processed	  for	  immunoblotting.	  (Figure	  19	  B).	  	  
	  
Figure	  19:	  Pull	  down	  analysis	  of	  SUMO-­‐Atg21	  
(A)	  Scheme	  of	  the	  6xHis-­‐SUMO-­‐Atg21	  construct	  (B)	  Recombinant	  6xHis-­‐SUMO	  and	  6xHis-­‐SUMO-­‐
Atg21	  were	   purified	   using	  Ni-­‐NTA	   beads	   and	   incubated	  with	   crude	   extract	   of	   growing	  atg21∆	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cells	   expressing	   mCherry-­‐Atg19	   and	   GFP-­‐Atg8.	   The	   respective	   yeast	   and	   E.	  coli	   lysates	   (L),	  
cleared	  lysate	  (E.	  coli	  S),	  unbound	  fraction	  (yeast	  S)	  and	  the	  purified	  proteins	  (E)	  were	  subjected	  
to	  SDS-­‐PAGE	  analyzed	  by	   immunoblotting	  using	  anti-­‐His,	  anti-­‐Red	  and	  anti-­‐GFP	  antibodies.	  (C)	  
Isolated	   proteins	   (E)	   were	   further	   analyzed	   by	   Coomassie	   staining	   and	   subjected	   to	   mass	  
spectrometry	  (MS)	  analysis	  for	  identification.	  (D)	  Identified	  members	  of	  the	  TORC1	  complex	  are	  
listed.	   The	   respective	   peptide	   number,	   coverage	   and	   quantitative	   values	   determined	   by	   the	  
Scaffold3	  software	  are	  shown.	  	  
	  
6xHis-­‐SUMO-­‐Atg21	  was	  present	   in	  both	   the	  E.	  coli	   lysate	  and	  supernatant	  after	  
centrifugation	   in	   comparable	   amounts,	   suggesting	   that	   recombinant	   6xHis-­‐
SUMO-­‐Atg21	  was	  soluble.	  Furthermore,	  6xHis-­‐SUMO-­‐Atg21	  could	  be	  successfully	  
purified	  in	  sufficient	  amounts	  (see	  E	  in	  Figure	  19	  B	  and	  C).	  Though	  the	  potential	  
Atg21	   interaction	   partner	   GFP-­‐Atg8	   did	   not	   co-­‐precipitate	   with	   6xHis-­‐SUMO-­‐
Atg21	   (see	   below),	   the	   Cvt	   receptor	   mCherry-­‐Atg19	   could	   be	   specifically	   co-­‐
precipitated.	   Since	   Atg21	   is	   required	   for	   the	   Cvt	   pathway,	   this	   indicates	   that	  
6xHis-­‐SUMO-­‐Atg21	  was	  functional.	  	  
In	   addition,	   the	   eluates	   of	   the	   6xHis-­‐SUMO-­‐Atg21	   and	   6xHis-­‐SUMO	   pull	   down	  
were	  loaded	  on	  a	  SDS-­‐PAGE	  and	  analyzed	  by	  colloidal	  Coomassie	  staining.	  Only	  
three	   additional	   bands	   to	   6xHis-­‐SUMO	  were	   visible	   in	   the	   6xHis-­‐SUMO	   eluate,	  
whereas	   several	   additional	   bands	   representing	   potential	   interaction	   partner	  
were	   prominent	   in	   the	   eluate	   of	   the	   6xHis-­‐SUMO-­‐Atg21	   pull	   down.	   For	  
identification	   of	   the	   potential	   interaction	   partner,	   the	   eluate	   samples	   were	  
subjected	   to	   mass	   spectrometry	   analysis	   (performed	   by	   Bioanalytical	   Mass	  
Spectrometry	  Group	  of	  Prof.	  Henning	  Urlaub,	  Universität	  Göttingen).	  In	  total,	  912	  
proteins	   were	   identified.	   Based	   on	   quantitative	   values,	   those	   proteins	   were	  
excluded	   that	   were	   present	   in	   the	   negative	   control	   (6xHis-­‐SUMO)	   in	   an	  
equivalent	   or	   higher	   amount	   compared	   to	   the	   6xHis-­‐SUMO-­‐Atg21	   sample.	  
Regardless	  of	   the	   low	  quantitative	  values	  of	  some	  of	   the	  proteins,	  728	  proteins	  
were	   specifically	   identified	   that	   bind	   to	   6xHis-­‐SUMO-­‐Atg21.	   Curiously,	   none	   of	  
them	   represented	   an	   Atg	   protein.	   However,	   all	   components	   of	   the	   target	   of	  
rapamycin	   complex	   1	   (TORC1)	   were	   identified	   (Figure	   19	  D).	   Among	   other	  
functions,	   TORC1	   is	   a	   key	   actor	   in	   autophagy	   regulation.	   TORC1	   consists	   of	  
Tco89,	  Kog1,	  Lst8	  and	  either	  Tor1	  or	  Tor2	  (Loewith	  and	  Hall,	  2011).	  Tor1,	  Tor2,	  
Tco89	   and	   Kog1	  were	   present	   in	   high	   quantitative	   values	   in	   the	   6xHis-­‐SUMO-­‐
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Atg21	   sample.	   The	   negative	   control	   6xHis-­‐SUMO	   showed	   no	   binding	   to	   the	  
subunits	  of	  TORC1	  other	   than	  Lst8.	  Though	   the	  quantitative	  value	  was	   slightly	  
higher	   in	   the	   negative	   control,	   only	   one	   peptide	   was	   detected	   leading	   to	   a	  
peptide	  coverage	  of	  only	  2.3%.	  In	  contrast,	  in	  the	  6xHis-­‐SUMO-­‐Atg21	  pull	  down	  
four	  peptides	  of	  Lst8	  were	  identified	  leading	  to	  a	  peptide	  coverage	  of	  19%.	  Based	  
on	   this,	   the	  probability	   in	   the	  6xHis-­‐SUMO	  pull	  down	  was	   limited	   to	  only	  50%	  
compared	   to	   100%	   in	   the	   6xHis-­‐SUMO-­‐Atg21	   sample	   (Figure	   19	  D).	   However,	  
these	  data	  supported	  an	  interaction	  of	  6xHis-­‐SUMO-­‐Atg21	  with	  TORC1.	  	  
4.3.3 Split-­‐ubiquitin	  analysis	  of	  Atg21	  
The	  split-­‐ubiquitin	  assay	  represents	  an	  analytic	  tool	  for	  measurement	  of	  protein	  
interaction	  in	  living	  yeast	  cells	  (Müller	  and	  Johnsson,	  2008)	  and	  was	  used	  for	  a	  
large-­‐scale	  search	  for	  potential	  interaction	  partners	  of	  Atg21.	  	  
	  
	  
Figure	  20:	  Scheme	  of	  the	  principle	  of	  the	  split-­‐ubiquitin	  assay	  (adapted	  from	  (Müller	  and	  Johnsson,	  
2008))	  
For	  this	  purpose,	  ubiquitin	  is	  split	   into	  two	  halves	  and	  fused	  to	  two	  proteins	  of	  
interests	  (Figure	  20).	  In	  detail,	  the	  N-­‐terminal	  half	  of	  ubiquitin	  (Nui)	  was	  fused	  to	  
the	  N-­‐terminus	  of	  one	  of	  the	  proteins	  (prey)	  and	  the	  C-­‐terminal	  half	  of	  ubiquitin	  
(Cub)	  was	   fused	   to	   the	   C-­‐terminus	   of	   the	   other	   protein	   (bait).	   In	   addition,	   the	  
Cub	  fragment	  was	  attached	  to	  the	  reporter	  protein	  R-­‐Ura3.	  Ura3	  represents	  the	  
orotidine	  5-­‐phosphate	  decarboxylase	  and	  plays	  a	  crucial	  role	  in	  the	  synthesis	  of	  
uracil.	   Furthermore,	   it	   is	   able	   to	   convert	   5-­‐Fluoroorotic	   acid	   (5-­‐FOA)	   into	   the	  
toxic	   compound	   5-­‐fluorouracil,	   so	   that	   it	   can	   be	   used	   as	   both	   a	   positive	   and	  
negative	   reporter	  protein.	   If	   both	  proteins	  of	   interest	   interact	  with	   each	  other,	  
the	   two	  halves	  of	  ubiquitin	  reassemble	   into	  native-­‐like	  ubiquitin.	  Ubiquitin	  can	  
now	  be	  recognized	  by	  ubiquitin	  specific	  proteases,	  which	   in	   turn	  cleave	  off	   the	  
reporter	  protein	  R-­‐Ura3.	  Because	  an	  arginine	  residue	  was	  introduced	  at	  the	  Cub-­‐
Ura3	  junction,	  the	  free	  R-­‐Ura3	  protein	  exposes	  an	  N-­‐terminally	  arginine	  residue,	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which	  is	  according	  to	  the	  N-­‐end-­‐rule	  a	  destabilizing	  amino	  acid	  and	  leads	  to	  the	  
rapid	   degradation	   of	   R-­‐Ura3	   and	   therefore	   to	   uracil	   auxotrophy	   (Müller	   and	  
Johnsson,	  2008).	  Consequently,	  cells	  expressing	  interacting	  proteins	  are	  able	  to	  
grow	  on	  plates	  containing	  5-­‐FOA	  but	  not	  on	  plates	  lacking	  uracil.	  The	  other	  way	  
round,	   if	   the	   two	   proteins	   do	   not	   interact	   with	   each	   other,	   the	   two	   halves	   of	  
ubiquitin	  do	  not	  reassemble	  to	  native	  ubiquitin.	  Therefore,	  the	  reporter	  protein	  
R-­‐Ura3	   is	   not	   cleaved	   off	   and	   degraded.	   Thus,	   cells	   expressing	   non-­‐interacting	  
proteins	  are	  able	  to	  grow	  on	  plates	  lacking	  uracil	  but	  not	  on	  plates	  containing	  5-­‐
FOA.	  	  
Atg21	   was	   tested	   for	   an	   interaction	   with	   several	   autophagy	   related	   proteins.	  
1	  OD600	   cells	   expressing	   Atg21-­‐Cub	   and	   the	   respective	   Nui-­‐Atg	   protein	   were	  
diluted	  in	  10-­‐fold	  steps	  and	  spotted	  on	  CM-­‐Trp-­‐His	  (growth	  control),	  on	  CM-­‐Trp-­‐
His	  +FOA	  (growth	  indicated	  interaction	  of	  the	  proteins)	  and	  on	  CM-­‐Trp-­‐His-­‐Ura	  
(growth	  indicated	  no	  interaction	  of	  the	  proteins).	  The	  expression	  of	  the	  proteins	  
of	  interest	  was	  induced	  by	  the	  addition	  of	  either	  100	  µM	  CuSO4	  (Nui)	  or	  250	  µM	  
methionine	  (Cub)	  to	  the	  selective	  medium	  (Laser	  et	  al.,	  2000).	  After	  two	  to	  three	  
days	  the	  growth	  pattern	  was	  analyzed.	  Cells	  expressing	  the	  interacting	  proteins	  
Ste14-­‐Cub	  and	  Nui-­‐Ubc6	  served	  as	  a	  positive	  control,	  cells	  expressing	  Ste14-­‐Cub	  
and	  the	  empty	  vector	  (pRS314)	  as	  a	  negative	  control	  (Krick	  et	  al.,	  2010).	  Atg21-­‐
Cub	   was	   tested	   for	   an	   interaction	   with	   Nui-­‐Atg1,	   -­‐Atg5,	   -­‐Atg7,	   -­‐Atg8,	   -­‐Atg9,	   -­‐
Atg12,	  -­‐Atg16,	  -­‐Atg18,	  -­‐Atg19,	  -­‐Atg21,	  -­‐Atg23,	  -­‐Atg27,	  -­‐Hsv2,	  -­‐Trs85	  and	  -­‐Vam1.	  
Three	  of	   them,	  Atg27,	  Atg8	  and	  Atg16	  showed	  a	  potential	   interaction	  and	  have	  
been	  analyzed	  in	  more	  detail.	  	  
4.3.4 Interaction	  studies	  of	  Atg21	  und	  At27	  
Atg27	   is	   a	   type	   I	   membrane	   protein.	   It	   directly	   interacts	   with	   the	   second	  
autophagy	   related	   membrane	   protein	   Atg9,	   which	   in	   turn	   interacts	   with	   the	  
cytosolic	   protein	   Atg23	   to	   form	   a	   trimeric	   complex.	   All	   three	   proteins	   cycle	  
between	   the	   PAS	   and	   a	   peripheral	   pool	   and	   are	   dependent	   on	   each	   other	   for	  
efficient	   cycling	   (Legakis	   et	   al.,	   2007;	   Yen	   et	   al.,	   2007).	   Comparable	   to	   Atg21,	  
Atg27	   is	   absolutely	   required	   for	   the	   Cvt	   pathway,	  whereas	  macroautophagy	   is	  
only	  significantly	  reduced	   in	  atg27∆	   cells	   (Yen	  et	  al.,	  2007).	  Both,	  PI3P	  binding	  
and	   interaction	   with	   its	   interacting	   partner	   Atg2,	   are	   crucial	   for	   proper	   PAS	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localization	  of	  the	  Atg21	  homologue	  Atg18	  (Rieter	  et	  al.,	  2013).	  As	  a	  membrane	  
protein	  required	  for	  the	  Cvt	  pathway,	  Atg27	  would	  be	  a	  good	  candidate	  for	  the	  
missing	  interaction	  partner	  of	  Atg21	  at	  the	  PAS.	  	  
4.3.4.1 Atg27	  and	  Atg21	  interact	  with	  each	  other	  in	  split-­‐ubiquitin	  assay	  
In	  the	  split-­‐ubiquitin	  assay,	  Atg21-­‐Cub	  showed	  neither	  an	  interaction	  with	  Nui-­‐
Atg9	   nor	   Nui-­‐Atg27	   (Figure	   21	  A).	   Furthermore,	   there	   was	   no	   interaction	  
detectable	   between	   Atg23-­‐Cub	   and	   Nui-­‐Atg21	   or	   its	   indirect	   binding	   partner	  
Nui-­‐Atg27	  (Figure	  21	  B).	   In	  contrast,	  an	   interaction	  of	  Atg23-­‐Cub	  and	   its	  direct	  
interaction	  partner	  Nui-­‐Atg9	  was	  detected,	  serving	  as	  a	  positive	  control.	  	  
	  
Figure	  21:	  An	  interaction	  of	  Atg27	  and	  Atg21	  in	  split-­‐ubiquitin	  assay	  was	  detected	  
(A)+(B)	   1	   OD600	  WT	   cells	   expressing	   the	   indicated	   Cub	   (bait)	   and	  Nui	   (prey)	   constructs	  were	  
diluted	   in	   10-­‐fold	   steps	   and	   spotted	   on	   CM-­‐Trp-­‐His	   (growth	   control),	   on	   CM-­‐Trp-­‐His	  +FOA	  
(growth	  implies	   interaction	  of	  the	  respective	  proteins)	  and	  CM-­‐Trp-­‐His-­‐Ura	  (growth	  implies	  no	  
interaction	  of	   the	   respective	  proteins).	  Pictures	  were	   taken	  after	   three	  days	  of	  growth	  at	  30°C.	  
Ste14-­‐Cub/Nui-­‐Ubc6:	  positive	  control;	  Ste14-­‐Cub/pRS314:	  negative	  control	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Using	  Atg27-­‐Cub	  as	  bait,	  an	  interaction	  with	  Nui-­‐Atg9,	  Nui-­‐Atg21	  and	  Nui-­‐Atg23,	  
but	   not	  with	   the	   empty	   vector	  was	   detected.	   Atg27	   and	   Atg9	   interact	   directly	  
with	   each	   other,	   resulting	   in	   a	   strong	   growth	   on	   selective	  medium	   containing	  
FOA.	   The	   interaction	   with	   Atg23	   was	   mediated	   by	   Atg9	   and	   represented	  
therefore	   an	   indirect	   interaction,	   resulting	   in	   a	   significantly	  weaker	   growth	  on	  
selective	   medium	   containing	   FOA.	   Cells	   expressing	   Atg27-­‐Cub	   and	   Nui-­‐Atg21	  
showed	  a	  medium	  growth	  (Figure	  21	  B).	  	  
Atg27	  consists	  of	  271	  amino	  acids	  and	  is	  a	  membrane	  protein	  type	  I.	  Therefore	  
its	  C-­‐terminal	  region	  faces	  towards	  the	  cytosol.	  Additionally,	  Atg27	  contains	  a	  N-­‐
terminal	  signal	  sequence.	  Amino	  acids	  199	  to	  221	  represent	  the	  transmembrane	  
domain	  (see	  Figure	  22	  A).	  Amino	  acid	  1	  to	  198	  or	  amino	  acid	  1	  to	  221	  of	  Atg27	  
were	   fused	   to	   the	   C-­‐terminal	   half	   of	   ubiquitin	   (Atg271-­‐198-­‐Cub	   and	   Atg271-­‐221-­‐
Cub)	  and	  tested	   for	  an	   interaction	  with	   its	  known	   interacting	  partner	  Nui-­‐Atg9	  
or	  –Atg21	  (Figure	  22	  A+B).	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Figure	  22:	  Interaction	  analysis	  of	  truncated	  Atg27	  in	  split-­‐ubiquitin	  assay	  
(A)	  Predicted	  domain	  structure	  of	  Atg27	  (Yen	  et	  al.,	  2007)	  (B)+(C)	  1	  OD600	  WT	  cells	  expressing	  
the	  indicated	  Cub	  (bait)	  and	  Nui	  (prey)	  constructs	  were	  diluted	  in	  10-­‐fold	  steps	  and	  spotted	  on	  
CM-­‐Trp-­‐His	  (growth	  control),	  on	  CM-­‐Trp-­‐His	  +FOA	  (growth	  implies	  interaction	  of	  the	  respective	  
proteins)	   and	   CM-­‐Trp-­‐His-­‐Ura	   (growth	   implies	   no	   interaction	   of	   the	   respective	   proteins).	  
Pictures	  were	   taken	   after	   three	  days	  of	   growth	   at	   30°C.	   Ste14-­‐Cub/Nui-­‐Ubc6:	   positive	   control;	  
Ste14-­‐Cub/pRS314:	  negative	  control	  
	  
The	   control	   combination	   Atg27-­‐Cub	   and	   Nui-­‐Atg9	   interacted	   with	   each	   other,	  
resulting	   in	  a	  growth	  on	  selective	  medium	  containing	  FOA,	  whereas	  Atg27-­‐Cub	  
and	   the	   empty	   vector	   did	   not.	   A	   strong	   interaction	   between	   Atg271-­‐198-­‐Cub,	  
representing	  only	  the	  lumenal	  part	  of	  Atg27,	  and	  Nui-­‐Atg9	  was	  detected,	  as	  the	  
growth	   on	   selective	   medium	   containing	   FOA	   was	   improved.	   In	   contrast,	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Atg271-­‐221-­‐Cub,	  additionally	  containing	  the	  transmembrane	  domain,	  only	  weakly	  
interacted	  with	  Nui-­‐Atg9	  (Figure	  22	  A).	  	  
Nearly	   the	   same	  result	  was	  obtained	   for	  an	   interaction	  with	  Nui-­‐Atg21.	  Atg27-­‐
Cub	   interacted	   with	   Nui-­‐Atg21,	   but	   not	   with	   the	   empty	   vector	   alone,	   as	   seen	  
before.	  An	  enhanced	   interaction	  of	  Atg271-­‐198-­‐Cub	  and	  Nui-­‐Atg21	  was	  detected,	  
whereas	   Atg271-­‐221-­‐Cub	   interacted	   only	   very	   weakly	   with	   Nui-­‐Atg21	   (Figure	  
22	  B).	  	  
4.3.4.2 Atg21	  and	  Atg27	  colocalized	  in	  direct	  fluorescence	  microscopy	  
Legakis	   et	   al.	   (2007)	   analyzed	   the	   Atg23-­‐Atg9-­‐Atg27	   complex	   by	   direct	  
fluorescence	   microscopy	   analysis	   and	   showed	   that	   approximately	   50%	   of	   the	  
Atg9-­‐RFP	   dots	   per	   cell	   were	   colocalized	  with	   both	   Atg23-­‐GFP	   and	   Atg27-­‐GFP.	  
The	   same	  situation	  was	  obtained	   for	  Atg23-­‐RFP	  and	  Atg27-­‐GFP	   (Legakis	   et	   al.,	  
2007).	  To	  support	  a	  potential	  interaction	  of	  Atg27	  and	  Atg21,	  both	  proteins	  were	  
also	   analyzed	   by	   direct	   fluorescence	  microscopy.	   For	   this	   purpose,	  ATG21	  was	  
deleted	  in	  a	  strain,	  chromosomally	  expressing	  Atg27-­‐GFP	  (cAtg27-­‐GFP).	  cAtg27-­‐
GFP	   was	   fully	   functional	   as	   it	   showed	   wild	   type	   ApeI	   maturation	   under	   both	  
growing	  and	  starvation	  conditions	  (Figure	  23	  A).	  In	  cAtg27-­‐GFP	  atg21∆	  cells	  the	  
maturation	   of	   ApeI	   was	   completely	   blocked	   under	   growing	   conditions	   and	  
severely	   impaired	  under	   starvation,	   confirming	  a	   successful	  deletion	  of	  ATG21.	  
Wild	   type	   and	  atg1∆	   cells	   served	   as	   a	   respective	  positive	   and	  negative	   control	  
(Figure	  23	  A).	  	  
cAtg27-­‐GFP	  atg21∆	  cells	  were	  transformed	  with	  mCherry-­‐Atg21	  expressed	  from	  
the	  MET25	  promoter,	  grown	  to	  log	  phase	  in	  the	  presence	  of	  0.3	  mM	  methionine	  
to	  induce	  endogenous	  mCherry-­‐Atg21	  expression	  level,	  and	  visualized	  by	  direct	  
fluorescence	  microscopy	  (Figure	  23	  B).	  cAtg27-­‐GFP	  was	  visible	  as	  several	  green	  
dots	   within	   the	   cell.	   As	   shown	   before,	   mCherry-­‐Atg21	   formed	   perivacuolar	  
puncta.	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Figure	  23:	  mCherry-­‐Atg21	  and	  Atg27-­‐GFP	  colocalized	  in	  direct	  fluorescence	  microscopy	  	  
(A)	   Complementation	   analysis	   of	   chromosomally	   tagged	   Atg27-­‐GFP	   (cAtg27-­‐GFP)	   in	   WT	   and	  
atg21∆	   cells	   by	   monitoring	   ApeI	   maturation.	   Wild	   type	   and	   atg1∆	   cells	   served	   as	   a	   control.	  
Samples	   were	   taken	   from	   growing	   cells	   (0	  h)	   and	   cells	   starved	   in	   SD-­‐N	   for	   four	   hours	   (4	  h),	  
alkaline	  lysed	  and	  immunoblotted.	  Precursor	  (prApeI)	  and	  matured	  ApeI	  (mApeI)	  were	  detected	  
using	   an	   anti-­‐ApeI	   antibody.	   (B)	   Growing	   cAtg27-­‐GFP	  atg21∆	   cells	   expressing	   mCherry-­‐Atg21	  
from	   the	   MET25	   promoter	   were	   grown	   to	   log	   phase	   and	   visualized	   using	   a	   DeltaVision	  
Deconvolution	   microscope	   equipped	   with	   a	   TRITC	   and	   FITC	   filter	   set.	   Pictures	   were	  
deconvoluted	   using	   SoftWoRx	   (Applied	   precision)	   software.	   (C)	   Colocalization	   rate	   was	  
quantified	  by	  counting	  the	  number	  of	  mCherry-­‐Atg21	  dots	  that	  colocalized	  with	  cAtg27-­‐GFP	  per	  
cell	  (n	  =	  76).	  The	  cells	  were	  sorted	  into	  the	  four	  indicated	  categories.	  	  
	  
The	   number	   of	  mCherry-­‐Atg21	   dots	   that	   colocalized	  with	   cAtg27-­‐GFP	   per	   cell	  
(Colocalization	   rate)	   was	   determined	   to	   correlate	   their	   expression	   pattern	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(Figure	  23	  C).	  In	  28%	  of	  the	  cells,	  all	  mCherry-­‐Atg21	  dots	  were	  colocalized	  with	  
Atg27-­‐GFP.	  At	  least	  50%	  colocalization	  was	  obtained	  in	  39%	  of	  the	  counted	  cells.	  
In	   24%	   of	   the	   cells,	   less	   than	   50%	   of	   the	   mCherry-­‐Atg21	   dots	   showed	   a	  
colocalization	   with	   cAtg27-­‐GFP,	   whereas	   in	   only	   9%	   of	   the	   cells,	   no	  
colocalization	  of	  both	  proteins	  was	  detected.	  Taken	  together,	  in	  more	  than	  50%	  
of	   the	   cells,	   at	   least	   50%	   of	   mCherry-­‐Atg21	   colocalized	   with	   cAtg27-­‐GFP,	  
supporting	  an	  interaction	  of	  both	  proteins.	  	  
4.3.4.3 Analysis	  of	  the	  potential	  interaction	  of	  Atg21	  and	  Atg27	  by	  pull	  down	  
and	  GFP-­‐TRAP®	  	  
To	  further	  investigate	  a	  potential	  interaction	  of	  Atg21	  and	  Atg27,	  the	  binding	  of	  
Atg27	   to	  Atg21	  was	  examined	   in	  pull	  down	  experiments	  and	  GFP-­‐TRAP®s.	  For	  
this	  purpose	  a	  chromosomally	  tagged	  Atg27-­‐HA	  (cAtg27-­‐HA)	  strain	  was	  used.	  As	  
mentioned	  before,	  Atg27	  has	  a	  specific	  Cvt	  phenotype	  (Yen	  et	  al.,	  2007).	  cAtg27-­‐
HA	  showed	  no	  defect	  in	  ApeI	  maturation	  in	  mid-­‐log	  phase,	  suggesting	  that	  it	  was	  
functional	  (Figure	  24	  A).	  	  	  
For	  pull	  down	  experiments,	  recombinant	  6xHis-­‐SUMO-­‐Atg21	  was	  purified	  using	  
Nickel-­‐NTA	  beads.	  Immobilized	  6xHis-­‐SUMO-­‐Atg21	  was	  subsequently	  incubated	  
with	   crude	   extract	   of	   log	   cAtg27-­‐HA	   yeast	   cells.	   After	   extensive	   washing,	   all	  
bound	  proteins	  were	  eluted	  from	  the	  beads,	  subjected	  to	  SDS-­‐PAGE	  and	  analyzed	  
by	   immunoblotting	  (Figure	  24	  B).	  A	  small	  part	  of	  cAtg27-­‐HA	  bound	  specifically	  
to	  6xHis-­‐SUMO-­‐Atg21,	  but	  not	   to	  6xHis-­‐SUMO	  alone,	  supporting	  an	   interaction.	  
Surprisingly,	   this	   was	   not	   reproducible,	   as	   a	   binding	   of	   Atg27-­‐HA	   to	   6xHis-­‐
SUMO-­‐Atg21	  could	  no	  longer	  be	  obtained	  in	  further	  pull	  down	  experiments	  (data	  
not	  shown).	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Figure	  24:	  Atg27	  does	  not	  specifically	  interact	  with	  Atg21	  in	  pull	  down	  and	  GFP-­‐TRAP®	  experiments	  
(A)	  Complementation	  study	  of	   cAtg27-­‐HA	  by	  monitoring	  ApeI	  maturation.	  WT,	  atg1∆	   and	  cells	  
chromosomally	   expressing	   Atg27-­‐HA	   (cAtg27-­‐HA)	   were	   alkaline	   lysed	   in	   growing	   phase	   and	  
immunoblotted.	  Precursor	  (prApeI)	  and	  matured	  (mApeI)	  ApeI	  were	  detected	  using	  an	  anti-­‐ApeI	  
antibody.	  (B)	  Recombinant	  6xHis-­‐SUMO-­‐Atg21	  and	  6xHis-­‐SUMO	  alone	  as	  negative	  control	  were	  
purified	   using	   Ni-­‐NTA	   beads	   and	   incubated	   with	   crude	   extract	   of	   growing	   cAtg27-­‐HA	   cells.	  
Samples	   from	   the	   respective	   E.	  coli	   and	   yeast	   lysates	   (L),	   cleared	   lysate	   (E.	  coli	   S),	   unbound	  
fractions	  (yeast	  S)	  and	  the	  purified	  proteins	  (E)	  were	  analyzed	  by	  immunoblotting	  using	  anti-­‐HA	  
and	   anti-­‐His	   antibodies.	   (C)	   Growing	   cAtg27-­‐HA	   cells	   expressing	   GFP-­‐Atg21	   or	   GFP	   alone	   as	  
negative	   control	   were	   lysed	   using	   the	   mild	   cell	   lysis	   procedure	   and	   subjected	   to	   GFP-­‐TRAP®	  
analysis.	  Samples	  from	  the	  cell	  lysate	  (L),	  the	  unbound	  fraction	  (S)	  and	  from	  the	  purified	  proteins	  
were	  analyzed	  by	  immunoblotting	  using	  anti-­‐HA	  and	  anti-­‐GFP	  antibodies.	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In	  addition,	  GFP-­‐TRAP®	  analysis	  with	  growing	  cAtg27-­‐HA	  cells	  expressing	  GFP-­‐
Atg21	  or	  GFP	  alone	  as	  control	  were	  performed.	  Here,	  a	  part	  of	  cAtg27-­‐HA	  bound	  
to	  GFP-­‐Atg21,	  but	  also	  to	  GFP	  alone	  (see	  Figure	  24	  C).	  Although	  the	  GFP-­‐bound	  
part	   was	   apparently	   smaller	   than	   the	   GFP-­‐Atg21-­‐bound	   part,	   an	   unspecific	  
binding	  of	  cAtg27-­‐HA	  to	  GFP-­‐Atg21	  could	  not	  be	  excluded.	  	  
4.3.5 Interaction	  studies	  of	  Atg21	  und	  Atg8	  
Atg8	   is	   one	   of	   the	   core	   autophagy	   related	   proteins.	   It	   plays	   dual	   roles	   in	  
autophagy.	   It	   is	  critical	   for	  the	  elongation	  of	  the	  forming	  autophagosome	  and	  it	  
also	  links	  the	  cargo	  to	  the	  autophagosome	  by	  direct	  binding	  to	  the	  cargo	  receptor	  
during	   selective	   types	   of	   autophagy.	   To	   fulfill	   its	   function,	   Atg8	   has	   to	   be	  
covalently	  coupled	  to	  PE	  in	  a	  ubiquitin-­‐like	  manner.	  Atg8	  is	  synthesized	  with	  an	  
additional	  arginine	  at	  its	  C-­‐terminal	  end,	  which	  is	  cleaved	  off	  by	  Atg4.	  Shortened	  
Atg8	   is	   subsequently	   activated	   by	   the	   E1	   enzyme	   Atg7,	   transferred	   to	   the	   E2	  
enzyme	   Atg3	   and	   finally	   covalently	   conjugated	   to	   PE	   by	   the	   help	   of	   the	   E3	  
complex	   Atg12-­‐Atg5/Atg16	   (see	   chapter	   2.2.4.4).	   Atg21	   was	   shown	   to	   be	  
involved	   in	   efficient	   lipidation	   and	   in	   the	   PAS	   recruitment	   of	   Atg8	   (Meiling-­‐
Wesse	  et	  al.,	  2004;	  Stromhaug	  et	  al.,	  2004).	  	  
For	  the	  split-­‐ubiquitin	  assay,	  Atg8	  was	  only	  N-­‐terminally	  fused	  to	  the	  N-­‐terminal	  
half	  of	  ubiquitin	  (Nui-­‐Atg8)	  because	  of	  its	  C-­‐terminal	  processing	  and	  was	  tested	  
for	  an	  interaction	  with	  Atg21-­‐Cub	  (Figure	  25).	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Figure	  25:	  Atg21	  and	  Atg8	  interact	  with	  each	  other	  in	  split-­‐ubiquitin	  assay	  
1	  OD600	  WT,	  atg4∆	  and	  atg5∆	  cells	  expressing	  the	  indicated	  Cub	  (bait)	  and	  Nui	  (prey)	  constructs	  
were	  diluted	  in	  10-­‐fold	  steps	  and	  spotted	  on	  CM-­‐Trp-­‐His	  (growth	  control),	  on	  CM-­‐Trp-­‐His	  +FOA	  
(growth	  implies	   interaction	  of	  the	  respective	  proteins)	  and	  CM-­‐Trp-­‐His-­‐Ura	  (growth	  implies	  no	  
interaction	  of	   the	   respective	  proteins).	  Pictures	  were	   taken	  after	   three	  days	  at	  growth	  at	  30°C.	  
Ste14-­‐Cub/Nui-­‐Ubc6:	  positive	  control;	  Ste14-­‐Cub/pRS314:	  negative	  control	  
	  
Cells	  expressing	  both	  constructs	  were	  able	  to	  grow	  on	  plates	  containing	  FOA,	  but	  
not	   on	   plates	   lacking	   uracil.	   In	   contrast,	   cells	   expressing	   Atg21-­‐Cub	   and	   the	  
empty	  vector	  (pRS314)	  showed	  the	  opposite	  growth	  phenotype	  and	  served	  as	  an	  
additional	  negative	  control	  (Figure	  25).	  Taken	  together,	  this	  strongly	  pointed	  to	  
an	  interaction	  of	  Atg21	  and	  Atg8.	  	  
Atg8	  exists	  in	  two	  forms	  within	  a	  cell,	  either	  unlipidated	  or	  covalently	  conjugated	  
to	  PE.	  To	  test	  which	  form	  interacts	  with	  Atg21,	  the	  interaction	  of	  Atg8	  and	  Atg21	  
was	  tested	  in	  strains	  lacking	  Atg4	  or	  Atg5,	  where	  Atg8	  lipidation	  is	  impaired.	  In	  
both	  strains,	  a	  clear	  interaction	  of	  Atg21	  and	  Atg8	  was	  detected	  (Figure	  25).	  	  
4.3.5.1 Bimolecular	  Fluorescence	  Complementation	  (BiFC)	  analysis	  
To	   further	   evaluate	   a	   possible	   interaction	   of	   Atg8	   and	   Atg21,	   Bimolecular	  
Fluorescence	  Complementation	  (BiFC)	  analysis	  was	  used.	  For	  this	  purpose,	  two	  
proteins	  of	  interest	  are	  fused	  to	  either	  the	  nonfluorescent	  N-­‐terminal	  (YN)	  or	  C-­‐
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terminal	  (YC)	  part	  of	  enhanced	  YFP	  (eYFP).	  Both	  fragments	  are	  brought	  together	  
and	  are	  able	  to	  reassemble	  into	  fluorescent	  eYFP,	   if	   the	  target	  proteins	  interact	  
with	   each	   other	   ((Skarp	   et	   al.,	   2008);Figure	   26	  A).	   The	   interaction	   of	   two	  
proteins	   within	   the	   living	   cell	   can	   be	   easily	   visualized	   by	   fluorescence	  
microscopy.	  Therefore,	  it	  is	  also	  possible	  to	  determine	  the	  interacting	  site	  within	  
the	  cell.	  	  
Atg8	  was	  only	  N-­‐terminally	  tagged,	  because	  it	  is	  processed	  at	  its	  C-­‐terminal	  end.	  
To	  exclude	  sterical	  hindrance,	  Atg8	  was,	  concerning	  the	  split-­‐ubiquitin	  assay,	  N-­‐
terminally	   fused	   to	   the	  N-­‐terminal	   fragment	   of	   eYFP	   (N-­‐YN	  Atg8)	   according	   to	  
the	  instructions	  of	  Skarp	  et	  al.	  (Skarp	  et	  al.,	  2008).	  Atg21	  and	  Atg4	  as	  a	  positive	  
control	  were	  fused	  to	  the	  corresponding	  C-­‐terminal	  fragment	  (YC)	  either	  at	  the	  
N-­‐	  or	  C-­‐terminus.	  All	  constructs	  were	  tested	  for	  functionality	  by	  monitoring	  ApeI	  
maturation.	  Wild	  type	  and	  atg1∆	  cells	  expressing	  the	  empty	  vector	  were	  used	  as	  
a	   positive	   and	   negative	   control	   respectively.	   N-­‐terminally	   tagged	   Atg4	   (N-­‐
YC	  Atg4)	   was	   able	   to	   restore	   ApeI	   maturation	   in	   both	   growing	   and	   nitrogen	  
starved	   atg4∆	   cells,	   whereas	   C-­‐terminally	   tagged	   Atg4	   (Atg4	  C-­‐YC)	   was	   not	  
(Figure	   26	  B).	   In	   contrast,	   C-­‐terminally	   tagged	   Atg21	   (Atg21	  C-­‐YC)	  
complemented	   the	   ApeI	   maturation	   defect	   in	   growing	   and	   nitrogen	   starved	  
atg21∆	   cells,	   whereas	   N-­‐terminal	   tagged	   Atg21	   (N-­‐YC	  Atg21)	   did	   not	   (Figure	  
26	  B).	   For	   this	   reason	   N-­‐YC	  Atg4	   and	   Atg21	  C-­‐YC	   were	   chosen	   for	   further	  
analysis.	   Interestingly,	   N-­‐YN	  Atg8	   was	   able	   to	   nearly	   fully	   restore	   ApeI	  
maturation	  in	  growing	  atg8∆	  cells	  coexpressing	  C-­‐YC	  alone	  (Figure	  26	  D).	  But	  in	  
growing	   atg8∆	   cells	   expressing	   both	   N-­‐YN	  Atg8	   and	   Atg21	  C-­‐YC,	   the	   ApeI	  
maturation	  was	  slightly	  delayed.	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Figure	  26:	  Bimolecular	  Fluorescence	  Complementation	  (BiFC)	  analysis	  of	  Atg8	  and	  Atg21	  
(A)	   Scheme	   of	   the	   BiFC	   analysis.	   (B)	   Complementation	   studies	   of	   N-­‐YC	  Atg4,	   Atg4	  C-­‐YC,	   N-­‐
YC	  Atg21	   and	   Atg21	  C-­‐YC	   by	   monitoring	   ApeI	   maturation.	   WT,	   atg1∆,	   atg4∆,	   atg21∆	   cells	  
expressing	  the	  indicated	  Atg4	  or	  Atg21	  constructs	  or	  the	  respective	  empty	  vector	  were	  grown	  to	  
mid-­‐log	   phase	   (0	  h)	   and	   further	   starved	   for	   four	   hours	   in	   SD-­‐N	   (4	  h).	   Samples,	   taken	   at	   the	  
indicated	  time	  points,	  were	  alkaline	  lysed	  and	  immunoblotted.	  Precursor	  (prApeI)	  and	  matured	  
ApeI	  (mApeI)	  were	  detected	  using	  an	  anti-­‐ApeI	  antibody.	  (C)	  Growing	  atg4∆	  cells	  expressing	  N-­‐
YC	  Atg4	   and	   N-­‐YN	  Atg8	   from	   an	   ADH	   promoter	   were	   visualized	   using	   a	   DeltaVision	  
Deconvolution	   microscope	   equipped	   with	   a	   TRITC	   and	   FITC	   filter	   set.	   Pictures	   were	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deconvoluted	  using	  SoftWoRx	  (Applied	  Precision)	  software.	  (D)	  Complementation	  studies	  of	  N-­‐
YN	  Atg8.	  ApeI	  maturation	  was	  analyzed	  as	  described	  in	  (B)	  (E)	  Growing	  atg21∆	  cells	  expressing	  
Atg21	  C-­‐YC	   and	   N-­‐YN	  Atg8	   from	   a	   ADH	   promoter	   were	   visualized	   as	   described	   in	   (C).	   Both,	  
atg21∆	   cells	  expressing	  N-­‐YN	  Atg8	  and	  C-­‐YC	  alone	  or	  Atg21	  C-­‐YC	  and	  N-­‐YN	  alone	   from	  an	  ADH	  
promoter	  served	  as	  negative	  controls.	  The	  PAS	  rate	  indicates	  the	  number	  of	  ApeI-­‐RFP	  dots	  that	  
colocalized	  with	  an	  eYFP	  dot.	  	  
	  
First,	   growing	   atg4∆	   cells	   coexpressing	   N-­‐YC	  Atg4	   and	   N-­‐YN	  Atg8	   from	   the	  
strong	   and	   constitutive	   ADH	   promoter	   were	   analyzed	   by	   direct	   fluorescence	  
microscopy.	  Since	  Atg4	  and	  Atg8	  interact	  directly	  with	  each	  other	  for	  C-­‐terminal	  
procession	  of	  Atg8	  (Kirisako	  et	  al.,	  2000;	  Lang	  et	  al.,	  1998),	  a	  clear	  eYFP	  signal	  
representing	   the	   Atg4-­‐Atg8-­‐eYFP	   complex,	   was	   detected.	   But	   unexpectedly,	   it	  
was	   exclusively	   present	   in	   the	   nucleus	   (Figure	   26	  C).	   A	   localization	   of	   Atg8	  
and/or	   Atg4	   in	   the	   nucleus	   has	   not	   been	   reported	   before,	   suggesting	   that	   N-­‐
YC	  Atg4	  and	  N-­‐YN	  Atg8	  were	  mislocalized.	  	  
Next,	  growing	  atg21∆	  cells	  expressing	  N-­‐YN	  Atg8	  and	  Atg21	  C-­‐YC	  from	  the	  ADH	  
promoter	   were	   analyzed	   by	   direct	   fluorescence	   microscopy.	   One	   to	   five,	   but	  
intensive	  green	   fluorescent	  dots	  per	   cell	  were	  detected,	   strongly	   suggesting	  an	  
interaction	  of	  Atg8	  and	  Atg21.	  Since	  these	  dots	  localized	  at	  the	  perivacuolar	  site,	  
the	   PAS	   marker	   ApeI-­‐RFP	   was	   coexpressed	   to	   determine	   if	   the	   interaction	  
occurred	   at	   the	   PAS.	   Indeed,	   60%	   of	   the	   ApeI-­‐RFP	   dots	   colocalized	   with	   the	  
Atg21-­‐Atg8-­‐eYFP	   complexes,	   suggesting	   that	   Atg21	   and	   Atg8	   interacted	   with	  
each	  other	  at	  the	  PAS.	  	  
As	  expected,	  in	  the	  negative	  control,	  atg21∆	  cells	  expressing	  N-­‐YN	  Atg8	  and	  C-­‐YC	  
alone	   from	   the	  ADH	   promoter,	   no	   eYFP	   fluorescence	   signal	   could	   be	   obtained	  
(Figure	   26	  E).	   Surprisingly,	   in	   the	   second	   negative	   control,	   atg21∆	   cells	  
expressing	   Atg21	  C-­‐YC	   and	   N-­‐YN	   alone,	   green	   fluorescent,	   perivacuolar	   dots	  
were	   detectable,	   comparable	   to	   the	   signal	   obtained	   in	   cells	   expressing	   the	  
respective	  Atg21	  and	  Atg8	  constructs	  (Figure	  26	  E).	  In	  contrast,	  the	  PAS	  rate	  of	  
these	  dots	  was	  significantly	  reduced	  to	  only	  26%.	  	  
The	   fusion	   proteins	   tested	   so	   far	   were	   highly	   overexpressed	   from	   the	  
constitutive	   ADH	   promoter.	   To	   avoid	   overexpression	   artefacts,	   a	   plasmid	   was	  
constructed,	   where	   Atg21	  C-­‐YC	   was	   expressed	   from	   an	   inducible	   MET25	  
promoter.	  In	  addition	  to	  the	  regulation	  of	  the	  expression	  strength,	  it	  is	  possible	  
to	   induce	   the	   expression	   at	   a	   specific	   time	   point	   and	   therefore	   to	   limit	   the	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expression	   period	   of	   the	   target	   protein.	   To	   define	   the	   appropriate	   expression	  
level	   of	   Atg21	  C-­‐YC,	   that	   corresponds	   to	   the	   N-­‐YN	  Atg8	   level,	   atg21∆	   cells	  
carrying	   the	   pRS425-­‐ADH-­‐N-­‐YN	  Atg8	   and	   pUG36-­‐MET25-­‐Atg21	  C-­‐YC	   plasmids	  
were	  grown	  in	  media	  with	  different	  concentrations	  of	  methionine.	  Samples	  were	  
taken	  in	  mid-­‐log	  phase,	  alkaline	  lysed	  and	  analyzed	  by	  immunoblotting	  using	  an	  
anti-­‐GFP	  antibody	  (Figure	  27	  A).	  	  
	  
Figure	  27:	  BiFC	  study	  of	  MET25-­‐Atg21	  C-­‐YC	  and	  ADH-­‐N-­‐YN	  Atg8	  
(A)	   Expression	   test	   of	   MET25-­‐Atg21	  C-­‐YC	   and	   ADH-­‐N-­‐YN	  Atg8.	   Cells	   were	   grown	   in	   medium	  
containing	   the	   indicated	   methionine	   concentration	   to	   mid-­‐log	   phase.	   Samples	   were	   alkaline	  
lysed,	   subjected	   to	   immunoblotting	   and	   analyzed	   using	   an	   anti-­‐GFP	   (abcam)	   antibody.	   For	  
further	   studies	   a	   concentration	  of	   0.5	  mM	  methionine	  was	   chosen.	   (B)	  atg21∆	   cells	   expressing	  
MET25-­‐Atg21	  C-­‐YC	   and	   ADH-­‐N-­‐YN	  Atg8	   or	   ADH-­‐N-­‐YN	   alone	   were	   grown	   in	   the	   presence	   of	  
0.5	  mM	  methionine	  to	  log	  phase	  and	  subsequently	  visualized	  using	  a	  DeltaVision	  Deconvolution	  
microscope	   equipped	   with	   a	   TRITC	   and	   FITC	   filter	   set.	   Pictures	   were	   deconvoluted	   using	  
SoftWoRx	  (Applied	  Precision)	  software.	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Since	   N-­‐YN	   Atg8	   was	   still	   expressed	   from	   the	   constitutive	   ADH	   promoter,	   its	  
concentration	  remained	  the	  same	  independent	  of	  the	  methionine	  concentration.	  
In	   contrast,	   the	   amount	   of	   Atg21	  C-­‐YC	   decreased	   with	   increasing	   methionine	  
concentration.	   For	   further	   approaches,	   a	   concentration	   of	   0.5	  mM	   methionine	  
was	  chosen.	  
atg21∆	   cells	   expressing	   MET25-­‐Atg21	  C-­‐YC	   and	   ADH-­‐N-­‐YN	  Atg8	   or	   ADH-­‐N-­‐YN	  
alone	  were	  first	  grown	  in	  selective	  medium	  containing	  an	  excess	  of	  methionine	  
to	   inhibit	   the	   expression	   of	   Atg21	  C-­‐YC.	   Cells	   were	   diluted	   to	   an	   OD600	   of	  
approximately	   0.3	   in	   medium	   containing	   0.5	  mM	   methionine	   to	   induce	   the	  
Atg21	  C-­‐YC	   expression.	   After	   cells	   reached	   mid-­‐log	   phase	   (after	   three	   to	   four	  
hours	  at	  30°C),	  they	  were	  analyzed	  by	  direct	  fluorescence	  microscopy.	  Again,	  in	  
growing	  atg21∆	  cells	  expressing	  MET25-­‐Atg21	  C-­‐YC	  and	  ADH-­‐N-­‐YN	  Atg8	  one	  to	  
few	  perivacuolar,	  green	  fluorescent	  dots	  per	  cell	  were	  detectable	  (Figure	  27	  B).	  
In	   contrast	   to	   the	   conditions	   used	   before,	   the	   intensity	   of	   the	   dots	   was	  much	  
fainter,	   leading	   to	   a	   greater	   background	   noise.	   Unfortunately,	   the	   atg21∆	  cells	  
expressing	   MET25-­‐Atg21	  C-­‐YC	   and	   ADH-­‐N-­‐YN	   alone	   showed	   the	   same	  
fluorescence	  signals,	  pointing	  again	  to	  false	  positive	  signals.	  
As	   a	   next	   step,	   the	   amount	   of	   N-­‐YN	  Atg8	   was	   additionally	   reduced	   by	  
constructing	   a	   plasmid,	   where	   N-­‐YN	  Atg8	   was	   expressed	   from	   the	   MET25	  
promoter.	   As	   before,	   the	   expression	   level	   of	   both	   fusion	   proteins	   at	   different	  
methionine	   concentrations	   was	   tested	   via	   immunoblot	   analysis	   (Figure	   28	  A).	  
Again,	   the	  amount	  of	  MET25-­‐Atg21	  C-­‐YC	  decreased	  with	   increasing	  methionine	  
concentration.	   MET25-­‐N-­‐YN	  Atg8	   was	   only	   detectable	   in	   the	   full	   absence	   of	  
methionine	   and	   therefore	   at	   the	   strongest	   expression	   level.	   This	   amount	   was	  
comparable	   to	   N-­‐YN	  Atg8	   expressed	   from	   the	   ADH	   promoter.	   To	   avoid	  
overexpression	  artefacts,	  a	  methionine	  concentration	  of	  0.5	  mM	  was	  chosen.	  	  
As	  before,	  atg21∆	  cells	  expressing	  Atg21	  C-­‐YC	  and	  N-­‐YN	  Atg8	  or	  N-­‐YN	  alone	  from	  
the	  MET25	  promoter	  were	  grown	  in	  the	  presence	  of	  0.5	  mM	  methionine	  until	  log	  
phase	  and	  analyzed	  by	  direct	  fluorescence	  microscopy	  (Figure	  28	  B).	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Figure	  28:	  BiFC	  study	  of	  MET25	  Atg21	  C-­‐YC	  and	  MET25	  N-­‐YN	  Atg8	  
(A)	   Expression	   test	   of	  MET25	   Atg21	  C-­‐YC	  and	  MET25	  N-­‐YN	  Atg8.	  Cells	  were	   grown	   in	  medium	  
containing	   the	   indicated	   methionine	   concentration	   to	   mid-­‐log	   phase.	   Samples	   were	   alkaline	  
lysed,	   subjected	   to	   immunoblotting	   and	   analyzed	   using	   an	   anti-­‐GFP	   (abcam)	   antibody.	   For	  
further	   studies	   a	   concentration	  of	   0.5	  mM	  methionine	  was	   chosen.	   (B)	  atg21∆	   cells	   expressing	  
MET25	  Atg21	  C-­‐YC	  and	  MET25	  N-­‐YN	  Atg8	  or	  MET25	  N-­‐YN	  alone	  were	  grown	  in	  the	  presence	  of	  
0.5	  mM	  methionine	  to	  log	  phase	  and	  subsequently	  visualized	  using	  a	  DeltaVision	  Deconvolution	  
microscope	   equipped	   with	   a	   TRITC	   and	   FITC	   filter	   set.	   Pictures	   were	   deconvoluted	   using	  
SoftWoRx	  (Applied	  Precision)	  software.	  	  
	  
Again,	  there	  was	  no	  difference	  in	  the	  fluorescence	  signal	  in	  cells	  expressing	  both	  
protein	   constructs	   or	   in	   the	   negative	   control	   expressing	   only	   Atg21	  C-­‐YC.	   In	  
further	  efforts,	  the	  methionine	  concentration,	  the	  expression	  duration	  and	  strain	  
background	  was	  varied	  diversely	  (data	  not	  shown).	  But	  taken	  together,	  all	  cells	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expressing	   Atg21	  C-­‐YC	   exhibited	   a	   false-­‐positive	   signal,	   independent	   of	  
expression	  partner,	  expression	  level	  and	  duration.	  	  
4.3.5.2 Is	  Atg8	  part	  of	  the	  Atg21	  high	  molecular	  weight	  complex	  detected	  in	  
gelfiltration?	  
Part	  of	  Atg21	  was	  detected	  as	  a	  high	  molecular	  weight	   complex	   in	  gelfiltration	  
(Figure	  16	  B+C).	  To	  examine	  if	  Atg8	  was	  part	  of	  this	  complex,	  atg21∆	  pep4∆	  cells	  
were	   transformed	   with	   pRS313-­‐GFP-­‐Atg8	   and	   pMET25-­‐mCherry-­‐Atg21	   or	  
pMET25-­‐mCherry	   as	   negative	   control.	   0.3	  mM	   methionine	   was	   added	   to	   the	  
media	  to	  induce	  endogenous	  expression	  level	  of	  mCherry-­‐Atg21.	  The	  cells	  were	  
harvested	   in	   late	  growing	  phase	  and	  resuspended	  in	   lysis	  buffer	  (10	  mM	  MOPS	  
pH	  7.2,	  0.2	  M	  sorbitol,	  1	  mM	  EDTA,	  2	  mM	  PMSF,	  protease	  inhibitors).	  Cells	  were	  
lysed	  using	  the	  mild	  cell	  lysis	  procedure	  and	  subjected	  to	  gelfiltration	  analysis	  as	  
described	  before	  (chapter	  4.3.1.1).	  	  
The	  main	  part	  of	  mCherry-­‐Atg21	  was	  eluted	  in	  fraction	  10	  and	  fractions	  14	  to	  15	  
corresponding	  to	  ≥	  670	  kDa	  (Figure	  29	  A).	  The	  main	  part	  of	  GFP-­‐Atg8	  was	  eluted	  
in	   fractions	  15	   to	   17,	   and	  was	   therefore	  partly	   overlapping	  with	   the	  mCherry-­‐
Atg21	   fractions	   (Figure	   29	  B).	   However,	   the	   distribution	   of	   GFP-­‐Atg8	   was	   not	  
changed	  in	  the	  absence	  of	  mCherry-­‐Atg21,	  indicating,	  that	  GFP-­‐Atg8	  was	  not	  part	  
of	   the	   Atg21	   high	   molecular	   weight	   complex.	   Furthermore,	   GFP-­‐Atg8	   has	   a	  
molecular	  weight	   of	   about	  40	  kDa.	  The	   fractions,	  where	  GFP-­‐Atg8	  was	  present	  
corresponded	   to	   ≥	  65	  kDa,	   indicating	   that	   GFP-­‐Atg8	   was	   not	   present	   in	   its	  
monomeric	   form	   but	   as	   an	   oligomer	   or	   in	   a	   complex.	   Nevertheless,	   since	   the	  
distribution	  of	  GFP-­‐Atg8	  was	  not	  changed	  in	  the	  absence	  of	  mCherry-­‐Atg21,	  this	  
was	  independent	  of	  Atg21.	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Figure	  29:	  Atg8	  distribution	  in	  gelfiltration	  was	  not	  changed	  in	  the	  absence	  of	  Atg21	  
Growing	  atg21∆	  pep4∆	  cells	  expressing	  GFP-­‐Atg8	  and	  mCherry-­‐Atg21	  (A)	  or	  mCherry	  alone	  (B)	  
were	  lysed	  using	  the	  mild	  cell	  lysis	  procedure	  and	  subjected	  to	  size	  exclusion	  chromatography	  on	  
a	  Superose	  6	  column.	  The	  cell	  lysate	  was	  eluted	  from	  the	  column	  at	  a	  flow	  rate	  of	  0.5	  ml/ml	  and	  
0.8	  ml	   fractions	   were	   collected	   as	   it	   was	   described	   in	   (Obara	   et	   al.,	   2008b).	   Fractions	   were	  
precipitated	  and	  analyzed	  by	   immunoblotting	  using	  anti-­‐RED,	  anti-­‐GFP,	  anti-­‐ApeI	  and	  anti-­‐CPY	  
antibodies.	   (C)	   Quantification	   of	   the	   distribution	   of	   the	   individual	   proteins	   in	   the	   respective	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4.3.6 Interaction	  studies	  of	  Atg21	  und	  Atg16	  
Atg16	  is	  part	  of	  the	  Atg12-­‐Atg5/Atg16	  complex,	  which	  acts	  as	  an	  E3-­‐like	  enzyme	  
in	  the	  ubiquitin-­‐like	  conjugation	  of	  Atg8	  to	  PE	  (Fujita	  et	  al.,	  2008;	  Hanada	  et	  al.,	  
2007).	  	  
4.3.6.1 Atg21	  and	  Atg16	  interact	  with	  each	  other	  in	  the	  split-­‐ubiquitin	  assay	  
In	   the	   split-­‐ubiquitin	   assay,	   Atg21-­‐Cub	   was	   tested	   for	   an	   interaction	   with	   all	  
members	   of	   the	   Atg12-­‐Atg5/Atg16	   complex.	   Only	   cells	   expressing	   Atg21-­‐Cub	  
and	  Nui-­‐Atg16	  showed	  a	  weak	  growth	  in	  the	  presence	  of	  FOA,	  indicating	  a	  weak	  
interaction	  (Figure	  30	  A).	  The	  interaction	  could	  be	  disturbed	  by	  steric	  hindrance	  
and/or	   interference	   with	   endogenous	   Atg16.	   To	   improve	   the	   interaction	   of	  
Atg21	  and	  Atg16,	  atg16∆	  cells	  expressing	  Atg16-­‐Cub	  and	  Nui-­‐Atg21	  were	  tested	  
in	  the	  split-­‐ubiquitin	  assay	  (Figure	  30	  B).	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Figure	  30:	  Atg16	  and	  Atg21	  interact	  in	  the	  split-­‐ubiquitin	  assay	  
(A)+(B)+(C)	   1	   OD600	  WT,	   atg5∆	   and	   atg16∆	   cells	   expressing	   the	   indicated	   Cub	   (bait)	   and	   Nui	  
(prey)	   constructs	   were	   diluted	   in	   10-­‐fold	   dilution	   steps	   and	   spotted	   on	   CM-­‐Trp-­‐His	   (growth	  
control),	  CM-­‐Trp-­‐His+FOA	  (growth	  indicated	  interaction	  of	  the	  respective	  proteins)	  and	  CM-­‐Trp-­‐
His-­‐Ura	   (growth	   indicated	   no	   interaction	   of	   the	   respective	   proteins).	   Ste14-­‐Cub/Nui-­‐Ubc6:	  
positive,	  Ste14-­‐Cub/pRS314:	  negative	  control	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In	   the	  E3	   complex	  Atg16	  and	  Atg5	   interact	  directly.	  Therefore,	   the	  Atg16-­‐Atg5	  
interaction	  was	  used	  as	  a	  reference	  for	  direct	  interaction	  in	  this	  analysis.	  atg16∆	  
cells	  expressing	  Atg16-­‐Cub	  and	  Nui-­‐Atg5	  showed	  a	  strong	  growth	  phenotype	  in	  
the	   presence	   of	   FOA,	   whereas	   the	   same	   cells	   were	   not	   able	   to	   grow	   in	   the	  
absence	   of	   uracil.	   Atg12	   and	   Atg16	   interact	   indirectly	   via	   Atg5.	   Therefore,	   the	  
combination	   of	   Atg16-­‐Cub	   and	   Nui-­‐Atg12	   resulted	   in	   a	   reduced	   but	   still	  
detectable	   growth	  on	  FOA	  medium.	   Furthermore,	   the	   interaction	  of	  Atg16-­‐Cub	  
and	   Nui-­‐Atg12	   could	   no	   longer	   be	   obtained	   in	   atg5∆	   cells.	   Indeed,	   a	   clear	  
interaction	   of	   Atg16-­‐Cub	   and	  Nui-­‐Atg21	  was	   detected.	   The	   growth	   strength	   of	  
atg16∆	   cells	   expressing	   Atg16-­‐Cub	   and	   Nui-­‐Atg21	   on	   FOA	   medium	   was	  
significantly	   improved	   compared	   to	   wild	   type	   cells	   and	   ranged	   between	   the	  
observed	  direct	  and	   indirect	   control	   interactions.	  Furthermore,	   this	   interaction	  
was	  independent	  of	  Atg5,	  as	  shown	  in	  atg5∆	  cells.	  	  
To	   support	   further	   that	   Atg21	   interacts	   specifically	   with	   Atg16	   and	   not	   with	  
another	  member	  of	  the	  Atg12-­‐Atg5/Atg16	  complex,	  Atg5	  and	  Atg21	  were	  further	  
tested	  using	   the	   split-­‐ubiquitin	  assay	   (Figure	  30	  C).	  No	   interaction	  of	  Atg5-­‐Cub	  
and	  Nui-­‐Atg21	  was	  observed,	  either	  in	  WT	  or	  in	  atg16∆	  cells.	  In	  contrast,	  Atg5-­‐
Cub	   and	   Nui-­‐Atg16	   interacted	   with	   each	   other	   as	   expected,	   confirming	   the	  
functionality	  of	  Atg5-­‐Cub.	  	  
In	   conclusion,	   the	   split-­‐ubiquitin	   assay	  pointed	   to	   an	   interaction	  of	  Atg21	  with	  
Atg16,	  but	  with	  no	  other	  member	  of	  the	  Atg12-­‐Atg5/Atg16	  complex.	  	  
4.3.6.2 Fluorescence	  microscopy	  analysis	  of	  Atg5	  and	  Atg16	  	  
Atg5	   and	   Atg16	   are	   only	   transiently	   located	   at	   the	   PAS	   and	   therefore	   hardly	  
detectable	  in	  fluorescence	  microscopy.	  Stromhaug	  et	  al.	  (2004)	  showed,	  that	  the	  
PAS	   localization	   of	   Atg5-­‐GFP	   can	   be	   enhanced	   in	   mutants	   defective	   in	   the	  
progression	   of	   the	   Cvt	   /	   autophagy	   pathways	   as	  atg8∆	   cells.	   Furthermore,	   the	  
PAS	   localization	   of	   Atg5-­‐GFP	   observed	   in	   atg8∆	   cells	   was	   prevented	   in	   the	  
additional	  absence	  of	  Atg21	  (Stromhaug	  et	  al.,	  2004).	  Regarding	  Atg16,	  Nair	  et	  al.	  
(2010)	  showed	  that	  the	  perivacuolar	  puncta	  formation	  of	  chromosomally	  tagged	  
Atg16-­‐GFP	   was	   significantly	   decreased	   in	   starved	   atg18∆	  atg21∆	   cells.	   Since	  
Atg21	   is	   required	   for	   the	   Cvt	   pathway,	   which	   takes	   place	   under	   growing	  
conditions,	   the	   PAS	   localization	   of	   Atg16	   was	   observed	   in	   growing	   cells.	   As	   a	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prerequisite	  for	  further	  successful	  colocalization	  studies	  of	  Atg5	  and	  Atg16,	  the	  
observations	  reported	  by	  Stromhaug	  et	  al.	  (2004)	  should	  be	  reproduced.	  For	  this	  
purpose,	  atg8∆	  and	  atg8∆	  atg21∆	  cells	  expressing	  Atg5-­‐YFP	  and	  the	  PAS	  marker	  
ApeI-­‐RFP	   were	   grown	   to	   mid-­‐log	   phase	   and	   visualized	   using	   a	   DeltaVision	  
fluorescence	  microscope	  (Figure	  31	  A).	  	  
	  
Figure	  31:	  Atg5	  and	  Atg16	  are	  absent	  from	  the	  PAS	  in	  growing	  atg8∆	  atg21∆	  cells	  
(A)	  Growing	  atg8∆	   and	  atg8∆	  atg21∆	   cells	   expressing	  Atg5-­‐YFP	  and	   the	  PAS	  marker	  ApeI-­‐RFP	  
were	  visualized	  using	  a	  DeltaVision	  Deconvolution	  microscope	  equipped	  with	  YFP	  and	  RFP	  filter	  
sets.	   Pictures	   were	   deconvoluted	   using	   SoftWoRx	   (Applied	   Precision)	   software.	   (B)	   Growing	  
atg8∆	   and	   atg8∆	  atg21∆	   cells	   expressing	   Atg16-­‐GFP	   and	   the	   PAS	   marker	   ApeI-­‐RFP	   were	  
visualized	   as	   described	   in	   (A).	   (C)	   The	   percentage	   of	   cells	   showing	   a	   perivacuolar	   Atg5-­‐YFP	  
respective	  Atg16-­‐GFP	  puncta	  was	  determined	  for	  each	  strain.	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A	  clear	  perivacuolar	  Atg5-­‐YFP	  punctum	  was	  observed	  in	  58%	  of	  the	  atg8∆	  cells.	  
Nearly	  each	  of	   these	  puncta	  was	  colocalized	  with	   the	  PAS	  marker	  ApeI-­‐RFP.	   In	  
contrast,	  only	  13%	  of	  the	  atg8∆	  atg21∆	  cells	  showed	  a	  much	  fainter	  perivacuolar	  
Atg5-­‐YFP	   punctum	   (Figure	   31	  A+C).	   These	   observations	   correlated	   perfectly	  
with	  the	  data	  obtained	  by	  Stromhaug	  et	  al.	   (2004),	  confirming	  the	  functionality	  
of	   this	  assay.	  Next,	  atg8∆	  and	  atg8∆	  atg21∆	  cells	  expressing	  Atg16-­‐GFP	  and	  the	  
PAS	   marker	   ApeI-­‐RFP	   were	   grown	   to	   log	   phase	   and	   visualized	   by	   direct	  
fluorescence	  microscopy.	  In	  60%	  of	  the	  atg8∆	  cells,	  a	  clear	  perivacuolar	  Atg16-­‐
GFP	  punctum	  was	  observed	   (Figure	  31	  B+C).	  All	   these	  puncta	   colocalized	  with	  
the	   PAS	   marker	   ApeI-­‐RFP.	   The	   PAS	   localization	   of	   Atg16-­‐GFP	   could	   therefore	  
also	  be	  enhanced	  in	  mutants	  defective	  in	  the	  progression	  of	  the	  Cvt	  /	  autophagy	  
pathways	  as	  published	  for	  Atg5.	  Furthermore,	  the	  PAS	  localization	  of	  Atg16-­‐GFP	  
observed	   in	   atg8∆	   cells	   was	   significantly	   reduced	   by	   additional	   deletion	   of	  
ATG21,	   since	  only	  23%	  of	  atg8∆	  atg21∆	   cells	  showed	  a	  perivacuolar	  Atg16-­‐GFP	  
punctum	  (Figure	  31	  B+C).	  Again,	   these	  puncta	  were	  much	   fainter,	   compared	   to	  
those	  observed	  in	  atg8∆	  cells.	  In	  conclusion,	  both	  Atg5-­‐YFP	  and	  Atg16-­‐GFP	  were	  
absent	  from	  the	  PAS	  in	  growing	  atg8∆	  atg21∆	  cells.	  	  
Additionally,	  the	  colocalization	  of	  Atg5-­‐YFP	  and	  Atg16-­‐GFP	  with	  mCherry-­‐Atg21	  
was	  determined	  in	  different	  mutant	  strains	  (Figure	  32	  A+B).	  0.3	  mM	  methionine	  
was	   added	   to	   the	   selective	   medium	   to	   induce	   endogenous	   expression	   of	  
mCherry-­‐Atg21.	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Figure	  32:	  Atg16	  and	  Atg21	  colocalize	  in	  the	  absence	  of	  Atg5	  
(A)	  atg8∆	  atg21∆	   and	  atg8∆	  atg16∆	   cells	  expressing	  Atg5-­‐YFP	  and	  mCherry-­‐Atg21	  were	  grown	  
to	   mid-­‐log	   phase	   in	   the	   presence	   of	   0.3	  mM	   methionine	   and	   visualized	   using	   a	   DeltaVision	  
Deconvolution	   microscope	   equipped	   with	   YFP	   and	   mCherry	   filter	   sets.	   Pictures	   were	  
deconvoluted	   using	   SoftWoRx	   (Applied	   Precision)	   software.	   The	   percentage	   of	   Atg5-­‐YFP	  
colocalized	  with	  mCherry-­‐Atg21	  was	  determined.	   (B)	  atg8∆	  atg21∆	   and	  atg5∆	   cells	   expressing	  
Atg16-­‐GFP	  and	  mCherry-­‐Atg21	  were	  grown	  to	   log	  phase	   in	  the	  presence	  of	  0.3	  mM	  methionine	  
and	  visualized	  using	  a	  DeltaVision	  Deconvolution	  microscope	  equipped	  with	  GFP	  and	  mCherry	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filter	   sets.	   Pictures	   were	   deconvoluted	   using	   SoftWoRx	   (Applied	   Precision)	   software.	   The	  
percentage	  of	  Atg16-­‐GFP	  colocalized	  with	  mCherry-­‐Atg21	  was	  determined.	  
	  
In	  mid-­‐log	  atg8∆	  atg21∆	  cells	  63%	  of	  the	  perivacuolar	  Atg5-­‐YFP	  puncta	  and	  59%	  
of	   the	   perivacuolar	   Atg16-­‐GFP	   puncta	   were	   colocalized	   with	   mCherry-­‐Atg21	  
(Figure	   32	  A+B).	   mCherry-­‐Atg21	  most	   likely	   colocalized	   with	   both	   proteins	   at	  
the	  PAS,	   because	   all	   of	   the	  Atg16-­‐GFP	  and	  nearly	   all	   of	   the	  Atg5-­‐YFP	  dots	  was	  
located	  at	  the	  PAS	  under	  the	  same	  conditions	  (Figure	  31).	  Atg16	  links	  the	  Atg12-­‐
Atg5/Atg16	   complex	   to	   the	   PAS	   (Matsushita	   et	   al.,	   2007).	   Therefore,	   Atg5-­‐YFP	  
was	   completely	   cytosolic	   in	   mid-­‐log	   atg8∆	  atg16∆	   cells	   (Figure	   32	  A).	  
Importantly,	   the	   colocalization	   rate	   of	   Atg16-­‐GFP	   and	   mCherry-­‐Atg21	   did	   not	  
change	  in	  the	  absence	  of	  Atg5	  (Figure	  32	  B).	  	  
4.3.6.3 Interaction	   studies	   of	   Atg16	   and	   Atg21	   using	   pull	   down	   and	   GFP-­‐
TRAP®	  analysis	  
To	   further	   confirm	   a	   potential	   interaction	   of	   Atg21	   and	   Atg16,	   pull	   down	   and	  
GFP-­‐TRAP®	   analysis	   were	   performed	   using	   chromosomally	   tagged	   Atg16-­‐HA	  
(cAtg16-­‐HA).	  cAtg16-­‐HA	  was	  still	  able	  to	  mature	  ApeI	  under	  growing	  conditions,	  
indicating	  that	  it	  was	  functional	  (Figure	  33	  A).	  	  
For	   pull	   down	   experiments,	   recombinant	   6xHis-­‐SUMO-­‐Atg21	   and	   6xHis-­‐SUMO	  
alone	  as	  a	  control	  were	  purified	  using	  Ni-­‐NTA	  beads	  and	  subsequently	  incubated	  
with	   crude	   extract	   of	   growing	   cAtg16-­‐HA	   cells.	   After	   extended	   washing,	   the	  
isolated	   proteins	   were	   eluted	   from	   the	   beads	   by	   adding	   Laemmli	   buffer	  
containing	  100	  mM	  DTT.	  cAtg16-­‐HA	  bound	  specifically	  to	  6xHis-­‐SUMO-­‐Atg21	  but	  
not	  to	  6xHis-­‐SUMO	  alone	  (see	  Figure	  33	  B).	  
For	  GFP-­‐TRAP®	  analysis,	  growing	  cAtg16-­‐HA	  cells	  expressing	  GFP-­‐Atg21	  or	  GFP	  
alone	  as	  negative	  control,	  were	  lysed	  using	  the	  mild	  cell	  lysis	  procedure.	  The	  cell	  
lysates	   were	   subjected	   to	   GFP-­‐TRAP®	   beads.	   After	   extended	   washing,	   the	  
purified	  proteins	  were	  eluted	  by	  the	  addition	  of	  Laemmli	  buffer.	  cAtg16-­‐HA	  was	  
specifically	  co-­‐isolated	  by	  GFP-­‐Atg21,	  but	  not	  by	  GFP	  alone	  (Figure	  33	  C).	  Atg16	  
is	  a	  member	  of	  the	  E3-­‐like	  enzyme	  complex	  crucial	  for	  the	  lipidation	  of	  Atg8.	  As	  
shown	   before,	   Atg21	   interacted	   with	   Atg8	   in	   the	   split-­‐ubiquitin	   assay	   (see	  
chapter	   4.3.5).	   To	   exclude	   the	   possibility,	   that	   Atg16	  was	   co-­‐precipitated	   by	   a	  
bridging	   interaction	   of	   Atg8,	   a	   GFP-­‐TRAP®	   analysis	   was	   performed	   with	   cell	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lysate	  of	  cAtg16-­‐HA	  atg8∆	  cells	  expressing	  GFP-­‐Atg21	  or	  GFP	  alone	  as	  negative	  
control.	   Indeed,	   also	   in	   the	   absence	   of	   Atg8,	   cAtg16-­‐HA	   was	   specifically	   co-­‐
isolated	  by	  GFP-­‐Atg21,	  but	  not	  by	  GFP	  alone	  (Figure	  33	  C).	  	  
	  
Figure	  33:	  Interaction	  studies	  of	  Atg16	  and	  Atg21	  using	  GFP-­‐TRAP®	  and	  pull	  down	  experiments	  
(A)	  Complementation	  study	  of	  chromosomally	  tagged	  Atg16-­‐HA	  (cAtg16-­‐HA)	  by	  monitoring	  the	  
maturation	  of	  ApeI.	   Samples	   from	  growing	  WT,	  atg1∆	   and	  cAtg16-­‐HA	  cells	  were	  alkaline	   lysed	  
and	  immunoblotted.	  Precursor	  (prApeI)	  and	  matured	  (mApeI)	  ApeI	  were	  detected	  using	  an	  anti-­‐
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ApeI	  antibody.	  (B)	  Recombinant	  6xHis-­‐SUMO-­‐Atg21	  and	  6xHis-­‐SUMO	  alone	  as	  a	  negative	  control	  
were	  purified	  using	  Ni-­‐NTA	  beads	  and	  incubated	  with	  crude	  extract	  of	  growing	  cAtg16-­‐HA	  cells.	  
Samples	   from	  the	  respective	  E.	  coli	  and	  yeast	  cell	   lysates	  (L),	  cleared	   lysate	  (E.	  coli	  S),	  unbound	  
fraction	  (yeast	  S)	  and	  the	  purified	  proteins	  (E)	  were	  analyzed	  by	  immunoblotting	  using	  anti-­‐HA	  
and	  anti-­‐His	  antibodies.	  (C)	  Growing	  cAtg16-­‐HA	  cells	  or	  cAtg16-­‐HA	  atg8∆	  cells	  expressing	  GFP-­‐
Atg21	  or	  GFP	  as	  negative	  control	  were	  lysed	  using	  the	  mild	  cell	  lysis	  procedure	  and	  subjected	  to	  
GFP-­‐TRAP®	   analysis.	   Samples	   from	   the	   cell	   lysate	   (L),	   the	   unbound	   fraction	   (S)	   and	   from	   the	  
purified	  proteins	   (E)	  were	  analyzed	  by	   immunoblotting	  using	  anti-­‐HA	  and	  anti-­‐GFP	  antibodies.	  
(D)	  Immobilized	  recombinant	  6xHis-­‐SUMO-­‐Atg21	  was	  incubated	  with	  purified	  recombinant	  GST	  
and	   GST-­‐Atg16.	   Samples	   from	   purified	   GST-­‐Atg16	   and	   GST	   (L)	   and	   samples	   from	   the	   eluted	  
proteins	  (PD)	  were	  immunoblotted	  and	  detected	  using	  anti-­‐GST	  and	  anti-­‐His	  antibodies.	  	  
	  
To	   further	   confirm	  a	  direct	   interaction	  of	  Atg16	  and	  Atg21,	   a	  direct	  pull	   down	  
experiment	  using	  purified	  recombinant	  6xHis-­‐SUMO-­‐Atg21	  and	  GST-­‐Atg16	  were	  
performed.	   For	   this	   purpose,	   recombinant	   GST-­‐Atg16	   and	   GST	   alone	   as	   a	  
negative	   control	   were	   purified	   using	   glutathione	   sepharose.	   After	   extended	  
washing,	  GST	  and	  GST-­‐Atg16	  were	  eluted	  by	  addition	  of	  glutathione.	  Twice	   the	  
amount	   was	   incubated	   with	   immobilized	   6xHis-­‐SUMO-­‐Atg21.	   After	   extended	  
washing,	   the	   bound	   proteins	   were	   eluated	   by	   adding	   Laemmli	   buffer	   and	  
analyzed	  by	  immunoblot	  (Figure	  33	  D).	   In	  fact,	  GST-­‐Atg16	  bound	  specifically	  to	  
6xHis-­‐SUMO-­‐Atg21,	  whereas	  GST	  alone	  did	  not.	  	  
In	  conclusion,	  Atg21	  probably	  directly	  interacts	  with	  Atg16.	  	  
4.3.6.4 Determination	  of	  the	  Atg21-­‐	  interacting	  domain	  of	  Atg16	  
Atg16	   consists	   of	   150	   amino	   acids.	   Amino	   acids	   22	   to	   46	   are	   predicted	   to	  
constitute	   the	   Atg5-­‐binding	   region,	   followed	   by	   a	   short	   linker	   region.	   Amino	  
acids	  58	  to	  119	  form	  a	  coiled-­‐coil	  domain,	  which	  mediates	  dimerization	  of	  Atg16	  
((Fujioka	  et	  al.,	  2010);Figure	  34	  A).	  	  
To	   identify	   the	   Atg21-­‐interacting	   domain	   of	   Atg16,	   truncated	   GST-­‐Atg16	  
versions	  were	  constructed	  and	  tested	  for	  an	  interaction	  with	  6xHis-­‐SUMO-­‐Atg21	  
in	   direct	   pull	   down	   experiments	   as	   described	   before.	   For	   this	   purpose,	  
recombinant	  GST-­‐Atg16	  lacking	  the	  coiled-­‐coil	  domain	  (GST-­‐Atg16aa1-­‐57),	  lacking	  
the	   extreme	   C-­‐terminal	   end	   (GST-­‐Atg16aa1-­‐119),	   which	   is	   not	   required	   for	   the	  
coiled-­‐coil	   formation	   or	   lacking	   the	   Atg5-­‐binding	   domain	   and	   the	   following	  
linker	  region	  (GST-­‐Atg16aa58-­‐150)	  were	  purified	  and	  incubated	  with	  recombinant	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6xHis-­‐SUMO-­‐Atg21.	   GST-­‐Atg16	   and	   GST-­‐Atg16aa58-­‐150	   bound	   specifically	   to	  
6xHis-­‐SUMO-­‐Atg21,	  whereas	  GST	  alone,	  GST-­‐Atg16aa1-­‐57	  and	  GST-­‐Atg16aa1-­‐119	  did	  
not	  (Figure	  34	  B).	  	  
The	  same	  truncated	  versions	  of	  Atg16	  were	  created	  as	  Atg16-­‐HA	  constructs	  and	  
cloned	   into	   a	   pRS313	   vector	   under	   the	   control	   of	   a	  CUP1	   promoter.	  Wild	   type	  
Atg16-­‐HA	   and	   the	   truncated	   Atg16-­‐HA	   versions	   were	   co-­‐expressed	   with	   GFP-­‐
Atg21	  or	  GFP	  alone	  as	  negative	  control	  in	  atg16∆	  cells.	  The	  amount	  of	  Atg161-­‐119-­‐
HA	  and	  Atg1658-­‐150-­‐HA	  or	  Atg161-­‐57-­‐HA	  was	  adjusted	  by	  addition	  of	  25	  µM	  CuSO4	  
or	   50	  µM	  CuSO4	   to	   the	   selective	  medium	  over	  night	   (approximately	  12	  hours),	  
respectively.	  Cells	  were	  grown	  to	  mid-­‐log	  phase,	  lysed	  under	  mild	  conditions	  and	  
subjected	  to	  GFP-­‐TRAP®	  analysis	  (Figure	  34	  C).	  	  
	  
	  
Figure	  34:	  Atg21	  interacts	  with	  the	  coiled-­‐coil	  domain	  of	  Atg16	  
(A)	  Predicted	  domain	  structure	  of	  Atg16.	  Numbers	  indicate	  the	  respective	  amino	  acid	  position.	  It	  
can	  not	  be	   excluded	   that	   the	   coiled-­‐coil	   domain	  might	  be	   longer	   than	  proposed	   (Fujioka	   et	   al.,	  
2010)	   (B)	   Immobilized	   recombinant	   6xHis-­‐SUMO-­‐Atg21	   was	   incubated	   with	   purified	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recombinant	  GST,	  GST-­‐Atg16	  or	   the	   indicated	   truncated	  versions	  of	  GST-­‐Atg16.	   Samples	  of	   the	  
purified	  GST	  and	  GST-­‐Atg16	  versions	  (L)	  and	  the	  eluted	  proteins	  (PD)	  were	  immunoblotted	  and	  
analyzed	  using	  anti-­‐GST	  and	  anti-­‐His	  antibodies.	  (C)	  Growing	  atg16∆	  cells	  expressing	  GFP-­‐Atg21	  
or	  GFP	  alone	  as	  negative	  control	  and	  the	  indicated	  Atg16-­‐HA	  version	  were	  lysed	  using	  the	  mild	  
cell	   lysis	   procedure	   and	   subjected	   to	   GFP-­‐TRAP®	   analysis.	   Expression	   of	   Atg161-­‐119–HA	   and	  
Atg1658-­‐150-­‐HA	  or	  Atg161-­‐57-­‐HA	  was	  adjusted	  by	  addition	  of	  25	  µM	  CuSO4	  or	  50	  µM	  CuSO4	  to	  the	  
selective	   medium	   for	   approximately	   12	  h,	   respectively.	   Samples	   of	   the	   cell	   lysate	   (L),	   the	  
unbound	  fraction	  (S)	  and	  the	  purified	  proteins	  (E)	  were	  analyzed	  by	  immunoblotting	  using	  anti-­‐
HA	  and	  anti-­‐GFP	  antibodies.	  
	  
Atg16-­‐HA	   was	   specifically	   purified	   with	   GFP-­‐Atg21	   but	   not	   with	   GFP	   alone.	  
Interestingly,	  Atg161-­‐119-­‐HA	  and	  Atg1658-­‐150-­‐HA	  bound	  specifically	  to	  GFP-­‐Atg21.	  
Atg161-­‐57-­‐HA	   was	   rather	   unstable	   and	   therefore	   hardly	   detectable	   on	   the	  
immunoblot.	  However,	  even	  overexposed,	  no	  co-­‐precipitated	  Atg161-­‐57-­‐HA	  could	  
be	  detected.	  	  
Altogether,	   these	   data	   suggested,	   that	   the	   Atg21-­‐binding	   region	   might	   be	  
positioned	  within	  the	  coiled-­‐coil	  domain	  of	  Atg16.	  Fujioka	  et	  al.	   (2010)	  defined	  
highly	  conserved	  surface	  residues	  within	  the	  coiled-­‐coil	  domain	  of	  Atg16	  that	  are	  
required	   for	   its	   autophagic	   function.	   They	   measured	   ApeI	   maturation	   and	  
macroautophagy	  (ALP	  assay)	  of	  a	  set	  of	  mutants	  under	  growing	  and	  starvation	  
conditions.	  Mutation	   to	  alanine	  of	   the	  aspartic	  acid	  at	  position	  101	  (D101)	  and	  
glutamic	   acid	   at	   position	   102	   (E102)	   caused	   strong	   defects	   in	   both	   pathways	  
when	  mutated	  alone	  or	  in	  concert.	  Hypothetically,	  Atg16	  and	  Atg21	  might	  have	  
to	   interact	   with	   each	   other	   for	   proper	   autophagic	   function.	   Loss	   of	   the	  
interaction	   by	   the	   mentioned	   mutations	   in	   Atg16	   might	   therefore	   lead	   to	  
impaired	  autophagic	   activity.	  To	   test	   this	  hypothesis,	  Atg16-­‐GFP	  mutants	  were	  
constructed,	   that	   contained	   mutations	   of	   the	   aspartic	   acid	   at	   position	   101	  
(D101A)	   and	   the	   glutamic	   acid	   at	  position	  102	   (E102A)	   either	   individual	   or	   in	  
combination,	  and	  observed	  in	  direct	  fluorescence	  microscopy.	  atg8∆	  atg16∆	  cells	  
expressing	  mCherry-­‐Atg21	  and	  the	  respective	  Atg16-­‐GFP	  mutant	  were	  grown	  to	  
log	  phase	  in	  the	  presence	  of	  0.3	  mM	  methionine	  to	  induce	  endogenous	  mCherry-­‐
Atg21	   expression	   and	   imaged	   using	   a	   DeltaVision	   Deconvolution	   microscope	  
(Figure	  35).	  	  
	   	   	   Results	  
	   105	  
	  
Figure	  35:	  Fluorescence	  microscopic	  analysis	  of	  the	  Atg16-­‐GFP	  point	  mutants	  
Growing	   atg8∆	  atg16∆	   cells	   expressing	   mCherry-­‐Atg21	   and	   the	   indicated	   Atg16-­‐GFP	   mutant	  
were	   grown	   in	   the	   presence	   of	   0.3	  mM	   methionine	   to	   log	   phase	   and	   visualized	   using	   a	  
DeltaVision	   Deconvolution	   microscope	   equipped	   with	   GFP	   and	   RFP	   filter	   sets.	   Pictures	   were	  
deconvoluted	  using	  SoftWoRx	  (Applied	  Precision)	  software.	  	  
	  
Atg16-­‐GFP	  formed	  perivacuolar	  puncta,	  which	  partly	  colocalized	  with	  mCherry-­‐
Atg21	   as	   described	   before.	   In	   contrast,	   Atg16D101A-­‐GFP,	   Atg16E102A-­‐GFP	   and	  
Atg16D101A_E102A-­‐GFP	   were	   completely	   cytosolic.	   Only	   Atg16E102A-­‐GFP	   rarely	  
formed	  faint	  and	  hardly	  detectable	  perivacuolar	  puncta.	  The	  overall	  perivacuolar	  
punctate	   appearance	   of	  mCherry-­‐Atg21	   did	   not	   change	   in	   the	   cells	   expressing	  
the	  mutant	  versions	  of	  Atg16-­‐GFP.	  
Next,	   Atg16-­‐HA	   mutants	   were	   constructed,	   that	   contained	   mutations	   of	   the	  
aspartic	   acid	   at	   position	   101	   (D101A)	   and	   the	   glutamic	   acid	   at	   position	   102	  
(E102A)	  either	  individual	  or	  in	  combination.	  These	  mutants	  were	  subsequently	  
tested	  for	  an	  interaction	  with	  Atg21.	  As	  a	  control,	  Atg16-­‐HA	  mutants	  were	  used,	  
where	   the	   lysine	   at	  position	  95	   (K94A)	  or	   glutamic	   acid	   at	  position	  97	   (E97A)	  
were	   exchanged	   by	   alanine,	   since	   these	   mutants	   exhibited	   wild	   type-­‐like	  
autophagic	  activity	  (Fujioka	  et	  al.,	  2010).	  All	  residues	  were	  predicted	  to	  have	  no	  
influence	  on	  the	  formation	  of	  the	  parallel	  coiled-­‐coil	  domain	  conformation.	  Based	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on	   the	   structure,	   published	   from	   Fujioka	   et	   al.	   (2010),	   the	   mentioned	   amino	  
acids	   are	   located	   on	   the	   surface	   of	   the	   coiled-­‐coil	   domain,	   facing	   the	   cytosol	  
(Figure	  36	  A).	  Nevertheless	  it	  was	  confirmed,	  that	  the	  mutated	  residues	  did	  not	  
change	   the	   overall	   structure	   of	   Atg16,	  which	   could	   be	   another	   explanation	   for	  
impaired	   autophagic	   function.	   The	   coiled-­‐coil	   domain	   of	   Atg16	   mediates	   its	  
dimerization	   as	   a	   prerequisite	   for	   the	   formation	   of	   the	   Atg12-­‐Atg5/Atg16	  
complex	   essential	   for	   autophagy	   (Mizushima	   et	   al.,	   1999).	   In	   the	   GFP-­‐TRAP®	  
analysis,	  Atg16-­‐GFP	  could	  only	  interact	  and	  therefore	  co-­‐precipitate	  Atg16-­‐HA,	  if	  
its	   coiled-­‐coil	   domain	   was	   properly	   formed.	   For	   this	   purpose,	   cell	   lysates	   of	  
growing	  atg16∆	  cells	  expressing	  Atg16-­‐GFP,	  Atg16D101A_E102A-­‐GFP,	  Atg16K94A-­‐GFP	  
or	  GFP	   alone	   as	   control	  were	  mixed	  with	   the	   respective	   cell	   lysate	   of	   growing	  
atg16∆	   cells	   expressing	   Atg16-­‐HA,	   Atg16D101A_E102A-­‐HA	   or	   Atg16K94A-­‐HA.	   The	  
mixture	   was	   subjected	   to	   GFP-­‐TRAP®	   analysis	   and	   evaluated	   by	   immunoblot	  
(Figure	  36	  B).	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Figure	  36:	  Amino	  acids	  D101	  and	  E102	  of	  Atg16	  mediate	  the	  interaction	  with	  Atg21	  
(A)	   Ribbon	   diagram	   of	   the	   dimerized	   coiled-­‐coil	   domain	   of	   Atg16.	   The	   amino	   acids	   lysine	   at	  
position	   94	   (K94)	   and	   glutamic	   acid	   at	   position	   97	   (E97)	   are	   colored	   blue;	   aspartic	   acid	   at	  
position	   101	   (D101)	   and	   glutamic	   acid	   at	   position	   102	   (E102)	   are	   colored	   red.	   The	   structural	  
model	  was	  prepared	  based	  on	  the	  structural	  data	  reported	  by	  Fujioka	  et	  al.	  (Fujioka	  et	  al.,	  2010).	  
N:	  N-­‐Terminus;	  C:	  C-­‐terminus	  (B)	  Cell	  lysate	  of	  growing	  atg16∆	  cells	  expressing	  GFP	  as	  negative	  
control	  or	  the	  indicated	  Atg16-­‐GFP	  construct	  was	  mixed	  with	  cell	  lysate	  of	  growing	  atg16∆	  cells	  
expressing	  the	  indicated	  Atg16-­‐HA	  construct.	  The	  mixture	  was	  subjected	  to	  GFP-­‐TRAP®	  analysis.	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Samples	   of	   the	   cell	   lysate	   (L),	   the	   unbound	   fraction	   (S)	   and	   the	   purified	   proteins	   (E)	   were	  
analyzed	   by	   immunoblotting	   using	   anti-­‐HA	   and	   anti-­‐GFP	   antibodies.	   (C)	   Growing	   atg16∆	   cells	  
expressing	  GFP-­‐Atg21	  or	  GFP	  as	  negative	  control	  and	  the	  indicated	  Atg16-­‐HA	  version	  were	  lysed	  
using	   the	   mild	   cell	   lysis	   procedure	   and	   subjected	   to	   GFP-­‐TRAP®	   analysis.	   Evaluation	   was	  
performed	  as	  described	  in	  (B).	  	  
	  
Atg16-­‐GFP	   specifically	   co-­‐precipitated	   Atg16-­‐HA,	   whereas	   GFP	   alone	   did	   not.	  
Atg16D101A_E102A-­‐GFP	   specifically	   co-­‐precipitated	   Atg16D101A_E102A-­‐HA.	   The	   same	  
was	  observed	  for	  Atg16K94A-­‐GFP	  and	  Atg16K94A-­‐HA.	  In	  conclusion,	  the	  formation	  
of	   their	  coiled-­‐coil	  domain	  was	  most	   likely	  not	  affected	  as	   the	  GFP-­‐tagged	  wild	  
type	  and	  mutants	  were	  all	  able	  to	  co-­‐precipitate	  their	  HA-­‐tagged	  counterparts.	  	  
Next,	   atg16∆	   cells	   expressing	   GFP-­‐Atg21	   or	   GFP	   alone	   as	   control	   and	   the	  
respective	  Atg16-­‐HA	  construct	  were	  grown	  to	  mid-­‐log	  phase	  and	  lysed	  in	  a	  mild	  
way.	   The	   cell	   lysates	  were	   subjected	   to	   GFP-­‐TRAP®	   analysis	   and	   evaluated	   by	  
immunoblotting	   (Figure	   36	  C).	   Atg16-­‐HA	   bound	   specifically	   to	   GFP-­‐Atg21,	   but	  
not	  to	  GFP	  alone.	  Interestingly,	  the	  binding	  of	  Atg16E102A-­‐HA	  and	  Atg16K94A-­‐HA	  to	  
GFP-­‐Atg21	   was	   severely	   impaired,	   whereas	   the	   binding	   of	   Atg16D101A-­‐HA	   and	  
Atg16D101A_E102A-­‐HA	   was	   nearly	   completely	   abolished.	   Atg16E97A-­‐HA	   bound	   to	  
GFP-­‐Atg21	  in	  a	  wild	  type-­‐like	  manner.	  	  
	  
Both	   proteins,	   Atg21	   and	   Atg16,	   play	   a	   crucial	   role	   in	   the	   ubiquitin-­‐like	  
conjugation	   of	   Atg8	   to	   PE.	   If	   the	   interaction	   of	   Atg21	   and	  Atg16	   is	   needed	   for	  
proper	  Atg8	   lipidation,	   the	  Atg8-­‐PE	   formation	  should	  be	  affected	   in	   the	  Atg21-­‐
binding	   defective	   Atg16	   mutants.	   Therefore,	   the	   Atg8-­‐PE	   formation	   in	   the	  
presence	  of	   the	  Atg21-­‐binding	  defective	  Atg16	  mutants	  was	   tested.	  WT,	  atg1∆,	  
atg3∆,	  atg8∆,	  atg16∆	  and	  atg21∆	  cells	  expressing	  the	  empty	  vector	  were	  used	  as	  
controls.	  atg16∆	  cells	  expressing	  Atg16-­‐HA	  or	  the	   indicated	  either	  truncated	  or	  
mutated	   Atg16-­‐HA	   version	   from	   the	   CUP1	   promoter	   were	   grown	   to	   mid-­‐log	  
phase.	  Samples	  were	   lysed	  using	  a	  mild	  glass	  bead	   lysis	  protocol	  and	  prepared	  
for	   SDS-­‐PAGE	   as	   described	   in	   Suzuki	   et	  al.	   (Suzuki	   et	   al.,	   2001).	   To	   adjust	   the	  
expression	   level	   of	   the	   Atg16-­‐HA	   versions,	   the	   expression	   of	   Atg161-­‐57-­‐HA,	  
Atg161-­‐119-­‐HA	  and	  Atg1658-­‐150-­‐HA	  was	  adjusted	  by	  the	  addition	  of	  50	  µM,	  10	  µM	  
or	   25	  µM	   CuSO4	   to	   the	   selective	   medium,	   respectively.	   The	   samples	   were	  
separated	  on	  a	  15%	  SDS-­‐PAGE	  containing	  6	  M	  urea	  to	  distinguish	  between	  Atg8	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and	  Atg8-­‐PE.	  The	  SDS-­‐PAGE	  was	  subsequently	  immunoblotted	  and	  analyzed	  by	  
several	   antibodies	   (Figure	   37).	   As	   a	   loading	   control,	   the	   immunoblot	   was	  
decorated	   with	   anti-­‐PGK	   antibody,	   confirming	   similar	   protein	   amounts	   in	   all	  
samples.	  	  
	  
Figure	  37:	  Functional	  analysis	  of	  the	  Atg16	  point	  mutants	  
WT,	   atg1∆,	   atg3∆,	   atg8∆,	   atg16∆,	   atg21∆	   cells	   carrying	   the	   empty	   vector	   or	   atg16∆	   cells	  
expressing	  the	  indicated	  Atg16-­‐HA	  version	  were	  lysed	  in	  mid-­‐log	  phase	  using	  a	  mild	  glass	  beads	  
lysis	   protocol	   described	   in	   Suzuki	   et	  al.	   (2001).	   The	   expression	   of	   Atg161-­‐57-­‐HA,	   Atg161-­‐119-­‐HA	  
and	  Atg1658-­‐150-­‐HA	  was	  adjusted	  by	  the	  addition	  of	  50	  µM,	  10	  µM	  or	  25	  µM	  CuSO4	  to	  the	  selective	  
medium	   over	   night	   (12	  h),	   respectively.	   Samples	   were	   subjected	   to	   SDS-­‐PAGE	   containing	   6	  M	  
urea	  to	  separate	  Atg8	  and	  Atg8-­‐PE,	  immunoblotted	  and	  analyzed	  using	  anti-­‐Atg8,	  anti-­‐ApeI,	  anti-­‐
HA	  and	  anti-­‐PGK	  antibodies.	  	  
	  
In	  WT	  and	  atg1∆	  cells,	  where	  the	  lipidation	  of	  Atg8	  is	  unaffected,	  approximately	  
50%	  of	  Atg8	  was	   conjugated	   to	  PE.	   In	  atg3∆	   cells,	   defective	   in	  Atg8	   lipidation,	  
Atg8	  was	  present	  solely	  in	  its	  unconjugated	  form.	  In	  atg16∆	  and	  atg21∆	  cells,	  the	  
lipidation	  of	  Atg8	   is	   severely	   impaired,	   so	   that	  most	  of	  Atg8	  was	  present	   in	   its	  
unlipidated	  form.	  Atg16-­‐HA	  completely	  complemented	  the	  atg16∆	  phenotype,	  as	  
Atg8-­‐PE	   was	   formed	   in	   a	   wild	   type-­‐like	   manner.	   The	   same	   was	   observed	   in	  
atg16∆	   cells	   expressing	   Atg16E97A-­‐HA.	   In	   contrast,	   Atg8-­‐PE	   formation	   was	  
severely	   impaired	   in	   atg16∆	   cells	   expressing	   Atg16D101A-­‐HA,	   Atg16E102A-­‐HA,	  
Atg16D101A_E102A-­‐HA,	   Atg16K94A-­‐HA	   Atg161-­‐57-­‐HA,	   Atg161-­‐119-­‐HA	   and	   Atg1658-­‐150-­‐
HA	  comparable	   to	  atg16∆	  or	  atg21∆	   cells.	  Except	  of	  Atg161-­‐57-­‐HA,	  all	  Atg16-­‐HA	  
versions	  were	  present	  in	  comparable	  amounts.	  	  
The	   immunoblot	   was	   in	   addition	   decorated	   with	   an	   anti-­‐ApeI	   antibody	   to	  
monitor	   the	  autophagic	   activity.	   In	  WT	  cells,	   about	  half	  of	  ApeI	  was	  present	   in	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the	  matured	  form.	  As	  expected,	  the	  maturation	  of	  ApeI	  was	  completely	  blocked	  
in	  atg1∆,	  atg3∆,	  atg8∆,	  atg16∆	   and	  atg21∆	   cells.	  Atg16-­‐HA	   fully	   complemented	  
ApeI	   maturation	   when	   expressed	   in	   atg16∆	   cells.	   The	   same	  was	   observed	   for	  
Atg16E97A-­‐HA	   and	   Atg16K94A-­‐HA.	   ApeI	   maturation	   was	   severely	   impaired	   in	  
atg16∆	   cells	   expressing	   Atg16D101A-­‐HA	   and	   Atg16E102A-­‐HA	   mutants.	   In	   atg16∆	  
cells	  expressing	  Atg16D101A_E102A-­‐HA,	  Atg161-­‐57-­‐HA,	  Atg161-­‐119-­‐HA	  or	  Atg1658-­‐150-­‐
HA	  the	  maturation	  of	  ApeI	  was	  completely	  blocked.	  	  
	  
In	  conclusion,	  Atg16	  interacted	  directly	  with	  Atg21	  most	  likely	  via	  its	  coiled-­‐coil	  
domain.	  The	  conserved	  surface	  residues,	  E102	  and	  more	  important	  D101,	  were	  
identified	   to	   mediate	   proper	   interaction	   of	   both	   proteins.	   Atg21	   and	   Atg16	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5 	  Discussion	  
Autophagy	   is	   an	   important	   cellular	   degradation	   and	   recycling	   process.	   It	   is	  
characterized	  by	  the	  formation	  of	  double	  membrane	  layered	  transport	  vesicles,	  
the	  autophagosomes.	   In	  yeast,	   the	  formation	  of	  these	  autophagosomes	  starts	  at	  
the	   pre-­‐autophagosomal	   structure	   (PAS)	   as	   a	   cup	   shaped	   isolation	  membrane	  
(phagophore)	  that	  expands	  and	  thereby	  encloses	  cytoplasm	  and	  organelles.	  The	  
autophagosome	   finally	   fuses	  with	   the	  vacuolar	  membrane	   to	   release	  a	  still	  one	  
membrane	  layered	  vesicle	  (autophagic	  body)	  into	  the	  vacuole	  lumen,	  where	  it	  is	  
lysed.	   The	   contents	   are	   degraded	   and	   finally	   recycled.	   There	   are	   also	   several	  
selective	  types	  of	  autophagy	  like	  the	  Cvt	  pathway	  in	  yeast.	  During	  this	  pathway	  
the	   vacuole	   hydrolases	   aminopeptidase	  I,	   α-­‐mannosidase	   and	   aspartyl	  
aminopeptidase	  are	  constitutively	  transported	  from	  the	  cytoplasm	  to	  the	  vacuole	  
(see	  chapter	  2.2).	  	  
In	   this	   study,	   the	   localization	   and	   function	   of	   Atg21,	   one	   of	   the	   proteins	  
essentially	   required	   for	   the	   Cvt	   pathway,	   were	   investigated	   using	   the	   model	  
organism	   Saccharomyces	   cerevisiae.	   Autophagy	   is	   highly	   conserved	   among	   all	  
eukaryotes.	   Therefore,	   most	   of	   the	   autophagy-­‐related	   proteins	   are	   conserved	  
from	   yeast	   to	   mammals.	   This	   conservation	   includes	   their	   function	   and	  
recruitment	   hierarchy	   to	   the	   autophagosome	   formation	   site	   (Itakura	   and	  
Mizushima,	  2010).	  Thus,	  information	  obtained	  in	  yeast	  can	  often	  be	  transferred	  
to	  higher	  eukaryotes.	  
Atg21	  and	  its	  yeast	  homologues	  Atg18	  and	  Hsv2	  are	  members	  of	  the	  family	  of	  β-­‐
propellers	  that	  bind	  polyphosphoinositides	  (PROPPINs).	  They	  are	  WD40	  repeat	  
propellers	  and	  contain	  two	  lipid	  binding	  pockets,	  that	  preferential	  bind	  to	  PI3P	  
and	  PI(3.5)P2	   (Baskaran	  et	  al.,	  2012;	  Krick	  et	  al.,	  2012;	  Watanabe	  et	  al.,	  2012).	  
Atg21	   and	   its	   homologues	   are	   highly	   conserved,	   but	   required	   for	   different	  
variants	   of	   autophagy.	   While	   macroautophagy	   is	   only	   significantly	   reduced	   in	  
atg21∆	   cells,	   Atg21	   is	   required	   for	   selective	   types	   of	   autophagy	   like	   the	   Cvt	  
pathway	  (Barth	  et	  al.,	  2002).	  Selective	  types	  of	  autophagy	  require	  the	  very	  same	  
core	   autophagy	   proteins	   involved	   in	   bulk	   autophagy.	   Therefore,	   information	  
	   	   	   Discussion	  
	   112	  
obtained	   in	   the	   selective	   variants	   can	   often	   be	   transferred	   to	   other	   types	   of	  
autophagy.	  	  
Mammals	  contain	  four	  PROPPIN	  orthologs,	  termed	  WIPIs.	  Based	  on	  phylogenetic	  
tree	  analysis,	  WIPI-­‐1	  and	  WIPI-­‐2	  were	  assigned	  to	  Atg18	  and	  WIPI-­‐3	  and	  WIPI-­‐4	  
to	  Hsv2	   (Krick	  et	  al.,	   2012;	  Polson	  et	  al.,	   2010),	  whereas	  Atg21	  orthologs	  have	  
been	   only	   found	   in	   yeast	   species	   so	   far	   (Meijer	   et	   al.,	   2007).	   However,	  WIPI-­‐1	  
seems	   to	  be	   involved	   in	  LC3	   lipidation	  (Polson	  et	  al.,	  2010;	  Proikas-­‐Cezanne	  et	  
al.,	  2004).	  In	  addition,	  WIPI-­‐2	  was	  reported	  to	  positively	  regulate	  the	  lipidation	  
of	  the	  mammalian	  Atg8	  ortholog	  LC3	  (Polson	  et	  al.,	  2010).	  A	  similar	  function	  has	  
been	   observed	   specifically	   for	   yeast	   Atg21	   (Meiling-­‐Wesse	   et	   al.,	   2004;	  
Stromhaug	  et	  al.,	  2004),	  suggesting	  that	  not	  the	  protein	  itself,	  but	  its	  elementary	  
function	  in	  the	  autophagic	  process	  might	  be	  conserved	  in	  higher	  eukaryotes.	  
In	  addition	  to	  the	  efficient	  lipidation	  of	  Atg8,	  Atg21	  is	  required	  for	  recruitment	  of	  
Atg8	  and	  Atg5	   to	   the	  PAS	   (Meiling-­‐Wesse	  et	   al.,	   2004;	  Stromhaug	  et	   al.,	   2004).	  
Therefore,	   no	   Cvt	   vesicles	   are	   formed	   in	   the	   absence	   of	   Atg21,	   suggesting	   an	  
elementary	   role	   for	   Atg21	   in	   the	   PAS	   assembly	   especially	   in	   selective	   types	   of	  
autophagy.	  Thus,	  Atg21	  has	  not	  been	  detected	  at	  the	  PAS	  so	  far.	  	  
5.1 Part	  of	  Atg21	  localizes	  to	  the	  PAS	  
In	  this	  study,	  a	  potential	  PAS	  localization	  of	  Atg21	  was	  investigated	  using	  direct	  
fluorescence	  microscopy.	  Therefore,	  atg21∆	  cells	  expressing	  Atg21-­‐YFP	  from	  its	  
endogenous	   promoter	   and	   the	   PAS	  marker	   ApeI-­‐RFP	  were	   imaged.	   Cells	  were	  
analyzed	   under	   growing	   conditions,	   as	   Atg21	   is	   strictly	   required	   for	   the	  
constitutive	  Cvt	  pathway	  acting	  under	  those	  conditions.	  	  
Usually,	  Atg8	  is	  used	  as	  a	  PAS	  marker	  in	  Atg	  protein	  localization	  studies.	  In	  this	  
study,	  ApeI-­‐RFP	  was	  used	  as	  a	  PAS	  marker	  for	  two	  reasons.	  First,	  the	  expression	  
of	   Atg8	   is	   upregulated	   at	   autophagy-­‐inducing	   conditions,	   but	   under	   growing	  
conditions	   the	   amount	   of	   Atg8	   is	   significantly	   smaller	   (Huang	   et	   al.,	   2000).	  
Therefore,	   the	   part	   of	   Atg8	   at	   the	   PAS	   is	   hardly	   detectable	   in	   fluorescence	  
microscopy	  and	  not	  suitable	  for	  PAS	  rate	  determination	  under	  these	  conditions.	  
Second,	   in	   this	   study	   Atg8	  was	   identified	   as	   a	   potential	   interaction	   partner	   of	  
Atg21	  (see	  chapter	  5.6).	  Therefore,	  Atg21	  and	  Atg8	  could	  form	  a	  complex	  in	  the	  
cytosol	  that	  is	  subsequently	  recruited	  to	  the	  PAS.	  This	  has	  been	  reported	  for	  the	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Atg21	  homologue	  Atg18	  and	  its	  interaction	  partner	  Atg2	  (Obara	  et	  al.,	  2008b).	  A	  
cytosolic	   Atg21-­‐Atg8	   complex	   would	   mimick	   a	   colocalization	   at	   the	   PAS.	  
Therefore,	   the	   PAS	   marker	   ApeI-­‐RFP	   was	   used	   as	   an	   alternative.	   In	   addition,	  
ApeI	   is	   selectively	   transported	   to	   the	  PAS	  via	   the	  Cvt	  pathway,	  where	  Atg21	   is	  
active.	  	  
The	   percentage	   of	   ApeI-­‐RFP	   dots	   that	   colocalized	   with	   Atg21-­‐YFP	   was	  
determined	   (Colocalization	   rate).	   In	   fact,	   a	   considerable	   number	   of	   ApeI-­‐RFP	  
respectively	  PAS	  dots	  (49%)	  colocalized	  with	  Atg21-­‐YFP,	  indicating	  that	  indeed	  a	  
part	  of	  Atg21	  is	  present	  at	  the	  PAS	  (see	  Figure	  11).	  That	   is	  the	  first	  time	  that	  a	  
part	  of	  Atg21	  has	  been	  detected	  at	  the	  PAS.	  	  
Atg19	   is	   the	   Cvt	   cargo	   receptor	   and	   directs	   the	   ApeI	   complex	   to	   the	   PAS	   by	  
binding	  to	  Atg11	  and	  Atg8	  (Kim	  and	  Klionsky,	  2000;	  Shintani	  et	  al.,	  2002).	  The	  
colocalization	   rate	   in	  atg19∆	   cells	  was	  determined	   to	   exclude	  an	   interaction	  of	  
Atg21	   and	   ApeI.	   As	   expected,	   the	   colocalization	   rate	   of	   Atg21-­‐YFP	   and	  
perivacuolar	   ApeI-­‐RFP	   dots	   was	   significantly	   reduced	   in	   atg19∆	   cells	   (16%)	  
compared	   to	   the	   wild	   type	   (atg21∆=49%).	   Hence,	   ApeI-­‐RFP	   is	   a	   suitable	   PAS	  
marker	  for	  colocalization	  studies	  with	  Atg21-­‐YFP	  under	  the	  selected	  conditions.	  	  
Atg11	  is	  a	  component	  of	  the	  Atg1	  kinase	  complex	  and	  acts	  as	  a	  scaffold	  for	  PAS	  
assembly	  for	  selective	  types	  of	  autophagy.	  In	  addition,	  it	  acts	  in	  cargo	  recognition	  
via	   direct	   binding	   of	   receptor	   proteins	   like	   Atg19	   in	   the	   Cvt	   pathway.	  
Consequently,	  the	  Cvt	  complex	  is	  not	  directed	  to	  the	  PAS,	  although	  Atg19	  can	  still	  
bind	  to	  the	  ApeI	  complex	  (Shintani	  et	  al.,	  2002).	  Indeed,	  the	  colocalization	  rate	  of	  
Atg21-­‐YFP	   and	   ApeI-­‐RFP	   was	   significantly	   reduced	   in	   the	   absence	   of	   Atg11	  
(31%).	  Unexpectedly,	  the	  colocalization	  rate	  was	  only	  slightly	  reduced	  compared	  
to	   atg19∆	   cells	   (16%),	   though	   both	   deletions	   should	   result	   in	   the	   absence	   of	  
ApeI-­‐RFP	  from	  the	  PAS.	  Atg11	  might	  be	  partially	  replaced	  by	  Atg17	  that	  adapts	  
the	   Atg11	   scaffold	   function	   in	   the	   Atg1	   kinase	   complex	   under	   autophagy-­‐
inducing	  conditions	  (Cheong	  et	  al.,	  2008;	  Suzuki	  and	  Ohsumi,	  2007;	  Suzuki	  et	  al.,	  
2007).	  However,	   it	   is	  not	  known,	  if	  all	  proteins	  are	  simultaneous	  present	  in	  the	  
Atg1	   kinase	   complex	   or	   if	   there	   are	   subcomplexes,	   that	   vary	   dependent	   on	  
nutrient	   conditions.	   The	   amount	   of	   Atg11,	   Atg17	   and	   Atg19	   at	   the	   PAS	   are	  
proposed	  to	  be	  the	  same	  under	  both	  growing	  and	  starvation	  conditions	  (Geng	  et	  
al.,	   2008).	   Furthermore,	   though	   bulk	   autophagy	   is	   dramatically	   induced	   under	  
	   	   	   Discussion	  
	   114	  
stress	  conditions,	  it	  occurs	  also	  at	  a	  basal	  level	  under	  normal	  growth	  conditions	  
(Parzych	   and	   Klionsky,	   2013;	   Yorimitsu	   and	   Klionsky,	   2005).	   Therefore,	  
atg11∆	  atg17∆	   double	   mutants	   are	   usually	   used	   to	   completely	   block	  
autophagosome	   formation.	   Speculatively,	   the	   lack	   of	   Atg11	   could	   be	   partially	  
complemented	  by	  Atg17	  even	  under	  nutrient-­‐rich	  conditions.	  This	  would	  result	  
in	  a	  PAS	  formation	  at	  a	  low	  frequency	  and	  Atg19	  would	  still	  be	  able	  to	  direct	  the	  
ApeI	   complex	   to	   the	  PAS	  by	  binding	   to	  Atg8.	   In	   contrast,	   in	   the	  absence	  of	   the	  
receptor	  Atg19,	  the	  ApeI	  complex	  is	  not	  able	  to	  bind	  to	  any	  PAS	  component.	  This	  
could	   explain,	   why	   the	   deletion	   of	   ATG19	   has	   a	   more	   severe	   effect	   than	   the	  
deletion	  of	  ATG11.	  To	  prove	  this	  hypothesis,	  the	  colocalization	  rate	  of	  Atg21-­‐YFP	  
and	  ApeI-­‐RFP	  should	  be	  further	  determined	  in	  atg11∆	  atg17∆	  cells.	  
Atg21	  is	  peripherally	  membrane	  associated	  by	  binding	  to	  PI3P	  and/or	  PI(3,5)P2	  
(Krick	  et	  al.,	  2006).	  Yeast	  has	  only	  one	  phosphoinositide	  3-­‐kinase,	  Vps34,	  which	  
is	   present	   in	   two	   complexes.	   Each	   complex	   contains	   in	   addition	   to	   the	   core	  
components	  a	  unique	  factor,	  that	  links	  the	  kinase	  complex	  to	  a	  specific	  site	  and	  
therefore	  to	  a	  specific	  cellular	  function.	  Vps38,	  the	  unique	  subunit	  of	  complex	  II,	  
recruits	   the	   kinase	   complex	   to	   endosomes	   (Kihara	   et	   al.,	   2001;	   Obara	   et	   al.,	  
2006).	  Atg21-­‐YFP	   formed	  one	   to	   six	  perivacuolar	  dots	  within	   the	   cell.	   Some	  of	  
those	   have	   been	   colocalized	   earlier	  with	   endosomal	  marker	   proteins	   as	   FYVE-­‐
RFP	   or	   Snf7-­‐RFP	   (Krick	   et	   al.,	   2008a).	   The	   localization	   of	   Atg21	   at	   endosomal	  
compartments	   is	   dependent	   on	  Vps38	   and	   therefore	   on	   the	   endosome-­‐specific	  
PI3P	  pool	   (Krick	   et	   al.,	   2008a).	   The	   autophagy-­‐specific	  Vps34	   complex	   I	   at	   the	  
PAS	  specifically	  contains	  Atg38	  and	  Atg14	  (Araki	  et	  al.,	  2013;	  Obara	  et	  al.,	  2006).	  
In	  the	  absence	  of	  Atg14	  respectively	  the	  PAS-­‐specific	  PI3P	  pool,	  Atg21	  should	  be	  
also	  absent	  from	  the	  PAS.	  Indeed,	  the	  colocalization	  rate	  of	  Atg21-­‐YFP	  and	  ApeI-­‐
RFP	  was	  significantly	  reduced	  in	  atg14∆	  cells	  (22%)	  compared	  to	  wild	  type	  cells	  
(49%),	   confirming	   that	   the	   PAS	   localization	   of	   Atg21	   is	   PI3P-­‐dependent.	   In	  
contrast	  to	  vps38∆	  cells,	  where	  Atg21	  seems	  to	  be	  nearly	  completely	  released	  to	  
the	  cytosol	  (Krick	  et	  al.,	  2008a),	  the	  deletion	  of	  ATG14	  did	  not	  lead	  to	  a	  change	  in	  
the	   overall	   punctate	   appearance	   of	   Atg21-­‐YFP.	   Under	   growing	   conditions,	   the	  
majority	   of	   PI3P	   have	   been	   reported	   to	   locate	   at	   endosomes	   and	   the	   vacuolar	  
membrane,	  whereas	  only	  a	  minor	  amount	  has	  been	  found	  at	  the	  PAS	  (Obara	  et	  
al.,	  2008a).	  Therefore,	  probably	  only	  a	  small	  part	  of	  Atg21-­‐YFP	  is	  located	  at	  the	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PAS,	  whereas	  the	  major	  part	  is	   located	  at	  other	  sites	  as	  endosomes.	  That	  might	  
also	  be	  a	  reason	  why	  Atg21	  has	  not	  been	  detected	  at	  the	  PAS	  before.	  Stromhaug	  
et	  al.	   (2004)	   have	   explicitly	  monitored	   cells	   expressing	   chromosomally	   tagged	  
Atg21-­‐GFP	  and	  prApeI-­‐RFP	  as	  PAS	  marker	  and	  observed,	  that	  these	  two	  proteins	  
did	  not	  colocalize.	  The	  endogenous	  expression	  level	  of	  Atg21	  is	  quite	  low	  leading	  
to	  a	  weak	   fluorescence	   signal.	  The	  Atg21-­‐YFP	  construct	  used	   in	   this	   study	  was	  
also	   expressed	   from	   its	   endogenous	   promoter,	   but	   a	   higher	   resolution	  
microscopy	   has	   been	   used	   for	   analysis.	   Therefore,	   that	   Atg21	   has	   not	   been	  
detected	   at	   the	   PAS	   before	   could	   be	   due	   to	   a	   difference	   in	   the	   microscope	  
sensitivity.	   Furthermore,	   the	   PAS	   localization	   of	   Atg21	   was	   not	   immediately	  
obvious.	  Though	   the	  Cvt	  pathway	   is	  highly	  active	  under	   the	  elected	  conditions,	  
only	  35%	  of	  the	  cells	  averaged	  a	  perivacuolar	  ApeI-­‐RFP	  respectively	  PAS	  dot.	  In	  
addition,	   Atg21-­‐YFP	   forms	   approximately	   three	   to	   six	   dots	  within	   the	   cell.	   For	  
the	  quantification	  of	   the	  Atg21	  PAS	   localization,	   it	  was	  necessary	   to	  determine	  
the	   ApeI-­‐RFP	   and	   Atg21-­‐YFP	   dots	   in	   a	   high	   number	   of	   cells	   to	   validate	   the	  
results.	  	  
As	   shown	   for	   the	   Atg21	   homologue	   Atg18,	   proper	   membrane	   association	   is	  
mediated	   by	   two	   components,	   the	   PIP	   binding	   and	   an	   additional	   protein	  
interaction	  partner	   like	  Atg2	   (Obara	  et	  al.,	  2008b;	  Rieter	  et	  al.,	  2013).	  The	  PAS	  
localization	   of	   the	   Atg18-­‐Atg2	   complex	   additionally	   requires	   the	   membrane	  
protein	  Atg9	   (Reggiori	   et	  al.,	  2004).	  Atg9	   forms	  a	   trimeric	   complex	  with	  Atg23	  
and	  Atg27.	  All	  three	  proteins	  cycle	  between	  the	  PAS	  and	  a	  non-­‐PAS	  pool	  and	  the	  
PAS	  recruitment	  of	  all	  three	  proteins	  depends	  on	  the	  presence	  of	  each	  other.	  In	  
contrast,	   the	   retrograde	   transport	   of	  Atg9	   from	   the	  PAS	   to	   its	   non-­‐PAS	  pool	   is	  
independent	   of	   Atg23	   and	   Atg27	   but	   dependent	   on	   the	   Atg2-­‐Atg18	   complex	  
(Legakis	  et	  al.,	  2007).	  It	  has	  been	  already	  shown	  by	  two	  independent	  approaches	  
that	  the	  PIP	  binding	  is	  required	  for	  proper	  Atg21	  localization.	  First,	  Atg21	  is	  not	  
present	  at	  the	  PAS	  in	  the	  absence	  of	  PI3P	  (see	  above).	  Second,	  mutations	  within	  
the	   lipid	   binding	   domain	   of	   Atg21	   result	   into	   release	   of	   the	   protein	   into	   the	  
cytosol	   (Krick	   et	   al.,	   2006).	   In	   order	   to	   find	   the	   additional	   protein	   component	  
required	   for	   proper	   PAS	   localization	   of	   Atg21,	   further	   deletion	   strains	   were	  
tested	  for	  a	  loss	  of	  the	  Atg21	  PAS	  localization	  (see	  Figure	  11+Figure	  12).	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In	   the	   absence	   of	   Atg9,	   the	   PAS	   localization	   of	   Atg21-­‐YFP	   was	   significantly	  
reduced	   (26%),	   pointing	   to	   a	   potential	   influence	   of	   Atg9	   on	   the	   Atg21	   PAS	  
localization.	   In	   contrast,	   further	   split	   ubiquitin	   approaches	   did	   not	   detect	   an	  
interaction	   of	   Atg21	   and	   Atg9	   (see	   chapter	   5.5).	   Thus,	   the	   effect	   of	   Atg9	   is	  
probably	   indirect,	  because	  Atg9	   is	  required	   for	   the	  recruitment	  of	  Atg14	  to	   the	  
PAS	  and	  therefore	  for	  the	  generation	  of	  the	  PAS-­‐specific	  PI3P	  pool	  (Suzuki	  et	  al.,	  
2007).	   The	   absence	   of	   Atg2	   or	   Atg27	   had	   only	   a	   slight	   effect	   on	   the	   PAS	  
localization	   of	   Atg21-­‐YFP	   (34%	   respectively	   38%),	   whereas	   the	   deletion	   of	  
ATG23	   did	   not	   change	   the	   colocalization	   rate	   of	   Atg21-­‐YFP	   (48%).	   The	   Atg2-­‐
Atg18	   complex	   is	   required	   for	   efficient	   retrograde	   transport	   of	   Atg9	   from	   the	  
PAS	   (Reggiori	   et	   al.,	   2004).	   Therefore,	   the	   loss	   of	   Atg2	   could	   have	   a	   rather	  
indirect	  effect	  on	  the	  Atg21	  PAS	  localization.	  Similarly,	  also	  Atg27	  and	  Atg23	  are	  
required	  for	  the	  transport	  of	  Atg9	  to	  the	  PAS	  (Legakis	  et	  al.,	  2007).	  Nonetheless,	  
the	  loss	  of	  Atg27	  but	  not	  of	  Atg23	  slightly	  affected	  the	  Atg21	  PAS	  localization.	  In	  
addition,	  split-­‐ubiquitin	  approaches	  detected	  a	  potential	  interaction	  of	  Atg27	  and	  
Atg21	   (see	   Figure	   21),	   pointing	   to	   a	   stabilizing	   role	   for	   Atg27	   in	   Atg21	   PAS	  
localization.	  However,	  a	  potential	   interaction	  of	  Atg21	  and	  Atg27	  was	  analyzed	  
in	  further	  experiments	  and	  are	  discussed	  in	  more	  detail	  below	  (see	  chapter	  5.5).	  	  
As	  mentioned	  before,	  Atg21	  is	  required	  for	  the	  recruitment	  of	  Atg8	  and	  Atg5	  to	  
the	  PAS	  (Meiling-­‐Wesse	  et	  al.,	  2004;	  Stromhaug	  et	  al.,	  2004).	  Atg8	  is	  conjugated	  
to	  PE	  in	  a	  ubiquitin-­‐like	  manner,	  where	  the	  Atg12-­‐Atg5/Atg16	  complex	  functions	  
as	  an	  E3-­‐like	  enzyme	  ((Nakatogawa,	  2013),	  see	  chapter	  2.2.4.4).	  Both,	  Atg8	  and	  
Atg12-­‐Atg5/Atg16	  are	  among	  the	  last	  components,	  that	  are	  recruited	  to	  the	  PAS	  
(Suzuki	   et	   al.,	   2007).	   Furthermore,	   Atg16	  mediates	   the	   PAS	   localization	   of	   the	  
Atg12-­‐Atg5/Atg16	  complex	  (Hanada	  et	  al.,	  2007;	  Suzuki	  et	  al.,	  2001).	  The	  loss	  of	  
Atg8	   did	   not	   affect	   the	   PAS	   localization	   of	   Atg21-­‐YFP,	  whereas	   the	   Atg21	   PAS	  
localization	  was	   slightly	   reduced	   in	   the	   absence	   of	   Atg16	   (Colocalization	   rate:	  
52%	   respectively	   34%).	   Therefore,	   the	   Atg21	   PAS	   localization	   is	   most	   likely	  
independent	   on	   Atg8,	   but	   stabilized	   by	   Atg16.	   As	   discussed	   below,	   this	   study	  
revealed	   that	   Atg21	   and	  Atg16	   interact	   directly	  with	   each	   other.	   Furthermore,	  
two	  surface	  residues	  within	  the	  coiled-­‐coil	  domain	  were	  identified	  to	  specifically	  
bind	  to	  Atg21	  (see	  chapter	  4.3.6.4).	  The	  Atg12-­‐Atg5/Atg16	  complex	  is	  proposed	  
to	  be	  dimeric	  mediated	  by	  the	  coiled-­‐coil	  domain	  of	  Atg16	  (Fujioka	  et	  al.,	  2010;	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Kuma	   et	   al.,	   2002).	   Therefore,	   one	   Atg12-­‐Atg5/Atg16	   complex	   exhibits	   two	  
Atg16	  molecules	  and	  thus	  two	  potential	  Atg21	  binding	  sites.	  It	  could	  be	  possible,	  
that	   Atg16	   bridges	   two	   Atg21	   molecules	   resulting	   in	   a	   dimeric	   Atg21-­‐Atg16	  
respectively	   Atg21-­‐Atg16/Atg5-­‐Atg12	   complex.	   The	   Atg21	   dimerization	   would	  
further	   stabilize	   the	   PI3P-­‐dependent	   membrane	   association	   of	   Atg21.	  
Consequently,	  the	  Atg21	  PAS	  localization	  could	  be	  destabilized	  in	  the	  absence	  of	  
Atg16	   as	   observed	   in	   this	   study.	   This	   hypothesis	   is	   further	   supported	   by	   the	  
observation,	   that	   Atg5	   is	   not	   required	   for	   the	   colocalization	   of	   Atg16-­‐GFP	   and	  
mCherry-­‐Atg21	  at	   the	  PAS	  (see	  chapter	  4.3.6.2	  and	  Figure	  32).	  Dimerization	  of	  
Atg16	   is	   independent	  of	  Atg5	  and	  Atg12	   (Mizushima	  et	   al.,	   1999).	  Thus,	  Atg16	  
alone	   would	   be	   sufficient	   to	   bridge	   Atg21	   and	   thus	   stabilize	   the	   membrane	  
association	  of	  Atg21	  at	   the	  PAS.	  This	  model	  would	  also	  not	  exclude	  a	  potential	  
additional	  interaction	  with	  the	  membrane	  protein	  Atg27	  to	  stabilize	  membrane	  
association.	   As	   mentioned	   above,	   the	   Atg21	   homologue	   Atg18	   binds	   to	   the	  
cytosolic	  protein	  Atg2,	  and	  both	  proteins	  are	  recruited	  to	  the	  PAS	  by	  additional	  
interaction	   with	   the	  membrane	   protein	   Atg9	   (Reggiori	   et	   al.,	   2004).	   Similarly,	  
interaction	  with	  the	  membrane	  protein	  Atg27	  in	  addition	  to	  the	  cytosolic	  Atg16	  
could	  enhance	  the	  Atg21	  PAS	  localization.	  However,	  this	  model	  has	  to	  be	  proven	  
by	   further	   Atg21	   localization	   studies.	   The	   PAS	   localization	   of	   Atg21	   should	   be	  
determined	   in	  atg5∆	   and	  atg12∆	   cells	   to	  exclude	  an	   influence	  of	   the	   remaining	  
components	   of	   the	   Atg12-­‐Atg5/Atg16	   complex	   on	   the	   Atg21	   PAS	   localization.	  
Importantly,	  the	  deletion	  of	  Atg16	  or	  Atg27	  had	  only	  a	  slight	  effect	  on	  the	  Atg21	  
PAS	   localization,	   suggesting	   that	  more	   than	  one	   component	  might	   stabilize	   the	  
Atg21	   PAS	   localization.	   This	   implies	   that	   the	   simultaneous	   deletion	   of	   two	   or	  
more	   components	   should	   result	   in	   a	   more	   severe	   defect	   in	   Atg21	   PAS	  
localization.	   Therefore,	   the	   determination	   of	   the	   Atg21	   PAS	   localization	   in	  
atg14∆	  atg16∆,	   atg14∆	  atg27∆	   or	   atg16∆	  atg27∆	   cells	   should	   be	   further	  
determined	  to	  prove	  the	  hypothesis.	  	  
In	   conclusion,	   part	   of	   Atg21	   clearly	   localizes	   at	   the	   PAS	   in	   a	   PI3P-­‐dependent	  
manner.	  As	  mentioned	  before,	   the	   assembly	  of	   the	  PAS	  and	   the	   recruitment	  of	  
the	  Atg	  proteins	   is	   a	   quite	  dynamic	  process	   and	  occurs	   in	   a	   specific	   hierarchy.	  
Based	  on	  the	  results	  obtained	  from	  the	  PAS	  localization	  analysis	  of	  Atg21-­‐YFP	  in	  
this	   study,	   Atg21	   is	   most	   likely	   recruited	   to	   the	   PAS	   after	   localization	   of	   the	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Atg14-­‐containing	  Vps34	  kinase	  complex	  and	  therefore	  after	  the	  generation	  of	  the	  
PAS-­‐specific	   PI3P	  pool,	   but	   before	   recruitment	   of	  Atg8	   and	   its	  E3-­‐like	   enzyme,	  
the	  Atg12-­‐Atg5/Atg16	  complex.	  	  
5.2 Atg21	  is	  located	  on	  the	  outer	  autophagosomal	  membrane	  
Atg21	   is	  peripherally	  membrane	  associated	  at	   the	  PAS	  via	  binding	  of	  PI3P	  (see	  
Figure	   11).	   In	   the	   current	   model,	   the	   PAS	   assembles	   through	   hierarchical	  
interactions	  between	  Atg	  proteins	  and	  generates	  the	  phagophore,	  which	  expands	  
to	  become	  an	  autophagosome.	  The	  specific	  localization	  of	  each	  protein	  at	  the	  PAS	  
seems	  to	  correspond	  directly	  to	  its	  respective	  function	  (Suzuki	  et	  al.,	  2013).	  	  
A	  more	  detailed	   insight	   into	   the	  Atg	  protein	  distribution	  at	   the	  PAS	  and	  across	  
the	   phagophore	   membrane,	   was	   reported	   by	   Suzuki	   et	   al.	   (2013).	   By	   high	  
overexpression	  of	  prApeI,	  a	  giant	  prApeI	  complex	  is	  generated,	  that	  is	  too	  large	  
to	   be	   packed	   into	   a	   Cvt	   vesicle	   or	   even	   in	   an	   autophagosome.	   Instead,	   the	  
expansion	  of	  the	  phagophore	  arrests	  at	   its	  maximum	  length,	  resulting	  in	  a	  cup-­‐
shaped	   like	   structure	   associated	   with	   both	   the	   giant	   prApeI	   complex	   and	   the	  
vacuolar	   membrane.	   Moreover,	   the	   distribution	   pattern	   of	   the	   Atg	   proteins	  
across	   the	   phagophore	   and	   the	   PAS	   is	   also	   arrested	   and	   can	   be	   visualized	   by	  
direct	  fluorescence	  microscopy.	  Unfortunately,	  the	  distribution	  of	  Atg21	  was	  not	  
monitored,	  probably	  because	  it	  has	  not	  been	  detected	  at	  the	  PAS	  so	  far.	  However,	  
the	  Atg21	  homologue	  Atg18	  and	  its	  interaction	  partner	  Atg2	  localize	  to	  the	  edges	  
of	   the	   expanding	   phagophore	   (Suzuki	   et	   al.,	   2013).	   As	   discussed	   before,	   in	  
contrast	  to	  Atg18,	  Atg2	  most	  likely	  only	  indirectly	  affects	  the	  PAS	  localization	  of	  
Atg21.	   Therefore,	   the	   localization	   pattern	   of	   Atg18	   can	   probably	   not	   be	  
transferred	  to	  Atg21.	  	  
Atg8	   is	   distributed	   evenly	   across	   the	   outer	   and	   inner	   membrane	   of	   the	  
expanding	  phagophore,	  whereas	  the	  Atg12-­‐Atg5/Atg16	  complex	  is	  restricted	  to	  
the	  outer	  membrane	  (Kirisako	  et	  al.,	  2000;	  Mizushima	  et	  al.,	  2001;	  Suzuki	  et	  al.,	  
2001;	   Suzuki	   et	   al.,	   2013).	   As	   discussed	   below	   in	  more	   detail,	   Atg21	   probably	  
interacts	  with	  Atg8	  and	  the	  Atg12-­‐Atg5/Atg16	  complex	  (see	  chapter	  5.6+5.7).	  At	  
least	   the	   interaction	   with	   the	   Atg12-­‐Atg5/Atg16	   complex	   occurs	   at	   the	   PAS.	  
Furthermore,	   Atg21	   probably	   mediates	   membrane	   association	   of	   the	   Atg12-­‐
Atg5/Atg16	  complex	  by	  direct	  binding	  of	  Atg16	  (see	  chapter	  5.7),	  suggesting	  that	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Atg21	  and	  the	  Atg12-­‐Atg5/Atg16	  complex	  share	  the	  same	  localization	  pattern	  on	  
the	   forming	   autophagosome.	   In	   contrast,	   PI3P	   that	   mediates	   the	   peripheral	  
membrane	   association	   of	   Atg21,	   is	   distributed	   across	   the	   inner	   and	   outer	  
autophagosomal	   membrane	   (Obara	   and	   Ohsumi,	   2008).	   But	   among	   the	  
autophagy-­‐related	  proteins	  only	  those	  on	  the	  inner	  membrane	  of	  the	  expanding	  
phagophore	   are	   trapped	   inside	   the	   matured	   autophagosome	   and	   transported	  
into	   the	  vacuole.	  Using	  direct	   fluorescence	  microscopy,	  a	  potential	   transport	  of	  
mCherry-­‐Atg21	   into	   the	  vacuole	  was	   tested	   in	  growing	  atg21∆	  pep4∆	   cells	   (see	  
Figure	   14).	  mCherry-­‐Atg21	   is	  most	   probably	   not	   transported	   into	   the	   vacuole.	  
Therefore,	  as	   the	  Atg12-­‐Atg5/Atg16	  complex,	  Atg21	   is	  most	   likely	  restricted	   to	  
the	   outer	   membrane	   of	   the	   expanding	   phagophore	   and	   dissociates	   from	   that	  
structure	  immediately	  before	  or	  after	  completion	  of	  the	  autophagosome	  as	  it	  was	  
suggested	  for	  the	  Atg12-­‐Atg5	  complex	  before	  (Suzuki	  et	  al.,	  2001).	  Nevertheless,	  
using	   the	   above-­‐mentioned	   giant	   ApeI	   complex	   approach,	   the	   localization	   of	  
Atg21	  across	   the	  autophagosomal	  membranes	  should	  be	  determined	   in	   further	  
experiments.	  Electron	  microscopy	  could	  be	  additionally	  used	  to	  prove	  a	  potential	  
restriction	   of	   Atg21	   to	   the	   outer	   autophagosomal	   membrane.	   Up	   to	   now,	   a	  
transport	   of	   the	   Atg21	   homologue	   Atg18	   into	   the	   vacuole	   has	   also	   not	   been	  
reported,	   probably	   because	   Atg18	   is	   not	   located	   across	   the	   expanding	  
membranes	  but	  at	  the	  edges	  of	  the	  phagophore	  (Suzuki	  et	  al.,	  2013).	  
Maturation	  and/or	   fusion	  of	   the	  autophagosomes	  with	   the	  vacuolar	  membrane	  
require	   the	   dissociation	   of	   the	   autophagic	   machinery.	   The	   covalent	   anchored	  
Atg8	  is	  cleaved	  off	  by	  Atg4	  (Kirisako	  et	  al.,	  2000),	  whereas	  the	  major	  part	  of	  the	  
autophagic	  machinery	   is	   probably	   released	   by	   the	   degradation	   of	   PI3P	   via	   the	  
phosphatase	   Ymr1	   (Cebollero	   et	   al.,	   2012).	   As	   shown	   for	   Atg18,	   proper	  
membrane	  association	   is	  mediated	  by	  two	  components,	   the	  PIP	  binding	  and	  an	  
additional	   protein	   interaction	   partner.	   The	   degradation	   of	   PI3P	   leads	   to	   its	  
dissociation	  from	  the	  membrane	  (Cebollero	  et	  al.,	  2012).	  If	  this	  was	  also	  true	  for	  
Atg21,	  Atg21	  should	  remain	  associated	  with	  autophagosomes	   in	  the	  absence	  of	  
Ymr1	   as	   shown	   for	   its	   homologue	  Atg18.	   Since	   those	   autophagosomes	   are	   not	  
able	  to	  fuse	  with	  the	  vacuole	  (Cebollero	  et	  al.,	  2012),	  the	  deletion	  of	  YMR1	  would	  
result	   in	   an	   increased	   colocalization	   of	   Atg21-­‐YFP	   and	   the	   Cvt	   vesicle	   marker	  
ApeI-­‐RFP	   in	   fluorescence	   microscopy.	   Therefore,	   the	   influence	   of	   Ymr1	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respectively	   clearance	   of	   PI3P	   on	   the	   dissociation	   of	   Atg21	   from	   the	  
autophagosome	  should	  be	  further	  tested	  by	  determination	  of	   the	  colocalization	  
rate	  of	  Atg21-­‐YFP	  and	  ApeI-­‐RFP	  as	  described	  before	  (see	  chapter	  4.2.1).	  	  
Phosphorylation	  of	   the	  PIP	  binding	  site	  of	  Atg18	   from	  Pichia	  pastoris	   regulates	  
its	  ability	   to	  bind	  to	  PI(3,5)P2	  at	   the	  vacuolar	  membrane	  (Tamura	  et	  al.,	  2013),	  
pointing	  to	  an	  additional	  regulatory	  mechanism	  for	  PROPPIN	  dissociation.	  Along	  
this	  line,	  the	  serine/threonine	  kinase	  activity	  of	  Atg1	  is	  suggested	  to	  specifically	  
function	   in	   the	   regulation	  of	  Atg	  protein	   localization	   at	   the	  PAS	   (Cheong	   et	   al.,	  
2008).	  Atg21	  has	  originally	  been	  identified	  as	  a	  target	  of	  the	  Atg1	  kinase	  (Ptacek	  
et	   al.,	   2005).	   That	   led	   to	   the	   idea,	   that	   Atg1	   could	   regulate	   the	   Atg21	   PAS	  
localization	  via	  phosphorylation.	  Nevertheless,	   a	  potential	   influence	  of	  Atg1	  on	  
the	   PAS	   localization	   of	   Atg21	   is	   highly	   speculative	   and	   has	   to	   be	   carefully	  
analyzed	  further.	  	  
The	  respective	   interaction	  partner	  could	  represent	  another	  regulatory	   level	   for	  
membrane	  dissociation.	  Recently,	  a	  potential	  posttranslational	  modification	  site	  
was	   identified	   within	   Atg18,	   which	   could	   contribute	   to	   the	   regulation	   of	   the	  
Atg18-­‐Atg2	   interaction	   or	   other	   functions	   of	   Atg18	   (Rieter	   et	   al.,	   2013).	  
Therefore,	   identification	   of	   the	   interaction	   partner	   of	   Atg21	   at	   the	   PAS	   or	  
endosomes	   could	   give	   more	   hints	   for	   a	   regulation	   of	   the	   Atg21	   localization	  
within	  the	  cell.	  	  
In	   contrast	   to	   Atg21	   and	   Atg18,	   two	   of	   the	   mammalian	   PROPPIN	   orthologs,	  	  
WIPI-­‐1	  and	  WIPI-­‐2	  are	   located	  on	   the	   inner	  and	  outer	  membrane	  of	  generated	  
autophagosomes	   (Proikas-­‐Cezanne	   et	   al.,	   2011),	   suggesting	   a	   different	   sorting	  
mechanism	   in	   mammals	   and/or	   a	   function	   different	   from	   their	   yeast	  
counterparts.	  	  
5.3 Atg21	  is	  part	  of	  a	  high	  molecular	  weight	  complex	  
Atg21	  was	  detected	  as	  a	  part	  of	  a	  high	  molecular	  weight	  complex	  of	  ≥	  670	  kDa	  
using	   gelfiltration	   chromatography	   and	   density	   gradient	   centrifugation	   (see	  
Figure	   16+Figure	   18).	   This	   high	   molecular	   weight	   Atg21	   complex	   was	   highly	  
sensitive	  to	  the	  cell	  lysis	  and	  buffer	  conditions	  (see	  chapter	  4.3.1).	  In	  this	  study,	  a	  
mild	  cell	  lysis	  procedure	  was	  established	  that	  keeps	  the	  sensible	  complex	  intact	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as	   a	   prerequisite	   not	   only	   for	   further	   analysis	   of	   the	   complex	   but	   also	   for	   the	  
identification	  and	  verification	  of	  potential	  Atg21	  interacting	  proteins.	  	  
Sorbitol	   density	   gradient	   centrifugation	   was	   used	   to	   further	   analyze	   the	   high	  
molecular	   weight	   Atg21	   complex	   in	   depicted	   mutant	   strains	   (see	  
chapter	  4.3.1.2).	   Atg21	   is	   required	   for	   the	   Cvt	   pathway,	   which	   describes	   the	  
selective	   transport	   of	   ApeI	   to	   the	   vacuole.	   ApeI	   forms	   large	   dodecamers.	   One	  
dodecamer	  has	  a	  high	  molecular	  weight	  (~670	  kDa)	  and	  was	  therefore	  used	  as	  a	  
size	  marker	  in	  gelfiltration	  chromatography	  and	  density	  gradient	  centrifugation.	  
Otherwise,	   it	  would	   be	   also	   possible	   that	   the	  ApeI	   complex	   is	   part	   of	   the	   high	  
molecular	   weight	   Atg21	   complex.	   That	   would	   also	   explain	   the	   co-­‐elution	  
respectively	   –sedimentation	   in	   gelfiltration	   respectively	   sorbitol	   gradient	  
centrifugation.	   However,	   neither	   the	   absence	   of	   the	   cargo	   receptor	   Atg19	   (see	  
Figure	   18)	   nor	   the	   absence	   of	   ApeI	   itself	   (data	   not	   shown)	   did	   influence	   the	  
assembly	  of	   the	  high	  molecular	  weight	  Atg21	  complex	   in	   this	  study,	  suggesting	  
that	  ApeI	  is	  probably	  not	  part	  of	  that	  complex.	  	  
The	   type	   I	   membrane	   protein	   Atg27	   is,	   similar	   to	   Atg21,	   required	   for	   the	   Cvt	  
pathway,	  but	  only	  affects	  macroautophagy	  (Yen	  and	  Klionsky,	  2007).	  Therefore,	  
Atg27	  would	  be	  a	  good	  candidate	  for	  an	  interaction	  partner	  of	  Atg21.	  However,	  
the	   deletion	   of	   ATG27	   did	   not	   influence	   the	   assembly	   of	   the	   high	   molecular	  
weight	   Atg21	   complex.	   Furthermore,	   the	   loss	   of	   the	   kinase	   Atg1	   did	   also	   not	  
affect	  the	  assembly	  of	  the	  Atg21	  complex	  (see	  Figure	  18).	  However,	  it	  cannot	  be	  
excluded,	   that	  one	  of	   the	   tested	  proteins	   is	   a	   component	  of	   the	  Atg21	  complex	  
anyway.	  Due	  to	  their	  low	  molecular	  weight,	  a	  change	  in	  the	  distribution	  pattern	  
of	   the	  Atg21	  complex	  within	  the	  sorbitol	  density	  gradient	  centrifugation	  would	  
only	  be	  visible	   if	  one	  of	   the	   tested	  proteins	  was	  a	  stoichiometric	  component	  of	  
the	   complex.	   It	   can	  only	  be	   concluded,	   that	  none	  of	   the	   tested	  proteins	  had	  an	  
effect	  on	  the	  formation	  of	  the	  high	  molecular	  weight	  Atg21	  complex.	  
Hypothetically,	   the	   high	   molecular	   weight	   Atg21	   complex	   could	   constitute	   an	  
assembly	  of	  Atg18	  family	  members	  in	  a	  large	  scaffold	  structure.	  This	  hypothesis	  
is	   supported	  by	   the	   finding	   that	  Atg21	   interacts	  with	   itself	   and	   its	  homologues	  
Atg18	  and	  Hsv2	  (split-­‐ubiquitin	  assay	  data	  not	  shown	  and	  (Nair	  et	  al.,	  2010)).	  	  
As	  discussed	  below,	  6xHis-­‐SUMO-­‐Atg21	  specifically	  co-­‐precipitated	  all	  members	  
of	   the	   TOR	   complex	   1	   (TORC1)	   in	   pull	   down	   experiments	   (see	   chapter	   5.4).	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TORC1	   is	   a	   huge	  dimeric	   complex	  with	   a	   predicted	  molecular	   size	   of	  ~	  2	  MDa,	  
estimated	   by	   gelfiltration	   chromatography	   (Loewith	   and	  Hall,	   2011).	   The	   high	  
molecular	  weight	  Atg21	  complex	  was	  partly	  present	   in	  fractions	  corresponding	  
to	  a	  much	  higher	  molecular	  weight	   as	   the	  ApeI	   complex	   (670	  kDa)	   (see	  Figure	  
16+Figure	  18).	  Therefore,	  TORC1	  or	  part	  of	  it	  could	  represent	  another	  candidate	  
for	   the	   high	   molecular	   weight	   Atg21	   complex.	   However,	   this	   is	   highly	  
speculative.	  For	  determination	  of	  the	  Atg21	  complex	  components,	  the	  amount	  of	  
the	   complex	   should	   be	   scaled	   up	   to	   identify	   the	   respective	   proteins	   by	   mass	  
spectrometry.	   The	   formation	   of	   the	   complex	   was	   independent	   of	   Atg1	   (see	  
Figure	   18).	   In	   general,	   the	   loss	   of	   Atg1	   results	   in	   an	   arrest	   of	   most	   of	   the	  
autophagy-­‐related	  proteins	   at	   the	  PAS.	   If	   the	  Atg21	   complex	  was	   formed	  or	   at	  
least	  partially	  present	  at	  the	  PAS,	  atg1∆	  cells	  could	  be	  used	  to	  enrich	  the	  amount	  
of	   the	   Atg21	   complex.	   However,	   identification	   of	   its	   components	   would	  
contribute	  to	  elucidate	  the	  molecular	  function	  of	  Atg21.	  	  
5.4 Identification	  of	  Atg21	  interaction	  partner	  
The	  pull	  down	  approach	  was	  used	  to	  further	  identify	  Atg21	  interaction	  partner.	  
Recombinant	   6xHis-­‐SUMO-­‐Atg21	   and	   6xHis-­‐SUMO	   alone	   as	   negative	   control	  
were	   purified	   and	   incubated	  with	   yeast	   crude	   cell	   extract.	   The	   co-­‐precipitated	  
proteins	   were	   analyzed	   by	   both	   immunoblotting	   and	   mass	   spectrometry	   (see	  
Figure	  19).	  Curiously,	  no	  Atg	  protein	  has	  been	  identified	   in	  mass	  spectrometry,	  
although	   mCherry-­‐Atg19	   was	   clearly	   detected	   by	   the	   anti-­‐Red	   antibody	   in	  
immunoblotting.	   The	   samples	   tested	   by	   immunoblot	  were	   the	   same	   that	  were	  
subsequently	  subjected	   to	  mass	  spectrometry	  analysis,	  excluding	  differences	   in	  
the	   pull	   down	   procedure.	   Based	   on	   the	   immunoblot	   signal,	   the	   amount	   of	  
mCherry-­‐Atg19	   should	   be	   above	   the	   critical	   detection	   level	   for	   mass	  
spectrometry.	  Furthermore,	  prediction	  programs	  did	  not	  propose	  any	  secondary	  
modifications	   that	   would	   complicate	   an	   identification	   of	   Atg19	   in	   mass	  
spectrometry	   analysis.	   For	   the	   mass	   spectrometry	   analysis,	   the	   samples	   were	  
first	  separated	  by	  SDS-­‐PAGE.	  After	  Coomassie	  staining,	  the	  gel	  was	  cut	  into	  slices	  
and	   the	   protein	   content	   of	   each	   slice	   was	   determined.	   mCherry-­‐Atg19	   has	   a	  
molecular	  weight	  of	  about	  75	  kDa	  corresponding	  approximately	  to	  the	  molecular	  
weight	  of	  6xHis-­‐SUMO-­‐Atg21	  (70	  kDa).	  Therefore,	  mCherry-­‐Atg19	  was	  probably	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present	   in	   the	  same	  slice	  as	  at	   least	  part	  of	  6xHis-­‐SUMO-­‐Atg21.	  The	  amount	  of	  
6xHis-­‐SUMO-­‐Atg21	   was	   much	   higher	   than	   the	   amount	   of	   mCherry-­‐Atg19	   (see	  
Figure	  19).	  This	  could	  have	  resulted	  in	  a	  masking	  and	  therefore	  non-­‐detection	  of	  
mCherry-­‐Atg19	  in	  mass	  spectrometry	  analysis.	  Along	  this	  line,	  the	  huge	  amount	  
of	   6xHis-­‐SUMO-­‐Atg21	   probably	   also	   shifted	   adjacent	   proteins	  when	   loaded	   on	  
SDS-­‐PAGE,	  explaining	  the	  slight	  molecular	  shift	  of	  mCherry-­‐Atg19	   in	  the	  bound	  
fraction	  in	  immunoblotting	  (see	  Figure	  19).	  	  
Surprisingly,	  all	  components	  of	  the	  target	  of	  rapamycin	  complex	  I	  (TORC1)	  were	  
specifically	   co-­‐precipitated	   by	   6xHis-­‐SUMO-­‐Atg21	   (see	   Figure	   19).	   TORC1	  
consists	  of	  Tco89,	  Kog1,	  Lst8	  and	  the	  serine/threonine	  kinase	  Tor1	  or	  Tor2	  and	  
is	  most	   likely	  dimeric	   (Loewith	  and	  Hall,	  2011).	   Its	   large	  size	  (~	  2	  MDa)	  would	  
make	   it	   a	   good	   candidate	   as	   component	   of	   the	   high	   molecular	   weight	   Atg21	  
complex	   detected	   in	   gelfiltration	   chromatography	   and	   density	   gradient	  
centrifugation	   (see	   chapter	   5.3).	   TORC1	   has	   a	   central	   role	   in	   several	   cellular	  
processes	  that	  regulate	  cell	  growth	  in	  response	  to	  nutrients	  and	  growth	  factors.	  
In	   general,	   TORC1	   is	   active	   under	   growing	   conditions	   and	   is	   regulated	   by	   the	  
availability	  of	  nutrients	   such	  as	  nitrogen	  and	  carbon	   (Loewith	  and	  Hall,	  2011).	  
TORC1	   also	   acts	   as	   a	   negative	   regulator	   of	   autophagy.	   In	   yeast,	   it	   directly	  
phosphorylates	  Atg13	   (Kamada	  et	  al.,	  2010),	  which	  most	   likely	   regulates	  Atg1-­‐
kinase	   activity.	   Under	   autophagy-­‐inducing	   conditions,	   Atg13	   is	  
dephosphorylated	   and	   autophagy	   is	   induced.	   TORC1	   is	   highly	   conserved	   in	  
mammals.	   Recent	   studies	   revealed,	   that	   the	  Atg18	   ortholog	  WIPI-­‐1	   specifically	  
regulates	   TORC1	   signaling	   in	   melanosome	   formation	   by	   an	   unknown	  
mechanism,	  that	  is	  distinct	  from	  the	  regulation	  of	  autophagosome	  formation	  (Ho	  
et	  al.,	  2011).	  	  
However,	  at	  this	  point,	  it	  is	  highly	  speculative	  that	  Atg21	  might	  regulate	  TORC1	  
activity	   as	   it	   was	   proposed	   for	   the	   PROPPIN	   ortholog	  WIPI-­‐1	   or	   that	   Atg21	   is	  
conversely	   regulated	   via	   phosphorylation	   by	   TORC1	   as	   Atg13.	   Further	  
characterization	   of	   a	   potential	   interaction	   should	   clarify,	   if	   Atg21	   interacts	  
directly	   with	   one	   of	   the	   TORC1	   components	   or	   if	   Atg21	   and	   TORC1	   are	  
simultaneously	  present	  in	  the	  same	  complex.	  Thereby,	  a	  potential	  functional	  role	  
of	  this	  interaction	  could	  be	  proposed.	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5.5 Interaction	  studies	  of	  Atg21	  and	  Atg27	  
The	   membrane	   protein	   Atg27	   forms	   a	   trimeric	   complex	   with	   the	   second	  
membrane	  protein	  Atg9	  and	  the	  cytosolic	  protein	  Atg23	  with	  Atg9	  bridging	  both.	  
All	   three	   proteins	   cycle	   between	   the	   PAS	   and	   a	   peripheral	   site.	   The	   cycling	   of	  
each	   protein	   to	   the	   PAS	   is	   dependent	   on	   the	   presence	   of	   the	   other	   complex	  
components	  (Legakis	  et	  al.,	  2007).	  Recent	  studies	  revealed	  that	  Atg9	  resides	  on	  
peripheral	   vesicular	   structures,	   which	   directly	   contributes	   to	   the	   formation	   of	  
the	  phagophore	  upon	  autophagy	  induction	  (Kakuta	  et	  al.,	  2012;	  Mari	  et	  al.,	  2010;	  
Yamamoto	  et	  al.,	  2012).	  At	  least	  Atg27	  is	  present	  on	  the	  Atg9-­‐containing	  vesicles,	  
suggesting	   that	   the	   trimeric	   complex	   is	   required	   for	  membrane	  delivery	   to	   the	  
PAS	  (Kakuta	  et	  al.,	  2012).	  Atg9	  is	  required	  for	  this	  process	  under	  both	  growing	  
and	  starvation	  conditions,	  whereas	  Atg27	  is	  only	  required	  for	  efficient	  formation	  
of	   Cvt	   vesicles.	   Therefore,	   Atg27	   has	   the	   same	   autophagy	   phenotype	   as	   Atg21	  
and	   could	   be	   an	   appropriate	   protein	   interaction	   partner	   of	   Atg21.	   Indeed,	   an	  
interaction	  of	  both	  proteins	  was	  detected	  in	  the	  split-­‐ubiquitin	  assay	  (see	  Figure	  
21).	  Furthermore,	  Atg21	  specifically	  interacted	  with	  Atg27	  but	  not	  with	  Atg9	  or	  
Atg23.	   Atg27	   contains	   271	   amino	   acids	   and	   is	   a	   type	   I	   membrane	   protein.	  
Therefore,	   it	   has	   one	   transmembrane	   domain	   (residues	   199-­‐221)	   and	   its	   C-­‐
terminus	  faces	  the	  cytosol,	  whereas	  the	  N-­‐terminus	  extends	  into	  the	  lumen	  (Yen	  
et	  al.,	  2007)	  (see	  Figure	  22).	  Nui-­‐Atg27,	  where	  the	  Nui	  part	  was	  facing	  the	  lumen,	  
did	   not	   interact	  with	  Atg21-­‐Cub.	   Atg27	   contains	   a	  N-­‐terminal	   signal	   sequence,	  
which	  is	  cleaved	  off	  after	  membrane	  insertion	  (Yen	  et	  al.,	  2007).	  In	  the	  Nui-­‐Atg27	  
construct,	  the	  Nui	  part	  is	  N-­‐terminally	  fused	  to	  Atg27.	  This	  could	  either	  result	  in	  
a	  masking	  of	  the	  signal	  sequence	  and	  therefore	  in	  a	  mislocalization	  of	  Nui-­‐Atg27	  
or	   in	   a	   cleavage	  of	   the	  Nui	   part	   together	  with	   the	   signal	   sequence.	  This	  would	  
also	   explain	   why	   an	   indirect	   binding	   of	   Atg27-­‐Cub	   and	   Nui-­‐Atg23	   but	   not	   of	  
Atg23-­‐Cub	  and	  Nui-­‐Atg27	  was	  detected	   in	   the	   split-­‐ubiquitin	  assay	   (see	  Figure	  
21	  B).	  However,	  Nui-­‐Atg21	  and	  Atg27-­‐Cub,	  where	  the	  Cub	  part	  faces	  the	  cytosol,	  
did	   clearly	   interact	   with	   each	   other,	   suggesting	   that	   Atg21	   probably	   interacts	  
with	  Atg27	  on	  the	  cytosolic	  site.	  Atg9	  is	  a	  multispanning	  membrane	  protein	  and	  
both	   termini	   extend	   into	   the	   cytosol,	   whereas	   Atg23	   is	   a	   cytoplasmic	   protein,	  
which	  binds	  to	  Atg9	  on	  the	  cytoplasmic	  site	  (Legakis	  et	  al.,	  2007).	  Atg9	  interacts	  
directly	   with	   Atg27	   and	   served	   therefore	   as	   positive	   control	   for	   Atg27-­‐Cub.	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Atg23	   is	   a	   cytosolic	   protein	   and	   interacts	   indirectly	   with	   Atg27	   via	   Atg9.	  
Therefore,	  Atg23	  served	  as	  control	  how	  an	  indirect	  interaction	  looks	  like	  in	  the	  
split-­‐ubiquitin	   system	   (see	   Figure	   21).	   The	   interaction	   of	   Atg21	   with	   the	   C-­‐
terminal	  part	  of	  Atg27	  was	  indirectly	  confirmed	  by	  truncated	  versions	  of	  Atg27	  
in	   the	   split-­‐ubiquitin	   assay	   (see	   Figure	   22).	   Due	   to	   the	   N-­‐terminal	   signal	  
sequence	   only	   C-­‐terminal	   truncated	   versions	   of	   Atg27	   have	   been	   tested.	  	  	  	  
Atg271-­‐198-­‐Cub	   remained	   most	   likely	   cytosolic,	   because	   it	   was	   lacking	   its	  
transmembrane	  domain.	  In	  contrast,	  neither	  Atg9	  as	  positive	  control	  nor	  Atg21	  
interacted	  with	   Atg271-­‐221-­‐Cub.	   This	   construct	  was	   lacking	   the	   C-­‐terminus,	   but	  
still	   contained	   the	   transmembrane	  domain,	   supporting	   an	   interaction	   of	  Atg21	  
with	  the	  C-­‐terminus	  of	  Atg27	  on	  the	  cytosolic	  site.	  This	  would	  indicate	  that	  Atg27	  
serves	  as	  a	  protein	  interaction	  partner	  to	  mediate	  proper	  membrane	  association	  
of	  Atg21.	  But	  in	  fluorescence	  microscopy	  the	  PAS	  localization	  of	  Atg21-­‐YFP	  had	  
been	  only	  slightly	  influenced	  by	  the	  deletion	  of	  ATG27	  (see	  Figure	  12).	  As	  already	  
explained	  in	  more	  detail,	  Atg27	  could	  alternatively	  mediate	  the	  PAS	  localization	  
of	  Atg21	  together	  with	  an	  additional	  component.	  Only	  the	  simultaneous	  deletion	  
of	  both	  components	  would	  then	  disturb	  the	  Atg21	  PAS	  localization	  (see	  chapter	  
5.1).	  
Furthermore,	  the	  colocalization	  of	  cAtg27-­‐GFP	  and	  mCherry-­‐Atg21	  was	  analyzed	  
in	   direct	   fluorescence	   microscopy	   to	   support	   a	   potential	   interaction	   of	   both	  
proteins	  (see	  Figure	  23).	  Indeed,	  in	  more	  than	  half	  of	  the	  cells	  at	  least	  50%	  of	  the	  
mCherry-­‐Atg21	   dots	   colocalized	   with	   cAtg27-­‐GFP.	   This	   colocalization	   rate	  
corresponds	   perfectly	   to	   the	   colocalization	   rate	   obtained	   for	   Atg27	   and	   Atg9	  
respectively	   Atg23	   in	   previous	   studies	   (Legakis	   et	   al.,	   2007),	   supporting	   a	  
potential	   interaction	   of	   Atg21	   and	   Atg27.	   Atg1	   is	   required	   for	   the	   retrograde	  
movement	   of	   the	   all	   three	   proteins	   Atg9,	   Atg23	   and	   Atg27	   from	   the	   PAS	   to	   a	  
peripheral	  site.	  Thus	  all	  three	  proteins	  should	  be	  restricted	  to	  the	  PAS	  by	  the	  loss	  
of	  Atg1	  (Legakis	  et	  al.,	  2007;	  Yen	  et	  al.,	  2007).	  The	  colocalization	  of	  cAtg27-­‐GFP	  
and	   mCherry-­‐Atg21	   was	   obtained	   in	   atg1∆	   cells	   to	   test	   if	   both	   proteins	  
colocalized	   at	   the	   PAS	   (data	   not	   shown).	   Surprisingly,	   cAtg27-­‐GFP	   still	   formed	  
several	  dots	  within	  the	  cell	  comparable	  to	  wild	  type	  cells.	  The	  successful	  deletion	  
of	  ATG1	  was	  verified	  by	  control	  PCR	  analysis	  and	  ApeI	  maturation	  defect	  (data	  
not	   shown).	   In	   addition,	   cAtg27-­‐GFP	   was	   completely	   functional	   (Figure	   23	  A),	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excluding	   a	  mislocalization	   of	   cAtg27-­‐GFP.	   This	   discrepancy	   in	   the	   localization	  
pattern	  might	  be	  caused	  by	  improved	  microscope	  sensitivity.	  
Yeast	   cells	   commonly	   exhibit	   only	   one	  PAS.	  However,	   in	   several	   cells,	   all	   or	   at	  
least	  most	  of	   the	  mCherry-­‐Atg21	  dots	   colocalized	  with	   cAtg27-­‐GFP	   (see	  Figure	  
23),	   suggesting	   that	  both	  proteins	  probably	  colocalized	  at	  multiple	  sites	  within	  
the	   cell.	   It	   has	   to	   be	   clarified	   if	   one	   of	   these	   sites	   corresponds	   to	   the	   PAS.	   A	  
colocalization	   respectively	   interaction	   of	   both	   proteins	   at	   a	   site	   different	   from	  
the	  PAS	  would	  also	  explain,	  why	  the	  deletion	  of	  ATG27	  had	  only	  a	  slight	  effect	  on	  
the	  PAS	  localization	  of	  Atg21-­‐YFP	  (see	  Figure	  12).	  	  
However,	  Atg27	  cycles	  between	  the	  PAS,	  Golgi	  and	  Mitochondria	  (Kakuta	  et	  al.,	  
2012;	   Yen	   and	   Klionsky,	   2007),	   whereas	   Atg21	   localizes	   to	   endosomes,	   the	  
vertices	  of	  vacuolar	  junctions	  and	  the	  PAS	  (Krick	  et	  al.,	  2008a;	  Meiling-­‐Wesse	  et	  
al.,	   2004)(this	   study).	   Determination	   of	   the	   colocalization	   site	   of	   Atg21	   and	  
Atg27	  could	  give	  further	  information	  about	  a	  potential	  interaction	  of	  both	  and	  its	  
physiological	  relevance.	  As	  mentioned	  before,	  Atg9-­‐containing	  vesicles	  probably	  
directly	   contribute	   to	   the	   formation	   of	   the	   phagophore	   (Mari	   et	   al.,	   2010;	  
Yamamoto	  et	  al.,	  2012).	  Atg27	  is	  required	  for	  the	  anterograde	  movement	  of	  Atg9	  
to	   the	   PAS	   and	   vice	   versa.	   Thus,	   Atg27	   is	   also	   present	   on	   the	   Atg9-­‐containing	  
vesicles	  and	  therefore	  probably	  involved	  in	  the	  membrane	  delivery	  to	  the	  PAS	  at	  
least	   under	   nutrient-­‐rich	   conditions	   (Kakuta	   et	   al.,	   2012).	   Moreover,	   the	  
retrograde	   moving	   of	   Atg9	   and	   Atg27	   from	   the	   PAS	   to	   their	   peripheral	   sites	  
occurs	   independently	   from	   each	   other,	   suggesting	   that	   these	   proteins	  may	   not	  
necessarily	   cycle	   together	   (Legakis	   et	   al.,	   2007).	   In	   addition	   to	   the	  Atg1-­‐Atg13	  
complex,	  which	  is	  needed	  for	  the	  retrograde	  moving	  of	  both	  Atg9	  and	  Atg27,	  the	  
Atg21	   homologue	   Atg18	   and	   its	   interaction	   partner	   Atg2	   are	   required	   for	   the	  
retrograde	  moving	  of	  Atg9,	  but	  not	  of	  Atg27	  (Yen	  et	  al.,	  2007).	  Cycling	  of	  Atg27	  is	  
required	  for	  its	  proper	  function	  in	  Cvt	  formation.	  This	  led	  to	  the	  idea	  that	  Atg21	  
might	   be	   involved	   in	   the	   retrograde	   cycling	   of	  Atg27.	  The	   loss	   of	  Atg21	  would	  
lead	  to	  a	  defect	  of	  Atg27	  cycling	  and	  therefore	  of	  the	  membrane	  delivery	  under	  
growing	   conditions	   resulting	   in	   a	   defect	   in	   Cvt	   vesicle	   formation,	   a	   phenotype	  
that	  is	  observed	  for	  both	  proteins.	  However,	  this	  is	  highly	  speculative	  and	  should	  
be	  further	  analyzed.	  The	  aspect	  that	  Atg27	  cycling	  is	  independent	  of	  Atg14	  (Yen	  
et	   al.,	   2007),	   which	   is	   in	   turn	   needed	   for	   proper	   Atg21	   PAS	   localization	   (see	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4.2.1),	   argues	   against	   that	   hypothesis.	   A	   localization	   study	   of	   Atg27	   in	   the	  
absence	  of	  Atg21	  will	   shed	   light	   on	   this	   question.	  As	   a	   next	   step,	   the	  potential	  
interaction	   of	   both	   proteins,	   suggested	   by	   the	   split-­‐ubiquitin	   assay	   and	   the	  
fluorescence	  microscopy,	  should	  be	  confirmed.	  In	  this	  study,	  pull	  down	  or	  GFP-­‐
TRAP®	  analysis	   failed	  to	  detect	  a	  potential	   interaction	  of	  Atg27	  and	  Atg21	  (see	  
Figure	  24).	  Atg27	  is	  a	  membrane	  protein.	  Thus,	  it	  is	  possible,	  that	  Atg27	  was	  not	  
properly	  solubilized	  under	  the	  chosen	  conditions.	  The	  cell	  lysis	  procedure	  could	  
be	   improved	   and	   different	   detergents	   could	   be	   tested	   to	   detect	   a	   potential	  
interaction	  with	  Atg21	  as	  a	  prerequisite	  for	  further	  functional	  studies.	  	  	  
5.6 Interaction	  studies	  of	  Atg21	  and	  Atg8	  
The	   small	   ubiquitin-­‐like	   protein	   Atg8	   represents	   one	   of	   the	   core	   autophagy	  
proteins	  and	  plays	  dual	  roles	  in	  autophagy.	  It	  is	  required	  for	  the	  expansion	  of	  the	  
phagophore.	  In	  addition,	  Atg8	  links	  the	  cargo	  to	  the	  forming	  autophagosome	  by	  
binding	  to	  the	  receptor	  protein	  and	  helps	  therefore	  in	  cargo	  recognition	  during	  
selective	  types	  of	  autophagy.	  To	  fulfill	  its	  function,	  Atg8	  has	  to	  be	  lipidated	  to	  PE	  
in	   a	   series	   of	   conjugation	   reactions	   similar	   to	   protein	   ubiquitination	  
(Nakatogawa,	   2013)	   (see	   chapter	   2.2.4.4).	   Atg21	   is	   required	   for	   efficient	  
lipidation	   of	   Atg8	   and	   for	   its	   recruitment	   to	   the	   PAS,	   but	   the	   underlying	  
mechanism	  remains	  elusive	  (Meiling-­‐Wesse	  et	  al.,	  2004;	  Stromhaug	  et	  al.,	  2004).	  	  
In	  this	  study,	  a	  potential	  interaction	  of	  Atg21	  and	  Atg8	  was	  detected	  in	  the	  split-­‐
ubiquitin	   assay	   (see	   Figure	   25).	   Bimolecular	   Fluorescence	   Complementation	  
(BiFC)	  was	  used	   to	   further	   verify	   a	  potential	   interaction	  of	   both	  proteins.	  As	   a	  
positive	   control,	   cells	   expressing	   N-­‐YN	  Atg8	   and	   its	   processing	   enzyme	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
N-­‐YC	  Atg4	   were	   used.	   Unfortunately,	   the	   resulting	   eYFP-­‐Atg8-­‐Atg4	   complex	  
completely	   located	   to	   the	  nucleus	   (see	  Figure	  26	  C).	  Since	  none	  of	   the	  proteins	  
has	   been	   detected	   in	   the	   nucleus	   before,	   they	   were	   probably	   completely	  
mislocated.	  Both	   constructs	  were	  expressed	   from	  a	   constitutive	  ADH	   promoter	  
and	  therefore	  highly	  overexpressed,	  which	  may	  have	  caused	  the	  mislocalization	  
of	   eYFP-­‐Atg4-­‐Atg8.	   In	   contrast,	   the	   expression	   of	   N-­‐YN	  Atg8	   and	   Atg21	  C-­‐YC	  
resulted	   in	  perivacuolar	  dots,	  which	  colocalized	  with	  the	  PAS	  marker	  ApeI-­‐RFP	  
in	  a	  high	  frequency	  (60%)	  (see	  Figure	  26	  E).	  This	  suggests	  a	  potential	  interaction	  
of	  Atg21	  and	  Atg8	  at	  the	  PAS.	  Cells	  expressing	  Atg21	  C-­‐YC	  and	  N-­‐YN	  alone	  were	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used	  as	  a	  negative	  control.	  Surprisingly,	   those	  cells	  also	  showed	  a	  perivacuolar	  
dot	  similar	  to	  cells	  expressing	  both	  proteins	  (see	  Figure	  26	  E).	  The	  formation	  of	  
those	   false-­‐positive	   signals	   did	   not	   change	   even	   after	   improvement	   of	   the	  
expression	  conditions.	  Taken	  together,	  all	  cells	  expressing	  Atg21	  C-­‐YC	  showed	  a	  
false-­‐positive	  signal	  independent	  of	  expression	  partner,	  level	  or	  duration.	  During	  
BiFC,	   the	   assembly	   of	   the	   two	   halves	   of	   eYFP	   is	   irreversible	   and	   results	   in	   a	  
significant	   stabilization	   of	   the	   eYFP-­‐protein	   complex.	   One	   advantage	   of	   this	  
method	   is	   the	   visualization	   of	   only	   weak	   and	   therefore	   hardly	   detectable	  
interactions	   (Skarp	   et	   al.,	   2008).	   In	   the	   negative	   control	   cells,	   N-­‐YN	   alone	  was	  
most	  likely	  evenly	  distributed	  throughout	  the	  cytosol.	  In	  addition,	  the	  amount	  of	  
N-­‐YN	  was	  much	   higher	   compared	   to	   the	   amount	   of	   N-­‐YN	  Atg8.	   Thereby,	   N-­‐YN	  
might	  have	  colocalized	  by	  chance	  close	  enough	  to	  Atg21	  C-­‐YC	  so	  that	  the	  eYFP-­‐
Atg21	  complex	  could	  reassemble.	  Due	  to	  the	  irreversible	  assembly	  of	  both	  eYFP	  
halves,	   those	   complexes	   would	   be	   stabilized	   and	   detected	   by	   fluorescence	  
microscopy	   as	   false	   positive	   signals.	   To	   avoid	   incidental	   eYFP-­‐Atg21	   complex	  
formation	  and	  therefore	  false-­‐positive	  signals,	  N-­‐YN	  could	  be	  fused	  to	  a	  protein	  
with	   a	   defined	   localization	   that	   does	   not	   interact	  with	   Atg21.	   Cells	   expressing	  
that	   fusion	  protein	  and	  Atg21	  C-­‐YC	  should	  be	   further	  analyzed	  by	   fluorescence	  
microcopy	  to	  prove	  if	  they	  could	  serve	  as	  a	  suitable	  negative	  control.	  	  
The	   split-­‐ubiquitin	   assay	   and	   BiFC	   are	   quite	   similar	   methods.	   BiFC	   directly	  
monitors	   the	   reassembly	   of	   eYFP,	   whereas	   split-­‐ubiquitin	   indirectly	   evaluates	  
the	   reassembly	   of	   two	  ubiquitin	   halves.	   In	   the	   split-­‐ubiquitin	   assay,	   the	   empty	  
vector	  was	  used	  as	  negative	  control.	  Therefore,	   it	  has	  never	  been	  tested,	   if	  one	  
half	  of	  ubiquitin	  expressed	  alone	  led	  to	  a	  false-­‐positive	  interaction	  signal	  as	  the	  
YN	   part	   in	   BiFC.	   In	   the	   split-­‐ubiquitin	   approach,	   even	   the	   difference	   between	  
direct	  and	  indirect	  interaction	  is	  clearly	  detectable	  and	  was	  therefore	  used	  as	  an	  
internal	   control	   (see	  Figure	  21+Figure	  30).	  This	   increases	   the	   reliability	   of	   the	  
method.	  Moreover,	   a	   potential	   interaction	   detected	   in	   split-­‐ubiquitin	  was	   only	  
taken	  as	  a	  hint	  and	  confirmed	  by	  further	  approaches.	  	  
Surprisingly,	  the	  initial	  functionality	  test	  of	  the	  BiFC	  constructs	  revealed	  a	  slight	  
ApeI	  maturation	  defect	  in	  atg8∆	  cells	  simultaneously	  expressing	  both	  N-­‐YN	  Atg8	  
and	  Atg21	  C-­‐YC	   (see	   Figure	   26	  D).	   In	   contrast,	  N-­‐YN	  Atg8	   alone	   complemented	  
the	   ApeI	  maturation	   defect	   of	  atg8∆	   cells.	   Fluorescence	  microscopy	   confirmed	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the	   reassembly	  of	   the	   two	  halves	  of	  eYFP	   to	  an	  Atg8-­‐Atg21-­‐eYFP	  complex	   (see	  
Figure	  26	  E).	  As	  mentioned	  above,	  the	  assembly	  of	  eYFP	  results	  in	  an	  irreversible	  
formation	  of	  the	  Atg8-­‐Atg21-­‐eYFP	  complex.	  These	  data	  led	  to	  the	  idea	  that	  both	  
proteins	  would	  have	  to	  dissociate	  at	  some	  point	  to	  fulfill	  their	  function.	  It	  could	  
be	   possible,	   that	   a	   necessary	   interaction	  with	   further	  Atg	   proteins	   is	   sterically	  
blocked.	   PI3P	   clearance	   by	   Ymr1	   and	   therefore	   dissociation	   of	   the	   autophagic	  
machinery	   from	  autophagosomal	  membranes	   is	   required	   for	   the	  maturation	  of	  
the	  autophagosome	  (Cebollero	  et	  al.,	  2012).	  Furthermore,	  the	  Atg8	  part	  present	  
on	   the	   outer	   autophagosomal	   membrane	   has	   to	   be	   cleaved	   off	   by	   Atg4	   as	   a	  
prerequisite	  for	  the	  maturation	  into	  a	  fusion-­‐capable	  autophagosome	  (Nair	  et	  al.,	  
2012;	  Yu	  et	  al.,	  2012).	  Nair	  et	  al.	  (2010)	  speculated,	  that	  Atg21	  and	  Atg18	  might	  
prevent	   premature	   cleavage	   of	   Atg8	   from	  PE	   by	   regulating	   the	   access	   to	  Atg8.	  
Due	   to	   the	   irreversible	   assembly	   of	   the	   eYFP-­‐Atg8-­‐Atg21	   complex,	   the	  
dissociation	   of	   Atg21,	   that	  would	   otherwise	   allow	   Atg4	   to	   cleave	   its	   substrate	  
Atg8,	  could	  be	  blocked.	  Therefore,	  the	  outer	  part	  of	  Atg8	  could	  not	  be	  cleaved	  off,	  
resulting	   in	   an	   at	   least	   delay	   of	   the	   Cvt	   vesicle	  maturation	   and	   therefore	   ApeI	  
maturation.	   However,	   since	   the	   effect	   on	   the	   ApeI	  maturation	   obtained	   in	   this	  
study	  is	  quite	  small,	  this	  hypothesis	  should	  be	  further	  analyzed.	  	  
In	  conclusion,	  a	  potential	  interaction	  of	  Atg21	  and	  Atg8	  was	  detected	  in	  the	  split-­‐
ubiquitin	   assay.	   The	   interaction	   was	   also	   detected	   in	   atg4∆	   and	   atg5∆	   cells,	  
where	   the	   lipidation	   of	   Atg8	   is	   blocked	   (Figure	   25).	   This	   pointed	   to	   a	   specific	  
interaction	   of	   Atg21	   with	   unlipidated	   Atg8.	   Furthermore,	   recent	   studies	  
identified	   WD40	   propeller	   as	   a	   new	   class	   of	   ubiquitin	   binding	   proteins	  
(Pashkova	   et	   al.,	   2010),	   supporting	   an	   interaction	  of	  Atg21	  with	   the	  ubiquitin-­‐
like	  Atg8.	  Atg21	  is	  required	  for	  efficient	  lipidation	  of	  Atg8	  and	  its	  recruitment	  to	  
the	  PAS	  by	  an	  unknown	  mechanism	  (Meiling-­‐Wesse	  et	  al.,	  2004;	  Stromhaug	  et	  al.,	  
2004).	  The	  fact	  that	  Atg21	  interacted	  with	  unlipidated	  Atg8	  in	  the	  split-­‐ubiquitin	  
assay	   improves	   a	   potential	   recruitment	   function	   for	   Atg21	   in	   Atg8	   lipidation.	  
Nevertheless,	   as	   a	   prerequisite	   for	   further	   functional	   studies,	   an	   interaction	   of	  
both	  proteins	  has	   to	  be	  confirmed	  by	   further	  approaches	  as	  pull	  down	  or	  GFP-­‐
TRAP®s.	   Almost	   all	   Atg8-­‐interacting	   proteins	   contain	   a	   specific	   WXXL	   motif,	  
called	   Atg8-­‐interacting	   motif	   (AIM).	   This	   binding	   motif	   is	   specific	   for	   Atg8	  
homologues,	   since	   the	   side	   chains	   of	   the	   tryptophan	   and	   the	   lysine	  within	   the	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AIM	  bind	   to	  hydrophobic	  pockets	   in	  Atg8.	  These	  pockets	  are	  conserved	  among	  
all	   Atg8	   homologues	   but	   not	   among	   other	   ubiquitin-­‐like	   proteins	   (Noda	   et	   al.,	  
2010).	   In	   addition,	   Atg8	   contains	   a	   N-­‐terminal	   helical	   domain	   (NHD)	   that	   is	  
absent	   in	   ubiquitin.	   This	   NHD	   is	   required	   for	   efficient	   autophagy,	   since	  
truncation	   or	   deletion	   of	   this	   domain	   affects	   autophagy	   (Nakatogawa	   et	   al.,	  
2007).	   Furthermore,	   the	   residues	   phenylalanine	   at	   position	   5	   and	   lysine	   at	  
position	   6	  within	   the	  NHD	   are	   essential	   for	   binding	   of	   at	   least	   one	   interaction	  
partner,	   Shp1	   (Krick	   et	   al.,	   2010).	   However,	   it	  would	   be	   interesting	   to	   further	  
elucidate,	   if	   Atg21	   contains	   an	   AIM	   or	   if	   the	   interaction	   of	   both	   proteins	   is	  
mediated	  by	  the	  NHD	  as	  it	  was	  shown	  for	  interaction	  with	  Shp1.	  	  	  
5.7 Interaction	  studies	  of	  Atg21	  and	  Atg16	  
Atg16	  is	  a	  small	  coiled-­‐coil	  protein,	  which	  forms	  a	  complex	  with	  the	  Atg12-­‐Atg5	  
conjugate	  via	  non-­‐covalently	  binding	  to	  Atg5.	  This	  complex	  plays	  a	  crucial	  role	  as	  
an	  E3-­‐like	  enzyme	  in	  the	  ubiquitin-­‐like	  conjugation	  reaction	  of	  Atg8	  to	  PE.	  Most	  
likely,	  Atg12	  directly	  binds	  and	  activates	  the	  E2	  enzyme	  Atg3.	  Therefore,	  Atg12-­‐
Atg5/Atg16	   probably	   acts	   as	   a	   platform	   to	   bring	   the	   Atg8-­‐carrying	   Atg3	   into	  
close	   proximity	   to	   the	   substrate	   PE	   (see	   chapter	   2.2.4.4).	   The	   Atg12-­‐Atg5	  
conjugate	  was	   shown	   to	   accelerate	   the	   Atg8-­‐PE	   conjugation	   in	   vitro,	   revealing	  
that	   Atg16	   is	   dispensable	   for	   the	   E3-­‐like	   function	   of	   the	   Atg12-­‐Atg5	   conjugate	  
(Hanada	  et	  al.,	  2007).	  In	  vitro	  Atg5	  seems	  to	  be	  able	  to	  bind	  to	  lipids,	  but	  it	  fails	  to	  
recruit	  the	  Atg12-­‐Atg5	  conjugate	  to	  the	  autophagic	  membranes	  in	  vivo	  (Romanov	  
et	   al.,	   2012).	   Consequently,	   in	   vivo	   Atg16	   is	   required	   for	   the	   membrane	  
recruitment	  of	  the	  Atg12-­‐Atg5/Atg16	  complex.	  In	  addition,	  the	  lipidation	  of	  Atg8	  
is	  severely	  impaired	  in	  atg16∆	  cells,	  suggesting	  that	  the	  membrane	  recruitment	  
of	  the	  complex	  by	  Atg16	  is	  crucial	  for	  its	  E3-­‐like	  function	  (Hanada	  et	  al.,	  2007).	  
The	   Atg16-­‐mediated	   PAS	   localization	   is	   dependent	   on	   Atg14	   and	   therefore	   on	  
the	  PAS-­‐specific	  PI3P	  pool.	  But	  Atg16	  does	  not	  contain	  an	  obvious	  PI3P	  binding	  
motif	   (Cebollero	   et	   al.,	   2012;	   Matsushita	   et	   al.,	   2007;	   Suzuki	   et	   al.,	   2001).	  
Therefore,	  the	  underlying	  mechanism	  for	  Atg16	  mediated	  membrane	  association	  
remains	  elusive.	  	  
The	   Atg12-­‐Atg5/Atg16	   complex	   is	   only	   transiently	   located	   at	   the	   PAS.	   For	  
detection	  via	  fluorescence	  microscopy,	  its	  PAS	  localization	  has	  to	  be	  enriched	  by	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gene	   deletions	   that	   affect	   the	   autophagic	   flux	   (Stromhaug	   et	   al.,	   2004).	  
Stromhaug	  et	  al.	  (2004)	  showed,	  that	  the	  PAS	  localization	  of	  Atg5-­‐YFP	  in	  such	  an	  
Atg8	  deletion	  strain	  is	  prevented	  by	  the	  additional	  loss	  of	  Atg21	  under	  growing	  
conditions.	  In	  addition,	  it	  was	  reported	  previously,	  that	  the	  perivacuolar	  puncta	  
formation	  of	  Atg16-­‐GFP	  was	  significantly	  decreased	  in	  atg18∆	  atg21∆	  cells	  under	  
starvation	   conditions	   (Nair	   et	   al.,	   2010).	   In	   this	   study,	   growing	  atg8∆	  cells	   and	  
atg8∆	   atg21∆	   cells	   expressing	   Atg16-­‐GFP	   and	   ApeI-­‐RFP	   were	   analyzed	   using	  
direct	   fluorescence	   microscopy	   to	   test,	   if	   Atg21	   had	   also	   an	   influence	   on	   the	  
Atg16	  PAS	   localization	  under	  growth	  conditions	  (see	  Figure	  31),	  since	  Atg21	   is	  
required	   for	   the	  Cvt	  pathway.	   Indeed,	   the	  absence	  of	  Atg21	   led	   to	  a	   significant	  
reduction	  in	  the	  Atg16-­‐GFP	  PAS	  rate,	  that	  was	  comparable	  to	  the	  reduction	  in	  the	  
Atg5-­‐YFP	  PAS	  rate.	  These	  results	  suggest	  that	  the	  Atg16	  PAS	  localization	  is	  also	  
dependent	   on	   Atg21	   under	   growing	   conditions	   (see	   Figure	   31).	   Furthermore,	  
mCherry-­‐Atg21	  colocalized	  with	  both	  Atg16-­‐GFP	  and	  Atg5-­‐YFP.	  All	  of	  the	  Atg16-­‐
GFP	  dots	   and	  almost	   all	   of	   the	  Atg5-­‐YFP	  dots	   colocalized	  with	   the	  PAS	  marker	  
ApeI-­‐RFP	   under	   those	   conditions,	   suggesting	   that	   their	   colocalization	   with	  
mCherry-­‐Atg21	   occured	   at	   the	   PAS	   (see	   Figure	   32).	   The	   colocalization	   of	  
mCherry-­‐Atg21	   and	  Atg5-­‐YFP	  was	   abolished	   in	   the	   absence	   of	   Atg16,	  whereas	  
the	   colocalization	   of	   mCherry-­‐Atg21	   and	   Atg16-­‐GFP	   was	   independent	   on	   the	  
absence	  of	  Atg5.	  Taken	  together,	   the	  PAS	   localization	  of	  Atg5	  depends	  on	  both,	  
Atg21	  and	  Atg16	  as	  reported	  before	  (Suzuki	  et	  al.,	  2001;	  Stromhaug	  et	  al.,	  2004),	  
whereas	   the	   presence	   of	   Atg16	   at	   the	   PAS	   depends	   on	   Atg21.	   These	   data	  
suggests	   that	   Atg21	   mediates	   the	   membrane	   association	   of	   the	   Atg12-­‐
Atg5/Atg16	   complex	   under	   growing	   conditions.	   In	   this	   study,	   it	   was	   already	  
shown,	   that	   part	   of	   Atg21	   localizes	   to	   the	   PAS	   by	   binding	   to	   PI3P	   (see	  
chapter	  5.1).	  Therefore,	  the	  recruitment	  of	  the	  Atg12-­‐Atg5/Atg16	  complex	  to	  the	  
PAS	  mediated	  by	  binding	  of	  Atg16	  to	  Atg21	  would	  explain	  both,	  the	  dependence	  
on	  Atg21	  and	  on	  Atg14	  respectively	  the	  PAS-­‐specific	  PI3P	  pool	  for	  proper	  Atg12-­‐
Atg5/Atg16	  complex	  localization.	  Therefore,	  a	  potential	  interaction	  of	  Atg21	  and	  
Atg16	   was	   analyzed	   via	   additional	   approaches.	   Pull	   down	   experiments	   using	  
purified	  recombinant	  6xHis-­‐SUMO-­‐Atg21	  incubated	  with	  yeast	  crude	  cell	  extract	  
further	   supported	   an	   interaction	   of	   Atg21	   and	   Atg16.	   In	   this	   approach,	   6xHis-­‐
SUMO-­‐Atg21,	  but	  not	  6xSUMO	  alone,	  specifically	  co-­‐precipitated	  Atg16-­‐HA	  (see	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Figure	  33	  B).	  Furthermore,	  Atg16-­‐HA	  specifically	  bound	  to	  GFP-­‐Atg21	  but	  not	  to	  
GFP	  alone	   in	  GFP-­‐TRAP®s	   (see	  Figure	  33	  C).	  Within	   the	  E3-­‐like	   complex	  Atg12	  
interacts	  with	  the	  E2	  enzyme	  Atg3	  (Noda	  et	  al.,	  2012).	  In	  this	  study,	  a	  potential	  
interaction	  of	  Atg21	  and	  Atg8	  was	  already	  shown.	  Therefore,	  it	  could	  be	  possible,	  
that	  Atg16	  is	  co-­‐precipitated	  via	  the	  bridging	  protein	  Atg8.	  That	  possibility	  was	  
excluded	   in	   a	  GFP-­‐TRAP®	  performed	  with	   the	   crude	   cell	   extract	   of	  atg8∆	   cells.	  
Atg16-­‐HA	   still	   specifically	   interacted	   with	   GFP-­‐Atg21,	   supporting	   a	   direct	  
interaction	  (see	  Figure	  33	  C).	  The	  split-­‐ubiquitin	  assay	  detected	  an	  interaction	  of	  
Atg21	   with	   Atg16	   (see	   Figure	   30).	   In	   contrast,	   Atg21	   interacted	   neither	   with	  
Atg5	   nor	   Atg12,	   supporting	   an	   exclusive	   binding	   to	   Atg16.	   Finally,	   direct	   pull	  
down	   experiments	   using	   recombinant	   proteins	   were	   performed	   to	   confirm	   a	  
direct	  interaction	  of	  both	  proteins.	  Indeed,	  purified	  GST-­‐Atg16	  bound	  specifically	  
to	   purified	   6xHis-­‐SUMO-­‐Atg21,	   whereas	   GST	   alone	   did	   not	   (see	   Figure	   33	  D).	  
Taken	  together,	  Atg16	  most	  likely	  binds	  directly	  to	  Atg21.	  	  
Atg16	   consists	   of	   a	  N-­‐terminal	  Atg5	  binding	   region	   that	   is	   followed	  by	   a	   short	  
linker	   region	   and	   a	   C-­‐terminal	   coiled-­‐coil	   domain	   (Fujioka	   et	   al.,	   2010)	   (see	  
Figure	  34	  A).	  Analysis	  of	  truncated	  versions	  of	  Atg16	  revealed	  in	  pull	  down	  and	  
GFP-­‐TRAP®s	  that	  the	  coiled-­‐coil	  domain	  of	  Atg16	  is	  required	  for	  the	  interaction	  
with	   Atg21	   (see	   Figure	   34	  C).	   In	   GFP-­‐TRAP®s,	   both	   Atg16	   lacking	   the	   Atg5-­‐
binding	  region	  (Atg1658-­‐150-­‐HA)	  or	  the	  extreme	  C-­‐terminus	  (Atg161-­‐119-­‐HA),	  that	  
is	  not	  required	  for	  the	  coiled-­‐coil	  formation,	  still	  bound	  to	  GFP-­‐Atg21.	  Atg161-­‐57-­‐
HA	   was	   rather	   unstable	   and	   therefore	   hardly	   detectable	   on	   the	   immunoblot.	  
However,	   even	   overexposed,	   no	   bound	   Atg161-­‐57-­‐HA	   could	   be	   detected.	   These	  
results	  suggest	  a	  specific	  Atg21	  binding	  region	  within	  the	  coiled-­‐coil	  domain	  of	  
Atg16.	  Pull	  down	  experiments	  in	  principle	  supported	  those	  findings	  (see	  Figure	  
34	  B).	   In	   contrast	   to	   Atg161-­‐119-­‐HA	   in	   the	   GFP-­‐TRAP®s,	   GST-­‐Atg161-­‐119	   did	   not	  
bind	   to	   6xHis-­‐SUMO-­‐Atg21.	   It	   cannot	   be	   excluded,	   that	   the	   coiled-­‐coil	   domain	  
might	  be	  longer	  than	  proposed	  (Fujioka	  et	  al.,	  2010).	  Therefore,	  the	  heterologous	  
expression	  of	  GST-­‐Atg161-­‐119	   in	  E.	  coli	  might	   lead	   to	   an	   incorrect	   folding	  of	   the	  
protein	  fragment.	  However,	  the	  direct	  interaction	  of	  Atg16	  and	  Atg21	  is	  probably	  
mediated	  by	  a	  region	  in	  the	  C-­‐terminal	  coiled-­‐coil	  domain	  of	  Atg16.	  	  
The	  coiled-­‐coil	  domain	   is	  crucial	   for	  dimerization	  respectively	   formation	  of	   the	  
Atg12-­‐Atg5/Atg16	  complex	  and	  is	  therefore	  required	  for	  its	  autophagic	  function	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(Kuma	  et	  al.,	  2002).	  Moreover,	  Fujioka	  et	  al.	  (2010)	  identified	  conserved	  surface	  
residues	   within	   the	   coiled-­‐coil	   domain	   of	   Atg16,	   that	   are	   dispensable	   for	   the	  
formation	   of	   the	   coiled-­‐coil	   structure,	   but	   are	   strictly	   required	   for	   the	   Cvt	  
pathway	  and	  macroautophagy	  under	  both	  growing	  and	  starvation	  conditions.	  As	  
mentioned	   before,	   the	   PAS	   recruitment	   of	   the	   Atg12-­‐Atg5/Atg16	   complex	   is	   a	  
prerequisite	   for	   its	  E3-­‐like	   function	   in	  autophagy	  (Hanada	  et	  al.,	  2007).	  Results	  
from	   this	   study	   propose	   that	   the	   PAS	   recruitment	   of	   the	   complex	   is	   probably	  
mediated	  by	  binding	  of	  Atg21	  to	  the	  coiled-­‐coil	  domain	  of	  Atg16.	  Therefore,	  the	  
conserved	   residues	   in	   the	   coiled-­‐coil	   domain	   of	   Atg16	   that	   are	   crucial	   for	  
autophagy,	   could	   mediate	   the	   interaction	   with	   Atg21.	   Two	   conserved	   Atg16	  
residues,	   the	   aspartic	   acid	   at	   position	   101	   (D101)	   and	   the	   glutamic	   acid	   at	  
position	  102	  (E102)	  were	  mutated	  either	  alone	  or	  in	  concert	  to	  alanine	  and	  the	  
interaction	   with	   Atg21	   was	   tested	   (see	   Figure	   36).	   Indeed,	   both	   amino	   acid	  
substitutions	   severely	   affected	   the	   interaction	  with	  GFP-­‐Atg21	   in	  GFP-­‐TRAP®s.	  
Interestingly,	  the	  interaction	  of	  Atg16E102A-­‐HA	  with	  GFP-­‐Atg21	  was	  significantly	  
reduced,	   whereas	   the	   binding	   of	   Atg16D101A-­‐HA	   and	   Atg16D101A_E102A-­‐HA	   was	  
completely	  abolished,	  suggesting	  a	  stricter	  requirement	  of	  amino	  acid	  D101	  for	  
the	   interaction	   with	   Atg21.	   Consequently,	   Atg21-­‐binding	   deficient	   Atg16-­‐GFP	  
mutants	   were	   not	   longer	   able	   to	   localize	   to	   the	   PAS	   and	   were	   completely	  
cytosolic	   in	   fluorescence	   microscopy	   (see	   Figure	   35).	   Interestingly,	   only	  
Atg16E102A-­‐GFP	  showed	  a	  rare	  and	  very	  faint	  perivacuolar	  dot	  in	  the	  same	  cells,	  
supporting	  a	  stricter	  requirement	  of	  D101	  for	  the	  Atg21	  interaction	  than	  E102.	  
The	  possibility,	  that	  the	  mutations	  of	  these	  amino	  acids	  disturb	  the	  structure	  of	  
the	   Atg16	   coiled-­‐coil	   domain	   leading	   to	   a	   misfolded	   protein	   unable	   to	   bind	  
Atg21,	  could	  be	  excluded	  for	  two	  reasons.	  First,	  the	  coiled-­‐coil	  domain	  of	  Atg16	  
mediates	  dimerization	  of	  Atg16	  and	  the	  ability	  of	  the	  Atg16	  mutants	  to	  dimerize	  
was	  verified	  in	  GFP-­‐TRAP®s	  (see	  Figure	  36	  B).	  Second,	  Fujioka	  et	  al.	  (2010)	  used	  
the	   Atg16D101A_E102A	   mutant	   to	   crystalize	   the	   coiled-­‐coil	   domain	   of	   Atg16.	   This	  
would	  have	  been	   impossible	  with	  mutations	   in	  Atg16	  that	  affect	   the	  coiled-­‐coil	  
formation.	  	  
Taken	  together,	  the	  conserved	  surface	  residues	  E102	  and	  more	  important	  D101	  
in	  the	  coiled-­‐coil	  domain	  of	  Atg16	  mediate	  the	  interaction	  with	  Atg21.	  Mutations	  
of	  these	  residues	  disturb	  the	  binding	  to	  Atg21	  and	  result	  in	  a	  severe	  Cvt	  pathway	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and	   autophagy	   defect	   (this	   study,(Fujioka	   et	   al.,	   2010)),	   indicating	   that	   the	  
interaction	  with	  Atg21	  is	  needed	  for	  the	  autophagic	  function	  of	  Atg16.	  In	  detail,	  
the	  autophagic	  function	  of	  Atg16	  is	  represented	  by	  its	  role	  in	  the	  E3-­‐like	  Atg12-­‐
Atg5/Atg16	   complex	   during	   lipidation	   of	   Atg8.	   Therefore,	   the	   ability	   of	   the	   E3	  
complex	   containing	   the	   Atg21-­‐binding	   deficient	   Atg16	   mutants	   to	   efficiently	  
conjugate	   Atg8	   to	   PE	   was	   tested	   under	   growing	   conditions	   (see	   Figure	   37).	  
Indeed,	   the	   lipidation	   of	   Atg8	   was	   significantly	   retarded	   in	   atg16∆	   cells	  
expressing	   the	  Atg21-­‐binding	   defective	  mutants	   (Atg16D101A-­‐HA,	  Atg16E102A-­‐HA	  
or	  Atg16D101A_E102A-­‐HA).	  The	  retardation	  is	  comparable	  to	  atg21∆	  or	  atg16∆	  cells.	  
It	   can	   be	   excluded,	   that	   the	   HA-­‐tag	   influenced	   the	   functionality	   of	   Atg16-­‐HA,	  
since	   the	   Atg16	   wild	   type	   construct	   fully	   complemented	   both	   the	   ApeI	  
maturation	  and	  Atg8	  lipidation	  defect	   in	  atg16∆	  cells.	  Consequently,	   the	  Atg21-­‐
binding	  deficient	  Atg16	  mutants	  showed	  an	  additional	  ApeI	  maturation	  defect	  as	  
previously	   described	   by	   Fujioka	   et	   al.	   (2010).	   Interestingly,	   D101A	   had	   a	  
stronger	   effect	   on	   the	   ApeI	   maturation	   as	   E102A,	   supporting	   a	   stronger	  
requirement	   for	   the	   interaction	   with	   Atg21.	   In	   contrast	   to	   the	   GFP-­‐TRAP®	  
results,	   the	   double	   mutation	   D101A_E102A	   exhibited	   the	   strongest	   effect	   and	  
caused	   a	   complete	   block	   in	   ApeI	   maturation.	   This	   further	   supports	   that	   both	  
amino	  acids	  contribute	  to	  the	  interaction	  with	  Atg21	  in	  vivo.	  	  
Atg8	  lipidation	  and	  ApeI	  maturation	  were	  also	  tested	  in	  atg16∆	  cells	  expressing	  
the	   truncated	   versions	   of	   Atg16	   (see	   Figure	   37).	   Atg8	   lipidation	   and	   ApeI	  
maturation	  was	  abolished	   in	  cells	  expressing	  Atg161-­‐57-­‐HA,	  most	   likely	  because	  
this	   construct	   was	   not	   stable	   in	   yeast	   cells	   resulting	   in	   an	   atg16∆	   phenotype.	  
Furthermore,	   Atg8	   lipidation	   was	   impaired	   in	   atg16∆	   cells	   expressing	  	  	  	  	  	  	  
Atg1658-­‐150-­‐HA.	  This	  truncated	  Atg16	  version	  is	  still	  able	  to	  bind	  to	  Atg21	  as	  seen	  
in	  GFP-­‐TRAP®s,	   but	   the	  Atg5-­‐binding	   domain	   is	   lacking.	   Therefore,	   the	   E3-­‐like	  
Atg12-­‐Atg5/Atg16	  complex	  could	  not	  be	   formed	  resulting	   in	  an	  Atg8	   lipidation	  
and	  ApeI	  maturation	  defect.	  atg16∆	  cells	  expressing	  Atg161-­‐119-­‐HA	  exhibited	  an	  
ApeI	  maturation	  defect	  as	  described	  before	   (Fujioka	  et	  al.,	  2010).	   Interestingly,	  
those	   cells	   additionally	   showed	   an	   impaired	   Atg8	   lipidation.	   This	   construct	   is	  
able	   to	  bind	  to	  Atg21	  as	  seen	   in	  GFP-­‐TRAP®s	  (see	  Figure	  34)	  and	  still	   contains	  
the	  Atg5-­‐binding	  region,	  suggesting	  that	  the	  extreme	  C-­‐terminal	  domain	  of	  Atg16	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might	  be	  involved	  in	  Atg8	  lipidation	  and	  autophagy	  in	  a	  mechanism	  independent	  
on	  formation	  of	  the	  Atg12-­‐Atg5/Atg16	  complex	  and	  binding	  to	  Atg21.	  
Taken	   together,	   the	   interaction	   of	   Atg16	   and	   Atg21	  mediated	   by	   the	   residues	  
D101	   and	   E102	  within	   the	   coiled-­‐coil	   region	   in	   Atg16	   is	   required	   for	   efficient	  
Atg8	  lipidation	  and	  therefore	  efficient	  ApeI	  transport.	  	  
One	   of	   the	   control	   mutants	   Atg16K94A-­‐HA	   showed	   an	   unexpected	   autophagic	  
activity	   under	   Cvt	   conditions	   in	   these	   studies.	   Originally,	   it	  was	   reported,	   that	  
K94	  and	  E97	  have	  no	  influence	  on	  the	  autophagic	  activity	  of	  Atg16	  (Fujioka	  et	  al.,	  
2010).	   Therefore,	   mutations	   to	   alanine	   of	   both	   residues	   were	   selected	   as	  
negative	  controls.	   Interestingly,	   the	   interaction	  of	  Atg16K94A-­‐HA	  and	  Atg21	  was	  
severely	  impaired	  in	  GFP-­‐TRAP®s,	  comparable	  to	  the	  defect	  seen	  with	  Atg21	  and	  
Atg16E102A-­‐HA	  (see	  Figure	  36	  C).	  Consequently,	  as	  interaction	  of	  Atg21	  and	  Atg16	  
is	  proposed	  to	  be	  essential	  for	  Atg8	  lipidation	  reaction,	  the	  formation	  of	  Atg8-­‐PE	  
was	   significantly	   retarded	   in	  atg16∆	   cells	   expressing	  Atg16K94A-­‐HA	   (see	   Figure	  
37).	   Surprisingly,	   the	   ApeI	   maturation	   occurred	   normally	   in	   these	   cells,	  
corresponding	   to	   results	   from	   Fujioka	   et	   al.	   (2010).	   In	   addition,	   the	   ability	   of	  
Atg16K94A	   to	   dimerize	   was	   confirmed	   by	   GFP-­‐TRAP®s	   (see	   Figure	   36	  B),	  
excluding	  a	  structural	  defect	  of	  the	  mutant.	  Taken	  together,	  these	  cells	  exhibited	  
normal	  Cvt	  pathway	   independent	  on	   lipidated	  Atg8.	  The	   lipidation	  of	  Atg8	  was	  
not	  completely	  blocked	  in	  these	  cells	  (see	  Figure	  37),	  suggesting	  that	  the	  residual	  
amount	   of	   Atg8-­‐PE	  might	   be	   sufficient	   for	   Cvt	   vesicle	   formation.	  However,	   the	  
amount	   of	   lipidated	   Atg8	   was	   comparable	   to	   that	   of	   other	   Atg21-­‐binding	  
deficient	  Atg16	  mutants,	  where	  ApeI	  maturation	  is	  blocked	  (see	  Figure	  37).	  The	  
mechanism	  that	  allows	  ApeI	  maturation	  without	  proper	  Atg8	   lipidation	   in	  cells	  
expressing	  Atg16K94A-­‐HA	  remains	  to	  be	  elucidated.	  	  
	  
Proposed	  model:	  
One	  elementary	  result	  of	  this	  study	  represents	  the	  detection	  of	  Atg21	  at	  the	  PAS	  
under	  growing	  conditions.	  This	  is	  the	  first	  time	  that	  Atg21	  has	  been	  detected	  at	  
the	  PAS	  (see	  Figure	  11).	  The	  Atg21	  PAS	  localization	  is	  dependent	  on	  Atg14	  and	  
thus	   on	   the	   PAS-­‐specific	   PI3P	   pool.	   Importantly,	   Atg21	   recruits	   the	   Atg12-­‐
Atg5/Atg16	  complex	  to	  the	  PAS	  via	  direct	  interaction	  with	  the	  coiled-­‐coil	  region	  
of	   Atg16	   (see	   chapter	   4.3.6.4).	   Thereby	   the	   underlying	   mechanism	   of	   PI3P-­‐
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dependent	  plus	  Atg16-­‐mediated	   recruitment	  of	   the	  Atg12-­‐Atg5/Atg16	  complex	  
to	   autophagosomal	   membranes	   has	   been	   elucidated	   in	   this	   study.	   More	  
importantly,	  the	  interaction	  of	  Atg21	  and	  Atg16	  is	  not	  only	  a	  prerequisite	  for	  the	  
proper	   PAS	   localization	   of	   the	   Atg12-­‐Atg5/Atg16	   complex	   but	   also	   for	   its	  
autophagic	   function	   (see	   chapter	  5.7).	   Consequently,	   interaction	   of	   Atg16	   and	  
Atg21	   is	   needed	   for	   efficient	   Atg8	   lipidation	   (see	   Figure	   37),	   providing	   a	  
reasonable	   explanation	   for	   the	   proposed	   function	   of	   Atg21	   in	   Atg8	   lipidation	  
(Meiling-­‐Wesse	  et	  al.,	  2004;	  Stromhaug	  et	  al.,	  2004).	  	  
Interestingly,	   also	   Atg21	   and	   Atg8	   probably	   interact	   with	   each	   other	  
(chapter	  5.6).	  This	  interaction	  occurs	  even	  if	  Atg8	  is	  unlipidated.	  Taken	  together,	  
these	  data	   suggest,	   that	  Atg21	  not	   only	  mediates	   the	  membrane	   association	  of	  
the	   E3	   enzyme	   Atg12-­‐Atg5/Atg16,	   but	   also	   acts	   as	   a	   scaffold	   for	   the	   Atg8	  
lipidation	  reaction	  by	  mediating	  interaction	  of	  activated	  Atg8	  and	  its	  E3-­‐enzyme	  
Atg12-­‐Atg5/Atg16.	   Importantly,	   this	   model	   provides	   a	   reasonable	   explanation	  
for	  the	  fundamental	  role	  of	  Atg21	  in	  Cvt	  vesicle	  formation.	  	  
	  
The	   Atg12-­‐Atg5/Atg16	   complex	   was	   proposed	   to	   specify	   the	   lipidation	   site	   of	  
Atg8	   via	   association	  with	  Atg8-­‐carrying	  Atg3	   and	   autophagosomal	  membranes	  
(Hanada	   et	   al.,	   2007).	   However,	   it	   was	   unclear	   how	   Atg16	   mediates	   the	  
membrane	   association	   of	   the	   E3-­‐like	   complex	   to	   determine	   the	   site	   of	   Atg8	  
lipidation.	  Regarding	  the	  proposed	  model,	  Atg21	  represents	  the	  missing	  link	  that	  
mediates	  PI3P-­‐dependent	  membrane	  association	  of	  the	  lipidation	  machinery	  by	  
recruiting	  the	  activated	  substrate	  Atg8	  and	  the	  E3	  enzyme	  required	  for	  the	  last	  
step	  of	  Atg8	  lipidation.	  Thereby,	  Atg21	  might	  represent	  the	  key	  factor	  to	  specify	  
the	  lipidation	  site.	  	  
In	   the	   absence	   of	   Atg8,	   Atg21	   and	   the	   otherwise	   hardly	   detectable	   Atg12-­‐
Atg5/Atg16	   complex	   colocalize	   at	   the	   PAS	   (see	   Figure	   32),	   suggesting	   that	   the	  
lack	   of	   Atg8	   leads	   to	   the	   accumulation	   of	   both	   proteins.	   This	   would	   however	  
indicate	   that	  Atg8	   is	   lipidated	  at	   the	  PAS.	   In	   fact,	   it	   is	   still	  highly	  under	  debate,	  
where	   the	   Atg8	   lipidation	   occurs	   within	   the	   cell.	   Recent	   studies	   suggest,	   that	  
Atg8	  lipidation	  does	  not	  only	  occur	  at	  the	  PAS	  or	  the	  phagophore	  in	  response	  to	  
autophagy-­‐inducing	  signals	  but	   in	  addition	  constitutively	  and	  non-­‐selectively	  at	  
other	  sites	  in	  the	  cell	  (Nair	  et	  al.,	  2012;	  Nakatogawa	  et	  al.,	  2012;	  Yu	  et	  al.,	  2012).	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These	  results	  have	  been	  obtained	  in	  a	  strain	  lacking	  Atg4,	  leading	  to	  an	  artificial	  
situation,	   where	   Atg8	   cannot	   be	   delipidated.	   Furthermore,	   a	   model	   has	   been	  
proposed,	   where	   Atg4	   should	   subsequently	   deconjugate	   the	   Atg8-­‐PE	   on	  
inappropriate	  membranes,	   but	   not	   from	   the	  PAS,	  where	   it	   is	   protected	   against	  
delipidation.	   This	   should	  maintain	   a	   cytoplasmic	   pool	   of	   unlipidated	   Atg8	   that	  
can	  undergo	   lipidation	  and	  participate	   in	  autophagosome	   formation	  at	   the	  PAS	  
(Nakatogawa	  et	  al.,	  2012).	  The	  mechanism	  that	  should	  restrict	  and	  regulate	  Atg4	  
activity	   is	   not	   known.	   As	  mentioned	   before,	   Nair	   et	  al.	   (2010)	   speculated	   that	  
both,	   Atg18	   and	   Atg21,	   prevent	   premature	   cleavage	   of	   Atg8	   from	   PE	   via	  
regulating	  the	  access	  to	  Atg8.	   It	  remains	  to	  be	  determined,	   if	  Atg21	  and	  Atg12-­‐
Atg5/Atg16	  were	  involved	  in	  the	  lipidation	  of	  Atg8	  at	  another	  site	  than	  the	  PAS	  
or	   if	   they	   were	   involved	   in	   the	   protection	   of	   Atg8	   from	   cleavage	   by	   Atg4	   as	  
discussed	  before	  (see	  chapter	  5.6).	  However,	  results	  from	  this	  study	  question	  the	  
proposed	  model	  of	  a	  ubiquitous	  Atg8	  lipidation	  within	  the	  cell.	  In	  the	  absence	  of	  
Atg8,	   the	  Atg12-­‐Atg5/Atg16	  complex	  was	  restricted	  specifically	   to	   the	  PAS	  and	  
no	  other	  site	  in	  the	  cell.	  	  
As	  already	  mentioned,	  recent	  studies	  revealed	  that	  Atg5	  alone	  is	  capable	  to	  bind	  
membranes	   in	   vitro.	   Fractionation	   experiments	   using	   different	   yeast	   deletion	  
strains	   supported	   that	   Atg5	   partially	  mediates	  membrane	   binding	   also	   in	   vivo	  
(Romanov	   et	   al.,	   2012).	   Surprisingly,	   this	   membrane	   binding	   is	   inhibited	   by	  
Atg12	  alone,	  but	  recovered	  upon	  binding	  of	  Atg16	  to	  the	  Atg12-­‐Atg5	  conjugate,	  
indicating	   that	   Atg16	   regulates	   association	   of	   the	   Atg12-­‐Atg5	   conjugate	   with	  
membranes	   in	   vivo	   (Romanov	   et	   al.,	   2012).	   This	   study	   now	   revealed	   that	   the	  
Atg12-­‐Atg5/Atg16	  membrane	   association	   is	  mediated	   via	   interaction	   of	   Atg16	  
with	  Atg21	  (see	  chapter	  5.7).	  The	  formation	  of	  the	  Atg12-­‐Atg5	  conjugate	  seems	  
unaffected	   in	  atg21∆	   cells	   (Stromhaug	   et	   al.,	   2004).	   Atg16	   and	   the	  Atg12-­‐Atg5	  
conjugate	   could	   either	   form	   a	   complex	   in	   the	   cytosol,	   which	   is	   subsequently	  
recruited	  to	  the	  PAS	  or	  Atg16	  localizes	  independently	  to	  the	  PAS	  via	  binding	  to	  
Atg21	   and	   subsequently	   recruits	   the	   Atg12-­‐Atg5	   conjugate	   to	   that	   site.	   In	   the	  
latter	  case,	  the	  binding	  of	  Atg21	  to	  Atg16	  would	  have	  to	  stimulate	  its	  interaction	  
with	   the	   Atg12-­‐Atg5	   conjugate	   by	   an	   unknown	   mechanism	   to	   preserve	   the	  
Atg12-­‐Atg5/Atg16	  complex	  formation	  in	  the	  cytosol.	  In	  another	  model,	  it	  is	  also	  
possible,	   that	   Atg21	   as	   a	   WD40	   propeller	   facilitates	   the	   Atg12-­‐Atg5/Atg16	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complex	   formation	   by	   binding	   both,	   Atg16	   and	   the	   Atg12-­‐Atg5	   conjugate.	   As	  
mentioned	   above,	   WD40	   propeller	   were	   identified	   to	   bind	   to	   ubiquitin-­‐like	  
proteins	   (Pashkova	   et	   al.,	   2010).	   Atg12	   contains	   one	   (Suzuki	   et	   al.,	   2005),	  
whereas	   Atg5	   exhibits	   two	   ubiquitin-­‐like	   folds	   (Matsushita	   et	   al.,	   2007).	   As	  
already	   shown	   before,	   Atg21	   probably	   binds	   to	   Atg8,	   supporting	   the	   ability	   of	  
Atg21	   to	   bind	   to	   ubiquitin-­‐like	   proteins.	   In	   contrast,	   the	   split-­‐ubiquitin	   assay	  
detected	  a	  specific	   interaction	  of	  Atg21	  with	  Atg16,	  but	  neither	  with	  Atg12	  nor	  
Atg5	  (see	  Figure	  30),	  arguing	  against	  a	  potential	  additional	  interaction	  with	  Atg5	  
and/or	   Atg12.	   Anyhow,	   an	   interaction	   of	   Atg21	  with	   Atg5	   or	   Atg12	   should	   be	  
analyzed	  by	  further	  approaches	  like	  pull	  down	  or	  GFP-­‐TRAP®s.	  Furthermore,	  the	  
formation	   of	   the	   Atg12-­‐Atg5/Atg16	   complex	   can	   be	   visualized	   by	   gelfiltration	  
chromatography	  as	  an	  approximately	  350	  kDa	  complex	  (Kuma	  et	  al.,	  2002).	  The	  
complex	   is	  most	   likely	  dimeric	  mediated	  by	  Atg16	  (Fujioka	  et	  al.,	  2010).	   In	   the	  
absence	  of	  Atg16,	   the	  Atg12-­‐Atg5	  conjugate	   remains	  monomeric	  and	  would	  be	  
easily	   distinguishable	   from	   the	   Atg12-­‐Atg5/Atg16	   complex	   in	   gelfiltration	  
chromatography.	   Therefore,	   determining	   the	   molecular	   weight	   range	   of	   the	  
Atg12-­‐Atg5	   conjugate	   in	   atg21∆	   cells	   by	   gelfiltration	   chromatography,	   should	  
reveal	  an	  influence	  of	  Atg21	  on	  the	  formation	  of	  the	  Atg12-­‐Atg5/Atg16	  complex.	  	  
Furthermore,	   the	   Atg16-­‐	   and	   Atg8-­‐interacting	   site	   within	   the	  WD40	   propeller	  
Atg21	  should	  be	  identified.	  WD40	  propeller	  are	  commonly	  known	  to	  serve	  as	  a	  
large	   interaction	   platform	   to	  mediate	   protein-­‐protein	   interactions.	  Mapping	   of	  
the	   Atg16-­‐	   and	   Atg8-­‐interacting	   site	   within	   Atg21	   would	   elucidate	   the	  
constitution	  of	   the	  proposed	  Atg8	   lipidation	   complex.	   It	   is	  possible,	   that	  Atg21	  
recruits	   additional	   proteins	   of	   the	   Atg8	   conjugation	   machinery	   in	   order	   to	  
further	   facilitates	   the	   lipidation	  reaction.	  A	  candidate	   for	  additional	   interaction	  
with	  Atg21	  would	   be	   at	   least	   the	  E2	   enzyme	  Atg3,	  which	   carries	   the	   activated	  
Atg8.	  Atg12	  directly	  binds	   and	  most	   likely	   activates	  Atg3	   (Hanada	  et	   al.,	   2007;	  
Sakoh-­‐Nakatogawa	  et	  al.,	  2013).	  Thereby,	  Atg8	  and	  Atg16	  are	  already	  indirectly	  
connected	   via	   the	  Atg12-­‐Atg5	   conjugate	  bound	   to	  Atg3.	   It	   can	  not	   be	   excluded	  
that	   a	   simultaneous	   binding	   of	   Atg8	   and	   Atg16	   is	   not	   possible	   due	   to	   steric	  
hinderance.	   As	   mentioned	   above,	   Atg5	   is	   able	   to	   partially	   mediate	   membrane	  
association	   after	   initial	   recruitment	   of	   Atg16	   to	   autophagosomal	   membranes	  
(Romanov	   et	   al.,	   2012).	   Therefore,	   it	   could	   be	   speculated,	   that	   Atg21	   is	   only	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needed	   for	   the	   initial	   recruitment	   of	   the	   Atg12-­‐Atg5/Atg16	   complex	   to	   the	  
autophagosomal	  membranes.	  Afterwards	   the	  complex	  would	  be	  able	   to	  remain	  
membrane	  associated	  mediated	  by	  Atg5	  and	  a	  simultaneous	  binding	  of	  Atg21	  to	  
Atg16	   and	   Atg8	  would	   not	   be	   absolutely	   necessary.	   However,	   identification	   of	  
the	   Atg16-­‐	   and	   Atg8-­‐interacting	   site	   within	   Atg21	   should	   shed	   light	   on	   this	  
question.	  Chopping	  Atg21	  in	  pieces,	  that	  could	  be	  used	  as	  Atg21	  versions	  in	  GFP-­‐
TRAP®s	   or	   pull	   downs,	   is	   not	   possible,	   because	   of	   the	   rigid	   propeller	   fold.	  
Alternatively,	   competition	   of	   short	   Atg21	   peptides	   representing	   potential	  
binding	  sites	  with	  full	  length	  Atg21	  in	  pull	  down	  experiments	  with	  Atg8	  or	  Atg16	  
could	  elucidate	  the	  binding	  site	  within	  Atg21.	  	  
In	  this	  study,	   the	  conserved	  surface	  residues	  D101	  and	  E102	  within	  the	  coiled-­‐
coil	   region	   of	   Atg16	   were	   identified	   to	   bind	   Atg21	   (see	   Figure	   36).	   These	  
residues	  originate	  from	  a	  set	  of	  mutants,	  that	  Fujioka	  et	  al.	  (2010)	  have	  tested	  for	  
a	   defect	   in	   the	   Cvt	   pathway	   and	   autophagy.	   In	   addition	   to	   D101	   and	   E102,	  
mutation	  of	  the	  isoleucines	  at	  position	  104	  and	  108	  (I104	  and	  I108)	  alone	  or	  in	  
concert	  caused	  strong	  defects	  in	  both	  pathways.	  It	  would	  be	  interesting	  to	  test	  if	  
these	  residues	  were	  additionally	  required	  for	  an	  interaction	  with	  Atg21.	  Results	  
from	   this	   study	   and	   observations	   from	   Fujioka	   et	   al.	   (2010)	   revealed	   that	   the	  
extreme	  C-­‐terminus	  of	  Atg16,	   that	   is	  not	  required	   for	   the	  coiled-­‐coil	   formation,	  
might	  have	  a	  crucial	  but	  yet	  unidentified	  role	  in	  autophagy	  independent	  of	  Atg21	  
(see	   above).	   Similarly,	   it	   could	   be	   possible,	   that	   the	   I104	   and	   I108	   have	   a	  
different	   role	   than	   binding	   to	   Atg21.	   Interaction	   studies	   with	   Atg16	   mutants	  
using	  GFP-­‐TRAP®s	  or	  further	  approaches	  should	  shed	  light	  on	  this	  question.	  	  
Atg21	   is	   required	   for	   the	   Cvt	   pathway.	   All	   approaches	   in	   this	   study	   were	  
therefore	  performed	  under	  growing	  conditions.	  Bulk	  autophagy	  is	  also	  severely	  
affected	   in	   the	  absence	  of	  Atg21	  under	  autophagy-­‐inducing	   conditions,	   but	  not	  
completely	  blocked	  (Barth	  et	  al.,	  2002;	  Stromhaug	  et	  al.,	  2004).	  Similar,	  Atg21	  is	  
required	   for	   the	   PAS	   recruitment	   of	   Atg8	   only	   under	   growing	   conditions,	   but	  
atg21∆	   cells	   accumulate	   unlipidated	  Atg8	   even	   after	   4	  h	   of	   nitrogen	   starvation	  
(Stromhaug	  et	  al.,	  2004).	  The	   lipidation	   is	  not	  completely	  blocked,	  but	  severely	  
delayed.	   The	   amount	   of	   Atg8	   is	   highly	   upregulated	   under	   autophagy-­‐inducing	  
conditions,	  suggesting	  that	  the	  small	  part	  of	  Atg8,	  that	  is	  lipidated	  in	  the	  absence	  
of	  Atg21,	  is	  sufficient	  to	  be	  detected	  at	  the	  PAS	  and	  to	  maintain	  a	  particular	  level	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of	   bulk	   autophagy.	   However,	   the	   fact	   that	   Atg8	   lipidation	   is	   impaired	   in	   the	  
absence	  of	  Atg21	  even	  under	  starvation,	  suggests	   that	  Atg21	   is	  also	  needed	  for	  
the	   recruitment	   of	   the	   Atg12-­‐Atg5/Atg16	   complex	   under	   those	   conditions.	   In	  
contrast,	  Nair	  et	  al.	   (2010)	  observed	  perivacuolar	  Atg16-­‐GFP	  puncta	   formation	  
after	   4	  h	   starvation	   in	   wild	   type	   and	   atg21∆	  /	  atg18∆	   single	   or	   atg21∆	  atg18∆	  
double	   deletion	   cells.	   Only	   the	   simultaneous	   loss	   of	   both	   Atg18	   and	   Atg21	  
resulted	  in	  a	  significant	  reduction	  in	  the	  Atg16-­‐GFP	  PAS	  localization	  (Nair	  et	  al.,	  
2010),	   suggesting	   that	   both	   proteins	   are	   required	   in	   concert	   for	   the	   Atg12-­‐
Atg5/Atg16	   recruitment	   under	   starvation	   conditions.	   However,	   this	   finding	  
seems	  to	  disagree	  with	  the	  observation	  that	  the	  loss	  of	  Atg18	  has	  no	  effect	  on	  the	  
Atg8	  recruitment	   to	   the	  PAS	  or	   its	   lipidation,	  neither	  under	  growing	  nor	  under	  
starvation	   conditions	   (Stromhaug	   et	   al.,	   2004;	   Suzuki	   et	   al.,	   2007).	   Further	  
investigation	   on	   the	   specific	   role	   of	   each	   homologue	   under	   both	   growing	   and	  
starvation	  conditions	  should	  shed	  light	  on	  these	  discrepancies.	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